Painwiki - User contributions [en-gb]

Main Page

2026-04-20T00:30:12Z

Yatreyu:

<strong>This is a test website not yet ready for clinical use:</strong>

<strong>Phase one will start with differentiating pain patterns for the distribution of TMJ pain.</strong>

<imagemap>
File:Homunculous.png|

poly 219 5 239 10 251 22 260 36 263 51 263 66 263 70 267 87 255 115 263 127 272 139 273 143 284 136 294 161 289 163 275 177 256 182 239 178 222 180 195 182 178 180 160 177 138 173 129 166 131 160 153 154 163 146 170 141 177 127 173 117 168 110 163 105 160 95 158 81 154 68 158 61 161 51 165 39 168 24 173 15 194 3 207 -2 221 5 [[Head & Neck|Head & Neck Pain]]
poly 667 182 693 175 713 170 725 175 735 177 742 170 742 148 739 141 737 131 737 112 739 107 744 104 747 98 750 85 752 68 749 53 745 34 742 15 732 12 716 5 683 3 669 8 659 17 647 37 643 61 643 73 643 87 650 98 659 107 659 114 660 122 [[Head & Neck|Head & Neck Pain]]
poly 112 244 139 228 149 204 143 185 129 168 78 185 8 474 46 328 115 348 122 284 [[Upper Back-Arm-Shoulder|Upper Back-Arm-Shoulder Pain]]
poly 294 178 278 195 287 236 306 263 304 302 314 350 372 338 353 256 360 214 312 177 295 171 273 178 280 197 [[Upper Back-Arm-Shoulder|Upper Back-Arm-Shoulder Pain]]
poly 657 141 598 177 569 188 555 222 555 263 545 329 593 353 609 307 604 265 611 307 781 317 789 301 803 346 852 334 840 263 837 211 820 182 788 173 749 158 742 177 671 180 [[Upper Back-Arm-Shoulder|Upper Back-Arm-Shoulder Pain]]
poly 139 173 272 175 289 243 309 263 294 350 139 353 127 306 114 253 [[Torso|Torso Pain]]
poly 608 282 786 287 776 346 623 358 [[Torso|Torso Pain]]
poly 375 345 536 329 593 357 552 586 362 589 309 350 [[Forearm & Hand|Forearm & Hand Pain]]
poly 44 326 2 555 14 599 56 589 117 350 [[Forearm & Hand|Forearm & Hand Pain]]
poly 795 346 857 333 907 540 888 594 849 577 [[Forearm & Hand|Forearm & Hand Pain]]
poly 131 350 292 351 302 416 267 453 241 497 231 516 216 526 200 516 163 453 131 426 [[Lower Torso|Lower Torso Pain]]
poly 613 484 626 526 659 533 699 523 730 538 762 526 774 477 795 474 810 725 744 766 606 732 593 584 [[Hip, Thigh, Knee|Hip, Thigh, Knee Pain]]
poly 131 426 107 601 115 710 144 739 177 737 280 744 311 710 328 615 297 426 255 472 238 511 214 535 183 487 163 450 [[Hip, Thigh, Knee|Hip, Thigh, Knee Pain]]
poly 124 713 122 735 107 761 104 783 104 801 105 830 114 851 124 874 122 895 126 918 126 934 124 946 115 964 107 978 100 991 105 1002 124 1007 139 1007 156 1003 165 995 166 983 165 968 166 949 168 930 171 910 165 896 170 874 171 856 178 839 182 823 182 808 183 795 182 771 178 754 178 744 253 745 248 784 246 803 251 820 256 834 261 849 260 866 261 883 263 905 265 922 258 944 260 961 267 976 270 991 282 1000 295 1005 317 998 328 1000 331 991 321 973 312 949 307 934 307 912 307 893 309 868 307 849 312 825 314 805 314 793 316 778 312 759 311 740 306 732 311 720 256 744 185 744 [[Leg, Ankle, Foot|Leg, Ankle, Foot Pain]]
poly 601 728 584 783 613 896 609 944 593 968 589 993 613 998 620 1007 638 1010 654 1015 672 1012 694 1010 718 1008 739 1007 759 1010 774 1008 793 1003 803 1000 815 986 818 969 812 952 800 946 786 937 795 907 793 881 800 857 800 830 806 801 803 766 803 747 800 732 740 774 728 776 723 801 727 827 737 847 740 869 742 893 742 910 740 922 744 939 742 952 745 956 745 964 744 975 737 983 739 985 722 986 701 993 688 997 671 997 660 997 660 988 662 963 660 942 664 917 662 893 655 876 660 857 664 830 669 815 669 800 674 779 669 762 664 756 [[Leg, Ankle, Foot|Leg, Ankle, Foot Pain]]
poly 621 355 778 345 781 431 786 474 778 480 767 521 749 533 716 533 698 520 688 528 659 528 635 526 620 497 609 480 [[Lower Torso|Lower Torso Pain]]

desc bottom-left
</imagemap>

Main Page

2026-04-20T00:29:59Z

Yatreyu:

<igslkjss <strong>This is a test website not yet ready for clinical use:</strong>

<strong>Phase one will start with differentiating pain patterns for the distribution of TMJ pain.</strong>

<imagemap>
File:Homunculous.png|

poly 219 5 239 10 251 22 260 36 263 51 263 66 263 70 267 87 255 115 263 127 272 139 273 143 284 136 294 161 289 163 275 177 256 182 239 178 222 180 195 182 178 180 160 177 138 173 129 166 131 160 153 154 163 146 170 141 177 127 173 117 168 110 163 105 160 95 158 81 154 68 158 61 161 51 165 39 168 24 173 15 194 3 207 -2 221 5 [[Head & Neck|Head & Neck Pain]]
poly 667 182 693 175 713 170 725 175 735 177 742 170 742 148 739 141 737 131 737 112 739 107 744 104 747 98 750 85 752 68 749 53 745 34 742 15 732 12 716 5 683 3 669 8 659 17 647 37 643 61 643 73 643 87 650 98 659 107 659 114 660 122 [[Head & Neck|Head & Neck Pain]]
poly 112 244 139 228 149 204 143 185 129 168 78 185 8 474 46 328 115 348 122 284 [[Upper Back-Arm-Shoulder|Upper Back-Arm-Shoulder Pain]]
poly 294 178 278 195 287 236 306 263 304 302 314 350 372 338 353 256 360 214 312 177 295 171 273 178 280 197 [[Upper Back-Arm-Shoulder|Upper Back-Arm-Shoulder Pain]]
poly 657 141 598 177 569 188 555 222 555 263 545 329 593 353 609 307 604 265 611 307 781 317 789 301 803 346 852 334 840 263 837 211 820 182 788 173 749 158 742 177 671 180 [[Upper Back-Arm-Shoulder|Upper Back-Arm-Shoulder Pain]]
poly 139 173 272 175 289 243 309 263 294 350 139 353 127 306 114 253 [[Torso|Torso Pain]]
poly 608 282 786 287 776 346 623 358 [[Torso|Torso Pain]]
poly 375 345 536 329 593 357 552 586 362 589 309 350 [[Forearm & Hand|Forearm & Hand Pain]]
poly 44 326 2 555 14 599 56 589 117 350 [[Forearm & Hand|Forearm & Hand Pain]]
poly 795 346 857 333 907 540 888 594 849 577 [[Forearm & Hand|Forearm & Hand Pain]]
poly 131 350 292 351 302 416 267 453 241 497 231 516 216 526 200 516 163 453 131 426 [[Lower Torso|Lower Torso Pain]]
poly 613 484 626 526 659 533 699 523 730 538 762 526 774 477 795 474 810 725 744 766 606 732 593 584 [[Hip, Thigh, Knee|Hip, Thigh, Knee Pain]]
poly 131 426 107 601 115 710 144 739 177 737 280 744 311 710 328 615 297 426 255 472 238 511 214 535 183 487 163 450 [[Hip, Thigh, Knee|Hip, Thigh, Knee Pain]]
poly 124 713 122 735 107 761 104 783 104 801 105 830 114 851 124 874 122 895 126 918 126 934 124 946 115 964 107 978 100 991 105 1002 124 1007 139 1007 156 1003 165 995 166 983 165 968 166 949 168 930 171 910 165 896 170 874 171 856 178 839 182 823 182 808 183 795 182 771 178 754 178 744 253 745 248 784 246 803 251 820 256 834 261 849 260 866 261 883 263 905 265 922 258 944 260 961 267 976 270 991 282 1000 295 1005 317 998 328 1000 331 991 321 973 312 949 307 934 307 912 307 893 309 868 307 849 312 825 314 805 314 793 316 778 312 759 311 740 306 732 311 720 256 744 185 744 [[Leg, Ankle, Foot|Leg, Ankle, Foot Pain]]
poly 601 728 584 783 613 896 609 944 593 968 589 993 613 998 620 1007 638 1010 654 1015 672 1012 694 1010 718 1008 739 1007 759 1010 774 1008 793 1003 803 1000 815 986 818 969 812 952 800 946 786 937 795 907 793 881 800 857 800 830 806 801 803 766 803 747 800 732 740 774 728 776 723 801 727 827 737 847 740 869 742 893 742 910 740 922 744 939 742 952 745 956 745 964 744 975 737 983 739 985 722 986 701 993 688 997 671 997 660 997 660 988 662 963 660 942 664 917 662 893 655 876 660 857 664 830 669 815 669 800 674 779 669 762 664 756 [[Leg, Ankle, Foot|Leg, Ankle, Foot Pain]]
poly 621 355 778 345 781 431 786 474 778 480 767 521 749 533 716 533 698 520 688 528 659 528 635 526 620 497 609 480 [[Lower Torso|Lower Torso Pain]]

desc bottom-left
</imagemap>

Concept:Trigger Point

2026-04-20T00:06:38Z

Yatreyu: Created page with "=General Overview of Myofascial Trigger Points = ---- == A. Background == === Prevalence === Myofascial trigger points (TrPs) are extremely common and become a painful part of nearly everyone's life at some time or another. '''Latent TrPs''', which often cause motor dysfunction (stiffness and restricted range of motion) without pain, are far more common than '''active TrPs''', which additionally cause pain. Among 200 unselected asymptomatic young adults, focal tender..."

=General Overview of Myofascial Trigger Points =
----

== A. Background ==

=== Prevalence ===

Myofascial trigger points (TrPs) are extremely common and become a painful part of nearly everyone's life at some time or another. '''Latent TrPs''', which often cause motor dysfunction (stiffness and restricted range of motion) without pain, are far more common than '''active TrPs''', which additionally cause pain.

Among 200 unselected asymptomatic young adults, focal tenderness representing latent TrPs was found in the shoulder-girdle muscles of 54% of females and 45% of males. Referred pain was demonstrated in 25% of these subjects. In masticatory muscles, TrPs were found in 54% of right lateral pterygoid muscles, 45% of right deep masseter, 43% of right anterior temporalis, and 40% of intraoral examinations of the right medial pterygoid muscle. In the neck muscles, TrPs were identified in 35% of the right splenius capitis and 33% of the right upper trapezius.

{| class="wikitable"
|+ Table 2.1: Prevalence of Trigger Point Pain in Selected Patient Populations
! Region !! Practice !! Number Studied !! % with Myofascial Pain !! Source
|-
| General || Medical || 172 (54) || 30% || Skootsky ''et al.'', 1989
|-
| General || Pain Med. Center || 96 || 93% || Gerwin, 1995
|-
| General || Comprehensive Pain Center || 283 || 85% || Fishbain ''et al.'', 1986
|-
| Craniofacial || Head & Neck Pain Clinic || 164 || 55% || Fricton ''et al.'', 1985
|-
| Lumbogluteal || Orthopedic Clinic || 97 || 21% || Fröhlich and Fröhlich, 1995
|}

Among 283 consecutive admissions to a comprehensive pain center, a primary organic diagnosis of myofascial syndrome was assigned in 85% of cases. Active myofascial TrPs are clearly very common and are a major source of musculoskeletal pain and dysfunction, but poor agreement on appropriate diagnostic criteria has been a serious handicap to wider recognition.

=== Importance ===

Voluntary (skeletal) muscle is the largest single organ of the human body, accounting for nearly 50% of body weight. The ''Nomina Anatomica'' lists 200 paired muscles, totalling 400 muscles. Any one of these muscles can develop myofascial TrPs that refer pain and motor dysfunction, often to another location.

The severity of symptoms caused by myofascial TrPs ranges from agonising incapacitating pain caused by very active TrPs to the painless restriction of movement and distortion of posture due to latent TrPs. The economic cost is incalculable. Unrecognised myofascial headache, shoulder pain, and low back pain have become chronic major causes of industrial lost time and compensation applications. Active TrPs in their mature years of maximum activity are most likely to afflict individuals; with advancing age, latent TrPs tend to become more prominent than the pain of active TrPs.

'''Severity''' ranges from agonising incapacitation to the painless restriction of movement. Patients in a general medicine practice rated their pain as high as, or higher than, pain due to other causes. Patients who have had other kinds of severe pain — such as that due to a heart attack, broken bones, or renal colic — say that myofascial pain from TrPs can be just as severe.

=== Historical Review ===

The history of identifying specific sources of musculoskeletal pain has been slow and spotty.

{| class="wikitable"
|+ Table 2.2: Historical Muscle Pain Papers (Selected)
! Term Used !! Muscular Findings !! Author, Year
|-
| Muskelschwiele [Muscle callus] || Tender tight cord or band || Froriep, 1843
|-
| Muscular rheumatism || Tender, elongated infiltrations, radiating pain || Adler, 1900
|-
| Fibrositis || Tender fibrous beaded chains || Gowers, 1904
|-
| Fibrositis / Myofibrositis || Tender nodules with radiating pain || Llewellyn & Jones, 1915
|-
| Myogelose [muscle gelling] || Tender muscle indurations (persisted after death) || Schade, 1919
|-
| Muskelhärten [muscular indurations] || Tender indurations with or without muscular contraction || F. Lange, 1925
|-
| Muskelhärten, Myogelosen || The first "trigger point manual;" referred pain not mentioned || M. Lange, 1931
|-
| Muskelhärten || Introduction of ethyl chloride spray || Kraus, 1937
|-
| Referred pain || Experimental demonstration of pain referred from muscle || Kellgren, 1938
|-
| Idiopathic myalgia || Spot tenderness, referred pain, decreased ROM (first description of TrPs) || Travell ''et al.'', 1942
|-
| Myofascial TrPs || Tender spot, referred pain, 32 pain patterns || Travell R., 1952
|-
| Trigger Areas || Electromyographic activity of trigger areas first reported || Weeks & Travell, 1957
|-
| Fibromyalgia || Renamed the 1977 redefinition of fibrositis || Yunus ''et al.'', 1981
|-
| Myofascial TrP || Publication of Volume 1 of the Trigger Point Manual || Travell & Simons, 1983
|-
| Myofascial TrPs || Needle EMG activity characteristic of TrPs reported || Hubbard & Berkoff, 1993
|-
| Active Loci || Use of the rabbit as an experimental model to study the electrical activity of TrPs || Simons ''et al.'', 1995
|-
| Myofascial TrPs || New research data for selection of diagnostic criteria; experimental basis for the new dysfunctional endplate hypothesis || Simons, 1996
|-
| Myofascial TrPs || Interrater reliability; identified TrP diagnostic criteria || Gerwin ''et al.'', 1997
|}

Three clinicians on three continents simultaneously and independently published papers in English emphasising four cardinal features of tender muscle spots: a palpable nodular or band-like hardness in the muscle, a highly localised spot of extreme tenderness in that band, reproduction of the patient's distant pain complaint by digital pressure on that spot, and relief of the pain by massage or injection of the tender spot.

'''Michael Gutstein''' (published as Gut-stein, Gutstein-Good, and finally Good from Great Britain) published 12 or more papers in Britain between 1938 and 1957 using terms including myalgia, idiopathic myalgia, and nonarticular rheumatism.

'''Michael Kelly''' (Australia) published nearly a dozen papers on "fibrositis" between 1941 and 1963, was impressed by both the palpable hardness of the nodule and the distant referral of pain from the afflicted muscle.

'''Janet Travell''' (United States) published more than 40 papers between 1942 and 1990, and the first volume of ''The Trigger Point Manual'' was published in 1983. She reported the pain patterns of TrPs in 32 skeletal muscles. It was her opinion that any fibroblastic proliferation was secondary to a local muscular dysfunction and that pathologic changes occurred only after the condition continued for a long time.

By 1990, rheumatologists under the leadership of F. Wolfe officially established diagnostic criteria for fibromyalgia. Since then, remarkable progress has been made toward identifying its cause — it is now firmly established that central nervous system dysfunction is primarily responsible for the increased pain sensitivity of fibromyalgia.

An important milestone was reached by Hubbard and Berkoff in 1993 when they convincingly reported needle EMG activity characteristic of myofascial TrPs. In 1994, Hong and Torigoe demonstrated that the rabbit was a suitable experimental model for studying the LTR. In 1995, Simons ''et al.'' confirmed in rabbit experiments the electrical activity reported by Hubbard and Berkoff.

=== Related Diagnostic Terms ===

The cause of muscle pain syndromes has perplexed the medical community for more than a century. The subject has been plagued by a multitude of overlapping terms:

*'''Fibromyalgia''' — fundamentally a different condition from myofascial TrPs but often presents with confusingly similar symptoms. Characterised by central augmentation of nociception, causing generalised deep tissue tenderness that includes muscles. Different etiology, different treatment.

*'''Fibrositis''' — appeared in English literature in 1904; adopted into German as ''Fibrositissyndrom.'' Used the palpable "fibrositic" nodule as a diagnostic criterion. In 1977, Smythe and Moldofsky completely redefined the condition and it was officially established as fibromyalgia in 1990. Fibrositis is currently an outmoded diagnosis.

*'''Muskelhärten''' (literally "muscle hardenings" or "indurations") — the palpable firmness of the tender nodule responsible for the patient's pain.

*'''Myogelose''' (literally "muscle gellings") — refers to the same phenomena as Muskelhärten; the two terms have frequently been used interchangeably.

*'''Myofascial Pain Syndrome''' — has both a general meaning (any regional muscle pain syndrome of any soft tissue origin associated with muscle tenderness) and a specific meaning (a myofascial pain syndrome caused by TrPs, which is the subject of this book). The unmodified, unspecified use of the term is discouraged.

*'''Myofascitis''' — now rarely (and should not be) used synonymously with myofascial TrPs. Properly used to identify inflamed muscles.

*'''Nonarticular Rheumatism''' — a commonly used but not clearly defined general term for soft tissue pain syndromes not associated with a specific joint dysfunction or disease. Currently used synonymously with soft tissue rheumatism (''Weichteilrheumatismus'').

*'''Osteochondrosis''' — used by Russian vertebroneurologists as an inclusive term to cover the interaction of neural and muscular conditions, such as fibromyalgia, myofascial TrPs, and spinal nerve compromise.

*'''Tendomyopathy''' — English version of the German term. General tendomyopathy is considered synonymous with fibromyalgia; the localised form often includes myofascial TrPs.

----

== B. Clinical Characteristics of Trigger Points ==

=== Symptoms ===

'''Active TrPs''' produce a clinical complaint (usually pain) that the patient recognises when the TrP is digitally compressed. '''Latent TrPs''' can produce the other effects characteristic of a TrP — including increased muscle tension and muscle shortening — but do not produce spontaneous pain. Both active and latent TrPs can cause significant motor dysfunction. An active '''key TrP''' in one muscle can induce an active '''satellite TrP''' in another muscle. Inactivation of the key TrP often also inactivates its satellite TrP without treatment of the satellite TrP itself.

'''Onset.''' The activation of a TrP is usually associated with some degree of mechanical abuse of the muscle in the form of '''muscle overload''', which may be acute, sustained, and/or repetitive. Leaving the muscle in a '''shortened position''' can convert a latent TrP to an active TrP — this process is greatly aggravated if the muscle is contracted while in the shortened position. In paraspinal (and very likely other) muscles, a degree of '''nerve compression''' that causes identifiable neuropathic electromyographic changes is associated with an increase in the number of active TrPs.

'''Pain Complaint.''' Patients with active myofascial TrPs usually complain of poorly localised, regional, aching pain in subcutaneous tissues, including muscles and joints. They rarely complain of sharp, clearly-localised cutaneous-type pain. The myofascial pain is often referred to a distance from the TrP in a pattern that is characteristic for each muscle. Sometimes the patient is aware of numbness or paraesthesia rather than pain.

Active TrPs are found commonly in postural muscles of the neck, shoulder and pelvic girdles, and in the masticatory muscles. In addition, the upper trapezius, scalene, sternocleidomastoid, levator scapulae, and quadratus lumborum muscles are very commonly involved.

The intensity and extent of the referred pain pattern depends on the degree of irritability of the TrP, not on the size of the muscle.

'''Dysfunctions.''' In addition to the clinical symptoms produced by the sensory disturbances of referred pain, dysaesthesias, and hyperaesthesias, patients can also experience clinically important disturbances of autonomic and motor functions.

Disturbances of '''autonomic functions''' caused by TrPs include abnormal sweating, persistent lacrimation, persistent coryza, excessive salivation, and pilomotor activities. Related proprioceptive disturbances include imbalance, dizziness, tinnitus, and distorted weight perception of lifted objects.

Disturbances of '''motor functions''' caused by TrPs include spasm of other muscles, weakness of the involved muscle function, loss of coordination by the involved muscle, and decreased work tolerance of the involved muscle. The weakness and loss of work tolerance are often interpreted as an indication for increased exercise, but if this is attempted without inactivating the responsible TrPs, the exercise is likely to encourage and further ingrain substitution by other muscles.

'''Sleep Disturbances.''' Disturbance of sleep can be a problem for patients with a painful TrP syndrome. Sleep disturbance can, in turn, increase pain sensitivity the next day.

=== Physical Findings ===

A muscle harbouring a TrP is prevented by pain from reaching its full stretch range of motion, and is also restricted in its strength and/or endurance. Clinically, the TrP is identified as a localised spot of tenderness in a nodule in a palpable taut band of muscle fibres.

'''Taut Band.''' By gently rubbing across the direction of the muscle fibres of a superficial muscle, the examiner can feel a nodule at the TrP and a rope-like induration that extends from this nodule to the attachment of the taut muscle fibres at each end of the muscle. The taut band can be snapped or rolled under the finger in accessible muscles. With effective inactivation of the TrP, this palpable sign becomes less tense and often (but not always) disappears.

'''Tender Nodule.''' Palpation along the taut band reveals a nodule exhibiting a highly localised, exquisitely tender spot that is characteristic of a TrP.

'''Recognition.''' Application of digital pressure on either an active or latent TrP can elicit a referred pain pattern characteristic of that muscle. However, if the patient ''recognises'' the elicited sensation as a familiar experience, this establishes the TrP as being '''active''' and is one of the most important diagnostic criteria available when the palpable findings are also present. Similar recognition is frequently observed when a needle penetrates the TrP and encounters an active locus.

'''Referred Sensory Signs.''' In addition to referring pain to the reference zone, TrPs may refer other sensory changes such as tenderness and dysaesthesias.

'''Local Twitch Response (LTR).''' Snapping palpation of the TrP frequently evokes a transient twitch response of the taut band fibres. This is fully described in Section D of this chapter. The LTR can be elicited both from active and latent TrPs.

'''Limited Range of Motion.''' Muscles with active myofascial TrPs have a restricted passive (stretch) range of motion because of pain. An attempt to passively stretch the muscle beyond this limit produces increasingly severe pain because the involved muscle fibres are already under substantially increased tension at rest length.

'''Painful Contraction.''' When a muscle with an active TrP is strongly contracted against fixed resistance, the patient feels pain. This effect is most marked when an attempt is made to contract the muscle in a shortened position.

'''Weakness.''' Although weakness is generally characteristic of a muscle with active myofascial TrPs, the magnitude is variable. EMG studies indicate that, in muscles with active TrPs, the muscle starts out fatigued, fatigues more rapidly, and becomes exhausted sooner than normal muscles.

=== Testing ===

No laboratory test or imaging technique has been generally established as diagnostic of TrPs. However, three measurable phenomena help to substantiate objectively the characteristic TrP phenomena, and all are valuable as research tools:

'''Needle Electromyography (EMG).''' In 1993, Hubbard and Berkoff reported finding EMG activity identified as specific to myofascial TrPs — specifically the presence of spontaneous low-voltage motor endplate "noise" activity as well as high-voltage spike activity. Subsequent rabbit and human studies have confirmed the presence of these two distinctive components. This is considered highly characteristic of myofascial TrPs, though not pathognomonic. The source of the high-voltage spikes can be ambiguous. A detailed consideration of this phenomenon appears in Section D of this chapter.

'''Ultrasound Imaging.''' Visualisation of an LTR using ultrasound was first noted by Michael Margolis, M.D., and was followed up by Gerwin and Duranleau. This imaging procedure not only provides a second way, in addition to EMG recording, of substantiating and studying the LTR, but also has strong potential for providing a much-needed, available imaging technique to objectively substantiate the clinical diagnosis of TrPs.

'''Surface Electromyography (sEMG).''' Trigger points cause distortion or disruption of normal muscle function. A muscle with a TrP exhibits a three-fold problem: '''increased responsiveness''', '''delayed relaxation''', and '''accelerated fatigability''', which together increase overload and reduce work tolerance.

*''Increased responsiveness'' — abnormally high amplitude of EMG activity when the muscle is voluntarily contracted and loaded.
*''Accelerated fatigability''' — reduced work tolerance compared to a normal contralateral muscle. EMG amplitude increases and median power frequency decreases significantly.
*''Delayed relaxation''' — failure to relax; a common finding during repetitive exercises of muscles with myofascial TrPs. Loss of normal brief surface EMG gaps during repetitive movements contributes significantly to muscle fatigue.

'''Algometry.''' Sensitivity to pain has been measured as the pain threshold to applied pressure. Three endpoints are reported: onset of local pain (pressure pain threshold), onset of referred pain (referred pain threshold), and intolerable pressure (pain tolerance). A hand-held spring algometer is widely used in research. However, tenderness by itself cannot serve as a diagnostic criterion because it may be due to myofascial TrPs, fibromyalgia tender points, bursitis, severe spasm, etc.

'''Thermography.''' Thermograms can demonstrate cutaneous reflex phenomena characteristic of myofascial TrPs. The undisturbed TrP may tend to induce hyperthermia in a limited area of the skin overlying the TrP, whereas mechanical stimulation of the TrP induces a ''reflex'' hypothermia. However, thermographic evidence is not sufficient alone to identify a TrP, as similar temperature changes can occur from radiculopathy, articular dysfunction, enthesopathy, or local subcutaneous inflammation.

=== Treatment ===

Effective treatment of a myofascial pain syndrome caused by TrPs usually involves more than simply applying a procedure to the TrPs. It is often necessary to consider and deal with the cause that activated the TrPs, to identify and correct any perpetuating factors (which are often different from what activated the TrPs), and to help the patient restore and maintain normal muscle function.

Treatment approaches include the use of simple muscle stretch, augmented muscle stretch, postisometric relaxation, reciprocal inhibition, slow exhalation, eye movement, TrP pressure release, massage, range of motion, heat, ultrasound, high-voltage galvanic stimulation, drug treatment, biofeedback, and injection techniques.

'''Common Misconceptions About Treatment:'''

# ''Simply treating the TrP should be sufficient'' — this is occasionally true IF the stress that activated the TrP is not recurrent and IF there are no perpetuating factors. Otherwise, the TrP is likely to be reactivated by the same stress.
# ''The pain cannot be as severe as the patient says and must be largely psychogenic'' — the patients are trying to communicate their suffering. Believe them. The pain rates as fully as severe as that of rheumatoid arthritis.
# ''Myofascial pain syndromes are self-limiting and will cure themselves'' — an acute uncomplicated TrP activated by an unusual activity or muscle overload can revert spontaneously to a latent TrP within a week or two, IF the muscle is not over-stressed and IF there are no perpetuating factors. Otherwise, it evolves into a chronic myofascial pain syndrome.
# ''Relief of pain by treatment of skeletal muscles for myofascial TrPs rules out serious visceral disease'' — because of the referred pain nature of visceral pain, application of vapocoolant spray or infiltration of a local anaesthetic into the somatic reference zone can temporarily relieve the pain of myocardial infarction, angina, and acute abdominal disease.

=== Diagnostic Criteria ===

The lack of general agreement as to appropriate diagnostic criteria for examining TrPs has been an increasingly serious impediment to wider recognition of myofascial TrPs and to compatible studies of the effectiveness of treatment.

{| class="wikitable"
|+ Table 2.4A: Comparative Reliability of Diagnostic Examinations for Trigger Points (Mean Kappa across 4 studies)
! Examination !! Mean Kappa !! Difficulty !! Diagnostic Value Alone
|-
| Spot Tenderness || 0.70 || + || +*
|-
| Pain Recognition || 0.59 || ++ || +++
|-
| Palpable Band || 0.54 || +++ || ++*
|-
| Referred Pain || 0.47 || +++ || +
|-
| Twitch Response || 0.23 || ++++ || ++++
|}

<nowiki>*</nowiki>The combined presence of spot tenderness and palpable band will likely have high diagnostic value for sufficiently skilled examiners.

'''Recommended Criteria for Identifying a Latent or Active Trigger Point''' (Table 2.4B):

'''Essential Criteria:'''
# Taut band palpable (if muscle accessible).
# Exquisite spot tenderness of a nodule in a taut band.
# Patient's recognition of current pain complaint by pressure on the tender nodule (identifies an active trigger point).
# Painful limit to full stretch range of motion.

'''Confirmatory Observations:'''
# Visual or tactile identification of local twitch response.
# Imaging of a local twitch response induced by needle penetration of the tender nodule.
# Pain or altered sensation (in the distribution expected from a trigger point in that muscle) on compression of the tender nodule.
# EMG demonstration of spontaneous electrical activity characteristic of active loci in the tender nodule of a taut band.

The combination of '''spot tenderness in a palpable band''' and '''subject recognition of the pain''' are minimum acceptable criteria. There is no single examination that alone is a satisfactory criterion for routine clinical identification.

=== Differential Diagnosis and Confusions ===

Three possible sources of musculoskeletal pain are common and commonly overlooked: myofascial TrPs, fibromyalgia, and articular dysfunction that requires manual mobilisation. These three conditions often interact with one another, require different diagnostic examination techniques, and need significantly different treatment approaches.

{| class="wikitable"
|+ Table 2.5: Common Referral Diagnoses When Overlooked TrPs Were Actually the Cause (Selected)
! Initial Diagnosis !! Some Likely TrP Sources !! Manual Chapter (Vol. 1)
|-
| Angina Pectoris (atypical) || Pectoralis major || 42
|-
| Appendicitis || Lower rectus abdominis || 49
|-
| Atypical Angina || Pectoralis major || 42
|-
| Atypical Facial Neuralgia || Masseter, Temporalis, Sternal division of SCM, Upper trapezius || 8, 9, 7, 6
|-
| Atypical Migraine || Sternocleidomastoid, Temporalis, Posterior cervical || 7, 9, 16
|-
| Back Pain, Middle || Upper rectus abdominis, Thoracic paraspinals || 49, 48
|-
| Back Pain, Low || Lower rectus abdominis, Thoracolumbar paraspinals || 49, 48
|-
| Dysmenorrhoea || Lower rectus abdominis || 49
|-
| Earache (enigmatic) || Deep masseter || 8
|-
| Epicondylitis || Wrist extensors, Supinator, Triceps brachii || 34, 36, 32
|-
| Frozen Shoulder || Subscapularis || 26
|-
| Occipital Headache || Posterior cervicals || 16
|-
| Radiculopathy, C₆ || Pectoralis minor, Scalenes || 43, 20
|-
| Scapulocostal Syndrome || Scalenes, Middle trapezius, Levator scapulae || 20, 6, 19
|-
| Subacromial Bursitis || Middle deltoid || 28
|-
| Temporomandibular Joint Disorder || Masseter, Lateral pterygoid || 8, 11
|-
| Tennis Elbow || Finger extensors, Supinator || 35, 36
|-
| Tension Headache || SCM, Masticatory muscles, Posterior cervicals, Suboccipital muscles, Upper trapezius || 7, 8–11, 16, 17, 6
|-
| Thoracic Outlet Syndrome || Scalenes, Subscapularis, Pectoralis minor and major, Latissimus dorsi, Teres major || 20, 26, 43/42, 24, 25
|-
| Tietze's Syndrome || Pectoralis major enthesopathy, Internal intercostals || 42, 45
|}

'''Fibromyalgia Syndrome''' — Two of the three most common muscle pain syndromes, fibromyalgia and myofascial pain due to TrPs, are now recognised as quite separate clinical and etiological entities. Since both conditions are likely to cause severe muscle pain and frequently co-exist but need a different treatment approach, it is of great importance for the patient's sake that any clinician dealing with a patient who has muscle pain be able to clearly distinguish these two conditions.

{| class="wikitable"
|+ Table 2.6: ACR 1990 Criteria for Classification of Fibromyalgia
|-
| 1. History of widespread pain (left side, right side, above waist, below waist, axial skeleton). Present at least 3 months.
|-
| 2. Pain in at least 11 of 18 tender point sites on digital palpation at approximately 4 kg force. Sites include: bilateral suboccipital, low cervical (C5–C7 anterior intertransverse spaces), trapezius (midpoint upper border), supraspinatus (above scapular spine at origins), second rib (costochondral junctions), lateral epicondyle (2 cm distal), gluteal (upper outer quadrants), greater trochanter (posterior to prominence), knee (medial fat pad proximal to joint line).
|}

{| class="wikitable"
|+ Table 2.7: Clinical Features Distinguishing Myofascial TrPs from Fibromyalgia
! Myofascial Pain (TrPs) !! Fibromyalgia
|-
| 1 female : 1 male || 4–9 females : 1 male
|-
| Local or regional pain || Widespread, general pain
|-
| Focal tenderness || Widespread tenderness
|-
| Muscle feels tense (taut bands) || Muscle feels soft and doughy
|-
| Restricted range of motion || Hypermobile
|-
| Examine for trigger points || Examine for tender points
|-
| Immediate response to injection of TrPs || Delayed and poorer response to injection
|-
| 20% also have fibromyalgia || 72% also have active TrPs
|}

'''Articular Dysfunctions''' — Articular dysfunctions that require manual mobilisation make up one of the three major categories of musculoskeletal pain syndromes that are often overlooked. The pain in these syndromes is commonly caused by TrPs. The two conditions (TrPs and articular dysfunction) can aggravate each other: the increased tension of TrP taut bands and their facilitation of motor activity can maintain displacement stress on the joint, while abnormal sensory input from the dysfunctional joint can reflexly activate the TrP dysfunction.

'''Occupational Myalgias''' — Active TrPs are activated by acute overload or repeated overuse. A cardinal feature of myofascial TrPs is that they are activated either by acute overload or repeated overuse. Remarkably, among 56 occupational myalgia abstracts, NOT ONE indicated the authors had considered the possibility that myofascial TrPs may be contributing to the workers' problems.

'''Trigger Points and Acupuncture''' — There is a high degree of correspondence (71% based on Melzack ''et al.'''s analysis) between published locations of TrPs and classical acupuncture points for the relief of pain. Classical acupuncture points are identified as prescribed points along meridians. However, central myofascial TrPs occur only in the midbelly region of a muscle belly; classical acupuncture points for pain are not found outside of the midbelly region. The mechanisms responsible for pain relief associated with acupuncture and TrP treatment have until very recently been enigmatic.

'''Nonmyofascial Trigger Points''' — Trigger points that refer pain also may be observed in what appears to be normal skin, in scar tissue, fascia, ligaments, and the periosteum. Scar TrPs (in skin or mucous membranes) refer burning, prickling, or lightning-like jabs of pain. Periosteal TrPs also refer pain in response to injection of hypertonic saline, just as the muscles do.

'''Posttraumatic Hyperirritability Syndrome''' — These patients may sometimes be identified as suffering from severe sudden-onset fibromyalgia that is associated with physical trauma and myofascial TrPs. This syndrome follows a major trauma such as an automobile accident, a fall, or a severe blow. The patient has constant pain that may be exacerbated by vibration of a moving vehicle, slamming of a door, loud noise, jarring, bumping, mild thumping, a pat on the back, a TrP injection, prolonged physical activity, and emotional stress (such as anger). Recovery from such stimulation is slow.

----

== C. Muscle Structure and Function ==

Understanding the nature of myofascial TrPs requires understanding several aspects of basic muscle structure and function not usually emphasised.

=== Muscle Structure and Contractile Mechanism ===

A striated (skeletal) muscle is an assembly of fascicles, each of which is a bundle of roughly 100 muscle fibres. Each muscle fibre (a muscle cell) encloses approximately 1000–2000 myofibrils in most skeletal muscles. A '''myofibril''' consists of a chain of '''sarcomeres''' connected serially, end-to-end. The sarcomere is the basic contractile unit of skeletal muscle. Sarcomeres are connected to each other by their '''Z lines''' (or bands) like links in a chain.

Each sarcomere contains an array of filaments that consist of '''actin''' and '''myosin''' molecules which interact to produce contractile force. The myosin heads are a form of the enzyme adenosine triphosphatase (ATPase) that contacts and interacts with the actin to produce a contractile force.

*The middle panel of Figure 2.5 shows a resting-length sarcomere with '''complete overlap''' of actin and myosin filaments (maximum contractile force).
*During '''maximum shortening''', the myosin molecules impinge against the "Z" band blocking further contraction.
*The lower panel shows a nearly fully stretched sarcomere with '''incomplete overlap''' of actin and myosin molecules (reduced contractile force).

Each sarcomere of a muscle can generate maximum force only in the midrange of its length but it can expend energy in the fully shortened position trying to shorten further. '''This principle is critical to understanding TrPs''': a contraction knot keeps sarcomeres in a maximally shortened (energy-consuming) state.

'''Calcium''' is normally sequestered in the tubular network of the sarcoplasmic reticulum (SR) that surrounds each myofibril. Calcium is released from the SR when a propagated action potential reaches it from the surface of the cell through "T" tubules. Normally, after it has been released, the free calcium is quickly pumped back into the SR. The absence of free calcium terminates the contractile activity of the sarcomeres. In the absence of ATP, the myosin heads remain firmly attached ("failure to recock") and the muscle becomes stiff as in rigor mortis.

=== The Motor Unit ===

Motor units are the final common pathway through which the central nervous system controls voluntary muscular activity. A motor unit includes all of the muscle fibres innervated by one motoneuron. In summary, a motor unit includes one α-motoneuron and all of the muscle fibres that it supplies.

In postural and limb muscles, one motor unit supplies between 300 and 1500 muscle fibres. The smaller the number of fibres controlled by individual motoneurons (smaller motor units), the finer the motor control.

=== The Motor Endplate Zone ===

The motor endplate is the structure that links a terminal nerve fibre of the motoneuron to a muscle fibre. It contains the synapse where the electrical signal of the nerve fibre is converted to a chemical messenger (acetylcholine [ACh]) which in turn initiates another electrical signal in the cell membrane (sarcolemma) of the muscle fibre.

The endplate zone is the region where motor endplates innervate the fibres of the muscle. This region is now known as the '''motor point'''. The motor point is identified clinically as the area where a visible or palpable muscle twitch can be elicited in response to minimal surface electrical stimulation.

'''Location of Motor Endplates''' — Endplates in nearly all skeletal muscles are located near the middle of each fibre, midway between its attachments. Understanding the location of motor endplates is very important for the clinical diagnosis and management of myofascial TrPs. If, as appears to be the case, the pathophysiology of TrPs is intimately associated with endplates, one would expect to find TrPs only where there are motor endplates.

=== Neuromuscular Junction ===

The neuromuscular junction is a synapse which, like many in the CNS, depends on ACh as the neurotransmitter. The nerve terminal responds to the arrival of an action potential from the α-motoneuron by the opening of voltage-gated calcium channels. These channels allow ionised calcium to move from the synaptic cleft into the nerve terminal. The simultaneous release of many packets of ACh quickly overwhelms the barrier of cholinesterase in the synaptic cleft. Much of the ACh then crosses the synaptic cleft to reach the crests of the folds of the postjunctional membrane where the ACh receptors are located. The cholinesterase soon decomposes any remaining ACh, limiting its time of action.

The normal random release of individual packets of ACh from a nerve terminal produces well separated individual miniature endplate potentials (MEPPs). These individual MEPPs are not propagated and die out quickly.

=== Muscle Pain ===

Several endogenous substances are known to sensitise muscle nociceptors. These include bradykinin, E-type prostaglandins, and 5-hydroxytryptamine (serotonin), which in combination can potentiate sensitisation effects. The release of prostaglandins from nearby sympathetic fibres by noradrenalin may influence the TrP mechanism. There is evidence that prostaglandin-induced sensitisation of nociceptors is mediated by cyclic AMP. Other factors known to enhance sensitisation locally are increases in hydrogen ion concentration (pH decreased to 6.1) and substance P. Peripheral sensitisation of nociceptors would be responsible for local tenderness to pressure and most likely also for referred pain.

Several phenomena occurring at the spinal cord level can be related to referred pain. Injection of a pain-inducing substance into the muscular receptive field of a nociceptor neuron can result in the appearance of additional receptive fields in that limb — attributed to the "awakening" of "sleeping" nociceptive pathways in the spinal cord. An awareness of '''neuroplastic changes''' in the central nervous system is a relatively new and fundamental development with profound clinical implications. An acute nociceptive input can induce prolonged changes in the processing of nociceptive signals in the CNS that involve both functional and structural changes. More prolonged nociceptive input can induce more long-lasting changes that may not be reversible with time alone.

Much of the suffering from chronic pain is preventable if the acute pain is controlled promptly and effectively. Hong and Simons demonstrated that the length of treatment required for patients who had developed a pectoralis myofascial TrP syndrome as the result of whiplash injury was directly related to the length of time between the accident and the beginning of TrP therapy.

----

== D. Nature of Trigger Points ==

Our current understanding of TrPs results from the convergence of two independent lines of investigation, one electrodiagnostic and the other histopathological. Fitting together the lessons from each leads to an '''Integrated Hypothesis''' that appears to explain the nature of TrPs.

=== Electrodiagnostic Characteristics of Trigger Points ===

The basis for the electrodiagnostic approach to the study of TrPs was anticipated by Weeks and Travell in 1957 when they reported that TrPs in the resting trapezius muscle exhibited a series of high-frequency spike-shaped discharges while at the same time adjacent sites in this muscle were electrically silent. In 1993, Hubbard and Berkoff reported similar electrical activity as being characteristic of myofascial TrPs.

When Simons, Hong, and Simons investigated the electrical activity in TrPs described by Hubbard and Berkoff, they employed a five-fold higher amplification and ten-fold increase in sweep speed. It was immediately apparent that there were two significant components:
# A consistently present, lower amplitude (maximum of about 60 μV) noise-like component.
# Intermittent and variable high-amplitude spike potentials.

The neutral term '''Spontaneous Electrical Activity (SEA)''' was adopted to identify these two components (or either one if only one is present at a given minute needle site). These three investigators used the same slow insertion technique reported by Hubbard and Berkoff.

The '''low-amplitude noise-like SEA component''' corresponds to what electromyographers recognise as '''normal motor endplate potentials (endplate noise)'''. The '''high-amplitude spike component''' corresponds to '''endplate spikes'''. The similarity can be seen by comparing the recordings with endplate plate potentials illustrated in standard electrodiagnosis textbooks.

'''Spontaneous Electrical Activity (SEA)''' — The SEA here corresponds to an abnormal increase in the release of ACh packets by the motor nerve terminal. The resulting greatly increased number of MEPPs produces endplate noise and sustained partial depolarisation of the postjunctional membrane. This sustained depolarisation could cause a continuous release and uptake of calcium ions from the local sarcoplasmic reticulum, and produce sustained shortening (contracture) of sarcomeres.

'''Distribution of Active Loci''' — Active loci (where SEA occurs, or where SEA and spikes are found) were always found to be located within the endplate zone, the boundaries of which were determined independently. Active loci were four times more common in TrPs than in the endplate zone outside of a TrP (35:9). No active loci were observed in the taut band outside of the endplate zone. The SEA-type of endplate electrical activity is significantly related to myofascial TrPs.

=== Histopathological Characteristics of Trigger Points ===

'''Contraction knots''' are a characteristic histopathological finding in TrPs and in tender palpable nodules. They have been repeatedly noted, though their significance was not fully appreciated until the integrated hypothesis.

In 1976, Simons and Stolov used TrP criteria to examine canine muscles for a tender spot in a palpable taut band comparable to that observed in human patients. Some isolated, large, round muscle fibres and some groups of these darkly staining, enlarged, round muscle fibres appeared in cross sections. In longitudinal sections, the corresponding feature was a number of '''contraction knots'''. An individual knot appeared as a segment of muscle fibre with extremely contracted sarcomeres. This contracted segment showed a corresponding increase in diameter of the muscle fibre.

In 1996, Reitinger ''et al.'' biopsied in fresh cadavers the still-palpable nodules of myogelosis in the gluteus medius muscle. Cross sections showed the previously described, large, rounded, darkly staining muscle fibres and a statistically significant increase in the average diameter of muscle fibres in the myogelosis biopsies compared to non-myogelotic control biopsies from the same muscle. Electron microscopic cross sections showed an excess of A-Band and lack of the I-Band configuration — exclusive presence of A-Band in the absence of I-Band occurs only in fully contracted sarcomeres.

The structural features of contraction knots: each contraction knot is a segment of muscle fibre with extremely contracted sarcomeres. Normally, sarcomeres range in length from about 0.6 μm when fully shortened to about 1.3 μm when fully extended. Based on a minimum sarcomere length of 0.6 μm, the 100 sarcomeres of the contraction knot would extend 60 μm — within the 20 to 80 μm range of the length of normal motor endplates. Beyond the contraction knot, the muscle fibre becomes markedly thinned and consists of stretched sarcomeres to compensate for the contracted ones in the knot segment.

=== Integrated Trigger Point Hypothesis ===

The integrated hypothesis combines information from electrophysiological and histopathological sources. The energy crisis part of the hypothesis has been evolving for about 20 years and is compatible with recent electrodiagnostic findings, both of which fit the newly recognised histopathological picture.

==== Energy Crisis Component ====

This concept was developed to identify a pathophysiological process that could account for:
# The absence of motor unit action potentials in the palpable taut band of the TrP when the muscle was at rest.
# The fact that TrPs are often activated by muscle overload.
# The sensitisation of nociceptors in the TrP.
# The effectiveness of almost any therapeutic technique that restores the muscle's full stretch length.

The energy crisis concept was introduced in 1981 and was recently updated.

The '''energy crisis hypothesis''' postulates a vicious cycle of events (Figure 2.26):

: ''Initial Sustained Calcium Release from SR → Sustained Sarcomere Contracture → Increased Metabolism → Local Ischaemia → Energy Crisis → Failed Reuptake of Calcium into SR → (repeat)''

The initiating event — such as trauma or a marked increase in the endplate release of ACh — can result in excessive release of calcium from the SR. This calcium produces maximal contracture of a segment of muscle which creates a maximal energy demand and chokes off local circulation. The ischaemia interrupts the energy supply, which causes failure of the calcium pump of the SR, completing the cycle.

The sustained contractile activity of the sarcomeres would markedly increase metabolic demands and would squeeze shut the rich network of capillaries that supply the nutritional and oxygen needs of that region. Circulation in a muscle fails during a sustained contraction that is more than 30% to 50% of maximum effort.

==== Integrated Trigger Point Hypothesis (Full) ====

The full integrated hypothesis (Figure 2.28 in the source) is based on continuous excessive ACh release from a dysfunctional motor nerve terminal into its synaptic cleft. Impaired cholinesterase function would potentiate the effect. The excessive ACh activates ACh receptors in the postjunctional membrane to produce greatly increased numbers of MEPPs. These potentials are so numerous that they superimpose to produce endplate noise and a sustained partial depolarisation of the postjunctional membrane.

Based on this hypothesis, the TrP region should have three demonstrable characteristics:
# Be higher in temperature than surrounding muscle tissue because of increased energy expenditure with impaired circulation to remove heat.
# Be a region of significant hypoxia because of ischaemia.
# Have shortened sarcomeres (contraction knots).

Evidence for local hypoxia in TrPs has been provided by oxygen probe studies in human patients with Myogelosen, documenting profound hypoxia in the central region of the induration (pO₂ falling abruptly to nearly zero as the probe approached the palpable border of the tender induration).

'''Confirmation''' of the integrated hypothesis requires identifying myofascial TrPs with tender nodules responsible for the patient's pain complaint; locating the SEA of an active locus electrodiagnostically; marking that location electrolytically with iron from the EMG needle; biopsying the site; fixing the biopsy by liquid nitrogen; and preparing longitudinal sections stained for iron, for acetylcholinesterase, and a base stain. If the iron-stained regions include contraction knots with motor endplates attached to them, this would greatly advance understanding of TrPs and the acceptance of their diagnoses.

==== Clinical Correlations of the Integrated Hypothesis ====

If multiple active loci are part of the same pathophysiological process as multiple contraction knots, and if this relationship applies equally to TrPs and to tender nodules, it would represent a major step forward in understanding enigmatic myogenic pain. Based on the integrated hypothesis:

*The '''taut band''' of a TrP is caused by the increased tension of involved muscle fibres both because of the tension produced by the maximally shortened sarcomeres in the contraction knot and because of the increased (elastic) tension produced by all the remaining elongated (and therefore thin) sarcomeres.
*The '''palpable nodule''' of TrP-related diagnoses (fibrositis, myogelosis) can be explained by the presence of multiple contraction knots — each sarcomere must maintain a nearly constant volume, so it becomes broader as it shortens.
*The '''spot tenderness''' of both TrPs and nodules would be the result of sensitised nociceptors sensitised by substances released as a result of the local energy crisis and tissue distress associated with endplate dysfunction.
*The '''enthesopathy''' (tenderness at the muscle attachment where the taut band terminates) is explained by the inability of the muscle attachment structures to withstand the unrelieved sustained tension produced by the taut band.
*The '''myoglobin response to massage''' of fibrositic nodules can be explained on the basis of the histopathological changes in nodules — repeated deep massage of the fibrositic nodules produced transient episodes of myoglobinuria not produced by similar massage of normal muscle.

=== Other Hypotheses ===

'''Pain-Spasm-Pain Cycle''' — The old concept of a pain-spasm-pain cycle does not stand up to experimental verification. Physiological studies show that muscle pain tends to inhibit, not facilitate, reflex contractile activity of the same muscle. In 1989, Ernest Johnson, editor of the ''American Journal of Physical Medicine,'' summarised overwhelming evidence that the common perception of muscle pain being closely related to muscle spasm is a myth.

'''Muscle Spindle Hypothesis''' — Hubbard and Berkoff initially suggested that the source of the EMG activity in TrPs was a dysfunctional muscle spindle. They gave three reasons for dismissing the possibility that these potentials might arise from motor endplates. However, existing literature and experimental findings contradict all three assertions: (1) the degree of localisation described under Active Loci and Spikes corresponds closely to that in the classical paper on the source of motor endplate potentials; (2) recent studies explicitly examined the distribution within the muscle and found activity chiefly in a TrP, to some extent also in the endplate zone, but not found outside of the endplate zone; and (3) muscle spindles are not concentrated just in the endplate zone where TrPs are found. Botulinum toxin A injection for TrP treatment acts only on the neuromuscular junction, effectively denerving that muscle cell — this supports the endplate hypothesis.

'''Neuropathic Hypothesis''' — Gunn proposed that the cause of TrP hypersensitivity is neuropathy of the nerve serving the affected muscle. There is much clinical evidence that compression of motor nerves can activate and perpetuate the primary TrP dysfunction at the motor endplate.

'''Fibrotic Scar Tissue Hypothesis''' — The concept that palpable firmness represents fibrotic (scar) tissue is based on the assumption that damaged muscle tissue has healed by scar formation. However, only two studies have reported biopsies of TrPs (one on dogs, one on humans); both presented strong evidence for the presence of contraction knots and neither found fibrosis. The rapid resolution of the palpable taut band with specific TrP treatment argues against the fibrosis explanation.

=== Local Twitch Response ===

The '''local twitch response (LTR)''' is a brisk transient contraction of the palpable taut band of muscle fibres elicited by mechanical stimulation of the TrP in that taut band. Mechanical stimulation may be produced by needle penetration of the TrP, by mechanical impact applied directly to the muscle (or applied through the skin over the TrP), or by snapping palpation of the TrP.

Clinically, the LTR is most valuable as a '''confirmatory sign''' when injecting a TrP — an LTR signals that the needle has reached a part of the TrP that will be therapeutically effective. It is often not practical to include the LTR as a primary diagnostic criterion of a TrP because when an LTR can be elicited, it is often prohibitively painful to the patient.

'''Topographic Extent of the Local Twitch Response''' — The pioneering study by Hong and Torigoe (1994) identified a trigger spot (comparable to the human TrP) in the rabbit biceps femoris muscle by locating a taut band using pincer palpation and testing along its length for a maximum twitch response to snapping palpation. The LTR was very sensitive to small displacements of only a few millimetres when the stimulus was applied to muscle fibres adjacent to the trigger spot, and was similarly attenuated by displacement a few centimetres along the same fibres that pass through the trigger spot. These findings correspond to the location of tenderness at TrPs in human patients.

'''LTR is a Spinal Reflex''' — The LTR is the motor response resulting from the activation of the involved motor unit(s) of the taut band. The LTR is propagated essentially as a spinal reflex that is not dependent on supraspinal influences. Evidence: transection of the spinal cord rostral to the segments supplying the biceps femoris caused the LTR to disappear due to spinal shock; as the animal recovered from spinal shock, the LTR slowly returned. However, after the motor nerve was severed, localised twitch responses became unobtainable and remained that way.

The α-motoneurons whose endplates suffer from excessive ACh release appear to be preferentially responsive to the strong sensory spinal input from the sensitised nociceptors. This possibility is reinforced by the observation that snapping palpation of one TrP resulted in simultaneous LTRs in the taut band of that TrP and in a taut band of another nearby muscle.

----

== Summary: Key Concepts for Referencing in Muscle-Specific Chapters ==

The following concepts from Chapter 2 are referred to repeatedly throughout the muscle-specific chapters of the Manual:

; Taut Band
: A palpable rope-like induration in a muscle running the full length of the involved muscle fibres from attachment to attachment. It is caused by the sustained tension of involved muscle fibres at the contraction knot and by the elastic tension of the elongated sarcomeres on either side.

; Tender Nodule (Central Trigger Point, CTrP)
: The highly localised, exquisitely tender spot within the taut band at the location of the motor endplate zone. It is the palpable expression of multiple contraction knots.

; Attachment Trigger Point (ATrP)
: Localised tenderness at the musculotendinous attachment where the taut band terminates. Caused by the sustained tension exerted by the taut band at its attachment. Identified in the text by a red circle with a black border.

; Active Trigger Point
: A TrP that causes spontaneous pain at rest, or pain and/or referred pain with movement; that is tender to palpation with a referred pain pattern that is recognised by the patient as a familiar complaint; and that may produce referred motor and autonomic effects.

; Latent Trigger Point
: A TrP that is clinically quiescent with respect to spontaneous pain; is tender only when palpated; may have all the other clinical characteristics of an active TrP; and may restrict range of motion and cause weakness of the affected muscle.

; Key Trigger Point
: A TrP that activates a satellite TrP in its pain reference zone or in a muscle that it overloads. Inactivation of the key TrP often inactivates the satellite TrP without direct treatment.

; Satellite Trigger Point
: A TrP that is activated as a result of being in the pain reference zone or the zone of increased motor activity of a key TrP.

; Referred Pain Pattern
: The pattern of pain experienced at a distance from the responsible TrP. Characteristic of each muscle. The intensity and extent of the referred pain pattern depends on the degree of irritability of the TrP, not on the size of the muscle.

; Local Twitch Response (LTR)
: A brisk transient contraction of the taut band elicited by mechanical stimulation of the TrP. Propagated as a spinal reflex. Clinically the most specific sign of a TrP; most readily elicited by needle penetration.

; Spontaneous Electrical Activity (SEA)
: The characteristic electrical activity recorded at an active locus within a TrP consisting of low-amplitude continuous endplate noise and intermittent high-amplitude spikes. SEA corresponds to abnormal motor endplate activity. The SEA is always found within the endplate zone; never outside it.

; Contraction Knot
: A segment of a muscle fibre in which the sarcomeres are maximally contracted. The diameter of the fibre is markedly enlarged at the knot segment. The sarcomeres on either side of the knot are stretched thin to compensate. The contraction knot is the structural correlate of the active locus and the palpable nodule.

; Energy Crisis
: The vicious cycle maintaining a contraction knot: excessive ACh release → sustained sarcomere contracture → increased local metabolism → local ischaemia → failure of the calcium pump → further sustained calcium release → (repeat).

; Integrated Trigger Point Hypothesis
: The currently best-supported model of TrP pathophysiology, combining the energy crisis (metabolic/electrophysiological) component with the histopathological evidence of contraction knots. The TrP is essentially a region of many dysfunctional endplates, each associated with a section of muscle fibre that is maximally contracted (a contraction knot).

; Perpetuating Factors
: Factors that maintain TrP activity and interfere with healing. Often different from the factors that initially activated the TrP. Must be identified and corrected for effective lasting treatment. Covered in detail in Chapter 4 (not this chapter).

; Fibromyalgia vs. Myofascial TrPs
: Two distinct and separate conditions that frequently co-exist. Fibromyalgia: widespread pain, generalised tenderness, soft doughy muscles, hypermobile, female-predominant (4–9:1), characterised by central sensitisation. Myofascial TrPs: local or regional pain, focal tenderness, tense muscles (taut bands), restricted range of motion, equal sex ratio, characterised by focal peripheral endplate dysfunction.

----

== See Also ==

* [[Chapter 3: Perpetuating Factors]] (when created)
* [[Chapter 4: Perpetuating Factors in Detail]] (when created)
* [[Travell & Simons Trigger Point Manual — Index]]

----

== References ==

This page is based entirely on: Simons DG, Travell JG, Simons LS. ''Myofascial Pain and Dysfunction: The Trigger Point Manual. Volume 1: Upper Half of Body.'' 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 2: General Overview, pp. 11–93.

[[Category:Trigger Point Manual]]
[[Category:Myofascial Pain]]
[[Category:Reference Chapters]]
[[Category:Foundational Concepts]]

Concept:Iron and TrPs

2026-04-19T19:50:53Z

Yatreyu: /* Treatment Protocol */

'''Iron''' is an essential mineral whose deficiency is estimated to be present in 9–11% of adolescent girls and women of childbearing age in the United States — making it the most prevalent micronutrient deficiency in the developed world. Iron deficiency increases the irritability of myofascial trigger points (TrPs) through multiple mechanisms: it impairs oxygen transport to muscle, disrupts oxidative phosphorylation in mitochondria, impairs thermoregulation, disturbs catecholamine metabolism, and reduces work capacity — each of which directly converges on the energy crisis at the TrP endplate.

The symptom of coldness that is often seen in persons with chronic myofascial pain has iron deficiency as one of its causes — a fact confirmed when impaired thermoregulation was present in 57% of patients with myofascial pain syndrome, with tissue iron depletion found in 65%.

== Biochemical Functions ==

Iron serves essential roles throughout human metabolism:

=== Oxygen Transport and Storage ===

Iron is the central atom of '''haem''', the prosthetic group of:
* '''Haemoglobin''' — the oxygen-carrying protein of red blood cells; transports oxygen from lungs to all tissues
* '''Myoglobin''' — the oxygen-storage protein of muscle fibres; provides the immediate oxygen reserve for aerobic metabolism in muscle

The relation of iron to muscle pain has several facets. One is the essential role of iron in energy production and oxygenation that affects the ability of muscle to meet its energy demands. '''This energy factor relates strongly to the TrP mechanism''' (see Chapter 2, Section D of the source volume).

=== Mitochondrial Oxidative Phosphorylation ===

Iron is required for enzymatic reactions that have to do with '''tissue respiration''' and '''oxidative phosphorylation''':
* Cytochrome oxidase reactions — iron is the essential redox-active atom in the cytochromes of the electron transport chain
* Porphyrin metabolism
* Collagen synthesis (iron-dependent hydroxylases)
* Neurotransmitter synthesis and catabolism

Iron-deficient animals accumulate lactic acid as a result of impaired glycolysis, and this is also postulated to be the cause of reduced physical activity. The effect of iron on energy metabolism is of special interest because of the hypothesis that the myofascial TrP is a localised region of "energy crisis" that reflects the metabolic distress of the muscle stress.

=== Thyroid Hormone and Thermoregulation ===

Another role of iron in myofascial pain is its regulation of hormonal functions like thyroid hormone — which itself plays a critical role in energy metabolism and is clinically important in chronic myofascial pain syndromes. Iron deficiency anaemia is associated with:
* '''Impaired thermoregulation''' — the ability to maintain body temperature is compromised
* '''Impaired triiodothyronine (T₃) response to a cold stressor'''
* Impaired catecholamine response to environmental cold
* Increase in catecholamine levels may represent the body's attempt to raise core temperature

Iron deficiency anaemia in young women impaired the ability to maintain body temperature when exposed to a moderately cold environment. Plasma triiodothyronine and thyroxine levels were both decreased in women with iron-deficiency anaemia.

=== Catecholamine Metabolism ===

Iron is required for the synthesis and catabolism of catecholamines. Impaired catecholamine metabolism in iron deficiency produces additional autonomic dysregulation that compounds TrP irritability.

=== Immune Function ===

Iron-dependent enzymes are essential for the respiratory burst of neutrophils and for lymphocyte proliferation. Chronically iron-deficient patients have impaired immune surveillance, which contributes to susceptibility to the chronic infections that themselves perpetuate TrPs.

== Stages of Iron Deficiency ==

Iron deficiency occurs in three distinct stages:

# '''Stage 1 — Depletion of tissue iron stores:''' detected by serum ferritin levels; the patient may be entirely asymptomatic
# '''Stage 2 — Depletion of essential iron stores''' associated with metabolic and enzymatic activity: iron-dependent enzyme activities decline; the patient may experience reduced work capacity, impaired thermoregulation, and increased TrP irritability before anaemia develops
# '''Stage 3 — Deficient erythropoiesis''' leading to iron deficiency anaemia: haemoglobin and haematocrit fall; full clinical anaemia; the TrP-relevant metabolic effects of stages 1 and 2 are now compounded by tissue hypoxia

'''Detection of iron insufficiency before anaemia develops is most important''', because decreased work capacity and impaired energy metabolism are present in stages 1 and 2, before the haematological markers of anaemia appear.

Iron deficiency anaemia is associated with impaired thermoregulation or ability to maintain body temperature, with impaired triiodothyronine response to a cold stressor, and with impaired catecholamine response to environmental cold. '''The symptom of coldness was present in 57% of patients with myofascial pain syndrome''' in one study, and of these, tissue iron depletion was found in 65%. Work capacity is reduced in iron-deficient women.

== Laboratory Assessment ==

=== Serum Ferritin — The Key Test ===

Measurement of serum ferritin is an accurate way of assessing tissue iron stores. Normal serum ferritin levels have a two-fold diurnal variation and are less sensitive to the state of tissue iron stores than ferritin.

{| class="wikitable"
|-
! Ferritin level !! Clinical significance
|-
| < 20 ng/mL || Signifies iron loss without adequate replacement
|-
| 20–30 ng/mL || May signify iron loss without adequate replacement
|-
| 30–50 ng/mL || May indicate need for replacement of iron stores
|-
| > 50 ng/mL (up to 300 ng/mL) || Normal tissue iron stores
|}

Depletion of tissue iron is reflected in the lowering of serum ferritin levels, as non-essential iron stores are depleted first. Essential iron stores are depleted when serum ferritin levels reach 20 ng/ml.

=== Iron Requirements and Daily Losses ===

Iron requirements are determined by daily iron losses, which are about 0.8–1.0 mg daily, except in menstruating women whose losses are 1.4–2.4 mg/day. About 10% of dietary iron is absorbed, with a ceiling of 4–5 mg/day in anaemic individuals.

=== Complete Blood Count Limitations ===

The CBC provides important secondary information:
* Low erythrocyte count, low haemoglobin, and low/or microcytosis indicates anaemia — which tends to make muscles hypoxic and to increase TrP irritability
* An increased mean corpuscular volume (MCV) > 92 fl is suspicious as it rises from 95 to 100 fl — the likelihood of a folate or cobalamin deficiency increases
* Eosinophilia may be due to an active allergy or to infestation with an intestinal parasite such as a tapeworm
* An increased proportion of mononuclear cells (> 50%) may occur because of low thyroid function or due to active infectious mononucleosis or an acute viral infection

However, '''absence of anaemia does not exclude clinically significant iron deficiency''' — stages 1 and 2 are pre-anaemic but already metabolically consequential.

== Dietary Sources ==

Iron is present in food as easily absorbed '''haem iron''' or as poorly absorbed '''non-haem iron''':

=== Haem Iron (from animal products) ===
* Directly absorbed into intestinal cells as the intact haem molecule
* Absorption rate: approximately 20–30% regardless of the iron status of the individual
* Sources: red meat, organ meats, dark poultry meat, shellfish

=== Non-Haem Iron (from plant products and supplements) ===
* Absorption rate: highly variable, 1–15%, depending on numerous factors
* Sources: legumes (lentils, beans), dark leafy greens, fortified cereals, nuts and seeds, dried fruit, iron cooking vessels

=== Enhancers and Inhibitors of Non-Haem Iron Absorption ===

'''Major absorption promoter:'''
* '''Ascorbic acid (vitamin C)''' — the most potent absorption promoter; the strong iron absorption promoter ascorbic acid can overcome the effect of dietary inhibitors to a significant degree. This is why taking iron supplements with vitamin C significantly improves absorption

'''Major inhibitors:'''
* '''Calcium''' — calcium in milk, cheese, or as a supplement can decrease non-haem iron absorption by 50%, and can also significantly reduce absorption of haem iron. '''Calcium supplements should NOT be taken together with iron supplements'''
* '''Phytic acids''' — components of cereal grains, constituting 1–2% of many cereals, nuts, and legumes; chelate heavy metals and are potent inhibitors of iron absorption; however, the presence of phytic acids in nuts and soy is offset by the high iron content of these foods
* Polyphenols (in tea, coffee, red wine)
* Antacids and proton pump inhibitors

== Causes of Insufficiency and Deficiency ==

* '''Insufficient dietary intake''' — to replace menstrual blood loss places menstruating women at risk of iron insufficiency or deficiency
* '''Iron deficiency in men usually indicates a specific illness''' — such as carcinoma — that must be identified
* Gastric irritation with microscopic blood loss in both men and women who take non-steroidal anti-inflammatory drugs (NSAIDs)
* Also associated with pernicious anaemia, occurring in 43% of persons diagnosed with this condition
* Moderate exercise has been shown to reduce iron stores — but on the other hand, moderate exercise increases iron absorption

== Treatment: A Practical Guide ==

'''Suspect iron inadequacy when:'''
* Myofascial TrPs persist despite appropriate therapy
* Fatigue or coldness are prominent symptoms
* NSAIDs have been taken regularly for pain relief
* Menstruating women, particularly those whose menstrual flow is heavy
* Low erythrocyte volume or low mean cell haemoglobin concentration

=== Measurement ===

Measure iron stores by the serum ferritin test:
* Levels of 20 ng/mL or less signify iron store depletion
* Levels of 30–50 ng/mL may indicate need for replacement of iron stores

=== Treatment Protocol ===

Treat iron depletion at ferritin levels of 30 ng/ml or lower, and even levels up to 40 ng/ml, to prevent depletion. At ferritin levels of 30 ng/ml or less, iron supplements containing '''150 mg of iron (equivalent to 50 mg of elemental iron)''' are taken twice daily if tolerated, or once daily if necessitated by constipation or gastric irritation.

* '''Do not take with calcium supplements''' or with meals of dairy foods
* Taking them with vitamin C helps absorption
* Folic acid 1 mg taken with iron lessens the symptom of gastric irritation
* Supplements are available with stool softeners and in different formulations — finding one that is tolerable is usually possible
* Once the serum ferritin level reaches 30–40 ng/mL, a small daily supplement of 12–15 mg, commonly found in most multivitamin mineral preparations, is enough to maintain tissue iron stores

=== Warning ===

Iron supplementation should '''always be monitored''' to avoid excessive iron storage and haemochromatosis. Serum ferritin levels every 3 months are adequate to monitor supplementation at higher doses, and every 6 months until stable for lower dose maintenance.

'''Iron supplements should not be given unless iron insufficiency is established''' through the measurement of serum ferritin levels, because iron overload can lead to haemochromatosis — ischaemic heart disease and a poorer outcome after stroke.

== The Biology of Starvation: Iron ==

Iron occupies a paradoxical position in starvation biology. Unlike the water-soluble vitamins, iron is not lost rapidly during starvation — the body is exquisitely conservative with iron, having no dedicated excretory pathway. Instead, in starvation, iron deficiency emerges through the collapse of the absorptive infrastructure:

'''The starvation cascade:'''
# Reduction of dietary intake removes the primary iron source
# Atrophy of the gastrointestinal mucosa (driven by protein and folate deficiency) impairs the absorptive epithelium that would concentrate ingested iron
# Protein deficiency reduces the synthesis of transferrin (the iron transport protein) and ferritin (the iron storage protein) — tissue stores cannot be maintained even when some iron is present
# Progressive haemoglobin synthesis failure occurs as protein and iron simultaneously become limiting; anaemia develops
# The anaemia of starvation is therefore a '''combined deficiency anaemia''' — iron, protein, folate, B₁₂, and B₆ all contributing simultaneously

'''The muscle energy cascade in iron-deficient starvation:'''
In iron-deficient starvation, the mitochondrial electron transport chain is progressively impaired as iron-containing cytochromes are not replaced. The muscle cell shifts from efficient oxidative phosphorylation toward anaerobic glycolysis, with lactate accumulation even at rest or minimal activity. This is the '''same metabolic state hypothesised at the active locus of a TrP''' — a localised energy crisis with lactate accumulation, ATP depletion, and consequent failure of the calcium pump.

The evolutionary context is that in ancestral environments, dietary iron was predominantly haem iron from fresh animal products, absorbed at 20–30%. The dominance of plant-based iron with low bioavailability in many modern and traditional diets — combined with the inhibitory effect of phytic acids, calcium, and cooking losses — means that dietary iron adequacy is structurally precarious for large populations, particularly women of reproductive age.

In the chronic pain patient, this means that even patients who eat adequate calories may be iron-insufficient — particularly menstruating women, regular NSAID users, and patients with GI pathology. The symptom cluster of fatigue, coldness, reduced exercise tolerance, and treatment-resistant TrPs should always prompt ferritin measurement.

== Related Pages ==

* [[Concept:Perpetuating Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin C and TrPs|Vitamin C (Ascorbic Acid) and Trigger Points]] — primary enhancer of non-haem iron absorption
* [[Concept:Calcium and TrPs|Calcium and Trigger Points]] — major inhibitor of iron absorption; do not combine supplements
* [[Concept:Vitamin B12 Cobalamin and TrPs|Vitamin B₁₂ and Trigger Points]] — pernicious anaemia co-occurs with iron deficiency in 43%
* [[Concept:Hypometabolism and TrPs|Hypometabolism and Trigger Points]] — iron deficiency impairs thyroid hormone metabolism
* [[wikipedia:Iron_deficiency|Iron deficiency — Wikipedia]]
* [[wikipedia:Iron_deficiency_anaemia|Iron deficiency anaemia — Wikipedia]]
* [[wikipedia:Ferritin|Ferritin — Wikipedia]]
* [[wikipedia:Haemoglobin|Haemoglobin — Wikipedia]]
* [[wikipedia:Myoglobin|Myoglobin — Wikipedia]]
* [[wikipedia:Haem|Haem — Wikipedia]]
* [[wikipedia:Transferrin|Transferrin — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[index.php?title=Category:Concept]]
[[index.php?title=Category:Vol1 Ch4]]
[[index.php?title=Category:Perpetuating Factors]]
[[index.php?title=Category:Nutrition]]

Concept:Iron and TrPs

2026-04-19T19:50:26Z

Yatreyu: /* Measurement */

'''Iron''' is an essential mineral whose deficiency is estimated to be present in 9–11% of adolescent girls and women of childbearing age in the United States — making it the most prevalent micronutrient deficiency in the developed world. Iron deficiency increases the irritability of myofascial trigger points (TrPs) through multiple mechanisms: it impairs oxygen transport to muscle, disrupts oxidative phosphorylation in mitochondria, impairs thermoregulation, disturbs catecholamine metabolism, and reduces work capacity — each of which directly converges on the energy crisis at the TrP endplate.

The symptom of coldness that is often seen in persons with chronic myofascial pain has iron deficiency as one of its causes — a fact confirmed when impaired thermoregulation was present in 57% of patients with myofascial pain syndrome, with tissue iron depletion found in 65%.

== Biochemical Functions ==

Iron serves essential roles throughout human metabolism:

=== Oxygen Transport and Storage ===

Iron is the central atom of '''haem''', the prosthetic group of:
* '''Haemoglobin''' — the oxygen-carrying protein of red blood cells; transports oxygen from lungs to all tissues
* '''Myoglobin''' — the oxygen-storage protein of muscle fibres; provides the immediate oxygen reserve for aerobic metabolism in muscle

The relation of iron to muscle pain has several facets. One is the essential role of iron in energy production and oxygenation that affects the ability of muscle to meet its energy demands. '''This energy factor relates strongly to the TrP mechanism''' (see Chapter 2, Section D of the source volume).

=== Mitochondrial Oxidative Phosphorylation ===

Iron is required for enzymatic reactions that have to do with '''tissue respiration''' and '''oxidative phosphorylation''':
* Cytochrome oxidase reactions — iron is the essential redox-active atom in the cytochromes of the electron transport chain
* Porphyrin metabolism
* Collagen synthesis (iron-dependent hydroxylases)
* Neurotransmitter synthesis and catabolism

Iron-deficient animals accumulate lactic acid as a result of impaired glycolysis, and this is also postulated to be the cause of reduced physical activity. The effect of iron on energy metabolism is of special interest because of the hypothesis that the myofascial TrP is a localised region of "energy crisis" that reflects the metabolic distress of the muscle stress.

=== Thyroid Hormone and Thermoregulation ===

Another role of iron in myofascial pain is its regulation of hormonal functions like thyroid hormone — which itself plays a critical role in energy metabolism and is clinically important in chronic myofascial pain syndromes. Iron deficiency anaemia is associated with:
* '''Impaired thermoregulation''' — the ability to maintain body temperature is compromised
* '''Impaired triiodothyronine (T₃) response to a cold stressor'''
* Impaired catecholamine response to environmental cold
* Increase in catecholamine levels may represent the body's attempt to raise core temperature

Iron deficiency anaemia in young women impaired the ability to maintain body temperature when exposed to a moderately cold environment. Plasma triiodothyronine and thyroxine levels were both decreased in women with iron-deficiency anaemia.

=== Catecholamine Metabolism ===

Iron is required for the synthesis and catabolism of catecholamines. Impaired catecholamine metabolism in iron deficiency produces additional autonomic dysregulation that compounds TrP irritability.

=== Immune Function ===

Iron-dependent enzymes are essential for the respiratory burst of neutrophils and for lymphocyte proliferation. Chronically iron-deficient patients have impaired immune surveillance, which contributes to susceptibility to the chronic infections that themselves perpetuate TrPs.

== Stages of Iron Deficiency ==

Iron deficiency occurs in three distinct stages:

# '''Stage 1 — Depletion of tissue iron stores:''' detected by serum ferritin levels; the patient may be entirely asymptomatic
# '''Stage 2 — Depletion of essential iron stores''' associated with metabolic and enzymatic activity: iron-dependent enzyme activities decline; the patient may experience reduced work capacity, impaired thermoregulation, and increased TrP irritability before anaemia develops
# '''Stage 3 — Deficient erythropoiesis''' leading to iron deficiency anaemia: haemoglobin and haematocrit fall; full clinical anaemia; the TrP-relevant metabolic effects of stages 1 and 2 are now compounded by tissue hypoxia

'''Detection of iron insufficiency before anaemia develops is most important''', because decreased work capacity and impaired energy metabolism are present in stages 1 and 2, before the haematological markers of anaemia appear.

Iron deficiency anaemia is associated with impaired thermoregulation or ability to maintain body temperature, with impaired triiodothyronine response to a cold stressor, and with impaired catecholamine response to environmental cold. '''The symptom of coldness was present in 57% of patients with myofascial pain syndrome''' in one study, and of these, tissue iron depletion was found in 65%. Work capacity is reduced in iron-deficient women.

== Laboratory Assessment ==

=== Serum Ferritin — The Key Test ===

Measurement of serum ferritin is an accurate way of assessing tissue iron stores. Normal serum ferritin levels have a two-fold diurnal variation and are less sensitive to the state of tissue iron stores than ferritin.

{| class="wikitable"
|-
! Ferritin level !! Clinical significance
|-
| < 20 ng/mL || Signifies iron loss without adequate replacement
|-
| 20–30 ng/mL || May signify iron loss without adequate replacement
|-
| 30–50 ng/mL || May indicate need for replacement of iron stores
|-
| > 50 ng/mL (up to 300 ng/mL) || Normal tissue iron stores
|}

Depletion of tissue iron is reflected in the lowering of serum ferritin levels, as non-essential iron stores are depleted first. Essential iron stores are depleted when serum ferritin levels reach 20 ng/ml.

=== Iron Requirements and Daily Losses ===

Iron requirements are determined by daily iron losses, which are about 0.8–1.0 mg daily, except in menstruating women whose losses are 1.4–2.4 mg/day. About 10% of dietary iron is absorbed, with a ceiling of 4–5 mg/day in anaemic individuals.

=== Complete Blood Count Limitations ===

The CBC provides important secondary information:
* Low erythrocyte count, low haemoglobin, and low/or microcytosis indicates anaemia — which tends to make muscles hypoxic and to increase TrP irritability
* An increased mean corpuscular volume (MCV) > 92 fl is suspicious as it rises from 95 to 100 fl — the likelihood of a folate or cobalamin deficiency increases
* Eosinophilia may be due to an active allergy or to infestation with an intestinal parasite such as a tapeworm
* An increased proportion of mononuclear cells (> 50%) may occur because of low thyroid function or due to active infectious mononucleosis or an acute viral infection

However, '''absence of anaemia does not exclude clinically significant iron deficiency''' — stages 1 and 2 are pre-anaemic but already metabolically consequential.

== Dietary Sources ==

Iron is present in food as easily absorbed '''haem iron''' or as poorly absorbed '''non-haem iron''':

=== Haem Iron (from animal products) ===
* Directly absorbed into intestinal cells as the intact haem molecule
* Absorption rate: approximately 20–30% regardless of the iron status of the individual
* Sources: red meat, organ meats, dark poultry meat, shellfish

=== Non-Haem Iron (from plant products and supplements) ===
* Absorption rate: highly variable, 1–15%, depending on numerous factors
* Sources: legumes (lentils, beans), dark leafy greens, fortified cereals, nuts and seeds, dried fruit, iron cooking vessels

=== Enhancers and Inhibitors of Non-Haem Iron Absorption ===

'''Major absorption promoter:'''
* '''Ascorbic acid (vitamin C)''' — the most potent absorption promoter; the strong iron absorption promoter ascorbic acid can overcome the effect of dietary inhibitors to a significant degree. This is why taking iron supplements with vitamin C significantly improves absorption

'''Major inhibitors:'''
* '''Calcium''' — calcium in milk, cheese, or as a supplement can decrease non-haem iron absorption by 50%, and can also significantly reduce absorption of haem iron. '''Calcium supplements should NOT be taken together with iron supplements'''
* '''Phytic acids''' — components of cereal grains, constituting 1–2% of many cereals, nuts, and legumes; chelate heavy metals and are potent inhibitors of iron absorption; however, the presence of phytic acids in nuts and soy is offset by the high iron content of these foods
* Polyphenols (in tea, coffee, red wine)
* Antacids and proton pump inhibitors

== Causes of Insufficiency and Deficiency ==

* '''Insufficient dietary intake''' — to replace menstrual blood loss places menstruating women at risk of iron insufficiency or deficiency
* '''Iron deficiency in men usually indicates a specific illness''' — such as carcinoma — that must be identified
* Gastric irritation with microscopic blood loss in both men and women who take non-steroidal anti-inflammatory drugs (NSAIDs)
* Also associated with pernicious anaemia, occurring in 43% of persons diagnosed with this condition
* Moderate exercise has been shown to reduce iron stores — but on the other hand, moderate exercise increases iron absorption

== Treatment: A Practical Guide ==

'''Suspect iron inadequacy when:'''
* Myofascial TrPs persist despite appropriate therapy
* Fatigue or coldness are prominent symptoms
* NSAIDs have been taken regularly for pain relief
* Menstruating women, particularly those whose menstrual flow is heavy
* Low erythrocyte volume or low mean cell haemoglobin concentration

=== Measurement ===

Measure iron stores by the serum ferritin test:
* Levels of 20 ng/mL or less signify iron store depletion
* Levels of 30–50 ng/mL may indicate need for replacement of iron stores

=== Treatment Protocol ===

Treat iron depletion at ferritin levels of 30 ng/ml or lower, and even levels up to 40 ng/ml, to prevent depletion. At ferritin levels of 30 ng/ml or less, iron supplements containing '''150 mg of iron (equivalent to 50 mg of elemental iron)''' are taken twice daily if tolerated, or once daily if necessitated by constipation or gastric irritation.

* '''Do not take with calcium supplements''' or with meals of dairy foods
* Taking them with vitamin C helps absorption
* Folic acid 1 mg taken with iron lessens the symptom of gastric irritation
* Supplements are available with stool softeners and in different formulations — finding one that is tolerable is usually possible
* Once the serum ferritin level reaches 30–40 ng/ml, a small daily supplement of 12–15 mg, commonly found in most multivitamin mineral preparations, is enough to maintain tissue iron stores

=== Warning ===

Iron supplementation should '''always be monitored''' to avoid excessive iron storage and haemochromatosis. Serum ferritin levels every 3 months are adequate to monitor supplementation at higher doses, and every 6 months until stable for lower dose maintenance.

'''Iron supplements should not be given unless iron insufficiency is established''' through the measurement of serum ferritin levels, because iron overload can lead to haemochromatosis — ischaemic heart disease and a poorer outcome after stroke.

== The Biology of Starvation: Iron ==

Iron occupies a paradoxical position in starvation biology. Unlike the water-soluble vitamins, iron is not lost rapidly during starvation — the body is exquisitely conservative with iron, having no dedicated excretory pathway. Instead, in starvation, iron deficiency emerges through the collapse of the absorptive infrastructure:

'''The starvation cascade:'''
# Reduction of dietary intake removes the primary iron source
# Atrophy of the gastrointestinal mucosa (driven by protein and folate deficiency) impairs the absorptive epithelium that would concentrate ingested iron
# Protein deficiency reduces the synthesis of transferrin (the iron transport protein) and ferritin (the iron storage protein) — tissue stores cannot be maintained even when some iron is present
# Progressive haemoglobin synthesis failure occurs as protein and iron simultaneously become limiting; anaemia develops
# The anaemia of starvation is therefore a '''combined deficiency anaemia''' — iron, protein, folate, B₁₂, and B₆ all contributing simultaneously

'''The muscle energy cascade in iron-deficient starvation:'''
In iron-deficient starvation, the mitochondrial electron transport chain is progressively impaired as iron-containing cytochromes are not replaced. The muscle cell shifts from efficient oxidative phosphorylation toward anaerobic glycolysis, with lactate accumulation even at rest or minimal activity. This is the '''same metabolic state hypothesised at the active locus of a TrP''' — a localised energy crisis with lactate accumulation, ATP depletion, and consequent failure of the calcium pump.

The evolutionary context is that in ancestral environments, dietary iron was predominantly haem iron from fresh animal products, absorbed at 20–30%. The dominance of plant-based iron with low bioavailability in many modern and traditional diets — combined with the inhibitory effect of phytic acids, calcium, and cooking losses — means that dietary iron adequacy is structurally precarious for large populations, particularly women of reproductive age.

In the chronic pain patient, this means that even patients who eat adequate calories may be iron-insufficient — particularly menstruating women, regular NSAID users, and patients with GI pathology. The symptom cluster of fatigue, coldness, reduced exercise tolerance, and treatment-resistant TrPs should always prompt ferritin measurement.

== Related Pages ==

* [[Concept:Perpetuating Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin C and TrPs|Vitamin C (Ascorbic Acid) and Trigger Points]] — primary enhancer of non-haem iron absorption
* [[Concept:Calcium and TrPs|Calcium and Trigger Points]] — major inhibitor of iron absorption; do not combine supplements
* [[Concept:Vitamin B12 Cobalamin and TrPs|Vitamin B₁₂ and Trigger Points]] — pernicious anaemia co-occurs with iron deficiency in 43%
* [[Concept:Hypometabolism and TrPs|Hypometabolism and Trigger Points]] — iron deficiency impairs thyroid hormone metabolism
* [[wikipedia:Iron_deficiency|Iron deficiency — Wikipedia]]
* [[wikipedia:Iron_deficiency_anaemia|Iron deficiency anaemia — Wikipedia]]
* [[wikipedia:Ferritin|Ferritin — Wikipedia]]
* [[wikipedia:Haemoglobin|Haemoglobin — Wikipedia]]
* [[wikipedia:Myoglobin|Myoglobin — Wikipedia]]
* [[wikipedia:Haem|Haem — Wikipedia]]
* [[wikipedia:Transferrin|Transferrin — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[index.php?title=Category:Concept]]
[[index.php?title=Category:Vol1 Ch4]]
[[index.php?title=Category:Perpetuating Factors]]
[[index.php?title=Category:Nutrition]]

Concept:Iron and TrPs

2026-04-19T19:47:55Z

Yatreyu:

'''Iron''' is an essential mineral whose deficiency is estimated to be present in 9–11% of adolescent girls and women of childbearing age in the United States — making it the most prevalent micronutrient deficiency in the developed world. Iron deficiency increases the irritability of myofascial trigger points (TrPs) through multiple mechanisms: it impairs oxygen transport to muscle, disrupts oxidative phosphorylation in mitochondria, impairs thermoregulation, disturbs catecholamine metabolism, and reduces work capacity — each of which directly converges on the energy crisis at the TrP endplate.

The symptom of coldness that is often seen in persons with chronic myofascial pain has iron deficiency as one of its causes — a fact confirmed when impaired thermoregulation was present in 57% of patients with myofascial pain syndrome, with tissue iron depletion found in 65%.

== Biochemical Functions ==

Iron serves essential roles throughout human metabolism:

=== Oxygen Transport and Storage ===

Iron is the central atom of '''haem''', the prosthetic group of:
* '''Haemoglobin''' — the oxygen-carrying protein of red blood cells; transports oxygen from lungs to all tissues
* '''Myoglobin''' — the oxygen-storage protein of muscle fibres; provides the immediate oxygen reserve for aerobic metabolism in muscle

The relation of iron to muscle pain has several facets. One is the essential role of iron in energy production and oxygenation that affects the ability of muscle to meet its energy demands. '''This energy factor relates strongly to the TrP mechanism''' (see Chapter 2, Section D of the source volume).

=== Mitochondrial Oxidative Phosphorylation ===

Iron is required for enzymatic reactions that have to do with '''tissue respiration''' and '''oxidative phosphorylation''':
* Cytochrome oxidase reactions — iron is the essential redox-active atom in the cytochromes of the electron transport chain
* Porphyrin metabolism
* Collagen synthesis (iron-dependent hydroxylases)
* Neurotransmitter synthesis and catabolism

Iron-deficient animals accumulate lactic acid as a result of impaired glycolysis, and this is also postulated to be the cause of reduced physical activity. The effect of iron on energy metabolism is of special interest because of the hypothesis that the myofascial TrP is a localised region of "energy crisis" that reflects the metabolic distress of the muscle stress.

=== Thyroid Hormone and Thermoregulation ===

Another role of iron in myofascial pain is its regulation of hormonal functions like thyroid hormone — which itself plays a critical role in energy metabolism and is clinically important in chronic myofascial pain syndromes. Iron deficiency anaemia is associated with:
* '''Impaired thermoregulation''' — the ability to maintain body temperature is compromised
* '''Impaired triiodothyronine (T₃) response to a cold stressor'''
* Impaired catecholamine response to environmental cold
* Increase in catecholamine levels may represent the body's attempt to raise core temperature

Iron deficiency anaemia in young women impaired the ability to maintain body temperature when exposed to a moderately cold environment. Plasma triiodothyronine and thyroxine levels were both decreased in women with iron-deficiency anaemia.

=== Catecholamine Metabolism ===

Iron is required for the synthesis and catabolism of catecholamines. Impaired catecholamine metabolism in iron deficiency produces additional autonomic dysregulation that compounds TrP irritability.

=== Immune Function ===

Iron-dependent enzymes are essential for the respiratory burst of neutrophils and for lymphocyte proliferation. Chronically iron-deficient patients have impaired immune surveillance, which contributes to susceptibility to the chronic infections that themselves perpetuate TrPs.

== Stages of Iron Deficiency ==

Iron deficiency occurs in three distinct stages:

# '''Stage 1 — Depletion of tissue iron stores:''' detected by serum ferritin levels; the patient may be entirely asymptomatic
# '''Stage 2 — Depletion of essential iron stores''' associated with metabolic and enzymatic activity: iron-dependent enzyme activities decline; the patient may experience reduced work capacity, impaired thermoregulation, and increased TrP irritability before anaemia develops
# '''Stage 3 — Deficient erythropoiesis''' leading to iron deficiency anaemia: haemoglobin and haematocrit fall; full clinical anaemia; the TrP-relevant metabolic effects of stages 1 and 2 are now compounded by tissue hypoxia

'''Detection of iron insufficiency before anaemia develops is most important''', because decreased work capacity and impaired energy metabolism are present in stages 1 and 2, before the haematological markers of anaemia appear.

Iron deficiency anaemia is associated with impaired thermoregulation or ability to maintain body temperature, with impaired triiodothyronine response to a cold stressor, and with impaired catecholamine response to environmental cold. '''The symptom of coldness was present in 57% of patients with myofascial pain syndrome''' in one study, and of these, tissue iron depletion was found in 65%. Work capacity is reduced in iron-deficient women.

== Laboratory Assessment ==

=== Serum Ferritin — The Key Test ===

Measurement of serum ferritin is an accurate way of assessing tissue iron stores. Normal serum ferritin levels have a two-fold diurnal variation and are less sensitive to the state of tissue iron stores than ferritin.

{| class="wikitable"
|-
! Ferritin level !! Clinical significance
|-
| < 20 ng/ml || Signifies iron loss without adequate replacement
|-
| 20–30 ng/ml || May signify iron loss without adequate replacement
|-
| 30–50 ng/ml || May indicate need for replacement of iron stores
|-
| > 50 ng/ml (up to 300 ng/ml) || Normal tissue iron stores
|}

Depletion of tissue iron is reflected in the lowering of serum ferritin levels, as non-essential iron stores are depleted first. Essential iron stores are depleted when serum ferritin levels reach 20 ng/ml.

=== Iron Requirements and Daily Losses ===

Iron requirements are determined by daily iron losses, which are about 0.8–1.0 mg daily, except in menstruating women whose losses are 1.4–2.4 mg/day. About 10% of dietary iron is absorbed, with a ceiling of 4–5 mg/day in anaemic individuals.

=== Complete Blood Count Limitations ===

The CBC provides important secondary information:
* Low erythrocyte count, low haemoglobin, and low/or microcytosis indicates anaemia — which tends to make muscles hypoxic and to increase TrP irritability
* An increased mean corpuscular volume (MCV) > 92 fl is suspicious as it rises from 95 to 100 fl — the likelihood of a folate or cobalamin deficiency increases
* Eosinophilia may be due to an active allergy or to infestation with an intestinal parasite such as a tapeworm
* An increased proportion of mononuclear cells (> 50%) may occur because of low thyroid function or due to active infectious mononucleosis or an acute viral infection

However, '''absence of anaemia does not exclude clinically significant iron deficiency''' — stages 1 and 2 are pre-anaemic but already metabolically consequential.

== Dietary Sources ==

Iron is present in food as easily absorbed '''haem iron''' or as poorly absorbed '''non-haem iron''':

=== Haem Iron (from animal products) ===
* Directly absorbed into intestinal cells as the intact haem molecule
* Absorption rate: approximately 20–30% regardless of the iron status of the individual
* Sources: red meat, organ meats, dark poultry meat, shellfish

=== Non-Haem Iron (from plant products and supplements) ===
* Absorption rate: highly variable, 1–15%, depending on numerous factors
* Sources: legumes (lentils, beans), dark leafy greens, fortified cereals, nuts and seeds, dried fruit, iron cooking vessels

=== Enhancers and Inhibitors of Non-Haem Iron Absorption ===

'''Major absorption promoter:'''
* '''Ascorbic acid (vitamin C)''' — the most potent absorption promoter; the strong iron absorption promoter ascorbic acid can overcome the effect of dietary inhibitors to a significant degree. This is why taking iron supplements with vitamin C significantly improves absorption

'''Major inhibitors:'''
* '''Calcium''' — calcium in milk, cheese, or as a supplement can decrease non-haem iron absorption by 50%, and can also significantly reduce absorption of haem iron. '''Calcium supplements should NOT be taken together with iron supplements'''
* '''Phytic acids''' — components of cereal grains, constituting 1–2% of many cereals, nuts, and legumes; chelate heavy metals and are potent inhibitors of iron absorption; however, the presence of phytic acids in nuts and soy is offset by the high iron content of these foods
* Polyphenols (in tea, coffee, red wine)
* Antacids and proton pump inhibitors

== Causes of Insufficiency and Deficiency ==

* '''Insufficient dietary intake''' — to replace menstrual blood loss places menstruating women at risk of iron insufficiency or deficiency
* '''Iron deficiency in men usually indicates a specific illness''' — such as carcinoma — that must be identified
* Gastric irritation with microscopic blood loss in both men and women who take non-steroidal anti-inflammatory drugs (NSAIDs)
* Also associated with pernicious anaemia, occurring in 43% of persons diagnosed with this condition
* Moderate exercise has been shown to reduce iron stores — but on the other hand, moderate exercise increases iron absorption

== Treatment: A Practical Guide ==

'''Suspect iron inadequacy when:'''
* Myofascial TrPs persist despite appropriate therapy
* Fatigue or coldness are prominent symptoms
* NSAIDs have been taken regularly for pain relief
* Menstruating women, particularly those whose menstrual flow is heavy
* Low erythrocyte volume or low mean cell haemoglobin concentration

=== Measurement ===

Measure iron stores by the serum ferritin test:
* Levels of 20 ng/ml or less signify iron store depletion
* Levels of 30–50 ng/ml may indicate need for replacement of iron stores

=== Treatment Protocol ===

Treat iron depletion at ferritin levels of 30 ng/ml or lower, and even levels up to 40 ng/ml, to prevent depletion. At ferritin levels of 30 ng/ml or less, iron supplements containing '''150 mg of iron (equivalent to 50 mg of elemental iron)''' are taken twice daily if tolerated, or once daily if necessitated by constipation or gastric irritation.

* '''Do not take with calcium supplements''' or with meals of dairy foods
* Taking them with vitamin C helps absorption
* Folic acid 1 mg taken with iron lessens the symptom of gastric irritation
* Supplements are available with stool softeners and in different formulations — finding one that is tolerable is usually possible
* Once the serum ferritin level reaches 30–40 ng/ml, a small daily supplement of 12–15 mg, commonly found in most multivitamin mineral preparations, is enough to maintain tissue iron stores

=== Warning ===

Iron supplementation should '''always be monitored''' to avoid excessive iron storage and haemochromatosis. Serum ferritin levels every 3 months are adequate to monitor supplementation at higher doses, and every 6 months until stable for lower dose maintenance.

'''Iron supplements should not be given unless iron insufficiency is established''' through the measurement of serum ferritin levels, because iron overload can lead to haemochromatosis — ischaemic heart disease and a poorer outcome after stroke.

== The Biology of Starvation: Iron ==

Iron occupies a paradoxical position in starvation biology. Unlike the water-soluble vitamins, iron is not lost rapidly during starvation — the body is exquisitely conservative with iron, having no dedicated excretory pathway. Instead, in starvation, iron deficiency emerges through the collapse of the absorptive infrastructure:

'''The starvation cascade:'''
# Reduction of dietary intake removes the primary iron source
# Atrophy of the gastrointestinal mucosa (driven by protein and folate deficiency) impairs the absorptive epithelium that would concentrate ingested iron
# Protein deficiency reduces the synthesis of transferrin (the iron transport protein) and ferritin (the iron storage protein) — tissue stores cannot be maintained even when some iron is present
# Progressive haemoglobin synthesis failure occurs as protein and iron simultaneously become limiting; anaemia develops
# The anaemia of starvation is therefore a '''combined deficiency anaemia''' — iron, protein, folate, B₁₂, and B₆ all contributing simultaneously

'''The muscle energy cascade in iron-deficient starvation:'''
In iron-deficient starvation, the mitochondrial electron transport chain is progressively impaired as iron-containing cytochromes are not replaced. The muscle cell shifts from efficient oxidative phosphorylation toward anaerobic glycolysis, with lactate accumulation even at rest or minimal activity. This is the '''same metabolic state hypothesised at the active locus of a TrP''' — a localised energy crisis with lactate accumulation, ATP depletion, and consequent failure of the calcium pump.

The evolutionary context is that in ancestral environments, dietary iron was predominantly haem iron from fresh animal products, absorbed at 20–30%. The dominance of plant-based iron with low bioavailability in many modern and traditional diets — combined with the inhibitory effect of phytic acids, calcium, and cooking losses — means that dietary iron adequacy is structurally precarious for large populations, particularly women of reproductive age.

In the chronic pain patient, this means that even patients who eat adequate calories may be iron-insufficient — particularly menstruating women, regular NSAID users, and patients with GI pathology. The symptom cluster of fatigue, coldness, reduced exercise tolerance, and treatment-resistant TrPs should always prompt ferritin measurement.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin_C_and_TrPs|Vitamin C (Ascorbic Acid) and Trigger Points]] — primary enhancer of non-haem iron absorption
* [[Concept:Calcium_and_TrPs|Calcium and Trigger Points]] — major inhibitor of iron absorption; do not combine supplements
* [[Concept:Vitamin_B12_Cobalamin_and_TrPs|Vitamin B₁₂ and Trigger Points]] — pernicious anaemia co-occurs with iron deficiency in 43%
* [[Concept:Hypometabolism_and_TrPs|Hypometabolism and Trigger Points]] — iron deficiency impairs thyroid hormone metabolism
* [[wikipedia:Iron_deficiency|Iron deficiency — Wikipedia]]
* [[wikipedia:Iron_deficiency_anaemia|Iron deficiency anaemia — Wikipedia]]
* [[wikipedia:Ferritin|Ferritin — Wikipedia]]
* [[wikipedia:Haemoglobin|Haemoglobin — Wikipedia]]
* [[wikipedia:Myoglobin|Myoglobin — Wikipedia]]
* [[wikipedia:Haem|Haem — Wikipedia]]
* [[wikipedia:Transferrin|Transferrin — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Nutrition]]

Concept:Vitamin C and TrPs

2026-04-19T19:47:35Z

Yatreyu:

'''Vitamin C (ascorbic acid; L-ascorbic acid)''' is a water-soluble vitamin of major clinical importance to the muscles because it can prevent much postexercise muscle soreness or stiffness, corrects the increase in capillary fragility associated with ascorbic acid deficiency, and interacts strongly with numerous other vitamins important to muscle function. It is the only reducing substance that specifically regulates dopamine beta-monooxygenase activity in chromaffin cells (adrenal gland medullary cells) in the synthesis of norepinephrine — directly influencing the catecholamine arm of pain transmission.

A practical clinical consequence of vitamin C insufficiency specific to myofascial practice is that '''scorbutic patients are especially liable to develop post-injection haematomas''' — a complication of TrP injections that should be actively avoided. The rate of healing of pressure sores was nearly doubled by increasing serum ascorbic acid levels within the normal range from low normal to high normal.

== Discovery and History ==

Scurvy was the scourge of armies, explorers, and sailors on extended trips without fresh food — Vasco da Gama lost 100 of 160 sailors from scurvy on one voyage. In 1928, Albert Szent-Györgyi isolated a chemical that protects some fruits against discolouration and infection when bruised. The chemical is now known as ascorbic acid, or vitamin C. For its discovery, he won the Nobel Prize in 1937.

Some birds and a few mammals (man, monkeys, the guinea pig, and the Indian fruit bat) are unable to convert D-glucuronic acid to L-ascorbic acid, which makes them dependent on exogenous sources. Three exceptional guinea pigs out of several thousand were apparently able to synthesise it — a capability occasionally observed in this species by other investigators; a few people may possess a similar capability. Through recorded history, scurvy was the scourge of populations cut off from fresh produce.

== Biochemical Functions ==

Ascorbic acid is involved in a remarkable number of essential body functions:

=== Collagen Synthesis ===

'''The most abundant protein in mammals is collagen''' — it constitutes nearly one-quarter of the protein in body tissues. The strong reducing action of ascorbic acid is needed for the '''hydroxylation of the amino acids lysine and proline''' to form the protoprotein molecule. This function may be assisted by ascorbic acid inhibition of hyaluronidase. At least two other important body components have an amino acid sequence similar to collagen: the C1q sub-component of complement and the basement membrane of cells.

Without vitamin C to provide the collagen needed for a firm vessel wall, the patient experiences marked capillary fragility and easy bruising, with diffuse tissue bleeding following only minor trauma. This is the mechanism underlying:
* The classic scurvy presentation of spontaneous haemorrhages
* '''Post-TrP-injection haematomas''' in ascorbic acid-deficient patients — clinically important in myofascial practice
* Impaired wound healing and delayed resolution of tissue injury

Vitamin C is essential for the deposition of calcium phosphate crystals to form bone — linking ascorbic acid status to bone integrity as well as soft tissue quality.

=== Neurotransmitter Synthesis ===

Vitamin C is required for the synthesis of two essential neurotransmitters:
* '''Norepinephrine''' — via regulation of dopamine beta-monooxygenase (the specific enzyme that converts dopamine to norepinephrine)
* '''Serotonin''' — via the hydroxylation of tryptophan to 5-hydroxytryptophan (indirect, through ensuring cofactor function)

Vitamin C is the '''only reducing substance that specifically regulates dopamine beta-monooxygenase''' activity in chromaffin cells (adrenal gland medullary cells) in the synthesis of norepinephrine. Both norepinephrine and serotonin are important in the modulation of pain transmission in the central nervous system.

=== Amino Acid Oxidative Degradation ===

A 70-kg person on an average diet metabolises about 400 g of protein/day, of which 100 g of amino acids undergo oxidative degradation in a complicated manner that provides the many building blocks for re-generation of protein structures. Ascorbic acid is essential to the oxidative degradation of two amino acids: '''phenylalanine and tyrosine'''. With no protein ingestion, some 30 g of indigenous protein continues to be oxidatively degraded.

=== Free Radical Scavenging and Antioxidant Function ===

Ascorbic acid is one of the most active reducing agents known to occur naturally in living tissue — it provides a ready source of hydrogen atoms, since it is easily oxidised. This protects many vital tissues from oxidation damage:
* Protects tissue thiol (-SH) groups, needed to convert plasma transferrin to liver ferritin
* Enhances the absorption of iron in the gastrointestinal tract
* Contributes to fatty acid metabolism through the synthesis of carnitine
* Protects tissue from lipid peroxidation damage

Ascorbic acid is readily oxidised to dehydroascorbic acid, which retains 80% of its effectiveness. Further oxidation renders it inactive. Oxidation in solution is accelerated by heat, light, alkalinity, and a metallic iron or copper vessel.

=== Immune Function and Stress Response ===

* Tissue levels in the adrenal gland parallel those of the corticosteroids; both decrease markedly in response to stress — ascorbic acid participates in the synthesis of corticosterone and 17-hydroxycorticosterone, and may be depleted by its release to the circulation in stress states
* Increased susceptibility to infectious diseases has been observed consistently among people with scurvy
* Ascorbic acid has protected experimental animals against the formation of bladder tumours by 3-hydroxyanthranilic acid and against the hepatotoxic combination of sodium nitrite and aminopyrene
* Combined with acetylsalicylic acid, ascorbic acid caused a significant stimulation of interleukin-6 and may stimulate lymphocyte transformation and polymorphonuclear leukocyte motility
* In the authors' clinical experience, ascorbic acid helps to terminate bouts of diarrhoea due to food allergy, and to decrease toxicity and TrP irritability caused by chronic infection

=== Muscle-Specific Effects ===

* Prevents or markedly reduces the '''soreness and stiffness experienced the day after unusually strenuous exercise''' — 1 g or more of ascorbic acid taken shortly before, or at the time of, exercise prevents this phenomenon; supplementation of 3 g per day blunted reported soreness, the greatest effect occurring at the peak of delayed-onset muscle soreness. This postexercise soreness does not seem to be related to TrPs
* Reverses some of the electrocardiographic findings associated with increasing age
* Deficiency in guinea pigs caused dystrophic disorganisation of muscle structures, including fragmentation of myofilaments, swelling of mitochondria, and excessive glycogen accumulation
* Vitamin C may be important in the treatment of low back pain, presumably because it improves the quality of the connective tissue

== Insufficiency and Deficiency ==

=== Populations at Risk ===

In the United States, scurvy due to inadequate dietary intake of ascorbic acid is most likely to occur in:
* Smokers
* Alcoholics
* Older people
* Infants fed primarily on cow's milk (between the ages of 6 and 12 months)
* Food faddists and psychiatric patients

A series of 35 patients with alcohol-related illness had a 91% prevalence of ascorbic acid deficiency.

=== The Smoking–Vitamin C Connection ===

Cigarette smoking is a major cause of ascorbic acid deficiency:
* A study of 17 human volunteers who smoked more than 20 cigarettes/day showed that they required 140 mg of vitamin C daily to maintain a steady state plasma ascorbic acid level, compared to a daily intake of only 100 mg in non-smokers
* Another study showed that smokers needed an additional 65 mg/day on average to maintain serum levels equivalent to those of non-smokers
* The depression of their vitamin C level is only one reason patients should be encouraged to stop smoking

=== Clinical Presentation of Scurvy ===

Scurvy develops after 4–7 months of an insufficient diet. Elderly patients in a chronic disease hospital on an institutional diet with little fresh fruit had an average whole blood vitamin C level of only 0.35 mg/dl. Eight ounces of orange juice daily raised the level to 1.52 mg/dl.

Clinical progression of scurvy:
* Initially: weakness, lassitude, irritability, vague aching pains in joints and muscles; weight loss
* Progressive: awareness of easy bruising and even haematomas; gums become swollen, red, and bleed easily; teeth become loose and may fall out (gum symptoms develop only in response to contact with irritants such as dental plaque)
* Frank: perifollicular hyperkeratotic papules on the buttocks, thighs, and legs; later on arms and back; hairs become buried in the papules; petechiae appear buried around the lesions

'''The first sign of scurvy is perifollicular hyperkeratosis.'''

Borderline or subclinical cases are difficult to recognise. Initially, scorbutic patients present with non-specific symptoms of weakness, lassitude, irritability, and vague aching pains in the joints and muscles.

=== Decreased Absorption ===

* Decreased absorption of ascorbic acid is seen in diarrhoeal diseases
* Increased utilisation occurs in thyrotoxicosis
* There is evidence of decreasing tissue levels of ascorbic acid with increased age
* Damage to membranous cell structures by lipid peroxidation appears to contribute to the deterioration of cells in the absence of ascorbic acid's reductive protection of the tissue thiol groups

== Laboratory Tests ==

* '''Determination of plasma L-ascorbic acid''' — based on its reducing properties; available through most medical laboratories
* A simple, lingual screening test for ascorbic acid deficiency has been developed (Lingual Ascorbic Acid Test, Mineralab Inc.)

=== Blood Level Interpretation ===

{| class="wikitable"
|-
! Status !! Plasma ascorbic acid
|-
| Well nourished || > 1.0 mg/dl
|-
| Adequately nourished || 0.6–1.0 mg/dl
|-
| Poorly nourished || 0.3–0.6 mg/dl
|-
| Deficient || < 0.3 mg/dl
|}

Note: ordinary farm animals (horses, pigs) that synthesise ascorbic acid show average plasma concentrations of 0.33–0.40 mg/dl — suggesting that the "well nourished" value of > 1.0 mg/dl in humans, who cannot synthesise the vitamin, may represent a more demanding requirement than these population-derived norms imply.

== Requirements and Sources ==

=== Body Pool and Metabolism ===

The body pool of ascorbic acid averages about 1500 mg, and the daily rate of metabolism approximates 3% of the existing body pool. At this rate, it would require 45 mg/day to replenish the pool. Without any replacement, a filled body pool is depleted to the scorbutic level in about 2 months.

Vitamin C is readily absorbed from the upper small intestine, and excess is quickly excreted by the kidney — very little via other portals, and there is no extensive storage. The maximum body pool ranges between 1.5 and 5 g, but may be as low as 1 g.

Absorption efficiency drops significantly at higher intake levels:
* 70% of 180 mg is absorbed
* 50% of 1.5 g is absorbed
* 16% of 12 g is absorbed

Unabsorbed vitamin C may cause diarrhoea due to an osmotic effect.

The half-life in man ranges from 13–30 days; the larger the intake, the shorter the half-life.

=== The US Daily Recommended Intake ===

The basic recommended daily allowance is 200 mg/day (updated recommendation). At single doses of 500 mg and higher, the percentage of vitamin C absorbed declines — absorption is complete at a dose of 200 mg, but less than 50% of a 1250 mg dose is absorbed. Plateau plasma vitamin C is nearly maximal with the ingestion of 200 mg/day with no adverse effects, and is maximal at 400 mg/day.

=== Best Dietary Sources ===

Excellent sources (containing more than 100 mg/100 g raw food):
* Broccoli, Brussels sprouts, collards, kale, turnip greens
* Guava
* Sweet peppers (all colours)

Less rich but valuable sources:
* Cabbage, potatoes (commonly eaten in large quantities)
* Citrus fruits — the fresh juice of a large orange contains about 50 mg; thus 4 oranges would supply the 200 mg daily need

However, '''loss of the vitamin in processing or storage may be large''':
* Canned tomatoes retain a high percentage of their ascorbic acid content (20 mg/100g) because of the acid environment
* Cooking water contains substantial amounts — do not discard the pot liquor
* Vitamin C is highly soluble in water and is often discarded in the pot liquor of cooked foods
* Further oxidation renders it inactive; oxidation in solution is accelerated by heat, light, alkalinity, and a metallic iron or copper vessel

== Therapy ==

=== Prescription ===

Prescription of ascorbic acid can be based on the new recommended dietary allowance of 200 mg/day. At single doses of 500 mg and higher, the percent of vitamin C absorbed declines. A physiologic dose of 400 mg daily ensures a normal metabolic pool of ascorbic acid to meet emergency demands.

* The optimal intake required depends on highly variable stress factors — in sickness there is greater tolerance for vitamin C than in good health; this suggests that megadoses may be therapeutic when in poor health
* The vitamin C requirement in women taking oestrogen, or an oral contraceptive agent, may increase 3- to 10-fold, requiring daily amounts of up to 500 mg
* We consider it wise to supplement the diet routinely with 500 mg of a timed-release preparation daily — this supplementation programme is another cost-effective form of health insurance; vitamin C supplementation becomes increasingly critical with advancing age

=== Toxicity ===

* Vitamin C daily doses above 400 mg have no evident value
* Oxalate and urate excretion were elevated at 1000 mg/day of vitamin C, increasing the risk of renal stone formation
* Safe doses are therefore less than 1000 mg/day
* Scorbutic symptoms may develop in persons suddenly withdrawn from megadose therapy, just as these symptoms may appear post-partum in babies born to megadose-treated mothers
* A daily megadose can cause watery diarrhoea that has been misdiagnosed as spastic colon, and can cause a non-specific urethritis that has unnecessarily led to extensive studies for venereal infection

=== Important Drug Interactions ===

* Increased absorption of some metallic ions produced by supplemental vitamin C is desirable (iron), but undesirable in the case of mercury
* Ascorbic acid supplementation increases the amount of warfarin required to maintain the same therapeutic effect on blood clotting
* Supplemental vitamin C lowers the prothrombin time in patients on warfarin
* Antacids destroy the effectiveness of ascorbic acid and should be taken separately so they are not mixed in the stomach
* Ascorbic acid combined with acetylsalicylic acid caused a significant stimulation of interleukin-6

== The Biology of Starvation: Vitamin C ==

Among the vitamins, ascorbic acid occupies a unique position in the biology of starvation because humans cannot synthesise it — unlike most mammals — and because it governs the structural integrity of connective tissue, the immediate response to physiological stress, and the synthesis of the catecholamines that mediate the stress response itself.

The starvation cascade for vitamin C unfolds as follows:

'''Collagen collapse — the structural consequence:'''
Without continuous ascorbic acid, the hydroxylation of proline and lysine in collagen precursors ceases. Old collagen turns over and is not replaced; the supporting matrix of blood vessels, skin, tendons, and bone dissolves progressively. The clinical sequence — perifollicular haemorrhage → ecchymoses → haemarthrosis → subperiosteal haematoma → spontaneous bone fracture — traces the loss of structural integrity from the finest vessels outward.

This has direct relevance to myofascial injections: ascorbic acid-deficient patients form haematomas after needling at doses of local anaesthetic that would cause only minor bruising in a replete patient. The clinician must check vitamin C status before initiating injection therapy.

'''Adrenal exhaustion and the stress cascade:'''
The adrenal gland is the tissue most richly supplied with ascorbic acid. Both the adrenal cortex (for cortisol synthesis) and the adrenal medulla (for norepinephrine synthesis via dopamine beta-monooxygenase) depend critically on ascorbic acid. In starvation combined with stress — illness, injury, infection, or the psychological stress of chronic pain — adrenal ascorbic acid is rapidly consumed. The inability to mount an adequate adrenocortical and catecholamine response in ascorbic acid depletion creates a vulnerability to physiological insult at the very time that resistance is most needed.

'''The immune collapse:'''
Ascorbic acid is required for neutrophil function, lymphocyte proliferation, and antibody synthesis. In starvation-associated vitamin C depletion, wound infection becomes lethal — historically accounting for a large proportion of scurvy deaths, which were often attributed to the infection rather than the underlying nutritional deficiency.

'''Pain amplification:'''
The depletion of norepinephrine and serotonin synthesis capacity (both dependent on ascorbic acid) in prolonged insufficiency creates a state of impaired descending pain inhibition. This directly increases TrP irritability and pain amplification, and produces a clinical picture indistinguishable from central sensitisation.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin_B1_Thiamine_and_TrPs|Vitamin B₁ (Thiamine) and Trigger Points]]
* [[Concept:Iron_and_TrPs|Iron and Trigger Points]] — vitamin C enhances non-haem iron absorption
* [[Concept:Calcium_and_TrPs|Calcium and Trigger Points]]
* [[wikipedia:Ascorbic_acid|Ascorbic acid — Wikipedia]]
* [[wikipedia:Scurvy|Scurvy — Wikipedia]]
* [[wikipedia:Collagen|Collagen — Wikipedia]]
* [[wikipedia:Dopamine_beta-monooxygenase|Dopamine beta-monooxygenase — Wikipedia]]
* [[wikipedia:Norepinephrine|Norepinephrine — Wikipedia]]
* [[wikipedia:Refeeding_syndrome|Refeeding syndrome — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Nutrition]]

Concept:Folic Acid and TrPs

2026-04-19T19:47:06Z

Yatreyu:

'''Folic acid''' (pteroylglutamic acid; folate; folacin) is a water-soluble B-complex vitamin whose insufficiency is '''the most common vitamin inadequacy''' and among those most likely to perpetuate myofascial trigger points (TrPs). Its metabolism is inseparably intertwined with that of vitamin B₁₂ — the two vitamins share critical pathways, and treatment of one without establishing the status of the other risks precipitating a deficiency of the second. This page focuses on the distinct biology and clinical profile of folic acid; for the shared metabolic pathways with cobalamin, see [[Concept:Vitamin_B12_Cobalamin_and_TrPs|Vitamin B₁₂ (Cobalamin) and Trigger Points]].

Patients with myofascial pain who have marginally low serum folate levels — still within the "normal" range but in the lowest quartile — tire easily, sleep poorly, feel discouraged and depressed, frequently feel cold, and have a reduced basal temperature. These symptoms are similar to, but less intense than, those of patients with obvious neurological disorders responsive to folic acid therapy. In the clinical experience of Travell, Simons, and Gerwin, '''be sure to check your patients with chronic myofascial TrPs for low normal or abnormal serum folate levels.'''

== Discovery and History ==

Pteroylglutamic (folic) acid was purified in 1943 by Stokstad and was crystallised from liver in the same year by Pfiffner and associates. By 1948, Angier and his coworkers synthesised it and identified its structure. It then became clear that folic acid was the Wills factor — the vitamin M previously found in dry brewers' yeast, and the vitamin B_c of yeast identified in chick experiments — that had enabled Lucy Wills in 1931 to cure macrocytic anaemia of pregnancy in Indian women by feeding them Marmite.

The name derives from the Latin ''folium'' (leaf), reflecting that leafy green vegetables are the primary dietary source.

== Biochemical Functions ==

Folate acts as a carrier of single-carbon units — one-carbon fragments — at various levels of oxidation, and transfers them in biosynthetic reactions. The active form in the body is '''tetrahydrofolate (THF)''', which is produced by the reduction of dietary folate by dihydrofolate reductase.

The principal biochemical roles of folate are:

=== 1. DNA Synthesis — Thymidylate Synthesis ===

Folate is essential for the synthesis of '''thymidylate''' (the thymidine nucleotide unique to DNA) via the thymidylate synthase reaction. In this reaction, the methylene group of 5,10-methylenetetrahydrofolate is transferred to deoxyuridylate to form thymidylate, oxidising THF to dihydrofolate in the process.

'''Folate deficiency impairs the synthesis of deoxyribonucleic acid''', causing megaloblastosis in all duplicating cells of the body, most commonly observed in bone marrow cells. The impaired haematopoiesis produces a pancytopenia.

=== 2. Purine Synthesis ===

Two steps in purine synthesis require folate-mediated one-carbon transfers. Purines are the building blocks of both DNA and RNA, so folate deficiency affects RNA synthesis as well as DNA replication.

=== 3. The Methionine Cycle and DNA Methylation ===

The conversion of 5-methyltetrahydrofolate (5-Me-THF) to THF is coupled to the remethylation of homocysteine to methionine, which requires vitamin B₁₂ as cofactor. This reaction is the point of convergence of folate and cobalamin metabolism.

Methionine is metabolised to S-adenosylmethionine (SAM), the universal methyl donor for DNA methylation and for the synthesis of myelin, neurotransmitters (epinephrine, melatonin, creatine, phospholipids), and many other methylated compounds.

'''Failure of this cycle''' (from either folate or B₁₂ deficiency) results in:
* Accumulation of homocysteine — a cardiovascular risk factor
* Reduced SAM — impairing all methylation reactions
* Impaired DNA methylation — affecting gene expression in dividing tissues

=== 4. The Methyl-Folate Trap ===

When cobalamin is lacking, 5-Me-THF cannot be demethylated. Since the polyglutamated form of THF is needed for intracellular enzyme cofactor function and cannot be formed from 5-Me-THF directly, the polyglutamated THF pool is depleted — '''even when serum folate levels appear normal or elevated'''. This is the methyl-folate trap:

* Serum folate can appear '''high''' in cobalamin deficiency (because 5-Me-THF accumulates in serum rather than being converted)
* Intracellular folate function is simultaneously impaired
* Large doses of folic acid given to a cobalamin-deficient patient will further deplete cobalamin reserves by increasing the demand for cobalamin in the methylation cycle

This is why: '''Never give folic acid without first establishing the vitamin B₁₂ status.'''

=== 5. Amino Acid Metabolism ===

* Folate is required for the conversion of homocysteine to methionine
* It participates in the catabolism of histidine — in folate deficiency, formiminoglutamic acid (FIGLU) accumulates in the urine after a histidine load (the FIGLU test)
* Serine–glycine interconversion requires THF as a one-carbon acceptor

=== 6. Neural Tube Development ===

Adequate folate in the periconceptional period (before and in the first weeks after conception) is essential for normal closure of the neural tube. Deficiency at this critical stage causes neural tube defects (anencephaly, spina bifida). This is the biological rationale for folate supplementation of 400–800 μg/day recommended for all women of childbearing age.

== Insufficiency and Deficiency in the Context of Myofascial Pain ==

=== Insufficiency (Low Normal / Lower Quartile) ===

Patients with chronic MPS who have marginally low serum folate levels show a characteristic cluster of symptoms that overlap with, but are less severe than, frank deficiency:
* '''Increased muscular irritability and susceptibility to myofascial TrPs'''
* Easy fatigue
* Poor sleep
* Discouragement and depression
* Frequent sensation of cold; reduced basal temperature (mimicking thyroid hypofunction — the two conditions may coexist)
* These symptoms are often relieved by multivitamin therapy including folic acid

'''A disproportionately high percentage of psychiatric patients are folic acid deficient. Depression is their most probable psychiatric diagnosis.'''

=== Established Deficiency ===

The documented timeline of folate deprivation (from experimental studies):
* '''Week 3:''' Low serum folate
* '''Week 7:''' Hypersegmentation of polymorphonuclear leukocytes (earliest haematological sign)
* '''Week 14:''' Increased urinary excretion of FIGLU
* '''Week 18:''' Low erythrocyte folate and macroovalocytosis
* '''Week 19:''' Megaloblastic bone marrow and anaemia

Neuropsychiatric symptoms preceding haematological changes (fourth and fifth months):
* Sleeplessness and forgetfulness, gradually increasing
* Mental symptoms disappeared within 48 hours after starting oral folic acid therapy

Full clinical deficiency presents as:
* Megaloblastic anaemia (macrocytic) — large, structurally abnormal red cells; reduced oxygen-carrying efficiency per red cell
* Fatigue, diffuse muscular pain, restless legs
* Peripheral sensory neuropathy (less common than with B₁₂, but documented in 21% of one group of folate-deficient patients)
* Depression; peripheral sensory loss; diarrhoea
* In children with congenital enzyme deficiencies: severe and often irreversible mental retardation and/or megaloblastic anaemia

=== Specific Enzyme Deficiencies ===

Congenital abnormalities in folate-dependent pathways are generally seen initially in children with severe and often irreversible mental retardation and/or megaloblastic anaemia. Some are greatly improved by megadoses of folic acid or folacin:

* '''Methylenetetrahydrofolate reductase (MTHFR) deficiency''' — impairs the synthesis of 5-Me-THF; patients exhibit homocystinuria responsive to folate therapy; a common polymorphism (C677T) in this gene affects a significant proportion of the population and reduces folate utilisation
* '''5-Methyltetrahydrofolate transferase deficiency''' — liver enzyme studies reveal markedly decreased activity; causes increased excretion of homocysteine
* '''Glutamic formiminotransferase deficiency''' — blocks formation of glutamate from histidine, causing increased formiminoglutamate (FIGLU) in urine; congenital expression can significantly increase the dietary folate requirements of an individual
* '''Cystathionine synthase deficiency''' — also causes homocystinuria; requires supplemental vitamin B₆ (see [[Concept:Vitamin_B6_Pyridoxine_and_TrPs|Vitamin B₆]])

=== Low Serum Cholesterol as a Marker ===

Low serum cholesterol levels were correlated with low serum folate values at or below 6.2 ng/ml in 46 patients (r = 0.58). No such correlation was obtained between cobalamin deficiency and serum cholesterol level. Low thyroid function of thyroid (but not of pituitary) origin is likely to be associated with an increased serum cholesterol — providing a useful clinical differentiator.

== Laboratory Tests ==

=== Serum and Red Cell Folate ===

* Routine laboratory testing of folate levels in blood serum and in blood cells (tissue level) is now available
* Normal human serum contains approximately 7–16 ng/ml of folate
* '''Serum folate''' reflects recent dietary intake; it falls rapidly with dietary restriction
* '''Red cell (erythrocyte) folate''' reflects tissue stores accumulated over the lifespan of the red cell (approximately 120 days) — a more reliable indicator of chronic folate status

=== FIGLU Test ===

After a histidine load, urinary excretion of formiminoglutamic acid (FIGLU) is measured. In folate deficiency, histidine catabolism is blocked at the step requiring THF, and FIGLU accumulates and spills into the urine. Elevated FIGLU at 14 weeks of deficiency provides biochemical evidence before anaemia develops.

=== MCV and Its Limitations ===

Contrary to expectation, among hospitalised patients, a high MCV of 95 cu mm or more had only a 0.18 correlation with folate deficiency, and therefore would not have been useful to screen for it. In some patients, other conditions caused the macrocytosis despite the folate deficiency; in other patients, the tissue folate had not yet been sufficiently depleted to produce macrocytosis.

'''Absence of macrocytosis does not exclude folate deficiency.'''

=== Homocysteine ===

Homocysteine accumulates in the serum and urine when homocysteine cannot be converted to methionine (a folate-dependent step). Elevated homocysteine is found in both folate and vitamin B₁₂ deficiency, making it a sensitive but non-specific marker. Its elevation in folate deficiency (without B₁₂ deficiency) distinguishes folate from B₁₂ as the limiting factor, since methylmalonic acid only accumulates in B₁₂ deficiency.

== Requirements ==

The total folacin activity recommended as a daily dietary allowance:
* Adults and adolescents: '''400 μg/day'''
* During pregnancy: '''800 μg/day'''
* During lactation: '''500 μg/day'''

Evidence of depleted body stores of folacin appear in 2 months and symptoms become severe after 4 months of folic acid deprivation. Body stores are therefore not large.

== Sources ==

=== Best Dietary Sources ===

The dietary sources of folate are '''leafy vegetables''' (foliage — the name is literal). Sources include:
* Yeast, liver, and other organ meat
* Fresh or fresh-frozen uncooked fruit or fruit juice
* Lightly cooked fresh green vegetables: broccoli, asparagus, spinach, Brussels sprouts
* Beans and lentils

=== Folate Destruction in Food Preparation ===

Although folates are ubiquitous in nature, being present in nearly all natural foods, they are '''highly susceptible to oxidative destruction''':
* '''50–95% of the folate content of foods may be destroyed in processing and preparation'''
* All folate is lost from refined foods — hard liquor and hard candies contain none
* Heat, prolonged cooking, and oxidation destroy folate rapidly
* Food should be stored in a cool, dark place and consumed as fresh as possible
* Cooking water should not be discarded — the pot liquor of cooked vegetables contains substantial folate

This extraordinary vulnerability to destruction means that a diet dominated by cooked, processed, and refined foods is structurally deficient in folate regardless of the nominal food variety consumed.

=== Folate in Specific Foods ===

{| class="wikitable"
|-
! Food !! Approximate folate content
|-
| Liver (beef, 100g) || 220 μg
|-
| Spinach (raw, 100g) || 194 μg
|-
| Asparagus (cooked, 4 spears) || 89 μg
|-
| Broccoli (cooked, 100g) || 71 μg
|-
| Lentils (cooked, 100g) || 181 μg
|-
| Orange juice (250ml) || 55 μg
|-
| Avocado (half) || 59 μg
|}

== Causes of Insufficiency and Deficiency ==

The four commonest causes are:
# '''Advanced age''' — an increasing segment of the population; decreased nutritional intake, decreased absorption (partly due to folate deficiency itself impairing the dividing GI mucosal cells), and increased need
# '''Pregnancy or lactation''' — the demand for rapid cellular division in fetal tissue and placenta dramatically increases folate requirement
# '''Dietary indiscretion''' — restrictive diets, food faddism, economic disadvantage, social isolation
# '''Drug abuse''' — most commonly alcohol, which impairs folate absorption, reduces dietary folate intake, and interferes with folate metabolism

Additional causes:
* Malabsorption syndromes — coeliac disease, Crohn's disease, tropical sprue
* Drugs: methotrexate and other dihydrofolate reductase inhibitors; phenytoin and other anticonvulsants (increase folate catabolism); oral contraceptives; sulfasalazine; trimethoprim
* Dialysis — folate is lost in dialysate

=== The Alcohol–Folate Interaction ===

Alcohol impairs folate status through multiple mechanisms simultaneously:
# Reduced dietary intake of folate (alcohol displaces food)
# Impaired absorption from the small intestine
# Interference with the enterohepatic recirculation of folate
# Direct inhibition of dihydrofolate reductase at high concentrations
# Increased urinary excretion of folate

This multi-level impairment explains why alcoholism is one of the most potent causes of folate deficiency, and why the folate–alcohol interaction is clinically critical in patients with chronic musculoskeletal pain who drink regularly.

== Therapy ==

=== Oral Supplementation ===

* Standard replacement: '''1 mg/day orally'''
* The Schilling test is an unreliable indicator of oral absorption of vitamin B₁₂, and oral supplementation should always be monitored by subsequent serum levels of the vitamin
* It is wise to routinely prescribe adequate amounts of vitamin B₁₂ and folic acid together, not just one — a 500 μg tablet of B₁₂ and a 1 mg tablet of folic acid daily is safe and effective
* Patients should be cautioned that folic acid absorption is impaired by the simultaneous ingestion of antacids

=== The Homocysteine Rationale for Higher Doses ===

Reduction of elevated homocysteine levels to the point that there is no increased mortality from cardiac and cerebral thrombosis requires a higher daily dose of about '''700 μg'''. Hence, a daily dose of 1 mg has been considered adequate.

=== The B₁₂ First Rule ===

'''Never administer folic acid without first checking the vitamin B₁₂ level.'''

Daily intake of 400 μg of folic acid can:
* Aggravate the effects of vitamin B₁₂ deficiency
* Obscure the early haematological warning signs of possible combined degeneration of the spinal cord, by correcting the megaloblastic anaemia while the neurological damage progresses undetected
* In the presence of already-depleted cobalamin reserves, precipitate serious cobalamin deficiency

=== Pregnancy ===

Folate supplementation of 400–800 μg/day is recommended for all women of childbearing age, and should be started before conception since neural tube closure occurs in the first 28 days after fertilisation — before most pregnancies are confirmed. Supplementation to 800 μg/day is maintained throughout pregnancy and reduced to 500 μg/day during lactation.

== The Biology of Starvation: Folic Acid ==

Folic acid stands at the intersection of starvation biology and cell survival because it governs the capacity of dividing cells to replicate their DNA. When dietary folate fails — whether from outright starvation, food processing, or malabsorption — the consequences unfold through a distinctive hierarchy of vulnerable tissues:

'''Fastest-dividing tissues fail first:'''
# '''Bone marrow''' — megaloblastic arrest of erythropoiesis; the red cells produced are large, short-lived, and oxygen-inefficient; anaemia follows within weeks to months of depletion. This directly impairs oxygen delivery to skeletal muscle, creating or worsening the local energy crisis at TrP endplates
# '''Gastrointestinal epithelium''' — villous atrophy and impaired absorption develop, creating a vicious cycle: folate deficiency destroys the absorptive surface that would absorb replacement folate
# '''Lymphoid tissue and immune cells''' — impaired immune surveillance

'''Neural consequences:'''
Unlike vitamin B₁₂ deficiency, folate deficiency causes peripheral neuropathy less frequently, and the spinal cord lesions of subacute combined degeneration only in the most severe cases. However, folate deficiency '''impairs brain function through SAM depletion''' — reducing methylation capacity throughout the nervous system, affecting neurotransmitter turnover and myelin maintenance.

The specific vulnerability in starvation is that folate stores last only 2–4 months — far shorter than the 1–3 years required to exhaust vitamin B₁₂ stores. In conditions of restricted fresh vegetable and fruit intake (sieges, famines, long sea voyages without fresh provisions, prolonged institutional catering, restricted diets, excessive alcohol), folate depletion is the first B-vitamin crisis to emerge neurologically.

The evolutionary logic: folate is abundant in the fresh plant matter that constitutes the natural human diet; its destruction by heat and oxidation is a product of cooking and food storage. In this sense, folate deficiency is a disease of civilisation — specifically, of cooked and processed food — rather than true starvation.

In the chronic pain patient, the relevance is that folate insufficiency — even at low-normal levels — directly predicts increased TrP irritability, impaired treatment response, depression, fatigue, and poor sleep. These are simultaneously the most common complaints of patients with chronic myofascial pain and the most common symptoms of subclinical folate insufficiency. Correcting folate status is therefore both diagnostically informative and therapeutically necessary.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin_B12_Cobalamin_and_TrPs|Vitamin B₁₂ (Cobalamin) and Trigger Points]] — inseparable metabolic partner
* [[Concept:Vitamin_B6_Pyridoxine_and_TrPs|Vitamin B₆ (Pyridoxine) and Trigger Points]]
* [[Concept:Vitamin_C_and_TrPs|Vitamin C (Ascorbic Acid) and Trigger Points]]
* [[wikipedia:Folate|Folate — Wikipedia]]
* [[wikipedia:Folate_deficiency|Folate deficiency — Wikipedia]]
* [[wikipedia:Folate_metabolism|Folate metabolism — Wikipedia]]
* [[wikipedia:Methylenetetrahydrofolate_reductase|MTHFR — Wikipedia]]
* [[wikipedia:Neural_tube_defect|Neural tube defect — Wikipedia]]
* [[wikipedia:Homocysteine|Homocysteine — Wikipedia]]
* [[wikipedia:Tetrahydrofolate|Tetrahydrofolate — Wikipedia]]
* [[wikipedia:Megaloblastic_anaemia|Megaloblastic anaemia — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Nutrition]]

Concept:Folic Acid and TrPs

2026-04-19T19:45:16Z

Yatreyu: /* Serum and Red Cell Folate */

'''Folic acid''' (pteroylglutamic acid; folate; folacin) is a water-soluble B-complex vitamin whose insufficiency is '''the most common vitamin inadequacy''' and among those most likely to perpetuate myofascial trigger points (TrPs). Its metabolism is inseparably intertwined with that of vitamin B₁₂ — the two vitamins share critical pathways, and treatment of one without establishing the status of the other risks precipitating a deficiency of the second. This page focuses on the distinct biology and clinical profile of folic acid; for the shared metabolic pathways with cobalamin, see [[Concept:Vitamin B12 Cobalamin and TrPs|Vitamin B₁₂ (Cobalamin) and Trigger Points]].

Patients with myofascial pain who have marginally low serum folate levels — still within the "normal" range but in the lowest quartile — tire easily, sleep poorly, feel discouraged and depressed, frequently feel cold, and have a reduced basal temperature. These symptoms are similar to, but less intense than, those of patients with obvious neurological disorders responsive to folic acid therapy. In the clinical experience of Travell, Simons, and Gerwin, '''be sure to check your patients with chronic myofascial TrPs for low normal or abnormal serum folate levels.'''

== Discovery and History ==

Pteroylglutamic (folic) acid was purified in 1943 by Stokstad and was crystallised from liver in the same year by Pfiffner and associates. By 1948, Angier and his coworkers synthesised it and identified its structure. It then became clear that folic acid was the Wills factor — the vitamin M previously found in dry brewers' yeast, and the vitamin B_c of yeast identified in chick experiments — that had enabled Lucy Wills in 1931 to cure macrocytic anaemia of pregnancy in Indian women by feeding them Marmite.

The name derives from the Latin ''folium'' (leaf), reflecting that leafy green vegetables are the primary dietary source.

== Biochemical Functions ==

Folate acts as a carrier of single-carbon units — one-carbon fragments — at various levels of oxidation, and transfers them in biosynthetic reactions. The active form in the body is '''tetrahydrofolate (THF)''', which is produced by the reduction of dietary folate by dihydrofolate reductase.

The principal biochemical roles of folate are:

=== 1. DNA Synthesis — Thymidylate Synthesis ===

Folate is essential for the synthesis of '''thymidylate''' (the thymidine nucleotide unique to DNA) via the thymidylate synthase reaction. In this reaction, the methylene group of 5,10-methylenetetrahydrofolate is transferred to deoxyuridylate to form thymidylate, oxidising THF to dihydrofolate in the process.

'''Folate deficiency impairs the synthesis of deoxyribonucleic acid''', causing megaloblastosis in all duplicating cells of the body, most commonly observed in bone marrow cells. The impaired haematopoiesis produces a pancytopenia.

=== 2. Purine Synthesis ===

Two steps in purine synthesis require folate-mediated one-carbon transfers. Purines are the building blocks of both DNA and RNA, so folate deficiency affects RNA synthesis as well as DNA replication.

=== 3. The Methionine Cycle and DNA Methylation ===

The conversion of 5-methyltetrahydrofolate (5-Me-THF) to THF is coupled to the remethylation of homocysteine to methionine, which requires vitamin B₁₂ as cofactor. This reaction is the point of convergence of folate and cobalamin metabolism.

Methionine is metabolised to S-adenosylmethionine (SAM), the universal methyl donor for DNA methylation and for the synthesis of myelin, neurotransmitters (epinephrine, melatonin, creatine, phospholipids), and many other methylated compounds.

'''Failure of this cycle''' (from either folate or B₁₂ deficiency) results in:
* Accumulation of homocysteine — a cardiovascular risk factor
* Reduced SAM — impairing all methylation reactions
* Impaired DNA methylation — affecting gene expression in dividing tissues

=== 4. The Methyl-Folate Trap ===

When cobalamin is lacking, 5-Me-THF cannot be demethylated. Since the polyglutamated form of THF is needed for intracellular enzyme cofactor function and cannot be formed from 5-Me-THF directly, the polyglutamated THF pool is depleted — '''even when serum folate levels appear normal or elevated'''. This is the methyl-folate trap:

* Serum folate can appear '''high''' in cobalamin deficiency (because 5-Me-THF accumulates in serum rather than being converted)
* Intracellular folate function is simultaneously impaired
* Large doses of folic acid given to a cobalamin-deficient patient will further deplete cobalamin reserves by increasing the demand for cobalamin in the methylation cycle

This is why: '''Never give folic acid without first establishing the vitamin B₁₂ status.'''

=== 5. Amino Acid Metabolism ===

* Folate is required for the conversion of homocysteine to methionine
* It participates in the catabolism of histidine — in folate deficiency, formiminoglutamic acid (FIGLU) accumulates in the urine after a histidine load (the FIGLU test)
* Serine–glycine interconversion requires THF as a one-carbon acceptor

=== 6. Neural Tube Development ===

Adequate folate in the periconceptional period (before and in the first weeks after conception) is essential for normal closure of the neural tube. Deficiency at this critical stage causes neural tube defects (anencephaly, spina bifida). This is the biological rationale for folate supplementation of 400–800 μg/day recommended for all women of childbearing age.

== Insufficiency and Deficiency in the Context of Myofascial Pain ==

=== Insufficiency (Low Normal / Lower Quartile) ===

Patients with chronic MPS who have marginally low serum folate levels show a characteristic cluster of symptoms that overlap with, but are less severe than, frank deficiency:
* '''Increased muscular irritability and susceptibility to myofascial TrPs'''
* Easy fatigue
* Poor sleep
* Discouragement and depression
* Frequent sensation of cold; reduced basal temperature (mimicking thyroid hypofunction — the two conditions may coexist)
* These symptoms are often relieved by multivitamin therapy including folic acid

'''A disproportionately high percentage of psychiatric patients are folic acid deficient. Depression is their most probable psychiatric diagnosis.'''

=== Established Deficiency ===

The documented timeline of folate deprivation (from experimental studies):
* '''Week 3:''' Low serum folate
* '''Week 7:''' Hypersegmentation of polymorphonuclear leukocytes (earliest haematological sign)
* '''Week 14:''' Increased urinary excretion of FIGLU
* '''Week 18:''' Low erythrocyte folate and macroovalocytosis
* '''Week 19:''' Megaloblastic bone marrow and anaemia

Neuropsychiatric symptoms preceding haematological changes (fourth and fifth months):
* Sleeplessness and forgetfulness, gradually increasing
* Mental symptoms disappeared within 48 hours after starting oral folic acid therapy

Full clinical deficiency presents as:
* Megaloblastic anaemia (macrocytic) — large, structurally abnormal red cells; reduced oxygen-carrying efficiency per red cell
* Fatigue, diffuse muscular pain, restless legs
* Peripheral sensory neuropathy (less common than with B₁₂, but documented in 21% of one group of folate-deficient patients)
* Depression; peripheral sensory loss; diarrhoea
* In children with congenital enzyme deficiencies: severe and often irreversible mental retardation and/or megaloblastic anaemia

=== Specific Enzyme Deficiencies ===

Congenital abnormalities in folate-dependent pathways are generally seen initially in children with severe and often irreversible mental retardation and/or megaloblastic anaemia. Some are greatly improved by megadoses of folic acid or folacin:

* '''Methylenetetrahydrofolate reductase (MTHFR) deficiency''' — impairs the synthesis of 5-Me-THF; patients exhibit homocystinuria responsive to folate therapy; a common polymorphism (C677T) in this gene affects a significant proportion of the population and reduces folate utilisation
* '''5-Methyltetrahydrofolate transferase deficiency''' — liver enzyme studies reveal markedly decreased activity; causes increased excretion of homocysteine
* '''Glutamic formiminotransferase deficiency''' — blocks formation of glutamate from histidine, causing increased formiminoglutamate (FIGLU) in urine; congenital expression can significantly increase the dietary folate requirements of an individual
* '''Cystathionine synthase deficiency''' — also causes homocystinuria; requires supplemental vitamin B₆ (see [[Concept:Vitamin B6 Pyridoxine and TrPs|Vitamin B₆]])

=== Low Serum Cholesterol as a Marker ===

Low serum cholesterol levels were correlated with low serum folate values at or below 6.2 ng/ml in 46 patients (r = 0.58). No such correlation was obtained between cobalamin deficiency and serum cholesterol level. Low thyroid function of thyroid (but not of pituitary) origin is likely to be associated with an increased serum cholesterol — providing a useful clinical differentiator.

== Laboratory Tests ==

=== Serum and Red Cell Folate ===

* Routine laboratory testing of folate levels in blood serum and in blood cells (tissue level) is now available
* Normal human serum contains approximately 7–16 ng/ml of folate
* '''Serum folate < 4 mcg/L suggests folate deficiency'''
* '''Red cell (erythrocyte) folate''' reference values: 140–628 ng/ml in packed RBCs (IU: 317–1422 nmol/l) — reflects tissue stores accumulated over the lifespan of the red cell (approximately 120 days) and is a more reliable indicator of chronic folate status than serum folate
* '''Serum folate''' reflects recent dietary intake; it falls rapidly with dietary restriction

=== FIGLU Test ===

After a histidine load, urinary excretion of formiminoglutamic acid (FIGLU) is measured. In folate deficiency, histidine catabolism is blocked at the step requiring THF, and FIGLU accumulates and spills into the urine. Elevated FIGLU at 14 weeks of deficiency provides biochemical evidence before anaemia develops.

=== MCV and Its Limitations ===

Contrary to expectation, among hospitalised patients, a high MCV of 95 cu mm or more had only a 0.18 correlation with folate deficiency, and therefore would not have been useful to screen for it. In some patients, other conditions caused the macrocytosis despite the folate deficiency; in other patients, the tissue folate had not yet been sufficiently depleted to produce macrocytosis.

'''Absence of macrocytosis does not exclude folate deficiency.'''

=== Homocysteine ===

Homocysteine accumulates in the serum and urine when homocysteine cannot be converted to methionine (a folate-dependent step). Elevated homocysteine is found in both folate and vitamin B₁₂ deficiency, making it a sensitive but non-specific marker. Its elevation in folate deficiency (without B₁₂ deficiency) distinguishes folate from B₁₂ as the limiting factor, since methylmalonic acid only accumulates in B₁₂ deficiency.

== Requirements ==

The total folacin activity recommended as a daily dietary allowance:
* Adults and adolescents: '''400 μg/day'''
* During pregnancy: '''800 μg/day'''
* During lactation: '''500 μg/day'''

Evidence of depleted body stores of folacin appear in 2 months and symptoms become severe after 4 months of folic acid deprivation. Body stores are therefore not large.

== Sources ==

=== Best Dietary Sources ===

The dietary sources of folate are '''leafy vegetables''' (foliage — the name is literal). Sources include:
* Yeast, liver, and other organ meat
* Fresh or fresh-frozen uncooked fruit or fruit juice
* Lightly cooked fresh green vegetables: broccoli, asparagus, spinach, Brussels sprouts
* Beans and lentils

=== Folate Destruction in Food Preparation ===

Although folates are ubiquitous in nature, being present in nearly all natural foods, they are '''highly susceptible to oxidative destruction''':
* '''50–95% of the folate content of foods may be destroyed in processing and preparation'''
* All folate is lost from refined foods — hard liquor and hard candies contain none
* Heat, prolonged cooking, and oxidation destroy folate rapidly
* Food should be stored in a cool, dark place and consumed as fresh as possible
* Cooking water should not be discarded — the pot liquor of cooked vegetables contains substantial folate

This extraordinary vulnerability to destruction means that a diet dominated by cooked, processed, and refined foods is structurally deficient in folate regardless of the nominal food variety consumed.

=== Folate in Specific Foods ===

| Food | Approximate folate content |
|---|---|
| Liver (beef, 100g) | 220 μg |
| Spinach (raw, 100g) | 194 μg |
| Asparagus (cooked, 4 spears) | 89 μg |
| Broccoli (cooked, 100g) | 71 μg |
| Lentils (cooked, 100g) | 181 μg |
| Orange juice (250ml) | 55 μg |
| Avocado (half) | 59 μg |

== Causes of Insufficiency and Deficiency ==

The four commonest causes are:
# '''Advanced age''' — an increasing segment of the population; decreased nutritional intake, decreased absorption (partly due to folate deficiency itself impairing the dividing GI mucosal cells), and increased need
# '''Pregnancy or lactation''' — the demand for rapid cellular division in fetal tissue and placenta dramatically increases folate requirement
# '''Dietary indiscretion''' — restrictive diets, food faddism, economic disadvantage, social isolation
# '''Drug abuse''' — most commonly alcohol, which impairs folate absorption, reduces dietary folate intake, and interferes with folate metabolism

Additional causes:
* Malabsorption syndromes — coeliac disease, Crohn's disease, tropical sprue
* Drugs: methotrexate and other dihydrofolate reductase inhibitors; phenytoin and other anticonvulsants (increase folate catabolism); oral contraceptives; sulfasalazine; trimethoprim
* Dialysis — folate is lost in dialysate

=== The Alcohol–Folate Interaction ===

Alcohol impairs folate status through multiple mechanisms simultaneously:
# Reduced dietary intake of folate (alcohol displaces food)
# Impaired absorption from the small intestine
# Interference with the enterohepatic recirculation of folate
# Direct inhibition of dihydrofolate reductase at high concentrations
# Increased urinary excretion of folate

This multi-level impairment explains why alcoholism is one of the most potent causes of folate deficiency, and why the folate–alcohol interaction is clinically critical in patients with chronic musculoskeletal pain who drink regularly.

== Therapy ==

=== Oral Supplementation ===

* Standard replacement: '''folate 1 mg three times daily orally, followed by 1 mg/day''' for maintenance
* In acutely ill patients: 1–5 mg/day intravenously
* It is wise to routinely prescribe adequate amounts of vitamin B₁₂ and folic acid together, not just one — a 500 μg tablet of B₁₂ and a 1 mg tablet of folic acid daily is safe and effective
* Patients should be cautioned that folic acid absorption is impaired by the simultaneous ingestion of antacids
* '''Always exclude vitamin B₁₂ deficiency before starting folate replacement''' (see the B₁₂ First Rule below)

=== The Homocysteine Rationale for Higher Doses ===

Reduction of elevated homocysteine levels to the point that there is no increased mortality from cardiac and cerebral thrombosis requires a higher daily dose of about '''700 μg'''. Hence, a daily dose of 1 mg has been considered adequate.

=== The B₁₂ First Rule ===

'''Never administer folic acid without first checking the vitamin B₁₂ level.'''

Daily intake of 400 μg of folic acid can:
* Aggravate the effects of vitamin B₁₂ deficiency
* Obscure the early haematological warning signs of possible combined degeneration of the spinal cord, by correcting the megaloblastic anaemia while the neurological damage progresses undetected
* In the presence of already-depleted cobalamin reserves, precipitate serious cobalamin deficiency

=== Pregnancy ===

Folate supplementation of 400–800 μg/day is recommended for all women of childbearing age, and should be started before conception since neural tube closure occurs in the first 28 days after fertilisation — before most pregnancies are confirmed. Supplementation to 800 μg/day is maintained throughout pregnancy and reduced to 500 μg/day during lactation.

== The Biology of Starvation: Folic Acid ==

Folic acid stands at the intersection of starvation biology and cell survival because it governs the capacity of dividing cells to replicate their DNA. When dietary folate fails — whether from outright starvation, food processing, or malabsorption — the consequences unfold through a distinctive hierarchy of vulnerable tissues:

'''Fastest-dividing tissues fail first:'''
# '''Bone marrow''' — megaloblastic arrest of erythropoiesis; the red cells produced are large, short-lived, and oxygen-inefficient; anaemia follows within weeks to months of depletion. This directly impairs oxygen delivery to skeletal muscle, creating or worsening the local energy crisis at TrP endplates
# '''Gastrointestinal epithelium''' — villous atrophy and impaired absorption develop, creating a vicious cycle: folate deficiency destroys the absorptive surface that would absorb replacement folate
# '''Lymphoid tissue and immune cells''' — impaired immune surveillance

'''Neural consequences:'''
Unlike vitamin B₁₂ deficiency, folate deficiency causes peripheral neuropathy less frequently, and the spinal cord lesions of subacute combined degeneration only in the most severe cases. However, folate deficiency '''impairs brain function through SAM depletion''' — reducing methylation capacity throughout the nervous system, affecting neurotransmitter turnover and myelin maintenance.

The specific vulnerability in starvation is that folate stores last only 2–4 months — far shorter than the 1–3 years required to exhaust vitamin B₁₂ stores. In conditions of restricted fresh vegetable and fruit intake (sieges, famines, long sea voyages without fresh provisions, prolonged institutional catering, restricted diets, excessive alcohol), folate depletion is the first B-vitamin crisis to emerge neurologically.

The evolutionary logic: folate is abundant in the fresh plant matter that constitutes the natural human diet; its destruction by heat and oxidation is a product of cooking and food storage. In this sense, folate deficiency is a disease of civilisation — specifically, of cooked and processed food — rather than true starvation.

In the chronic pain patient, the relevance is that folate insufficiency — even at low-normal levels — directly predicts increased TrP irritability, impaired treatment response, depression, fatigue, and poor sleep. These are simultaneously the most common complaints of patients with chronic myofascial pain and the most common symptoms of subclinical folate insufficiency. Correcting folate status is therefore both diagnostically informative and therapeutically necessary.

== Related Pages ==

* [[Concept:Perpetuating Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin B12 Cobalamin and TrPs|Vitamin B₁₂ (Cobalamin) and Trigger Points]] — inseparable metabolic partner
* [[Concept:Vitamin B6 Pyridoxine and TrPs|Vitamin B₆ (Pyridoxine) and Trigger Points]]
* [[Concept:Vitamin C and TrPs|Vitamin C (Ascorbic Acid) and Trigger Points]]
* [[wikipedia:Folate|Folate — Wikipedia]]
* [[wikipedia:Folate_deficiency|Folate deficiency — Wikipedia]]
* [[wikipedia:Folate_metabolism|Folate metabolism — Wikipedia]]
* [[wikipedia:Methylenetetrahydrofolate_reductase|MTHFR — Wikipedia]]
* [[wikipedia:Neural_tube_defect|Neural tube defect — Wikipedia]]
* [[wikipedia:Homocysteine|Homocysteine — Wikipedia]]
* [[wikipedia:Tetrahydrofolate|Tetrahydrofolate — Wikipedia]]
* [[wikipedia:Megaloblastic_anaemia|Megaloblastic anaemia — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[index.php?title=Category:Concept]]
[[index.php?title=Category:Vol1 Ch4]]
[[index.php?title=Category:Perpetuating Factors]]
[[index.php?title=Category:Nutrition]]

Concept:Hypometabolism and TrPs

2026-04-19T19:43:29Z

Yatreyu: Created page with "'''Hypometabolism''' (thyroid inadequacy) describes the condition of someone whose serum levels of thyroid hormones are in the low euthyroid range, or just below the "normal" two standard deviation limit. It is covered in depth as a perpetuating factor for myofascial trigger points (TrPs) because, when present, the results of specific therapy for myofascial pain syndrome (MPS) can be '''utterly frustrating''' until the hypometabolism is corrected — patients obtain only..."

'''Hypometabolism''' (thyroid inadequacy) describes the condition of someone whose serum levels of thyroid hormones are in the low euthyroid range, or just below the "normal" two standard deviation limit. It is covered in depth as a perpetuating factor for myofascial trigger points (TrPs) because, when present, the results of specific therapy for myofascial pain syndrome (MPS) can be '''utterly frustrating''' until the hypometabolism is corrected — patients obtain only temporary relief with specific myofascial therapy, yet recover promptly once thyroid function is adequately supported.

The importance of this perpetuating factor is illustrated by Dr. Gerwin's clinical observation: achieving a TSH of 0.5–2.0 mIU/L in hypothyroid myofascial pain patients can produce spontaneous resolution of TrPs and '''full recovery from MPS within 4–6 weeks''' — a result that corresponds to spontaneous recovery in patients without any perpetuating factors.

This page covers the full clinical, molecular, and diagnostic landscape of hypometabolism as a TrP perpetuator. For the related metabolic conditions of hypoglycaemia and hyperuricaemia, see [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]].

== Thyroid Hormone Biology ==

=== The Thyroid Hormones ===

* '''Thyroxine (T₄)''' — the primary product of the thyroid gland; the dominant form of circulating thyroid hormone; physiologically relatively inactive
* '''Triiodothyronine (T₃)''' — the biologically active form; over 80% of circulating T₃ is derived by deiodination of extrathyroidal T₄ by the enzyme thyroxine 5'-deiodinase

T₄ is converted to T₃ at rates determined by the state of the individual. The most physiological means of providing T₃, therefore, is to give thyroxine and to let the body needs regulate the rate of conversion of T₄ to T₃.

=== Molecular Basis of Thyroid Hormone Action ===

Brent has reviewed the molecular basis of thyroid function in detail. Inactive thyroxine (T₄) is the primary product of the thyroid gland and the dominant form of circulating thyroid hormone. It is converted to the active form triiodothyronine (T₃) by thyroxine 5'-deiodinase. The functions of thyroid hormone are primarily mediated through the action of T₃ receptors of the cell nucleus.

The receptors are '''hormone-responsive nuclear transcription factors''' determining which genes are stimulated or suppressed by T₃. Interaction of the T₃-receptor complex with DNA regulatory regions modifies gene expression. Transport of T₃ from outside the cell to the cell nucleus is a complex chain of events beyond the reach of current clinical laboratory testing.

'''The effects of T₃ include:'''
* '''T₄ affects growth''' by increasing the rate of microsomal protein synthesis through a direct effect on translation that does not require synthesis of RNA
* '''T₃ increases both ribosomal RNA and protein synthesis''' through an increase in RNA polymerase activity
* Thyroxine selectively increases the activity of some enzymes 5–10 times — this helps to explain why adequate thyroid hormone is critical for the replication of many kinds of cells

=== Thyroid Hormones and Energy Metabolism ===

The chief product of oxidative phosphorylation is adenosine triphosphate (ATP), the primary source of energy for muscular contraction. The production of ATP by mitochondria is significantly increased when the concentration of T₃ increases. The hormone acts at the inner membrane of the mitochondrion, which is the site of oxidative phosphorylation.

'''A major mechanism by which T₃ causes increased energy expenditure is the increase of adenosine triphosphatase (ATPase) activity in cell membrane.''' ATP supplies the energy for muscle contraction and drives the sodium-potassium pump that maintains gradients of these ions across cell membranes. These gradients are essential to the excitability of muscle and nerve fibres and apparently have a "vent" system so that, although overactivity of the pump expends additional energy, it does not produce serious hyperpolarisation of the membrane.

=== Muscle Changes in Hypothyroidism ===

Muscle changes occur in hypothyroidism that may be reflected in the clinical signs of weakness and fatigue:
* Myosin develops the characteristics of '''slow fibres'''
* Certain mitochondrial enzymes show reduced activity
* Studies using phosphorus-31 nuclear magnetic resonance spectroscopy showed that the ratio of phosphocreatine to inorganic phosphate (PCr/Pi) was low at rest in patients with hypothyroidism; PCr depletion during exercise was increased; and postexercise recovery of PCr/Pi was delayed — consistent with impaired oxidative phosphorylation in hypothyroid muscle
* These changes may be the result of impaired mitochondrial function resulting in abnormal oxidative metabolism of chiefly type I fibres and impaired glycolytic metabolism affecting type 2 fast-twitch muscle fibres

'''Muscle relaxation is controlled by the balance between fast and slow forms of calcium ATPase in the sarcoplasmic membrane of skeletal muscle.''' The genes for transcription of these two forms of ATPase are controlled by T₃. Likewise, lipogenesis, lipolysis, and levels of total serum cholesterol and low-density lipoprotein cholesterol are controlled by T₃ receptor-regulated genes.

=== Thermogenesis and T₃ ===

Thermogenesis is regulated in part by T₃ and adrenergic receptors on brown-fat-specific genes found in rodents and recently found in humans. Growth hormone synthesis in the pituitary gland is T₃-regulated, including nocturnal secretion of growth hormone and secretion of insulin-like growth factor 1 — both are decreased in patients with FMS.

=== Cold Intolerance — The Clinical Hallmark ===

Hypometabolism patients nearly always experience '''cold intolerance'''; occasionally they are intolerant of both heat and cold. They tend to wear additional clothing (a sweater, jacket, or pullover) when others do not, rarely sweat, and frequently complain of cold hands and, especially, cold feet. These patients are "weather conscious," and muscular pain increases with the onset of cold, rainy weather.

Cold intolerance directly overlaps with the symptom of coldness seen in iron deficiency (see [[Concept:Iron_and_TrPs|Iron and TrPs]]) — the two conditions can coexist and compound each other. Both should be screened simultaneously.

== Hypometabolism and Myofascial Pain ===

=== Clinical Evidence ===

'''Gerwin identified hypothyroidism in 10% of a cohort of chronic myofascial pain patients''', using clinical symptomatology and determinations of T₃, T₄, FT₄, TSH, or TRH stimulation test. A striking feature of these patients was the widespread distribution of myofascial TrPs.

In FMS patients, TrPs were found, and the semispinalis capitis was the next most likely muscle to have TrPs (6 patients). TrP palpation clearly reproduced the headache in 8 of 11 patients. TrPs were predominantly on the most symptomatic side.

The relationship of hypothyroidism to widespread muscle pain, whether fibromyalgia or myofascial pain, remains a controversial issue and is not widely accepted by endocrinologists. This may be true largely because, until very recently, the causes of those two pain diagnoses were not convincingly identified.

=== The TrP Response ===

As many FMS patients have persistent or recurrent TrPs, and as none of the studies excluded myofascial TrPs as a cause of tender points, FMS findings are likely to be relevant to chronic myofascial pain as well. Despite these reports, the relationship of hypothyroidism to widespread muscle pain, whether fibromyalgia or myofascial pain, remains controversial.

* Patients referred to us with MPS often arrive untreated for their slightly low thyroid function because they have only mild symptoms of hypothyroidism and borderline low, or low normal, thyroid tests
* Experience has shown that these patients are more susceptible to myofascial TrPs and they obtain only temporary pain relief with specific myofascial therapy
* Their poor response to therapy is greatly improved by supplemental thyroid, if they have no other major perpetuating factor
* In hyperthyroidism, active TrPs are uncommon, but respond well to therapy — Dr. Travell could not remember seeing a hyperthyroid patient with TrPs unresponsive to specific myofascial therapy

=== The Thiamine-Thyroid Interaction ===

Thyroid hormone therapy ''alone'' may not clear the TrPs in hypothyroid patients any more than these patients might recover spontaneously if they were euthyroid patients. However, one author (RDG) has repeatedly seen considerable reduction in TrPs and even full recovery from MPS within 4–6 weeks of achieving a TSH of 0.5–2.0 mIU/L in hypothyroid myofascial pain patients.

A critical interaction: '''before starting treatment with thyroid hormone it is important that the patient have an adequate vitamin B₁ level.''' Since thiamine increases metabolism and thiamine requirements are metabolism-dependent, thyroid therapy can convert a vitamin B₁ inadequacy to a severe vitamin B₁ deficiency. If there is any doubt, the patient should first be given a sufficient supplement of vitamin B₁ to establish a safe level (25–100 mg, three times daily, for at least 2 weeks before starting thyroid medication). Thiamine in a reduced dosage should be continued during thyroid therapy.

Smoking impairs the action of thyroid hormone and will accentuate the clinical features of hypothyroidism, including raising thyrotropin levels, total and LDL cholesterol levels, and CK levels, and prolonging the ankle reflex duration. Every effort should be made to help the patient stop smoking.

== Forms of Hypothyroidism ==

=== Mild (Subclinical) Hypothyroidism ===

The issues relating to hypometabolism in patients with chronic myofascial pain more often concern mild hypothyroidism rather than overt, clinically advanced disease. Mild hypothyroid failure is often called subclinical hypothyroidism. Danese et al. defined this condition as an elevated serum TSH in the presence of a normal serum free T₄, and noted that it may or may not be symptomatic. The condition is more common in women than men, and increases in frequency with age. Some studies report the prevalence to be as high as 17% in women and 7% in men.

Identification and treatment of individuals with subclinical hypothyroidism can reverse subtle clinical symptoms of thyroid hormone deficiency, including multiple muscles with myofascial TrPs that may not be thought of as a manifestation of thyroid disease.

=== Hashimoto's Thyroiditis ===

Chronic autoimmune (Hashimoto's) thyroiditis is a common disorder, causing the majority of cases of hypothyroidism. Autopsy prevalence rates of significant thyroiditis are as high as 15% in women and 5% in men. When iodine deficiency is not an issue, 50% of individuals with serum TSH levels > 5 mIU/L and 80% of those with TSH levels > 10 mIU/L had thyroid antibodies characteristic of thyroiditis. The presence of antithyroid microsomal antibodies indicates autoimmune thyroiditis.

=== Causes of Hypothyroidism ===

Hypothyroidism can be produced by:
* Inorganic iodine in excess of that normally provided in the diet
* Organic iodine in pharmacological preparations such as the antiarrhythmic agent amiodarone, the asthma drug combination elixophyllin-KI, and intravenous contrast agents — especially true in patients with autoimmune thyroiditis or otherwise impaired damaged thyroid
* Lithium inhibits the secretion of thyroid hormone; subclinical hypothyroidism (abnormalities of thyroid function tests) and clinically overt hypothyroidism each occur in 20% of patients taking lithium on a long-term basis
* Anticonvulsant drugs (phenytoin and carbamazepine) displace thyroid hormone from its binding to serum proteins, resulting in lower serum T₄ and T₃ levels; however, this results in increased free hormone fractions, resulting in normal free T₃ and T₄ concentrations
* Glucocorticoids in large doses decrease the activity of T₄ 5'-deiodinase, inhibiting the conversion of T₄ to T₃, resulting in significant decreases of serum T₃
* Chronic opiate use (methadone, slow release morphine, oxycodone) increases serum TBG concentrations, raising the serum T₄ concentration but not necessarily increasing the active, free fraction of the hormone

== Confusing Symptoms of Hypometabolism ==

Inadequate metabolism may cause additional symptoms that are suggestive of myxoedema or, in some patients, just the opposite:
* The latter group of patients are thin, nervous, and hyperactive — '''confusingly, just as if they were hyperthyroid'''
* Constipation is much more likely than diarrhoea
* Disturbed menses may be evidenced by menorrhagia, amenorrhoea, or irregular menses
* Patients are likely to suffer from dry, rough, sallow skin — they often mask this with an emollient skin cream
* Some individuals have difficulty losing weight
* Patients are intolerant to low-dose thyroid therapy repeatedly — this has been due to this dose aggravating symptoms of vitamin B₁ deficiency

Rosen has reported the occurrence of myoedema in response to TrP injections, which he attributes to histamine sensitivity. However, myoedema is a well-described phenomenon in hypothyroidism, and such patients should be evaluated for hypothyroidism.

Sonkin notes that diffuse muscle tenderness may be the major physical finding in mild hypothyroidism. Sonkin points out that 73% of the patients treated with thyroid supplementation had symptomatic improvement; responsiveness was correlated with the degree of change in the basal metabolic rate and in cholesterol levels.

== Thyroid Function Measurement ==

=== The Testing Cascade ===

The measurement of thyroid function has undergone great changes in the past two or three decades. The basal metabolic rate test gave way to thyroxine-based testing that in turn has been replaced by the newer sensitive thyrotropin (sTSH) assays.

'''Klee and Hay recommend a scheme for evaluating thyroid function employing a second generation sTSH test''' that can measure to 0.1 mIU/L. If that is normal, no further testing need be done.

# Perform '''second generation sTSH test'''
# If sTSH is elevated: obtain FT₄ and microsomal antibody tests
# If sTSH is low (less than 0.3 mIU/L): obtain FT₄
# If FT₄ is normal: obtain FT₃
# If the second generation sTSH is below 0.1 mIU/l: perform a '''third generation sTSH test'''

This "thyroid cascade" can be performed on the initial sample of blood, providing a rapid turnaround time and minimising patient discomfort and inconvenience.

=== Key Tests and Their Interpretation ===

'''sTSH (sensitive thyrotropin):'''
* The preferred initial test for stable ambulatory patients with normal pituitary function — the pituitary gland is a sensitive monitor of the body's requirement for thyroid hormone
* Elevated sTSH indicates primary hypothyroidism or inadequate thyroid hormone replacement therapy
* A very low sTSH level (less than 0.1 mIU/L) indicates hyperthyroidism, either exogenous or primary

'''Free thyroxine (FT₄):'''
* Gives an indication of the severity of the thyroid dysfunction
* FT₄ is elevated in hyperthyroidism and is low in hypothyroidism
* Almost all T₄ and T₃ is bound to one of the three major transport proteins, primarily thyroxine-binding-globulin (TBG) — only the 0.1% free hormone concentration is active
* Drugs that alter the binding of thyroxine to these proteins will alter total serum levels of T₄ and T₃, but do not affect the serum concentrations of free T₄ and T₃

'''Free triiodothyronine (FT₃):'''
* Useful in the assessment of hyperthyroidism, and is appropriately assessed when sTSH is low and FT₄ is normal

'''sTSH determinations are not affected by renal or hepatic disease, or by oestrogen therapy.'''

=== Drug Effects on Thyroid Function Tests ===

* '''Estrogen raises TBG concentrations''' — resulting in elevations of serum T₄ concentrations of 20–35% at usual doses of estradiol. TrPs are more common in women with a chronic deficiency of oestrogen, and oestrogen supplement decreases TrP activity
* '''Salicylates in high doses''' (>2.0 g/day) inhibit the binding of T₃ and T₄ to TBG, but do not affect the serum free T₄ concentration
* '''Androgens and glucocorticoid steroids''' decrease TBG concentrations, although free T₃ and T₄ concentrations remain unchanged
* '''Lithium''' inhibits the secretion of thyroid hormone; subclinical and overt hypothyroidism each occur in 20% of patients taking lithium long-term
* '''Amiodarone''' — especially true in patients with autoimmune thyroiditis

=== Thyroid Tests in Clinical Practice ===

Practical clinical indicators suggesting thyroid evaluation in MPS patients:

* '''TSH should be obtained''' if it is clearly elevated, then treatment with levothyroxine (T₄) should be started
* If the TSH is between 4.0 and 6.0 mIU/L, the sTSH and FT₄ should be evaluated
* If these levels are borderline, the CK and serum cholesterol can help reach a determination of thyroid status
* If either are elevated, thyroid supplementation can be started
* Once supplementation is started, sTSH is used to monitor the result; the target range is being 0.5–2.5 mIU/L

Clinical tip-offs for hypothyroidism screening:
* Symptoms of widespread chronic fatigue, coldness or cold intolerance, constipation, dry skin, dry hair, husky voice, or mild periorbital oedema
* Slowed ankle reflex return
* Multiple treatment-resistant TrPs

== Treatment of Hypothyroidism ==

=== Levothyroxine (T₄) ===

Levothyroxine (T₄) is the treatment of choice for hypothyroidism. Adults require about 1.7 μg/kg of body weight for complete replacement of thyroid hormone. In younger individuals, treatment can be initiated at the full dose. In persons over the age of 50, the replacement dose needed may be less, and the starting dose should be 0.025–0.05 mg of levothyroxine daily.

In persons with peripheral resistance to thyroid hormone, the eventual dose of T₄ needed to normalise function can be quite high. The maintenance dose is monitored by measuring serum TSH, which should be in the lower normal range. Thyroxine has a half-life of about one week — therefore the steady state of serum T₄ is not reached for about 4 weeks after initiation of therapy. Tests of serum TSH levels to monitor the dose of thyroxine should be done no sooner than every 4–5 weeks.

T₄ is physiologically converted to T₃ at rates that are determined by the state of the individual. Over 80% of circulating T₃ is derived by deiodination of extrathyroidal T₄. The most physiological means of providing T₃, therefore, is to give thyroxine and to let the body needs regulate the rate of conversion of T₄ to T₃.

Several generic and brand name levothyroxine products have been compared and found to be bioequivalent — an important factor in a drug that is being used for long periods of time and in many persons.

=== The B₁ Prerequisite ===

'''Before starting treatment with thyroid hormone it is important that the patient have an adequate vitamin B₁ level.'''

Since thiamine increases metabolism and thiamine requirements are metabolism-dependent, thyroid therapy can convert a vitamin B₁ inadequacy to a severe vitamin B₁ deficiency. Suggested protocol:
* Give vitamin B₁, 25–100 mg three times daily, for at least 2 weeks before starting thyroid medication
* Continue thiamine in a reduced dosage during thyroid therapy
* "Intolerance" to low-dose thyroid therapy that has repeatedly occurred should be recognised as a sign of thiamine deficiency being unmasked, not as true intolerance to the thyroid hormone

=== Smoking and Thyroid Therapy ===

Smoking impairs the action of thyroid hormone and will accentuate the clinical features of hypothyroidism, including raising thyrotropin levels, total and LDL cholesterol levels, and CK levels, and prolonging the ankle reflex duration. Every effort should be made to help the patient stop smoking and to prevent others from becoming addicted. See [[wikipedia:Smoking_cessation|Smoking cessation — Wikipedia]].

=== Thyroid Hormone and Pregnancy ===

Thyroid supplementation in hypothyroid patients must be increased during pregnancy, with the additional dose determined by the serum TSH level. TrPs are more common in women with a chronic deficiency of oestrogen.

== The Biology of Starvation: Thyroid Function ==

The relationship between starvation and thyroid function illustrates how the body prioritises survival over metabolic efficiency in conditions of acute caloric deprivation:

'''The euthyroid sick syndrome (non-thyroidal illness syndrome):'''
In any significant illness, injury, or starvation, serum T₃ falls while reverse T₃ (rT₃) rises — this is not hypothyroidism but an adaptive response that reduces basal metabolic rate to conserve energy. The conversion of T₄ to the active T₃ is reduced, and the conversion to the inactive rT₃ is increased.

In the context of chronic pain and myofascial pain specifically:
* Chronic stress, pain, and inflammatory cytokines all suppress T₃ conversion — creating a functional hypometabolic state that perpetuates TrPs even when thyroid gland function is structurally normal
* Severe caloric restriction (crash dieting, restrictive eating) reduces T₃ levels within days — the body responds to reduced caloric intake as if to starvation, reducing its basal metabolic rate
* Refeeding after starvation must therefore be accompanied by normalisation of thyroid function monitoring, as thyroid requirements may shift rapidly

'''The chromatin remodelling cascade:'''
T₃ receptors are nuclear transcription factors — meaning that thyroid hormones directly regulate gene expression across virtually every cell type. In starvation, the fall in T₃ reduces the transcription of genes encoding:
* Mitochondrial ATP synthase subunits — reducing maximal ATP production capacity
* SERCA (sarcoplasmic/endoplasmic reticulum Ca²⁺-ATPase) — impairing the calcium pump that relaxes muscle and normally prevents the sustained sarcomere shortening of TrPs
* Fast myosin heavy chain isoforms — shifting muscle toward slow, energy-inefficient fibres

This means that in starvation, the muscle becomes structurally less capable of efficient contraction and complete relaxation — setting the stage for the sustained shortened sarcomeres and energy depletion that define TrP formation.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin_B1_Thiamine_and_TrPs|Vitamin B₁ (Thiamine) and Trigger Points]] — critical prerequisite before starting thyroid therapy
* [[Concept:Iron_and_TrPs|Iron and Trigger Points]] — iron deficiency impairs T₃ response to cold; cold intolerance is shared symptom
* [[Concept:Calcium_and_TrPs|Calcium and Trigger Points]] — T₃ controls calcium ATPase in sarcoplasmic membrane; hypothyroidism impairs muscle relaxation
* [[wikipedia:Hypothyroidism|Hypothyroidism — Wikipedia]]
* [[wikipedia:Subclinical_hypothyroidism|Subclinical hypothyroidism — Wikipedia]]
* [[wikipedia:Hashimoto%27s_thyroiditis|Hashimoto's thyroiditis — Wikipedia]]
* [[wikipedia:Thyroid_hormones|Thyroid hormones — Wikipedia]]
* [[wikipedia:Thyroxine|Thyroxine — Wikipedia]]
* [[wikipedia:Triiodothyronine|Triiodothyronine — Wikipedia]]
* [[wikipedia:Thyroid-stimulating_hormone|TSH — Wikipedia]]
* [[wikipedia:Euthyroid_sick_syndrome|Euthyroid sick syndrome — Wikipedia]]
* [[wikipedia:Thyroid_function_tests|Thyroid function tests — Wikipedia]]
* [[wikipedia:Smoking_cessation|Smoking cessation — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section D. With contributions by Robert D. Gerwin, MD.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Endocrine]]

Concept:Calcium and TrPs

2026-04-19T19:43:00Z

Yatreyu: Created page with "'''Calcium''' is the most abundant mineral in the human body and is essential to muscle contraction, nerve impulse transmission, and the release of acetylcholine (ACh) at the neuromuscular junction — making it directly relevant to the trigger point (TrP) mechanism. Calcium ions control the molecular machinery that initiates and terminates the actin-myosin interaction at the heart of every muscle twitch, and their dysregulation at the motor endplate is central to the hy..."

'''Calcium''' is the most abundant mineral in the human body and is essential to muscle contraction, nerve impulse transmission, and the release of acetylcholine (ACh) at the neuromuscular junction — making it directly relevant to the trigger point (TrP) mechanism. Calcium ions control the molecular machinery that initiates and terminates the actin-myosin interaction at the heart of every muscle twitch, and their dysregulation at the motor endplate is central to the hypothesis of TrP formation (see Chapter 2 of the source volume).

There is no study that has directly linked an abnormality of calcium metabolism to myofascial pain syndromes, and disturbances in serum calcium levels are extremely uncommon in patients with chronic MPS. Nevertheless, calcium is of great interest in MPS because of its role in the contraction of muscle, and also because of its role in modulating pain responses at the nociceptor cell level through voltage-gated calcium channels, at the triad where the sarcoplasmic reticulum communicates with the T tubule, and in the dorsal horn of the spinal cord.

== Biochemical Functions ==

=== The Role of Calcium in Muscle Contraction ===

Calcium is essential to the transmission of an action potential across the myoneural junction and to normal excitation-contraction of the myofilaments.

The molecular sequence of skeletal muscle contraction depends on calcium at every step:

# An action potential travels along the motor nerve and arrives at the motor endplate
# The action potential triggers voltage-gated Ca²⁺ channels in the presynaptic terminal, causing Ca²⁺ influx — this Ca²⁺ influx is '''essential for the release of acetylcholine''' from synaptic vesicles into the synaptic cleft
# ACh crosses the cleft and binds nicotinic receptors on the muscle fibre membrane
# The resulting depolarisation propagates along the T-tubules deep into the muscle fibre
# Voltage sensors in the T-tubule membrane (dihydropyridine receptors) trigger opening of calcium-release channels (ryanodine receptors) in the sarcoplasmic reticulum
# '''Intracellular Ca²⁺ floods the cytoplasm''' — this is the calcium signal that initiates contraction
# Ca²⁺ binds to troponin C on the thin filament, causing a conformational change that moves tropomyosin away from the actin-binding sites
# Myosin heads can now bind actin and execute the power stroke — muscle shortening occurs
# Relaxation requires active re-sequestration of Ca²⁺ into the sarcoplasmic reticulum by the Ca²⁺-ATPase pump (SERCA)
# '''Removal of Ca²⁺ from the cytoplasm returns troponin C to its inhibitory conformation''' — the muscle relaxes

'''Muscle relaxation is controlled by the balance between fast and slow forms of calcium ATPase in the sarcoplasmic membrane''' — a process controlled by thyroid hormone T₃. In hypothyroidism, this balance is disturbed, causing the slow muscle relaxation characteristic of hypothyroid myopathy.

In excitation and contraction of skeletal muscle, depolarisation of the T-tubule membrane results in the opening of Ca²⁺ (ionised calcium) release channels in the sarcoplasmic reticulum. '''Intracellular Ca²⁺ plays a greater role than extracellular Ca²⁺''' in this response to neural stimulation. Removal of Ca²⁺ depresses the twitch tension, and there is a dependence of muscle contraction on extracellular calcium concentration. Extracellular calcium concentration or blockade of Ca²⁺ entry can modulate contractile responses.

=== Calcium and the TrP Mechanism ===

In the integrated hypothesis of TrP formation (Travell and Simons), the sustained abnormal ACh release at the dysfunctional motor endplate creates a persistent localised calcium release from the sarcoplasmic reticulum. This results in:
* Sustained sarcomere shortening — the taut band
* Local energy depletion as SERCA pumps consume ATP attempting to restore Ca²⁺ to the SR
* Local acidosis and accumulation of metabolic byproducts that sensitise nociceptors

The failure of the calcium pump under conditions of ATP depletion (from ischaemia or metabolic insufficiency) allows Ca²⁺ to remain elevated intracellularly — perpetuating the contraction and the energy crisis in a self-reinforcing loop. This is the molecular basis for the "energy crisis" hypothesis of TrP pathophysiology.

=== Calcium at the Nociceptor ===

Beyond the muscle itself, calcium plays roles in pain modulation:
* Voltage-gated calcium channels in nociceptor cell membranes regulate the threshold for nociceptor firing
* Ca²⁺ entry into dorsal horn neurons influences the release of excitatory neurotransmitters (glutamate, substance P) and contributes to the phenomenon of central sensitisation
* Blockade of voltage-gated calcium channels (by gabapentinoids, for example) reduces nociceptor sensitivity — the pharmacological relevance of calcium to pain management

=== Calcium and Acetylcholine Release ===

Calcium is essential at the nerve terminal for release of acetylcholine — it is essential for release of acetylcholine at the nerve terminal and for the excitation-contraction mechanism of the actin and myosin filaments. The importance of this to TrP theory is that any state of abnormal calcium channel function at the motor endplate — whether from metabolic insufficiency, focal ischaemia, or neuromuscular junction abnormality — will dysregulate ACh release and potentially initiate the TrP cascade.

A careful search of the literature demonstrates reduced endplate activity that is lower in amplitude and harder to find in the context of low potassium. This indicates reduced release of excessive acetylcholine characteristic of active loci of TrPs — the role of calcium in ACh release makes calcium status relevant to the spontaneous electrical activity at TrP endplates.

=== Calcium in Bone ===

Calcium phosphate crystals form bone. Without vitamin C to provide the collagen needed for a firm vessel wall, and without calcium to deposit as the mineral phase, bone mineralisation fails. The roles of vitamin C (see [[Concept:Vitamin_C_and_TrPs|Vitamin C and TrPs]]) and calcium are complementary in bone maintenance.

=== Calcium and the Magnesium Relationship ===

'''Hypocalcaemia that develops as the result of magnesium deficiency improves only with the administration of magnesium as well as calcium''' — low serum calcium from this cause will usually return to normal levels within a week after initiating magnesium repletion by oral supplements of antacid or laxative preparations containing magnesium.

The Ca/Mg ratio is important: the optimal Ca/Mg ratio of 2:1 — when not reached — may reduce the efficiency of Mg absorption, accentuate the effects of low oestrogen, and result in lowered Mg entry into bone, with consequent increased risk of osteoporosis. Many older individuals do not achieve the recommended dietary intake of Mg, yet take calcium supplements — in these individuals, the optimal Ca/Mg ratio is not reached.

== Insufficiency, Deficiency and Hypocalcaemia ==

There is no study that has linked an abnormality of calcium metabolism to myofascial pain syndromes. Disturbances in serum calcium levels are extremely uncommon in patients with chronic MPS. Nonetheless, calcium insufficiency affects:
* Neuromuscular transmission — hypocalcaemia produces increased neuromuscular excitability (tetany, positive Chvostek and Trousseau signs), which is the clinical manifestation of disordered Ca²⁺-dependent modulation of action potential generation
* '''Note:''' Chvostek and Trousseau signs are also signs of magnesium deficiency; hypomagnesaemia often coexists with hypocalcaemia and may be the primary driver
* Cardiac muscle function — the action potential duration and the plateau phase are calcium-dependent; hypocalcaemia can produce an abnormal electrocardiogram

A '''low serum total calcium''' on the blood chemistry profile suggests a calcium deficiency, but for determination of the adequacy of available calcium, a serum '''ionised calcium''' measurement is needed. A normal value of total serum calcium does not ensure adequate calcium nutrition — the physiologic effects of calcium depend on the free ionic calcium; the total calcium, much of which is bound to protein, has no direct correlation with the concentration of serum ionised calcium.

== Requirements ==

Optimum calcium intake is estimated to be:
* '''1200–1500 mg/day''' for adolescents and young adults
* '''1000 mg/day''' for women between the ages of 25 and 50
* '''1500 mg/day''' for postmenopausal women taking oestrogen replacement therapy
* '''1500 mg/day''' for postmenopausal women not taking oestrogen replacement therapy
* '''1000 mg/day''' for adult men
* '''1500 mg''' for all persons over the age of 65

Vitamin D is essential for optimal absorption of calcium — it helps absorption of approximately 85% of calcium and 40% of phosphorus via the gut. Calcium intakes up to 2500 mg/day do not result in hypercalcaemia in normal persons.

Adequate absorption of calcium clearly requires sufficient vitamin D, with evidence that fluoride, phosphate, magnesium, and sometimes oestrogen are also important for its absorption and utilisation. '''Patients with gastrointestinal malabsorption disorders such as Crohn's disease may have low plasma calcium alongside deficiencies of vitamin C, copper, niacin, and zinc''' — calcium status should always be evaluated in the context of the full nutritional picture.

== Sources ==

=== Dietary Sources ===

A simple way to meet dietary calcium needs is to eat at least 2 servings daily from the milk group:
* 30 g (1.5 oz) brick cheese
* A serving of yogurt
* 2 cups of cottage cheese

For those who cannot drink milk because of allergy or lactose intolerance, calcium may be obtained from milk that is predigested by the enzyme lactase. One can avoid increased intake of saturated fat when eating dairy foods by using low-fat or no-fat dairy products.

Other food sources with meaningful calcium content:
* Green leafy vegetables (broccoli, kale, bok choy)
* Legumes
* Canned salmon and sardines (with bones)
* Oysters, clams
* Dried figs and soybean curd (tofu)
* Fortified non-dairy milks

=== Supplementation ===

If the patient cannot tolerate dietary sources, a supplement such as calcium phosphate or calcium carbonate should be prescribed — e.g., Os-Cal, from ground oyster shell, which has vitamin D added. Three 250-mg tablets provide 750 mg of elemental calcium and 375 units of vitamin D₂. However, the large 500-mg tablets contain no vitamin D. Calcium supplements have the same bioavailability as calcium supplied by drinking milk.

'''Important interactions:'''
* Calcium supplements should '''not''' be taken together with iron supplements — calcium can decrease non-haem iron absorption by 50%, and can also significantly reduce absorption of haem iron (see [[Concept:Iron_and_TrPs|Iron and TrPs]])
* Take calcium supplements at a different time of day from iron supplements
* High dietary phosphate (from soft drinks and processed foods) impairs calcium absorption and may contribute to negative calcium balance

== The Biology of Starvation: Calcium ==

Calcium's behaviour in starvation reveals a fundamental conflict between the body's short-term priorities and its long-term structural needs.

'''The conservation paradox:'''
Unlike the water-soluble vitamins, calcium is not simply excreted in excess and depleted by restriction. Instead, the body maintains serum calcium within an extraordinarily narrow range (2.2–2.6 mmol/L) through a hormonal system — parathyroid hormone (PTH), calcitriol (1,25-dihydroxyvitamin D₃), and calcitonin — that will sacrifice bone to maintain serum calcium. In starvation:

# Dietary calcium restriction triggers PTH secretion
# PTH stimulates osteoclastic bone resorption — mobilising calcium from bone into blood
# Serum calcium remains normal until bone stores are substantially depleted
# Meanwhile, calcitriol increases intestinal calcium absorption efficiency to extract maximum calcium from reduced dietary intake

This means that '''serum calcium will appear normal throughout most of the starvation period despite progressive bone demineralisation'''. Standard blood tests for calcium are therefore poor indicators of calcium nutritional status in starvation.

'''Protein-energy starvation accelerates bone loss through additional mechanisms:'''
* IGF-1 (which supports bone formation) falls in protein-energy malnutrition
* Cortisol (elevated in starvation and chronic stress) directly inhibits osteoblast activity and reduces intestinal calcium absorption
* The chronic inflammatory cytokines that accompany both starvation and chronic pain (TNF-α, IL-1, IL-6) stimulate osteoclast differentiation and bone resorption
* Vitamin D deficiency — extremely common in populations with limited sunlight exposure and dietary restriction — impairs the intestinal absorption of calcium and the mineralisation of osteoid

'''The muscle relevance of starvation-related calcium dysregulation:'''
In protein-energy malnutrition, muscle contractile protein is degraded for gluconeogenesis. As myosin and actin are consumed, the structural context for the Ca²⁺-dependent contractile cycle is disrupted. The sarcoplasmic reticulum, which sequesters and releases calcium in each contraction cycle, is itself a membrane-bound structure whose integrity depends on phospholipid synthesis (requiring B vitamins) and protein maintenance. Structural degradation of the SR in starvation impairs calcium handling at the most fundamental level — the SERCA pump cannot sequester Ca²⁺ efficiently when its membrane environment is damaged — creating the conditions for sustained intracellular Ca²⁺ elevation that characterises the TrP active locus.

In the context of myofascial pain, this means that patients with chronic pain who are simultaneously protein-malnourished (common in elderly patients, in patients with anorexia secondary to depression or chronic illness, and in patients on severely restricted diets) are at risk for impaired calcium handling in muscle independent of their serum calcium levels. The treatment implication is that nutritional rehabilitation — adequate protein, calcium, vitamin D, and magnesium — is a prerequisite for effective TrP management in nutritionally depleted patients.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Iron_and_TrPs|Iron and Trigger Points]] — calcium inhibits iron absorption; do not combine supplements
* [[Concept:Vitamin_C_and_TrPs|Vitamin C and Trigger Points]] — vitamin C essential for collagen that supports bone
* [[Concept:Hypometabolism_and_TrPs|Hypometabolism and Trigger Points]] — thyroid hormone T₃ controls calcium ATPase in sarcoplasmic membrane; hypothyroidism impairs muscle relaxation
* [[wikipedia:Calcium_in_biology|Calcium in biology — Wikipedia]]
* [[wikipedia:Calcium_metabolism|Calcium metabolism — Wikipedia]]
* [[wikipedia:Muscle_contraction|Muscle contraction — Wikipedia]]
* [[wikipedia:Troponin|Troponin — Wikipedia]]
* [[wikipedia:Sarcoplasmic_reticulum|Sarcoplasmic reticulum — Wikipedia]]
* [[wikipedia:SERCA|SERCA — Wikipedia]]
* [[wikipedia:Voltage-gated_calcium_channel|Voltage-gated calcium channel — Wikipedia]]
* [[wikipedia:Parathyroid_hormone|Parathyroid hormone — Wikipedia]]
* [[wikipedia:Hypocalcaemia|Hypocalcaemia — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Nutrition]]

Concept:Iron and TrPs

2026-04-19T19:42:48Z

Yatreyu: Created page with "'''Iron''' is an essential mineral whose deficiency is estimated to be present in 9–11% of adolescent girls and women of childbearing age in the United States — making it the most prevalent micronutrient deficiency in the developed world. Iron deficiency increases the irritability of myofascial trigger points (TrPs) through multiple mechanisms: it impairs oxygen transport to muscle, disrupts oxidative phosphorylation in mitochondria, impairs thermoregulation, disturb..."

'''Iron''' is an essential mineral whose deficiency is estimated to be present in 9–11% of adolescent girls and women of childbearing age in the United States — making it the most prevalent micronutrient deficiency in the developed world. Iron deficiency increases the irritability of myofascial trigger points (TrPs) through multiple mechanisms: it impairs oxygen transport to muscle, disrupts oxidative phosphorylation in mitochondria, impairs thermoregulation, disturbs catecholamine metabolism, and reduces work capacity — each of which directly converges on the energy crisis at the TrP endplate.

The symptom of coldness that is often seen in persons with chronic myofascial pain has iron deficiency as one of its causes — a fact confirmed when impaired thermoregulation was present in 57% of patients with myofascial pain syndrome, with tissue iron depletion found in 65%.

== Biochemical Functions ==

Iron serves essential roles throughout human metabolism:

=== Oxygen Transport and Storage ===

Iron is the central atom of '''haem''', the prosthetic group of:
* '''Haemoglobin''' — the oxygen-carrying protein of red blood cells; transports oxygen from lungs to all tissues
* '''Myoglobin''' — the oxygen-storage protein of muscle fibres; provides the immediate oxygen reserve for aerobic metabolism in muscle

The relation of iron to muscle pain has several facets. One is the essential role of iron in energy production and oxygenation that affects the ability of muscle to meet its energy demands. '''This energy factor relates strongly to the TrP mechanism''' (see Chapter 2, Section D of the source volume).

=== Mitochondrial Oxidative Phosphorylation ===

Iron is required for enzymatic reactions that have to do with '''tissue respiration''' and '''oxidative phosphorylation''':
* Cytochrome oxidase reactions — iron is the essential redox-active atom in the cytochromes of the electron transport chain
* Porphyrin metabolism
* Collagen synthesis (iron-dependent hydroxylases)
* Neurotransmitter synthesis and catabolism

Iron-deficient animals accumulate lactic acid as a result of impaired glycolysis, and this is also postulated to be the cause of reduced physical activity. The effect of iron on energy metabolism is of special interest because of the hypothesis that the myofascial TrP is a localised region of "energy crisis" that reflects the metabolic distress of the muscle stress.

=== Thyroid Hormone and Thermoregulation ===

Another role of iron in myofascial pain is its regulation of hormonal functions like thyroid hormone — which itself plays a critical role in energy metabolism and is clinically important in chronic myofascial pain syndromes. Iron deficiency anaemia is associated with:
* '''Impaired thermoregulation''' — the ability to maintain body temperature is compromised
* '''Impaired triiodothyronine (T₃) response to a cold stressor'''
* Impaired catecholamine response to environmental cold
* Increase in catecholamine levels may represent the body's attempt to raise core temperature

Iron deficiency anaemia in young women impaired the ability to maintain body temperature when exposed to a moderately cold environment. Plasma triiodothyronine and thyroxine levels were both decreased in women with iron-deficiency anaemia.

=== Catecholamine Metabolism ===

Iron is required for the synthesis and catabolism of catecholamines. Impaired catecholamine metabolism in iron deficiency produces additional autonomic dysregulation that compounds TrP irritability.

=== Immune Function ===

Iron-dependent enzymes are essential for the respiratory burst of neutrophils and for lymphocyte proliferation. Chronically iron-deficient patients have impaired immune surveillance, which contributes to susceptibility to the chronic infections that themselves perpetuate TrPs.

== Stages of Iron Deficiency ==

Iron deficiency occurs in three distinct stages:

# '''Stage 1 — Depletion of tissue iron stores:''' detected by serum ferritin levels; the patient may be entirely asymptomatic
# '''Stage 2 — Depletion of essential iron stores''' associated with metabolic and enzymatic activity: iron-dependent enzyme activities decline; the patient may experience reduced work capacity, impaired thermoregulation, and increased TrP irritability before anaemia develops
# '''Stage 3 — Deficient erythropoiesis''' leading to iron deficiency anaemia: haemoglobin and haematocrit fall; full clinical anaemia; the TrP-relevant metabolic effects of stages 1 and 2 are now compounded by tissue hypoxia

'''Detection of iron insufficiency before anaemia develops is most important''', because decreased work capacity and impaired energy metabolism are present in stages 1 and 2, before the haematological markers of anaemia appear.

Iron deficiency anaemia is associated with impaired thermoregulation or ability to maintain body temperature, with impaired triiodothyronine response to a cold stressor, and with impaired catecholamine response to environmental cold. '''The symptom of coldness was present in 57% of patients with myofascial pain syndrome''' in one study, and of these, tissue iron depletion was found in 65%. Work capacity is reduced in iron-deficient women.

== Laboratory Assessment ==

=== Serum Ferritin — The Key Test ===

Measurement of serum ferritin is an accurate way of assessing tissue iron stores. Normal serum ferritin levels have a two-fold diurnal variation and are less sensitive to the state of tissue iron stores than ferritin.

| Ferritin level | Clinical significance |
|---|---|
| < 20 ng/ml | Signifies iron loss without adequate replacement |
| 20–30 ng/ml | May signify iron loss without adequate replacement |
| 30–50 ng/ml | May indicate need for replacement of iron stores |
| > 50 ng/ml (up to 300 ng/ml) | Normal tissue iron stores |

Depletion of tissue iron is reflected in the lowering of serum ferritin levels, as non-essential iron stores are depleted first. Essential iron stores are depleted when serum ferritin levels reach 20 ng/ml.

=== Iron Requirements and Daily Losses ===

Iron requirements are determined by daily iron losses, which are about 0.8–1.0 mg daily, except in menstruating women whose losses are 1.4–2.4 mg/day. About 10% of dietary iron is absorbed, with a ceiling of 4–5 mg/day in anaemic individuals.

=== Complete Blood Count Limitations ===

The CBC provides important secondary information:
* Low erythrocyte count, low haemoglobin, and low/or microcytosis indicates anaemia — which tends to make muscles hypoxic and to increase TrP irritability
* An increased mean corpuscular volume (MCV) > 92 fl is suspicious as it rises from 95 to 100 fl — the likelihood of a folate or cobalamin deficiency increases
* Eosinophilia may be due to an active allergy or to infestation with an intestinal parasite such as a tapeworm
* An increased proportion of mononuclear cells (> 50%) may occur because of low thyroid function or due to active infectious mononucleosis or an acute viral infection

However, '''absence of anaemia does not exclude clinically significant iron deficiency''' — stages 1 and 2 are pre-anaemic but already metabolically consequential.

== Dietary Sources ==

Iron is present in food as easily absorbed '''haem iron''' or as poorly absorbed '''non-haem iron''':

=== Haem Iron (from animal products) ===
* Directly absorbed into intestinal cells as the intact haem molecule
* Absorption rate: approximately 20–30% regardless of the iron status of the individual
* Sources: red meat, organ meats, dark poultry meat, shellfish

=== Non-Haem Iron (from plant products and supplements) ===
* Absorption rate: highly variable, 1–15%, depending on numerous factors
* Sources: legumes (lentils, beans), dark leafy greens, fortified cereals, nuts and seeds, dried fruit, iron cooking vessels

=== Enhancers and Inhibitors of Non-Haem Iron Absorption ===

'''Major absorption promoter:'''
* '''Ascorbic acid (vitamin C)''' — the most potent absorption promoter; the strong iron absorption promoter ascorbic acid can overcome the effect of dietary inhibitors to a significant degree. This is why taking iron supplements with vitamin C significantly improves absorption

'''Major inhibitors:'''
* '''Calcium''' — calcium in milk, cheese, or as a supplement can decrease non-haem iron absorption by 50%, and can also significantly reduce absorption of haem iron. '''Calcium supplements should NOT be taken together with iron supplements'''
* '''Phytic acids''' — components of cereal grains, constituting 1–2% of many cereals, nuts, and legumes; chelate heavy metals and are potent inhibitors of iron absorption; however, the presence of phytic acids in nuts and soy is offset by the high iron content of these foods
* Polyphenols (in tea, coffee, red wine)
* Antacids and proton pump inhibitors

== Causes of Insufficiency and Deficiency ==

* '''Insufficient dietary intake''' — to replace menstrual blood loss places menstruating women at risk of iron insufficiency or deficiency
* '''Iron deficiency in men usually indicates a specific illness''' — such as carcinoma — that must be identified
* Gastric irritation with microscopic blood loss in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) — clinically important in chronic pain patients who use these regularly for pain relief
* Also associated with pernicious anaemia, occurring in 43% of persons diagnosed with this condition; iron deficiency and vitamin B₁₂ deficiency should always be screened together
* Bariatric surgery (particularly Roux-en-Y gastric bypass) reduces stomach size and leads to lower levels of intrinsic factor, gastrin, and hydrochloric acid, impairing iron absorption; long-term monitoring is required as signs may take months or years to appear
* Moderate exercise has been shown to reduce iron stores — but on the other hand, moderate exercise increases iron absorption

== Treatment: A Practical Guide ==

'''Suspect iron inadequacy when:'''
* Myofascial TrPs persist despite appropriate therapy
* Fatigue or coldness are prominent symptoms
* NSAIDs have been taken regularly for pain relief
* Menstruating women, particularly those whose menstrual flow is heavy
* Low erythrocyte volume or low mean cell haemoglobin concentration

=== Measurement ===

Measure iron stores by the serum ferritin test:
* Levels of 20 ng/ml or less signify iron store depletion
* Levels of 30–50 ng/ml may indicate need for replacement of iron stores

=== Treatment Protocol ===

Treat iron depletion at ferritin levels of 30 ng/ml or lower, and even levels up to 40 ng/ml, to prevent depletion. At ferritin levels of 30 ng/ml or less, iron supplements containing '''150 mg of iron (equivalent to 50 mg of elemental iron)''' are taken twice daily if tolerated, or once daily if necessitated by constipation or gastric irritation.

* '''Do not take with calcium supplements''' or with meals of dairy foods
* Taking them with vitamin C helps absorption
* Folic acid 1 mg taken with iron lessens the symptom of gastric irritation
* Supplements are available with stool softeners and in different formulations — finding one that is tolerable is usually possible
* Once the serum ferritin level reaches 30–40 ng/ml, a small daily supplement of 12–15 mg, commonly found in most multivitamin mineral preparations, is enough to maintain tissue iron stores

=== Warning ===

Iron supplementation should '''always be monitored''' to avoid excessive iron storage and haemochromatosis. Serum ferritin levels every 3 months are adequate to monitor supplementation at higher doses, and every 6 months until stable for lower dose maintenance.

'''Iron supplements should not be given unless iron insufficiency is established''' through the measurement of serum ferritin levels, because iron overload can lead to haemochromatosis — ischaemic heart disease and a poorer outcome after stroke.

== The Biology of Starvation: Iron ==

Iron occupies a paradoxical position in starvation biology. Unlike the water-soluble vitamins, iron is not lost rapidly during starvation — the body is exquisitely conservative with iron, having no dedicated excretory pathway. Instead, in starvation, iron deficiency emerges through the collapse of the absorptive infrastructure:

'''The starvation cascade:'''
# Reduction of dietary intake removes the primary iron source
# Atrophy of the gastrointestinal mucosa (driven by protein and folate deficiency) impairs the absorptive epithelium that would concentrate ingested iron
# Protein deficiency reduces the synthesis of transferrin (the iron transport protein) and ferritin (the iron storage protein) — tissue stores cannot be maintained even when some iron is present
# Progressive haemoglobin synthesis failure occurs as protein and iron simultaneously become limiting; anaemia develops
# The anaemia of starvation is therefore a '''combined deficiency anaemia''' — iron, protein, folate, B₁₂, and B₆ all contributing simultaneously

'''The muscle energy cascade in iron-deficient starvation:'''
In iron-deficient starvation, the mitochondrial electron transport chain is progressively impaired as iron-containing cytochromes are not replaced. The muscle cell shifts from efficient oxidative phosphorylation toward anaerobic glycolysis, with lactate accumulation even at rest or minimal activity. This is the '''same metabolic state hypothesised at the active locus of a TrP''' — a localised energy crisis with lactate accumulation, ATP depletion, and consequent failure of the calcium pump.

The evolutionary context is that in ancestral environments, dietary iron was predominantly haem iron from fresh animal products, absorbed at 20–30%. The dominance of plant-based iron with low bioavailability in many modern and traditional diets — combined with the inhibitory effect of phytic acids, calcium, and cooking losses — means that dietary iron adequacy is structurally precarious for large populations, particularly women of reproductive age.

In the chronic pain patient, this means that even patients who eat adequate calories may be iron-insufficient — particularly menstruating women, regular NSAID users, and patients with GI pathology. The symptom cluster of fatigue, coldness, reduced exercise tolerance, and treatment-resistant TrPs should always prompt ferritin measurement.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin_C_and_TrPs|Vitamin C (Ascorbic Acid) and Trigger Points]] — primary enhancer of non-haem iron absorption
* [[Concept:Calcium_and_TrPs|Calcium and Trigger Points]] — major inhibitor of iron absorption; do not combine supplements
* [[Concept:Vitamin_B12_Cobalamin_and_TrPs|Vitamin B₁₂ and Trigger Points]] — pernicious anaemia co-occurs with iron deficiency in 43%
* [[Concept:Hypometabolism_and_TrPs|Hypometabolism and Trigger Points]] — iron deficiency impairs thyroid hormone metabolism
* [[wikipedia:Iron_deficiency|Iron deficiency — Wikipedia]]
* [[wikipedia:Iron_deficiency_anaemia|Iron deficiency anaemia — Wikipedia]]
* [[wikipedia:Ferritin|Ferritin — Wikipedia]]
* [[wikipedia:Haemoglobin|Haemoglobin — Wikipedia]]
* [[wikipedia:Myoglobin|Myoglobin — Wikipedia]]
* [[wikipedia:Haem|Haem — Wikipedia]]
* [[wikipedia:Transferrin|Transferrin — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Nutrition]]

Concept:Vitamin C and TrPs

2026-04-19T19:42:32Z

Yatreyu: Created page with "'''Vitamin C (ascorbic acid; L-ascorbic acid)''' is a water-soluble vitamin of major clinical importance to the muscles because it can prevent much postexercise muscle soreness or stiffness, corrects the increase in capillary fragility associated with ascorbic acid deficiency, and interacts strongly with numerous other vitamins important to muscle function. It is the only reducing substance that specifically regulates dopamine beta-monooxygenase activity in chromaffin ce..."

'''Vitamin C (ascorbic acid; L-ascorbic acid)''' is a water-soluble vitamin of major clinical importance to the muscles because it can prevent much postexercise muscle soreness or stiffness, corrects the increase in capillary fragility associated with ascorbic acid deficiency, and interacts strongly with numerous other vitamins important to muscle function. It is the only reducing substance that specifically regulates dopamine beta-monooxygenase activity in chromaffin cells (adrenal gland medullary cells) in the synthesis of norepinephrine — directly influencing the catecholamine arm of pain transmission.

A practical clinical consequence of vitamin C insufficiency specific to myofascial practice is that '''scorbutic patients are especially liable to develop post-injection haematomas''' — a complication of TrP injections that should be actively avoided. The rate of healing of pressure sores was nearly doubled by increasing serum ascorbic acid levels within the normal range from low normal to high normal.

== Discovery and History ==

Scurvy was the scourge of armies, explorers, and sailors on extended trips without fresh food — Vasco da Gama lost 100 of 160 sailors from scurvy on one voyage. In 1928, Albert Szent-Györgyi isolated a chemical that protects some fruits against discolouration and infection when bruised. The chemical is now known as ascorbic acid, or vitamin C. For its discovery, he won the Nobel Prize in 1937.

Some birds and a few mammals (man, monkeys, the guinea pig, and the Indian fruit bat) are unable to convert D-glucuronic acid to L-ascorbic acid, which makes them dependent on exogenous sources. Three exceptional guinea pigs out of several thousand were apparently able to synthesise it — a capability occasionally observed in this species by other investigators; a few people may possess a similar capability. Through recorded history, scurvy was the scourge of populations cut off from fresh produce.

== Biochemical Functions ==

Ascorbic acid is involved in a remarkable number of essential body functions:

=== Collagen Synthesis ===

'''The most abundant protein in mammals is collagen''' — it constitutes nearly one-quarter of the protein in body tissues. The strong reducing action of ascorbic acid is needed for the '''hydroxylation of the amino acids lysine and proline''' to form the protoprotein molecule. This function may be assisted by ascorbic acid inhibition of hyaluronidase. At least two other important body components have an amino acid sequence similar to collagen: the C1q sub-component of complement and the basement membrane of cells.

Without vitamin C to provide the collagen needed for a firm vessel wall, the patient experiences marked capillary fragility and easy bruising, with diffuse tissue bleeding following only minor trauma. This is the mechanism underlying:
* The classic scurvy presentation of spontaneous haemorrhages
* '''Post-TrP-injection haematomas''' in ascorbic acid-deficient patients — clinically important in myofascial practice
* Impaired wound healing and delayed resolution of tissue injury

Vitamin C is essential for the deposition of calcium phosphate crystals to form bone — linking ascorbic acid status to bone integrity as well as soft tissue quality.

=== Neurotransmitter Synthesis ===

Vitamin C is required for the synthesis of two essential neurotransmitters:
* '''Norepinephrine''' — via regulation of dopamine beta-monooxygenase (the specific enzyme that converts dopamine to norepinephrine)
* '''Serotonin''' — via the hydroxylation of tryptophan to 5-hydroxytryptophan (indirect, through ensuring cofactor function)

Vitamin C is the '''only reducing substance that specifically regulates dopamine beta-monooxygenase''' activity in chromaffin cells (adrenal gland medullary cells) in the synthesis of norepinephrine. Both norepinephrine and serotonin are important in the modulation of pain transmission in the central nervous system.

=== Amino Acid Oxidative Degradation ===

A 70-kg person on an average diet metabolises about 400 g of protein/day, of which 100 g of amino acids undergo oxidative degradation in a complicated manner that provides the many building blocks for re-generation of protein structures. Ascorbic acid is essential to the oxidative degradation of two amino acids: '''phenylalanine and tyrosine'''. With no protein ingestion, some 30 g of indigenous protein continues to be oxidatively degraded.

=== Free Radical Scavenging and Antioxidant Function ===

Ascorbic acid is one of the most active reducing agents known to occur naturally in living tissue — it provides a ready source of hydrogen atoms, since it is easily oxidised. This protects many vital tissues from oxidation damage:
* Protects tissue thiol (-SH) groups, needed to convert plasma transferrin to liver ferritin
* Enhances the absorption of iron in the gastrointestinal tract
* Contributes to fatty acid metabolism through the synthesis of carnitine
* Protects tissue from lipid peroxidation damage

Ascorbic acid is readily oxidised to dehydroascorbic acid, which retains 80% of its effectiveness. Further oxidation renders it inactive. Oxidation in solution is accelerated by heat, light, alkalinity, and a metallic iron or copper vessel.

=== Immune Function and Stress Response ===

* Tissue levels in the adrenal gland parallel those of the corticosteroids; both decrease markedly in response to stress — ascorbic acid participates in the synthesis of corticosterone and 17-hydroxycorticosterone, and may be depleted by its release to the circulation in stress states
* Increased susceptibility to infectious diseases has been observed consistently among people with scurvy
* Ascorbic acid has protected experimental animals against the formation of bladder tumours by 3-hydroxyanthranilic acid and against the hepatotoxic combination of sodium nitrite and aminopyrene
* Combined with acetylsalicylic acid, ascorbic acid caused a significant stimulation of interleukin-6 and may stimulate lymphocyte transformation and polymorphonuclear leukocyte motility
* In the authors' clinical experience, ascorbic acid helps to terminate bouts of diarrhoea due to food allergy, and to decrease toxicity and TrP irritability caused by chronic infection

=== Muscle-Specific Effects ===

* Prevents or markedly reduces the '''soreness and stiffness experienced the day after unusually strenuous exercise''' — 1 g or more of ascorbic acid taken shortly before, or at the time of, exercise prevents this phenomenon; supplementation of 3 g per day blunted reported soreness, the greatest effect occurring at the peak of delayed-onset muscle soreness. This postexercise soreness does not seem to be related to TrPs
* Reverses some of the electrocardiographic findings associated with increasing age
* Deficiency in guinea pigs caused dystrophic disorganisation of muscle structures, including fragmentation of myofilaments, swelling of mitochondria, and excessive glycogen accumulation
* Vitamin C may be important in the treatment of low back pain, presumably because it improves the quality of the connective tissue

== Insufficiency and Deficiency ==

=== Populations at Risk ===

In the United States, scurvy due to inadequate dietary intake of ascorbic acid is most likely to occur in:
* Smokers
* Alcoholics
* Older people
* Infants fed primarily on cow's milk (between the ages of 6 and 12 months)
* Food faddists and psychiatric patients

A series of 35 patients with alcohol-related illness had a 91% prevalence of ascorbic acid deficiency.

=== The Smoking–Vitamin C Connection ===

Cigarette smoking is a major cause of ascorbic acid deficiency:
* A study of 17 human volunteers who smoked more than 20 cigarettes/day showed that they required 140 mg of vitamin C daily to maintain a steady state plasma ascorbic acid level, compared to a daily intake of only 100 mg in non-smokers
* Another study showed that smokers needed an additional 65 mg/day on average to maintain serum levels equivalent to those of non-smokers
* The depression of their vitamin C level is only one reason patients should be encouraged to stop smoking

=== Clinical Presentation of Scurvy ===

Scurvy develops after 4–7 months of an insufficient diet. Elderly patients in a chronic disease hospital on an institutional diet with little fresh fruit had an average whole blood vitamin C level of only 0.35 mg/dl. Eight ounces of orange juice daily raised the level to 1.52 mg/dl.

Clinical progression of scurvy:
* Initially: weakness, lassitude, irritability, vague aching pains in joints and muscles; weight loss
* Progressive: awareness of easy bruising and even haematomas; gums become swollen, red, and bleed easily; teeth become loose and may fall out (gum symptoms develop only in response to contact with irritants such as dental plaque)
* Frank: perifollicular hyperkeratotic papules on the buttocks, thighs, and legs; later on arms and back; hairs become buried in the papules; petechiae appear buried around the lesions

'''The first sign of scurvy is perifollicular hyperkeratosis.'''

Borderline or subclinical cases are difficult to recognise. Initially, scorbutic patients present with non-specific symptoms of weakness, lassitude, irritability, and vague aching pains in the joints and muscles.

=== Decreased Absorption ===

* Decreased absorption of ascorbic acid is seen in diarrhoeal diseases
* Increased utilisation occurs in thyrotoxicosis
* There is evidence of decreasing tissue levels of ascorbic acid with increased age
* Damage to membranous cell structures by lipid peroxidation appears to contribute to the deterioration of cells in the absence of ascorbic acid's reductive protection of the tissue thiol groups

== Laboratory Tests ==

* '''Plasma HPLC for ascorbic acid levels''' — the preferred current method
* Conventional reference values (fasting): 0.6–2.0 mg/dl
* Significant deficiency: < 0.3 mg/dl
* Absence of vitamin C in urine is also indicative of deficiency
* A simple lingual screening test for ascorbic acid deficiency has been developed (Lingual Ascorbic Acid Test)

=== Blood Level Interpretation ===

| Status | Plasma ascorbic acid |
|---|---|
| Well nourished | > 1.0 mg/dl |
| Adequately nourished | 0.6–1.0 mg/dl |
| Poorly nourished | 0.3–0.6 mg/dl |
| Deficient (significant) | < 0.3 mg/dl |

== Requirements and Sources ==

=== Body Pool and Metabolism ===

The body pool of ascorbic acid averages about 1500 mg, and the daily rate of metabolism approximates 3% of the existing body pool. At this rate, it would require 45 mg/day to replenish the pool. Without any replacement, a filled body pool is depleted to the scorbutic level in about 2 months.

Vitamin C is readily absorbed from the upper small intestine, and excess is quickly excreted by the kidney — very little via other portals, and there is no extensive storage. The maximum body pool ranges between 1.5 and 5 g, but may be as low as 1 g.

Absorption efficiency drops significantly at higher intake levels:
* 70% of 180 mg is absorbed
* 50% of 1.5 g is absorbed
* 16% of 12 g is absorbed

Unabsorbed vitamin C may cause diarrhoea due to an osmotic effect.

The half-life in man ranges from 13–30 days; the larger the intake, the shorter the half-life.

=== Recommended Daily Intake ===

Updated recommended daily allowances (RDA) by age group:
* Infants 0–12 months: 40–50 mg/day
* Children 1–8 years: 15–25 mg/day
* Children 9–13 years: 45 mg/day
* Ages 14–18 years: 65–75 mg/day
* Adults ≥19 years: 75–90 mg/day
* Pregnant women: 80–85 mg/day; lactating women: 115–120 mg/day

For therapeutic purposes, adults: 200–800 mg/day in divided doses; children: 100–300 mg/day in divided doses. Higher dosage (1–2 g/day) may decrease symptom duration in deficiency states. Deficient intake for as few as 3 months can lead to scurvy.

=== Best Dietary Sources ===

Excellent sources (containing more than 100 mg/100 g raw food):
* Broccoli, Brussels sprouts, collards, kale, turnip greens
* Guava
* Sweet peppers (all colours)

Less rich but valuable sources:
* Cabbage, potatoes (commonly eaten in large quantities)
* Citrus fruits — the fresh juice of a large orange contains about 50 mg; thus 4 oranges would supply the 200 mg daily need

However, '''loss of the vitamin in processing or storage may be large''':
* Canned tomatoes retain a high percentage of their ascorbic acid content (20 mg/100g) because of the acid environment
* Cooking water contains substantial amounts — do not discard the pot liquor
* Vitamin C is highly soluble in water and is often discarded in the pot liquor of cooked foods
* Further oxidation renders it inactive; oxidation in solution is accelerated by heat, light, alkalinity, and a metallic iron or copper vessel

== Therapy ==

=== Prescription ===

Prescription of ascorbic acid can be based on the new recommended dietary allowance of 200 mg/day. At single doses of 500 mg and higher, the percent of vitamin C absorbed declines. A physiologic dose of 400 mg daily ensures a normal metabolic pool of ascorbic acid to meet emergency demands.

* The optimal intake required depends on highly variable stress factors — in sickness there is greater tolerance for vitamin C than in good health; this suggests that megadoses may be therapeutic when in poor health
* The vitamin C requirement in women taking oestrogen, or an oral contraceptive agent, may increase 3- to 10-fold, requiring daily amounts of up to 500 mg
* We consider it wise to supplement the diet routinely with 500 mg of a timed-release preparation daily — this supplementation programme is another cost-effective form of health insurance; vitamin C supplementation becomes increasingly critical with advancing age

=== Toxicity ===

* Vitamin C daily doses above 400 mg have no evident value
* Oxalate and urate excretion were elevated at 1000 mg/day of vitamin C, increasing the risk of renal stone formation
* Safe doses are therefore less than 1000 mg/day
* Scorbutic symptoms may develop in persons suddenly withdrawn from megadose therapy, just as these symptoms may appear post-partum in babies born to megadose-treated mothers
* A daily megadose can cause watery diarrhoea that has been misdiagnosed as spastic colon, and can cause a non-specific urethritis that has unnecessarily led to extensive studies for venereal infection

=== Important Drug Interactions ===

* Increased absorption of some metallic ions produced by supplemental vitamin C is desirable (iron), but undesirable in the case of mercury
* Ascorbic acid supplementation increases the amount of warfarin required to maintain the same therapeutic effect on blood clotting
* Supplemental vitamin C lowers the prothrombin time in patients on warfarin
* Antacids destroy the effectiveness of ascorbic acid and should be taken separately so they are not mixed in the stomach
* Ascorbic acid combined with acetylsalicylic acid caused a significant stimulation of interleukin-6

== The Biology of Starvation: Vitamin C ==

Among the vitamins, ascorbic acid occupies a unique position in the biology of starvation because humans cannot synthesise it — unlike most mammals — and because it governs the structural integrity of connective tissue, the immediate response to physiological stress, and the synthesis of the catecholamines that mediate the stress response itself.

The starvation cascade for vitamin C unfolds as follows:

'''Collagen collapse — the structural consequence:'''
Without continuous ascorbic acid, the hydroxylation of proline and lysine in collagen precursors ceases. Old collagen turns over and is not replaced; the supporting matrix of blood vessels, skin, tendons, and bone dissolves progressively. The clinical sequence — perifollicular haemorrhage → ecchymoses → haemarthrosis → subperiosteal haematoma → spontaneous bone fracture — traces the loss of structural integrity from the finest vessels outward.

This has direct relevance to myofascial injections: ascorbic acid-deficient patients form haematomas after needling at doses of local anaesthetic that would cause only minor bruising in a replete patient. The clinician must check vitamin C status before initiating injection therapy.

'''Adrenal exhaustion and the stress cascade:'''
The adrenal gland is the tissue most richly supplied with ascorbic acid. Both the adrenal cortex (for cortisol synthesis) and the adrenal medulla (for norepinephrine synthesis via dopamine beta-monooxygenase) depend critically on ascorbic acid. In starvation combined with stress — illness, injury, infection, or the psychological stress of chronic pain — adrenal ascorbic acid is rapidly consumed. The inability to mount an adequate adrenocortical and catecholamine response in ascorbic acid depletion creates a vulnerability to physiological insult at the very time that resistance is most needed.

'''The immune collapse:'''
Ascorbic acid is required for neutrophil function, lymphocyte proliferation, and antibody synthesis. In starvation-associated vitamin C depletion, wound infection becomes lethal — historically accounting for a large proportion of scurvy deaths, which were often attributed to the infection rather than the underlying nutritional deficiency.

'''Pain amplification:'''
The depletion of norepinephrine and serotonin synthesis capacity (both dependent on ascorbic acid) in prolonged insufficiency creates a state of impaired descending pain inhibition. This directly increases TrP irritability and pain amplification, and produces a clinical picture indistinguishable from central sensitisation.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin_B1_Thiamine_and_TrPs|Vitamin B₁ (Thiamine) and Trigger Points]]
* [[Concept:Iron_and_TrPs|Iron and Trigger Points]] — vitamin C enhances non-haem iron absorption
* [[Concept:Calcium_and_TrPs|Calcium and Trigger Points]]
* [[wikipedia:Ascorbic_acid|Ascorbic acid — Wikipedia]]
* [[wikipedia:Scurvy|Scurvy — Wikipedia]]
* [[wikipedia:Collagen|Collagen — Wikipedia]]
* [[wikipedia:Dopamine_beta-monooxygenase|Dopamine beta-monooxygenase — Wikipedia]]
* [[wikipedia:Norepinephrine|Norepinephrine — Wikipedia]]
* [[wikipedia:Refeeding_syndrome|Refeeding syndrome — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Nutrition]]

Concept:Folic Acid and TrPs

2026-04-19T19:42:14Z

Yatreyu: Created page with "'''Folic acid''' (pteroylglutamic acid; folate; folacin) is a water-soluble B-complex vitamin whose insufficiency is '''the most common vitamin inadequacy''' and among those most likely to perpetuate myofascial trigger points (TrPs). Its metabolism is inseparably intertwined with that of vitamin B₁₂ — the two vitamins share critical pathways, and treatment of one without establishing the status of the other risks precipitating a deficiency of the second. This page..."

'''Folic acid''' (pteroylglutamic acid; folate; folacin) is a water-soluble B-complex vitamin whose insufficiency is '''the most common vitamin inadequacy''' and among those most likely to perpetuate myofascial trigger points (TrPs). Its metabolism is inseparably intertwined with that of vitamin B₁₂ — the two vitamins share critical pathways, and treatment of one without establishing the status of the other risks precipitating a deficiency of the second. This page focuses on the distinct biology and clinical profile of folic acid; for the shared metabolic pathways with cobalamin, see [[Concept:Vitamin_B12_Cobalamin_and_TrPs|Vitamin B₁₂ (Cobalamin) and Trigger Points]].

Patients with myofascial pain who have marginally low serum folate levels — still within the "normal" range but in the lowest quartile — tire easily, sleep poorly, feel discouraged and depressed, frequently feel cold, and have a reduced basal temperature. These symptoms are similar to, but less intense than, those of patients with obvious neurological disorders responsive to folic acid therapy. In the clinical experience of Travell, Simons, and Gerwin, '''be sure to check your patients with chronic myofascial TrPs for low normal or abnormal serum folate levels.'''

== Discovery and History ==

Pteroylglutamic (folic) acid was purified in 1943 by Stokstad and was crystallised from liver in the same year by Pfiffner and associates. By 1948, Angier and his coworkers synthesised it and identified its structure. It then became clear that folic acid was the Wills factor — the vitamin M previously found in dry brewers' yeast, and the vitamin B_c of yeast identified in chick experiments — that had enabled Lucy Wills in 1931 to cure macrocytic anaemia of pregnancy in Indian women by feeding them Marmite.

The name derives from the Latin ''folium'' (leaf), reflecting that leafy green vegetables are the primary dietary source.

== Biochemical Functions ==

Folate acts as a carrier of single-carbon units — one-carbon fragments — at various levels of oxidation, and transfers them in biosynthetic reactions. The active form in the body is '''tetrahydrofolate (THF)''', which is produced by the reduction of dietary folate by dihydrofolate reductase.

The principal biochemical roles of folate are:

=== 1. DNA Synthesis — Thymidylate Synthesis ===

Folate is essential for the synthesis of '''thymidylate''' (the thymidine nucleotide unique to DNA) via the thymidylate synthase reaction. In this reaction, the methylene group of 5,10-methylenetetrahydrofolate is transferred to deoxyuridylate to form thymidylate, oxidising THF to dihydrofolate in the process.

'''Folate deficiency impairs the synthesis of deoxyribonucleic acid''', causing megaloblastosis in all duplicating cells of the body, most commonly observed in bone marrow cells. The impaired haematopoiesis produces a pancytopenia.

=== 2. Purine Synthesis ===

Two steps in purine synthesis require folate-mediated one-carbon transfers. Purines are the building blocks of both DNA and RNA, so folate deficiency affects RNA synthesis as well as DNA replication.

=== 3. The Methionine Cycle and DNA Methylation ===

The conversion of 5-methyltetrahydrofolate (5-Me-THF) to THF is coupled to the remethylation of homocysteine to methionine, which requires vitamin B₁₂ as cofactor. This reaction is the point of convergence of folate and cobalamin metabolism.

Methionine is metabolised to S-adenosylmethionine (SAM), the universal methyl donor for DNA methylation and for the synthesis of myelin, neurotransmitters (epinephrine, melatonin, creatine, phospholipids), and many other methylated compounds.

'''Failure of this cycle''' (from either folate or B₁₂ deficiency) results in:
* Accumulation of homocysteine — a cardiovascular risk factor
* Reduced SAM — impairing all methylation reactions
* Impaired DNA methylation — affecting gene expression in dividing tissues

=== 4. The Methyl-Folate Trap ===

When cobalamin is lacking, 5-Me-THF cannot be demethylated. Since the polyglutamated form of THF is needed for intracellular enzyme cofactor function and cannot be formed from 5-Me-THF directly, the polyglutamated THF pool is depleted — '''even when serum folate levels appear normal or elevated'''. This is the methyl-folate trap:

* Serum folate can appear '''high''' in cobalamin deficiency (because 5-Me-THF accumulates in serum rather than being converted)
* Intracellular folate function is simultaneously impaired
* Large doses of folic acid given to a cobalamin-deficient patient will further deplete cobalamin reserves by increasing the demand for cobalamin in the methylation cycle

This is why: '''Never give folic acid without first establishing the vitamin B₁₂ status.'''

=== 5. Amino Acid Metabolism ===

* Folate is required for the conversion of homocysteine to methionine
* It participates in the catabolism of histidine — in folate deficiency, formiminoglutamic acid (FIGLU) accumulates in the urine after a histidine load (the FIGLU test)
* Serine–glycine interconversion requires THF as a one-carbon acceptor

=== 6. Neural Tube Development ===

Adequate folate in the periconceptional period (before and in the first weeks after conception) is essential for normal closure of the neural tube. Deficiency at this critical stage causes neural tube defects (anencephaly, spina bifida). This is the biological rationale for folate supplementation of 400–800 μg/day recommended for all women of childbearing age.

== Insufficiency and Deficiency in the Context of Myofascial Pain ==

=== Insufficiency (Low Normal / Lower Quartile) ===

Patients with chronic MPS who have marginally low serum folate levels show a characteristic cluster of symptoms that overlap with, but are less severe than, frank deficiency:
* '''Increased muscular irritability and susceptibility to myofascial TrPs'''
* Easy fatigue
* Poor sleep
* Discouragement and depression
* Frequent sensation of cold; reduced basal temperature (mimicking thyroid hypofunction — the two conditions may coexist)
* These symptoms are often relieved by multivitamin therapy including folic acid

'''A disproportionately high percentage of psychiatric patients are folic acid deficient. Depression is their most probable psychiatric diagnosis.'''

=== Established Deficiency ===

The documented timeline of folate deprivation (from experimental studies):
* '''Week 3:''' Low serum folate
* '''Week 7:''' Hypersegmentation of polymorphonuclear leukocytes (earliest haematological sign)
* '''Week 14:''' Increased urinary excretion of FIGLU
* '''Week 18:''' Low erythrocyte folate and macroovalocytosis
* '''Week 19:''' Megaloblastic bone marrow and anaemia

Neuropsychiatric symptoms preceding haematological changes (fourth and fifth months):
* Sleeplessness and forgetfulness, gradually increasing
* Mental symptoms disappeared within 48 hours after starting oral folic acid therapy

Full clinical deficiency presents as:
* Megaloblastic anaemia (macrocytic) — large, structurally abnormal red cells; reduced oxygen-carrying efficiency per red cell
* Fatigue, diffuse muscular pain, restless legs
* Peripheral sensory neuropathy (less common than with B₁₂, but documented in 21% of one group of folate-deficient patients)
* Depression; peripheral sensory loss; diarrhoea
* In children with congenital enzyme deficiencies: severe and often irreversible mental retardation and/or megaloblastic anaemia

=== Specific Enzyme Deficiencies ===

Congenital abnormalities in folate-dependent pathways are generally seen initially in children with severe and often irreversible mental retardation and/or megaloblastic anaemia. Some are greatly improved by megadoses of folic acid or folacin:

* '''Methylenetetrahydrofolate reductase (MTHFR) deficiency''' — impairs the synthesis of 5-Me-THF; patients exhibit homocystinuria responsive to folate therapy; a common polymorphism (C677T) in this gene affects a significant proportion of the population and reduces folate utilisation
* '''5-Methyltetrahydrofolate transferase deficiency''' — liver enzyme studies reveal markedly decreased activity; causes increased excretion of homocysteine
* '''Glutamic formiminotransferase deficiency''' — blocks formation of glutamate from histidine, causing increased formiminoglutamate (FIGLU) in urine; congenital expression can significantly increase the dietary folate requirements of an individual
* '''Cystathionine synthase deficiency''' — also causes homocystinuria; requires supplemental vitamin B₆ (see [[Concept:Vitamin_B6_Pyridoxine_and_TrPs|Vitamin B₆]])

=== Low Serum Cholesterol as a Marker ===

Low serum cholesterol levels were correlated with low serum folate values at or below 6.2 ng/ml in 46 patients (r = 0.58). No such correlation was obtained between cobalamin deficiency and serum cholesterol level. Low thyroid function of thyroid (but not of pituitary) origin is likely to be associated with an increased serum cholesterol — providing a useful clinical differentiator.

== Laboratory Tests ==

=== Serum and Red Cell Folate ===

* Routine laboratory testing of folate levels in blood serum and in blood cells (tissue level) is now available
* Normal human serum contains approximately 7–16 ng/ml of folate
* '''Serum folate < 4 mcg/l suggests folate deficiency'''
* '''Red cell (erythrocyte) folate''' reference values: 140–628 ng/ml in packed RBCs (IU: 317–1422 nmol/l) — reflects tissue stores accumulated over the lifespan of the red cell (approximately 120 days) and is a more reliable indicator of chronic folate status than serum folate
* '''Serum folate''' reflects recent dietary intake; it falls rapidly with dietary restriction

=== FIGLU Test ===

After a histidine load, urinary excretion of formiminoglutamic acid (FIGLU) is measured. In folate deficiency, histidine catabolism is blocked at the step requiring THF, and FIGLU accumulates and spills into the urine. Elevated FIGLU at 14 weeks of deficiency provides biochemical evidence before anaemia develops.

=== MCV and Its Limitations ===

Contrary to expectation, among hospitalised patients, a high MCV of 95 cu mm or more had only a 0.18 correlation with folate deficiency, and therefore would not have been useful to screen for it. In some patients, other conditions caused the macrocytosis despite the folate deficiency; in other patients, the tissue folate had not yet been sufficiently depleted to produce macrocytosis.

'''Absence of macrocytosis does not exclude folate deficiency.'''

=== Homocysteine ===

Homocysteine accumulates in the serum and urine when homocysteine cannot be converted to methionine (a folate-dependent step). Elevated homocysteine is found in both folate and vitamin B₁₂ deficiency, making it a sensitive but non-specific marker. Its elevation in folate deficiency (without B₁₂ deficiency) distinguishes folate from B₁₂ as the limiting factor, since methylmalonic acid only accumulates in B₁₂ deficiency.

== Requirements ==

The total folacin activity recommended as a daily dietary allowance:
* Adults and adolescents: '''400 μg/day'''
* During pregnancy: '''800 μg/day'''
* During lactation: '''500 μg/day'''

Evidence of depleted body stores of folacin appear in 2 months and symptoms become severe after 4 months of folic acid deprivation. Body stores are therefore not large.

== Sources ==

=== Best Dietary Sources ===

The dietary sources of folate are '''leafy vegetables''' (foliage — the name is literal). Sources include:
* Yeast, liver, and other organ meat
* Fresh or fresh-frozen uncooked fruit or fruit juice
* Lightly cooked fresh green vegetables: broccoli, asparagus, spinach, Brussels sprouts
* Beans and lentils

=== Folate Destruction in Food Preparation ===

Although folates are ubiquitous in nature, being present in nearly all natural foods, they are '''highly susceptible to oxidative destruction''':
* '''50–95% of the folate content of foods may be destroyed in processing and preparation'''
* All folate is lost from refined foods — hard liquor and hard candies contain none
* Heat, prolonged cooking, and oxidation destroy folate rapidly
* Food should be stored in a cool, dark place and consumed as fresh as possible
* Cooking water should not be discarded — the pot liquor of cooked vegetables contains substantial folate

This extraordinary vulnerability to destruction means that a diet dominated by cooked, processed, and refined foods is structurally deficient in folate regardless of the nominal food variety consumed.

=== Folate in Specific Foods ===

| Food | Approximate folate content |
|---|---|
| Liver (beef, 100g) | 220 μg |
| Spinach (raw, 100g) | 194 μg |
| Asparagus (cooked, 4 spears) | 89 μg |
| Broccoli (cooked, 100g) | 71 μg |
| Lentils (cooked, 100g) | 181 μg |
| Orange juice (250ml) | 55 μg |
| Avocado (half) | 59 μg |

== Causes of Insufficiency and Deficiency ==

The four commonest causes are:
# '''Advanced age''' — an increasing segment of the population; decreased nutritional intake, decreased absorption (partly due to folate deficiency itself impairing the dividing GI mucosal cells), and increased need
# '''Pregnancy or lactation''' — the demand for rapid cellular division in fetal tissue and placenta dramatically increases folate requirement
# '''Dietary indiscretion''' — restrictive diets, food faddism, economic disadvantage, social isolation
# '''Drug abuse''' — most commonly alcohol, which impairs folate absorption, reduces dietary folate intake, and interferes with folate metabolism

Additional causes:
* Malabsorption syndromes — coeliac disease, Crohn's disease, tropical sprue
* Drugs: methotrexate and other dihydrofolate reductase inhibitors; phenytoin and other anticonvulsants (increase folate catabolism); oral contraceptives; sulfasalazine; trimethoprim
* Dialysis — folate is lost in dialysate

=== The Alcohol–Folate Interaction ===

Alcohol impairs folate status through multiple mechanisms simultaneously:
# Reduced dietary intake of folate (alcohol displaces food)
# Impaired absorption from the small intestine
# Interference with the enterohepatic recirculation of folate
# Direct inhibition of dihydrofolate reductase at high concentrations
# Increased urinary excretion of folate

This multi-level impairment explains why alcoholism is one of the most potent causes of folate deficiency, and why the folate–alcohol interaction is clinically critical in patients with chronic musculoskeletal pain who drink regularly.

== Therapy ==

=== Oral Supplementation ===

* Standard replacement: '''folate 1 mg three times daily orally, followed by 1 mg/day''' for maintenance
* In acutely ill patients: 1–5 mg/day intravenously
* It is wise to routinely prescribe adequate amounts of vitamin B₁₂ and folic acid together, not just one — a 500 μg tablet of B₁₂ and a 1 mg tablet of folic acid daily is safe and effective
* Patients should be cautioned that folic acid absorption is impaired by the simultaneous ingestion of antacids
* '''Always exclude vitamin B₁₂ deficiency before starting folate replacement''' (see the B₁₂ First Rule below)

=== The Homocysteine Rationale for Higher Doses ===

Reduction of elevated homocysteine levels to the point that there is no increased mortality from cardiac and cerebral thrombosis requires a higher daily dose of about '''700 μg'''. Hence, a daily dose of 1 mg has been considered adequate.

=== The B₁₂ First Rule ===

'''Never administer folic acid without first checking the vitamin B₁₂ level.'''

Daily intake of 400 μg of folic acid can:
* Aggravate the effects of vitamin B₁₂ deficiency
* Obscure the early haematological warning signs of possible combined degeneration of the spinal cord, by correcting the megaloblastic anaemia while the neurological damage progresses undetected
* In the presence of already-depleted cobalamin reserves, precipitate serious cobalamin deficiency

=== Pregnancy ===

Folate supplementation of 400–800 μg/day is recommended for all women of childbearing age, and should be started before conception since neural tube closure occurs in the first 28 days after fertilisation — before most pregnancies are confirmed. Supplementation to 800 μg/day is maintained throughout pregnancy and reduced to 500 μg/day during lactation.

== The Biology of Starvation: Folic Acid ==

Folic acid stands at the intersection of starvation biology and cell survival because it governs the capacity of dividing cells to replicate their DNA. When dietary folate fails — whether from outright starvation, food processing, or malabsorption — the consequences unfold through a distinctive hierarchy of vulnerable tissues:

'''Fastest-dividing tissues fail first:'''
# '''Bone marrow''' — megaloblastic arrest of erythropoiesis; the red cells produced are large, short-lived, and oxygen-inefficient; anaemia follows within weeks to months of depletion. This directly impairs oxygen delivery to skeletal muscle, creating or worsening the local energy crisis at TrP endplates
# '''Gastrointestinal epithelium''' — villous atrophy and impaired absorption develop, creating a vicious cycle: folate deficiency destroys the absorptive surface that would absorb replacement folate
# '''Lymphoid tissue and immune cells''' — impaired immune surveillance

'''Neural consequences:'''
Unlike vitamin B₁₂ deficiency, folate deficiency causes peripheral neuropathy less frequently, and the spinal cord lesions of subacute combined degeneration only in the most severe cases. However, folate deficiency '''impairs brain function through SAM depletion''' — reducing methylation capacity throughout the nervous system, affecting neurotransmitter turnover and myelin maintenance.

The specific vulnerability in starvation is that folate stores last only 2–4 months — far shorter than the 1–3 years required to exhaust vitamin B₁₂ stores. In conditions of restricted fresh vegetable and fruit intake (sieges, famines, long sea voyages without fresh provisions, prolonged institutional catering, restricted diets, excessive alcohol), folate depletion is the first B-vitamin crisis to emerge neurologically.

The evolutionary logic: folate is abundant in the fresh plant matter that constitutes the natural human diet; its destruction by heat and oxidation is a product of cooking and food storage. In this sense, folate deficiency is a disease of civilisation — specifically, of cooked and processed food — rather than true starvation.

In the chronic pain patient, the relevance is that folate insufficiency — even at low-normal levels — directly predicts increased TrP irritability, impaired treatment response, depression, fatigue, and poor sleep. These are simultaneously the most common complaints of patients with chronic myofascial pain and the most common symptoms of subclinical folate insufficiency. Correcting folate status is therefore both diagnostically informative and therapeutically necessary.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin_B12_Cobalamin_and_TrPs|Vitamin B₁₂ (Cobalamin) and Trigger Points]] — inseparable metabolic partner
* [[Concept:Vitamin_B6_Pyridoxine_and_TrPs|Vitamin B₆ (Pyridoxine) and Trigger Points]]
* [[Concept:Vitamin_C_and_TrPs|Vitamin C (Ascorbic Acid) and Trigger Points]]
* [[wikipedia:Folate|Folate — Wikipedia]]
* [[wikipedia:Folate_deficiency|Folate deficiency — Wikipedia]]
* [[wikipedia:Folate_metabolism|Folate metabolism — Wikipedia]]
* [[wikipedia:Methylenetetrahydrofolate_reductase|MTHFR — Wikipedia]]
* [[wikipedia:Neural_tube_defect|Neural tube defect — Wikipedia]]
* [[wikipedia:Homocysteine|Homocysteine — Wikipedia]]
* [[wikipedia:Tetrahydrofolate|Tetrahydrofolate — Wikipedia]]
* [[wikipedia:Megaloblastic_anaemia|Megaloblastic anaemia — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Nutrition]]

Concept:Vitamin B12 Cobalamin and TrPs

2026-04-19T19:42:00Z

Yatreyu: Created page with "'''Vitamin B₁₂ (cobalamin)''' is one of the most structurally complex of all vitamins and the only one whose only primary food source is bacteria. It is considered together with folic acid because their metabolism and function are intimately linked — the two independently essential enzyme cofactors share critical pathways, and deficiency of one can mask or precipitate deficiency of the other. Both are required for DNA synthesis, and inadequacy of either aggravates..."

'''Vitamin B₁₂ (cobalamin)''' is one of the most structurally complex of all vitamins and the only one whose only primary food source is bacteria. It is considered together with folic acid because their metabolism and function are intimately linked — the two independently essential enzyme cofactors share critical pathways, and deficiency of one can mask or precipitate deficiency of the other. Both are required for DNA synthesis, and inadequacy of either aggravates myofascial trigger points (TrPs) through mechanisms that include impaired red cell production, reduced oxygen-carrying capacity of muscle, neuropathy, and increased TrP irritability.

In one study of chronic myofascial pain subjects, 16% of 57 patients had serum vitamin B₁₂ levels below 261 pg/ml, and 10% had low serum or erythrocyte folate levels — proportions more convincing than in the fibromyalgia syndrome (FMS) comparison group. Two of the three FMS subjects with vitamin B₁₂ deficiency cleared completely with cobalamin replacement (Gerwin, unpublished data).

== Discovery and History ==

In 1926, Minot and Murphy successfully treated pernicious anaemia by feeding patients liver. Previously, the disease had been invariably fatal. In 1948, the responsible agent, a cobalamin, was finally discovered and crystallised. Hodgkin won the 1964 Nobel Prize in Chemistry for delineating the structure of this complex molecule.

Understanding the overlapping contributions of folic acid and vitamin B₁₂ to the aetiology of macrocytic anaemia evolved slowly. Pteroylglutamic (folic) acid was purified in 1943 by Stokstad and was crystallised from liver in the same year by Pfiffner and associates. By 1948, Angier and his coworkers synthesised it and identified its structure. It then became clear that folic acid was the Wills factor, the vitamin M previously found in dry brewers' yeast, and the vitamin B_c of yeast identified in chick experiments.

== The Cobalamin Molecule ==

Its central cobalt atom is linked to a variable anionic group:
* '''-CN''' in cyanocobalamin (the common synthetic form)
* '''-OH''' in hydroxocobalamin (the major form in plasma)
* '''-CH₃''' in methylcobalamin

At least three other forms are known. It has been officially recommended that the term vitamin B₁₂ be reserved specifically for the cyanocobalamin form; "cobalamin" may apply to any of its forms. '''Methylcobalamin and 5'-deoxyadenosinecobalamin are the only two forms of the vitamin known to be physiologically active.''' Cyanocobalamin is physiologically inactive and must be converted to other forms — first to be absorbed, and then to be metabolically useful.

== Biochemical Functions ==

Cobalamins serve numerous essential metabolic functions:

# '''DNA synthesis''' — deoxyribonucleic acid (DNA) synthesis through the regeneration of intrinsic folate
# '''Regeneration of intrinsic folate''' — critical to the synthesis of DNA
# '''Transport of folate to, and its storage in, cells'''
# '''Fat and carbohydrate metabolism''' — the conversion of methylalanate to succinate is cobalamin-dependent
# '''Protein metabolism'''
# '''Reduction of sulfhydryl groups'''

Since cobalamin and folic acid are required for the synthesis of DNA, both are necessary for normal growth and tissue repair.

=== The Methylation Cycle and Homocysteine ===

Cobalamin is essential for the '''methylation of homocysteine to methionine''' through a reaction involving methionine synthase, for which methylcobalamin (Me-Cbl) is the cofactor. The conversion of homocysteine to methionine is a key reaction in the synthesis of DNA, and requires both Me-Cbl and tetrahydrofolate (THF). The methyl donor is Me-THF (methyltetrahydrofolate).

Folic acid is stored intracellularly as a polyglutamate, which is the form that is also necessary for its enzyme cofactor function. When cobalamin is lacking, Me-THF cannot be demethylated, and an essential conversion prior to polyglutamation cannot proceed. Hence, the polyglutamated form of THF is decreased in serum and intracellularly when cobalamin is inadequate — the so-called '''methyl-folate trap'''. When cobalamin reserves are already depleted, large doses of folic acid increase the utilisation of cobalamin and can precipitate a serious cobalamin deficiency.

=== Fat Metabolism and Myelin ===

The cobalamins are involved in '''fat and carbohydrate metabolism''' since the conversion of methylalanate to succinate is cobalamin-dependent. It has been proposed, but not proved, that the neurological deficits characteristic of cobalamin deficiency are due to compromise of the lipid portion of the lipoprotein myelin sheath surrounding the affected nerve fibres.

In both the central and peripheral nervous systems, cobalamin deficiency is associated with inadequate myelin synthesis that leads to:
1. First, '''demyelination'''
2. Then, '''axonal degeneration'''
3. Finally, '''neuronal death'''

Comparable neurologic disease is less frequently caused by folate deficiency. Lesions of the myelinated peripheral nerves due to cobalamin deficiency occur more frequently and earlier than the central nervous system lesions of the myelinated posterior and lateral cords of the spinal column. The latter advanced deficiency is known as '''subacute combined degeneration''' — combined system disease, posterior lateral sclerosis, or funicular degeneration.

=== Nerve Function and TrPs ===

Vitamin B₁₂ inadequacy or deficiency causes a myelopathy — this has long been known. It is now known that there is also a peripheral neuropathy associated with vitamin B₁₂ deficiency. Folic acid deficiency has also been reported to cause a peripheral neuropathy that is less common than that seen with vitamin B₁₂ deficiency.

'''Neuropathy is associated with increased TrP irritability.''' The role of both vitamin B₁₂ and folic acid on nerve function raises the possibility that these vitamins produce central or peripheral nerve dysfunction that predisposes to altered nerve/muscle junction or motor endplate dysfunction. The mechanism in MPS patients is not clear.

Persons with acute lumbar or cervical radiculopathy can present with an acute MPS before there is any clinical sign of radiculopathy. Likewise, post-lumbar laminectomy scarring with nerve root entrapment can present with MPS in the distribution of the entrapped nerve root. These observations, made by Dr. Gerwin, support the concept that at least some cases of MPS are the result of nerve injury — and that metabolic nerve dysfunction (injury) can also result in the formation or the persistence of the myofascial trigger point.

== Insufficiency and Deficiency ==

=== Cobalamin Insufficiency ===

The symptomatology of a marginal amount of cobalamin in the body may be highly variable and difficult to interpret:
* '''Nonspecific depression'''
* Fatiguability
* Increased susceptibility to myofascial TrPs
* An exaggerated startle reaction to unexpected noise or touch is occasionally a helpful guide

In Dr. Gerwin's experience, several cases presented only with '''fatigue, disturbed sleep, and diffuse muscle pain''', all of which improved with cobalamin replacement.

=== Folate Insufficiency ===

Insufficient folate is the most common vitamin inadequacy and among those most likely to perpetuate myofascial TrPs. Patients with myofascial pain who have marginally low serum folate levels have symptoms similar in kind to, but less intense than, many of the symptoms reported by patients with obvious neurologic disorders responsive to folic acid therapy:
* Increased muscular irritability and susceptibility to TrPs
* They tire easily, sleep poorly, and feel discouraged and depressed
* These patients also frequently feel cold and have a reduced basal temperature (as do patients with thyroid hypofunction; their symptoms are often relieved by multivitamin therapy including folic acid)

=== Established Cobalamin Deficiency ===

The clinical presentations of megaloblastic anaemia (pernicious anaemia) and the neurological dysfunction caused by vitamin B₁₂ deficiency occur as two distinct syndromes, although there is considerable overlap in that 67% of persons with pernicious anaemia with pancytopenia will have some neurologic disorder. Neurologic dysfunction can occur in the absence of megaloblastic anaemia, and progress independently.

Symptoms are those of '''combined degeneration of the spinal cord''':
* Loss of vibratory and position sense (posterior spinal cord column functions)
* Weakness and spasticity (lateral spinal cord column motor functions)
* Peripheral neuropathy — both an axonal and a demyelinating neuropathy; tends to be predominantly, but not exclusively, sensory
* Gait ataxia and spasticity produce neuromuscular stress in addition to that of the nerve disorder itself
* Constipation occurs when bowel motility is impaired
* Fatigue, personality change, memory loss are less specific symptoms
* '''Dementia, visual loss, and psychosis''' are seen in more severe cases, not likely to present as muscle pain syndromes

=== Established Folate Deficiency ===

Folic acid deficiency is associated with:
* Fatigue, diffuse muscular pain, restless legs
* In addition: megaloblastic anaemia, depression, peripheral sensory loss, and diarrhoea
* A subnormal serum folate level in time causes megaloblastic hematopoiesis and anaemia
* Evidence of peripheral neuropathy was found in 21% of one group of folate-deficient patients
* Similar findings in another group responded to folic acid therapy

'''Experimental deprivation of folate for 6 months''' produced the following documented effects:
* In 3 weeks: low serum folate
* In 7 weeks: hypersegmentation of polymorphonuclear leukocytes
* In 14 weeks: increased urinary excretion of formiminoglutamic acid
* In 18 weeks: low erythrocyte folate and macroovalocytosis
* In 19 weeks: megaloblastic bone marrow and anaemia
* During the fourth month: sleeplessness and forgetfulness appeared and gradually increased through the fifth month
* Mental symptoms disappeared within 48 hours after starting oral folic acid therapy

=== Epidemiology of Deficiency ===

Pernicious anaemia due to cobalamin deficiency occurs in 1–3% of persons of European ancestry over age 60, and is more common in younger persons, especially women, of Hispanic and African ancestry. Deficiency of both vitamin B₁₂ and folic acid is much more prevalent in the elderly — vitamin B₁₂ deficiency occurring in as many as 40% of subjects as determined by measuring homocysteine and methylmalonic acid levels.

Five percent of healthy elderly and 19% of hospitalised elderly were deficient in folic acid. In the cases of both vitamin B₁₂ and folic acid, metabolic deficiency was found in subjects whose serum vitamin levels were within the accepted range of normal.

The four commonest causes of folate deficiency are advanced age, pregnancy or lactation, dietary indiscretion, and drug abuse, most commonly alcohol.

One-third of all pregnant women in the world develop a folate deficiency so severe that they have megaloblastic anaemia. The prevalence of folate deficiency is so high, especially in vulnerable groups, that many more individuals must have insufficient folate nutrition. Among 269 pregnant low-income patients in Gainesville, FL, 15% were deficient in serum folate (< 3 ng/ml), and 48% were low (insufficient) in serum folate (3–6 ng/ml), on their first maternity visit.

== Laboratory Tests and Diagnosis ==

=== Cobalamin ===

The diagnosis of cobalamin deficiency cannot be made reliably only by measuring serum vitamin B₁₂ levels. The conventional reference range is 200–835 pg/ml (IU: 148–616 pmol/l). More sensitive assessment uses serum levels of methylmalonic acid and homocysteine — both are elevated early in vitamin B₁₂ deficiency; in folate deficiency, homocysteine levels are elevated but methylmalonic acid levels are normal.

* When the serum B₁₂ level is 350 pg/ml or lower, '''serum and urine homocysteine and methylmalonic acid levels should be obtained''' — if these are elevated, supplementation should be given
* When serum B₁₂ levels are between 300–400 pg/ml, homocysteine and methylmalonic acid levels are obtained; if any are elevated, supplementation should be given
* If the situation is still unclear, cystathionine and HTC II levels are obtained
* The diagnosis of cobalamin deficiency cannot be made reliably only by measuring serum vitamin B₁₂ levels — several cases presented only with fatigue, disturbed sleep, and diffuse muscle pain, all of which improved with cobalamin replacement. Serum B₁₂ was below 300 pg/ml in these individuals
* '''Note:''' The use of the Schilling test has been largely supplanted by serologic testing for anti-parietal cell and anti-intrinsic factor antibodies as the preferred diagnostic approach for pernicious anaemia.

'''Assay pitfalls:'''
* Assay kits containing R binding proteins that bind other cobalamin analogues will result in falsely higher values of vitamin B₁₂
* Non-cobalamin corrinoids that are inactive analogues of vitamin B₁₂ can falsely elevate serum B₁₂ levels if the assay method does not use pure intrinsic factor
* Large amounts of vitamin C or other reducing agents can destroy vitamin B₁₂, giving falsely low values
* Acquired immunodeficiency syndrome can also give falsely low serum values of cobalamin
* Studies have shown that persons with vitamin B₁₂ levels in the normal range can have other laboratory or clinical evidence of vitamin B₁₂ deficiency

'''The Schilling test''' assesses absorption of an oral dose of radiolabelled vitamin B₁₂ by measuring the fraction excreted in the urine over 24 hours. The stage I test without intrinsic factor should always be abnormal in pernicious anaemia, and should be corrected by the concurrent administration of intrinsic factor in the stage II test. However, the test has serious limitations — the crystalline form of vitamin B₁₂ is not the same as food-bound vitamin B₁₂, and is absorbed more readily; hence the stage I Schilling test can be normal even in the presence of pernicious anaemia, particularly since only about 10% of the normal level of intrinsic factor is needed to absorb vitamin B₁₂.

=== Folate ===

Routine laboratory testing of folate levels in blood serum and in blood cells (tissue level) is now available. Normal human serum contains approximately 7–16 ng/ml of folate in the serum. Contrary to expectation, among hospitalised patients, a high mean corpuscular volume (MCV) of 95 cu mm or more had only a 0.18 correlation with folate deficiency, and therefore would not have been useful to screen for it — the absence of macrocytosis does not exclude folate deficiency.

== Requirements ==

* '''Vitamin B₁₂:''' The daily requirement needed to maintain body stores is between 1–6 μg. The enterohepatic circulation is so frugal in conserving vitamin B₁₂ that little is lost each day — it can take nearly a year to deplete body stores. Recommended daily allowances (RDA) by age:
** Infants 0–12 months: 0.4–0.5 mcg/day
** Children 1–8 years: 0.9–1.2 mcg/day
** Children 9–13 years: 1.8 mcg/day
** ≥14 years: 2.4 mcg/day
** Pregnant women: 2.6 mcg/day; lactating women: 2.8 mcg/day
* '''Folacin:''' The total folacin activity recommended as a daily dietary allowance is 400 μg/day for adults and adolescents; 800 μg/day during pregnancy; 500 μg/day during lactation. Evidence of depleted body stores of folacin appear in 2 months and symptoms become severe after 4 months of folic acid deprivation

== Sources ==

=== Cobalamin ===

'''Cobalamins are unique because the only primary food source is bacteria.''' The cobalamins are synthesised by certain microorganisms found in soil, sewage, water, intestines, or rumen. Herbivorous animals depend entirely on microbial sources for their cobalamin. The vitamin is not found in vegetable food sources, and is available to man only from animal food products or supplements. Brewers' yeast, still used by some as a source of B vitamins, does not contain vitamin B₁₂ unless the yeast is grown on a special cobalamin-containing media.

=== Folate ===

The dietary sources of folate are leafy vegetables (foliage), as the name indicates. Sources also include yeast, liver and other organ meat, as well as fresh or fresh-frozen uncooked fruit or fruit juice, and lightly cooked fresh green vegetables, such as broccoli and asparagus.

Although folates are ubiquitous in nature, being present in nearly all natural foods, they are highly susceptible to oxidative destruction: 50–95% of the folate content of foods may be destroyed in processing and preparation. All folate is lost from refined foods, such as hard liquor and hard candies.

== Causes of Insufficiency and Deficiency ==

=== Cobalamin ===

The complicated chain of events required for absorption of cobalamin presents many links that can fail:
* Freeing of ingested cobalamins from their polypeptide linkages in food by gastric acid and by gastric and intestinal enzymes
* Formation of complexes with the intrinsic factor produced by normal gastric parietal cells
* On reaching a protein receptor on the microvillar membrane of the terminal ileum, in the presence of ionic calcium and at pH about 6, the cobalamin passes through the mucous membrane into the portal venous blood
* There it must join the transport protein, transcobalamin II, which carries it to the liver

Several drug interactions reduce serum cobalamin levels: neomycin, colchicine, p-aminosalicylic acid, biguanide therapy (e.g., metformin), and ethanol have been associated with malabsorption of cobalamin.

=== Folate ===

Tissue deficiency in folate is common even in high-income states, in 15% of the white population and in over 30% of the black and Spanish-American groups. The commonest causes are:
* Advanced age (an increasing segment of the population)
* Pregnancy or lactation
* Dietary indiscretion
* Drug abuse, most commonly alcohol

== Therapy ==

=== Cobalamin ===

Vitamin B₁₂ is only derived from animal products, whereas folic acid is available from both animal and vegetable foods. Treatment means replenishing body stores and then maintaining them at optimal levels.

* In pernicious anaemia, treatment is lifelong; it is associated with autoimmune endocrinopathy and may co-occur with vitiligo and alopecia areata
* In dietary deficiency, alteration of the diet may suffice once body stores have been replenished
* '''Initial replacement: cyanocobalamin (CNCbl) 1 mg intramuscularly twice weekly for 2 weeks, then weekly for 2 months, then monthly''' — weekly injections generally restore the body pool to normal levels
* '''Sublingual route is considered appropriate even in pernicious anaemia or states of abnormal absorption: 500 mcg/day of CNCbl''' — serum levels should be monitored periodically
* For those who can absorb vitamin B₁₂, '''oral administration of 500–1000 μg''' may maintain serum levels; however, serum B₁₂, homocysteine, and methylmalonic acid levels should be obtained at 6-month intervals for 2 years to ensure adequate absorption
* Passive absorption of ingested vitamin B₁₂ 1000 μg in the absence of intrinsic factor provides about 3 μg/day, supporting oral replacement in some pernicious anaemia patients
* Some persons cannot convert cyanocobalamin to hydroxocobalamin because of a genetic defect — these individuals do well with hydroxocobalamin replacement therapy

'''In Dr. Gerwin's experience, fatigue and sleep disturbance improve after 2–4 weeks of cobalamin replacement therapy, and reduction in the irritability of myofascial trigger points takes 4–6 weeks.'''

=== Folic Acid ===

Folic acid replacement and maintenance dose recommendations are determined both by the daily requirement needed to minimise the occurrence of neural tube defects in newborns, and by the concern that high doses of folic acid will aggravate the neurological deficits of vitamin B₁₂ and obscure the early haematological signs warning of possible combined degeneration of the spinal cord by correcting the megaloblastic anaemia alone.

'''CRITICAL: every physician should know NOT to administer folic acid without checking the vitamin B₁₂ level.''' Daily intake of 400 μg of folic acid can aggravate the effects of vitamin B₁₂ deficiency and will also reduce elevated homocysteine levels associated with folic acid deficiency. However, reduction of elevated homocysteine levels to the point that there is no increased mortality from cardiac and cerebral thrombosis requires a higher daily dose of about 700 μg.

* Hence, a daily dose of 1 mg has been considered adequate
* Higher doses of folic acid may in fact be required, and may be determined by the level of homocysteine, but should be given only if vitamin B₁₂ levels are normal as well
* Patients should be cautioned that folic acid absorption is impaired by the simultaneous ingestion of antacids
* It is wise to routinely prescribe adequate amounts of vitamin B₁₂ and folic acid together, not just one — they are both water-soluble vitamins, inexpensive, available without prescription, and can be taken orally as a 500 mg tablet of B₁₂ and a 1 mg tablet of folic acid daily. This dosage is safe and effective

=== Practical Considerations for B₁₂ Testing ===

Vitamin B₁₂ inadequacy or deficiency should be considered in persons with clinical evidence of peripheral neuropathy, in vegans or persons on a predominantly vegetarian diet who do not supplement their diet with vitamin B₁₂, diabetics and others who may not absorb cobalamin, and in persons over the age of 50, since gastric mucosal atrophy is progressive as age increases and impairs vitamin B₁₂ absorption. Persons with a macrocytic anaemia are also suspect.

Whenever serum levels of vitamin B₁₂ are less than 300 pg/ml, supplementation with cyanocobalamin should be given. When serum B₁₂ levels are between 300–400 pg/ml, serum and urine homocysteine and methylmalonic acid levels are obtained, and if any one of them are elevated, supplementation should be given.

== The Biology of Starvation: B₁₂ and Folate ==

Vitamin B₁₂ and folic acid occupy a unique position in the biology of starvation because they govern DNA synthesis itself — the fundamental capacity of dividing cells to replicate. When dietary supplies of either vitamin are restricted, the consequences appear first in the most rapidly dividing cells:

# '''Bone marrow''' — megaloblastic changes appear within weeks of folate depletion; erythropoiesis becomes inefficient, producing large, fragile red cells that carry less oxygen per unit of cell volume; the resulting anaemia deprives working muscle of oxygen and directly aggravates the energy crisis at TrPs
# '''Gastrointestinal mucosa''' — enterocytes fail to replicate efficiently, causing malabsorption; this creates a vicious cycle in which deficiency impairs the absorption machinery needed to correct the deficiency
# '''Neural tissue''' — in cobalamin deficiency specifically, the progressive failure of myelin synthesis destroys the structural integrity of long axons; the spinal cord lesions (subacute combined degeneration) represent the most catastrophic end-stage of a process that begins as subtle neuropathy affecting peripheral nerves — exactly the nerves most relevant to TrP irritability

The evolutionary context of this vulnerability is that neither vitamin can be synthesised by the human body. Vitamin B₁₂ is synthesised only by bacteria; folate by plants. In ancestral environments, both were readily available — animal products for B₁₂, fresh vegetation for folate. Modern food processing, cooking, and restrictive diets strip both away with remarkable efficiency.

In the context of chronic pain management, this means that a patient with even months-long restriction of animal products (B₁₂) or with a diet dominated by cooked, refined, or processed foods (folate) is accumulating a metabolic debt that will eventually manifest as increased TrP irritability, impaired treatment response, and diffuse muscle pain — often without the classic haematological markers that clinicians rely upon.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Folic_Acid_and_TrPs|Folic Acid and Trigger Points]]
* [[Concept:Vitamin_B6_Pyridoxine_and_TrPs|Vitamin B₆ (Pyridoxine) and Trigger Points]]
* [[Concept:Iron_and_TrPs|Iron and Trigger Points]]
* [[wikipedia:Cobalamin|Cobalamin — Wikipedia]]
* [[wikipedia:Vitamin_B12_deficiency|Vitamin B₁₂ deficiency — Wikipedia]]
* [[wikipedia:Pernicious_anaemia|Pernicious anaemia — Wikipedia]]
* [[wikipedia:Subacute_combined_degeneration_of_spinal_cord|Subacute combined degeneration — Wikipedia]]
* [[wikipedia:Folate_deficiency|Folate deficiency — Wikipedia]]
* [[wikipedia:Methylmalonic_acid|Methylmalonic acid — Wikipedia]]
* [[wikipedia:Homocysteine|Homocysteine — Wikipedia]]
* [[wikipedia:Methyl_trap|Methyl-folate trap — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Nutrition]]

Concept:Vitamin B1 Thiamine and TrPs

2026-04-19T19:41:38Z

Yatreyu: Created page with "'''Vitamin B₁ (thiamine)''' is an essential water-soluble vitamin whose primary biological role is in the oxidative metabolism of glucose. It is the vitamin most directly linked to the energy crisis at the heart of myofascial trigger point (TrP) pathophysiology. Thiamine insufficiency increases the susceptibility of muscles to TrPs that are resistant to local therapy until the serum thiamine level is raised to the mean normal level or above. Thiamine has been relative..."

'''Vitamin B₁ (thiamine)''' is an essential water-soluble vitamin whose primary biological role is in the oxidative metabolism of glucose. It is the vitamin most directly linked to the energy crisis at the heart of myofascial trigger point (TrP) pathophysiology. Thiamine insufficiency increases the susceptibility of muscles to TrPs that are resistant to local therapy until the serum thiamine level is raised to the mean normal level or above.

Thiamine has been relatively unexplored in relation to myofascial pain syndromes, yet it is considered potentially important because it is essential for the oxidative metabolism of glucose that leads to the production of pyruvate — the molecule at the gateway to the Krebs cycle and to ATP synthesis. Since an energy crisis is a key link in the chain of histochemical changes characteristic of TrPs, anything that interferes with the energy supply of the muscle will aggravate TrPs.

== Discovery and History ==

In 1884, Takaki of Japan decreased the disastrous incidence of beriberi in the Japanese navy by adding meat, vegetables and condensed milk to the rice diet of the sailors. By 1912, the therapeutic effectiveness of rice polishings had been demonstrated. In 1936, Williams and his coworkers announced the chemical structure and synthesis of the active principle, thiamine.

The disease beriberi — its name deriving from a Sinhalese word meaning extreme weakness — had been the scourge of Asian populations dependent on polished white rice, stripping away the germ and bran where thiamine is concentrated. The demonstration that a single dietary factor could eliminate a devastating neurological and cardiac syndrome was a founding event of nutritional biochemistry.

== Biochemical Functions ==

The active form of vitamin B₁ in the body is '''thiamine pyrophosphate (TPP)''', also known as thiamine diphosphate (TDP).

TPP is an essential coenzyme in three critical enzyme complexes:

# '''Pyruvate dehydrogenase''' — converts pyruvate to acetyl-CoA, which enters the Krebs citric acid cycle. Without TPP, pyruvate accumulates and the cell cannot proceed to oxidative phosphorylation. This is the rate-limiting step for glucose-derived energy in aerobic metabolism.
# '''α-ketoglutarate dehydrogenase''' — a second Krebs cycle reaction requiring TPP. Blockade here impairs the full citric acid cycle.
# '''Transketolase''' — a key enzyme of the anaerobic glycolytic pathway (pentose phosphate pathway); thiamine is therefore a coenzyme for transketolase, essential for normal energy production within the cell.

TPP is therefore essential for:
* Normal energy production at the cellular level
* The energy crisis that is part of the pathophysiology of a TrP (see Chapter 2, Part D of the source volume)
* Normal nerve function — neuropathy can be a significant factor in the development of myofascial TrPs. These issues urgently need well-designed research.
* Synthesis of neurotransmitters
* Normal thyroid hormone function: thiamine seems to potentiate the effectiveness of thyroid hormone; both are essential to energy metabolism. Patients with low thiamine levels given thyroid supplement may develop symptoms of excess thyroid hormone — the dose of thyroid supplement must be reduced once the thiamine deficiency is corrected

=== Thiamine and Thyroid Function ===

The interaction between thiamine and thyroid hormone is clinically important. In the presence of thiamine insufficiency, even a small dose of thyroid hormone may precipitate symptoms of acute thiamine deficiency, which in some respects mimics thyrotoxicosis and may be misinterpreted as intolerance to the thyroid medication. After the thiamine deficiency has been corrected, the same small dose, and often larger doses, of thyroid hormone are well tolerated. Conversely, thiamine insufficiency patients already taking thyroid supplement who receive sufficient thiamine to correct a deficiency of that vitamin may then develop symptoms of excess thyroid hormone, and the dose of thyroid supplement must be reduced.

== Insufficiency and Deficiency in the Context of Myofascial Pain ==

'''Thiamine insufficiency''' is indicated by a low normal, or marginally abnormal, serum thiamine level. The muscles of these patients have increased susceptibility to TrPs that are resistant to local therapy until the serum thiamine level is raised.

Clinically, thiamine insufficiency can be detected by the presence of '''peripheral neuropathy''', characterised by:
* Diminished distal pain and temperature perception in the legs and feet
* Loss of vibration sense
* Loss of ankle tendon reflexes (not necessarily present in mild sensory neuropathy)

Some thiamine-inadequate and many thiamine-deficient patients have:
* Nocturnal calf cramps
* Mild dependent oedema
* Constipation, fatigue
* Decreased vibratory perception in relation to nerve fibre length

When given thiamine parenterally, these patients may promptly lose several pounds by diuresis (the body ceases retaining fluid to supply the oedema), have softer stools, and are relieved of nocturnal calf cramps.

In contrast to the ''painful'' calf cramps sometimes associated with thiamine deficiency, ''painless'' contractions of the hand or other muscles may be due to a lack of pantothenic acid, and relieved by its oral supplementation. Tinnitus may be relieved by a combination of thiamine ''and'' niacin therapy, but not by one vitamin alone if both are low.

=== Thiamine Deficiency and Alcohol ===

The abuse of alcohol can lead to signs and symptoms that are a variable composite of three diseases: alcoholism, thiamine deficiency, and liver dysfunction. Not only is the diet of the alcoholic likely to be deficient in thiamine, but the intake of ethyl alcohol seriously reduces thiamine absorption in either the presence or absence of liver disease. The liver disease itself can severely impair the conversion of ingested thiamine to its active form, aggravating the thiamine deficiency. Of 43 alcoholic patients who showed enzyme evidence of thiamine deficiency, 74% also had gait and oculomotor disturbances; the others did not.

== Laboratory Tests ==

Tests for thiamine include:
* Chemical identification
* Microbiologic assay
* '''Erythrocyte transketolase (ETK) activity''' — historically used, but now considered an inadequate method as it is less sensitive than HPLC, has poor precision, and has specimen stability concerns. Its use has been supplanted by direct measurement.
* '''Whole blood or erythrocyte HPLC for thiamine diphosphate (TDP)''' — the active form of vitamin B₁; this is the preferred current method. Reference values (fasting): 70–180 nmol/l. A TDP level below 70 nmol/l suggests deficiency.
* Blood levels of pyruvate and α-ketoglutarate: '''the fasting blood pyruvate is elevated above 1.0 mg/dl''' in thiamine deficiency. Following ingestion of glucose, serum pyruvate peaks in nearly 1 hour due to the disturbed glycogenesis — this is a more specific indicator of thiamine deficiency than increased serum α-ketoglutarate.
* ''Lactobacillus viridescens'' is the most widely employed microbiologic test organism; the phytoflagellata ''Ochromonas danica'' appears to be the most sensitive indicator of thiamine deficiency, especially in the presence of severe liver disease.

== Requirements and Sources ==

The need for thiamine is directly related to caloric intake when this corresponds to energy expenditure. Recommended daily allowances (RDA) by age group:
* Infants 0–12 months: 0.2–0.3 mg/day
* Children 1–8 years: 0.5–0.6 mg/day
* Children 9–13 years: 0.9 mg/day
* Ages 14–18 years: 1.0–1.2 mg/day
* Adults ≥19 years: 1.1–1.2 mg/day
* Pregnant and lactating women: 1.4 mg/day

The RDA is increased for pregnant and lactating women. Normal thiamine reserves usually provide at least 5 weeks of protection from severe thiamine deprivation.

=== Food Sources ===

Thiamine is widely distributed in both animal and vegetable foods, but few foods are rich in it. '''Best sources:'''
* Lean pork (the richest common food source)
* Beans, nuts, and certain whole grain cereals
* Kidney, liver, beef, eggs, and fish

In cereal grains, the vitamin is present almost exclusively in the germ and hull. Since these are lost in milling and refining, processed grains need to have the thiamine replaced.

=== Factors That Destroy or Impair Thiamine ===

* '''Heat''' — thiamine can be destroyed by heating above 100°C (212°F); it is quickly leached out of foods during washing or boiling; degraded rapidly in foods fried in a hot pan or cooked under pressure; rapidly degraded in an alkaline medium
* Canned vegetables generally contain only about 30% of the thiamine initially available
* Retention in preprocessed meats ranges from 40–85%; increasing the roasting temperature of beef or pork reduces thiamine content from 62–51% of the original
* Pasteurisation of cow's milk destroys from 3–10% of its thiamine; additional heat in processing evaporated milk reduces its thiamine by 30%
* '''Bracken fern''' — grows in upland pastures where it can pose a hazard to foraging animals; destroyed by vitamin B₁ by a thiaminase enzyme
* '''Alcohol''' — seriously reduces thiamine absorption; excretion of thiamine is potentiated by diuretics and by regularly drinking large amounts of water
* '''Tea and gastric alkalinisers''' — tannic acid in tea, and also antacids, taken with food impair thiamine absorption
* Conversion of dietary and synthetic thiamine to thiamine pyrophosphate, the physiologically active form, is seriously compromised in liver disease

=== Bioavailability ===

* '''Impaired by alcohol ingestion, magnesium deficiency, tannic acid (tea), antacids, and diuretics'''
* '''Excretion''' is potentiated by diuretics and by drinking large amounts of water, which causes a diuresis

== Therapy ==

Thiamine is available over-the-counter in 10-, 50- and 100-mg tablets. It is also available for injection at a concentration of 100 mg/ml.

'''Oral therapy:'''
* The therapeutic oral dose usually recommended is 10 mg daily for several weeks, or until all evidence of deficiency has disappeared
* Increasing this to 50 mg daily will cause no harm and will ensure providing for patients with an exceptional need for the vitamin
* A '''B-50 vitamin supplement''' contains 50 mg of thiamine and is an ample daily dose to protect nearly all individuals from thiamine insufficiency — it can be taken indefinitely as a safe, inexpensive form of health insurance

'''Parenteral therapy (for established deficiency or malabsorption):'''
* '''100 mg three times daily intravenously for several days''', followed by 100 mg/day orally until complete recovery
* Infantile beriberi: 5–20 mg intravenously
* Biweekly intramuscular injections of 100 mg for 3–4 weeks bring serum concentration to an optimal level in patients with poor intestinal absorption or exceptional need

=== Toxicity ===

When taken in much larger amounts, excess thiamine is excreted in the urine and has no reported human toxicity. Intolerance to oral thiamine is extremely rare; daily doses of 500 mg have been administered for as long as a month without ill effects. However, in rare instances, intravenous thiamine has produced fatal anaphylactic shock. Most of these reactions occurred in patients who had previously received large doses of thiamine by injection — they apparently developed sensitivity to additives in the injected solution.

In one study, increasing an oral intake of thiamine above 10 mg altered neither its blood level nor the amounts excreted in the urine, supporting the belief that intestinal absorption was likely the limiting step.

== The Biology of Starvation: Thiamine ==

In starvation or severe caloric restriction, thiamine deficiency emerges with characteristic urgency because the body has no significant storage depot for this vitamin (normal reserves last only about 5 weeks). The timeline of thiamine depletion illustrates the relationship between nutrient availability and neurological function:

* Thiamine is consumed in proportion to caloric expenditure, specifically carbohydrate metabolism
* In glucose-overloaded states (refeeding syndrome with excessive glucose after starvation, or overloading thiamine-depleted tissues with glucose), acute Wernicke's encephalopathy can be precipitated — the brain, with its absolute dependence on glucose oxidation, is catastrophically vulnerable
* '''Wet beriberi''' (high-output cardiac failure with oedema) reflects the dependence of myocardial contractility on pyruvate dehydrogenase activity; without TPP, the heart cannot efficiently generate ATP and begins to fail at high-output, then low-output states
* '''Dry beriberi''' (peripheral sensorimotor neuropathy) reflects the dependence of axonal transport and myelin maintenance on thiamine-dependent energy metabolism
* '''Wernicke-Korsakoff syndrome''' (ophthalmoplegia, ataxia, confusion, and amnesia) represents the selective vulnerability of certain brainstem and diencephalic neurons to thiamine deficiency, mediated by the intense requirement of those neurons for oxidative glucose metabolism

The evolutionary logic is that starvation produces caloric deficit before thiamine deficit; but when dietary thiamine is low while caloric intake is maintained (polished rice diet, alcohol-displaced diet), the metabolic machinery runs down without the warning of starvation — a biochemical ambush that beriberi represents.

In the context of myofascial pain, this biology implies that any state of chronic partial caloric restriction, selective food avoidance, excessive alcohol, malabsorption, or high metabolic demand (illness, pregnancy, lactation) places a patient in a zone of thiamine insufficiency that directly aggravates TrP irritability, even when serum levels remain within the "normal" range.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin_B6_Pyridoxine_and_TrPs|Vitamin B₆ (Pyridoxine) and Trigger Points]]
* [[Concept:Vitamin_B12_Cobalamin_and_TrPs|Vitamin B₁₂ (Cobalamin) and Trigger Points]]
* [[Concept:Vitamin_C_and_TrPs|Vitamin C (Ascorbic Acid) and Trigger Points]]
* [[wikipedia:Beriberi|Beriberi — Wikipedia]]
* [[wikipedia:Thiamine_deficiency|Thiamine deficiency — Wikipedia]]
* [[wikipedia:Wernicke–Korsakoff_syndrome|Wernicke–Korsakoff syndrome — Wikipedia]]
* [[wikipedia:Thiamine_pyrophosphate|Thiamine pyrophosphate — Wikipedia]]
* [[wikipedia:Pyruvate_dehydrogenase_complex|Pyruvate dehydrogenase complex — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Nutrition]]

Concept:Vitamin B6 Pyridoxine and TrPs

2026-04-19T19:41:22Z

Yatreyu: Created page with "'''Vitamin B₆ (pyridoxine)''' is considered the single most important vitamin in myofascial pain syndrome (MPS) because of its role in energy metabolism, in nerve function, and critically in the '''synthesis and/or metabolism of nearly all the neurotransmitters'''. It is also essential to the metabolism of many proteins, including several neurotransmitters. Pyridoxine deficiency is almost never found alone — it usually occurs with deficiency of other B-complex vitami..."

'''Vitamin B₆ (pyridoxine)''' is considered the single most important vitamin in myofascial pain syndrome (MPS) because of its role in energy metabolism, in nerve function, and critically in the '''synthesis and/or metabolism of nearly all the neurotransmitters'''. It is also essential to the metabolism of many proteins, including several neurotransmitters. Pyridoxine deficiency is almost never found alone — it usually occurs with deficiency of other B-complex vitamins and interacts with nearly every other nutrient of relevance to myofascial pain.

== Discovery and History ==

In 1934, Szent-Györgyi identified a dietary factor that prevents rat acrodynia — a dermatitis of the tail, ears, mouth and paws characterised by oedema and scaliness of the skin. He later named this substance vitamin B₆. Vitamin B₆ is a complex formed from three distinct, chemically different compounds: '''pyridoxal''' (an alcohol), '''pyridoxal''' (an aldehyde), and '''pyridoxamine''' (an amine). These are the dietary precursors of the active coenzyme forms. The precursors are phosphorylated in the body, chiefly in the liver, by pyridoxal kinase to become the active coenzymes, '''pyridoxal phosphate''' and pyridoxamine phosphate.

In the early 1950s, its absence in an infant formula caused an epidemic of convulsions that were curable by pyridoxine injection. In 1968, the National Academy of Sciences recognised its essential nature in human nutrition by assigning it a required daily allowance (RDA).

== Biochemical Functions ==

More than 100 pyridoxal phosphate-dependent enzymes are known to man. The most important functions of this vitamin concern '''amino acid metabolism'''. For these functions, pyridoxine provides essential coenzyme reactions that include:

* '''Transamination''' — the reversible transfer of an α-amino group between an amino acid and an α-keto acid
* Oxidative deamination of an amino acid to an aldehyde
* Interconversion of the L and D isomers of an amino acid
* Decarboxylation
* Interconversion of glycine and serine
* Conversion of homocysteine and cystathionine to cysteine — failure of the methionine-to-cysteine pathway leads to homocystinuria; the failure of cystathione conversion leads to cystathioninuria
* '''Conversion of tryptophan to niacin''' — in the absence of an adequate exogenous source of niacin, pyridoxine deficiency enhances a niacin deficiency

=== Neurotransmitter Synthesis ===

Practically all of the compounds identified as '''neurotransmitters in the brain''' are synthesised and/or metabolised with the aid of pyridoxal phosphate. These include:

* '''Dopamine, norepinephrine, serotonin''' — the principal monoamine neurotransmitters involved in pain modulation, mood, and arousal
* Tyramine, tryptamine, taurine, histamine, γ-aminobutyric acid (GABA), and indirectly acetylcholine
* '''Serotonin''' is derived, with the help of pyridoxal phosphate, from 5-hydroxytryptophan
* '''Glutamic acid decarboxylase''' with pyridoxal phosphate catalyses the formation of GABA, the principal inhibitory neurotransmitter derived from glutamic acid
* Because pyridoxal phosphate strongly influences pain perception through both norepinephrine and serotonin synthesis, vitamin B₆ insufficiency directly lowers the threshold for pain amplification

=== Energy Metabolism ===

Although vitamin B₆ has no primary effect on metabolism, its deficiency indirectly influences both anaerobic and aerobic metabolism:

* '''Pyridoxal phosphate plays an important conformational or structural role in the enzyme phosphorylase''', which is essential to the release of glucose from glycogen — normally the chief substrate for oxidative metabolism in muscle
* Contributes to aerobic metabolism through the degradation of at least 11 amino acids, making the corresponding α-keto acid analogue available to enter the energy-releasing tricarboxylic acid cycle
* Deficiency of pyridoxal phosphate interferes seriously with the disposal of used amino acids, and their reconfiguration for synthesis to new amino acids

=== Haemoglobin Synthesis ===

Pyridoxal phosphate plays an essential role as a cofactor in the synthesis of porphyrin, which is a part of the haemoglobin molecule. Adults with proven pyridoxine deficiency may show a microcytic hypochromic anaemia that fails to respond to iron, but the anaemia improves dramatically following treatment with small doses of pyridoxine.

=== Other Coenzyme Functions ===

* Reduced absorption and storage of cobalamin (vitamin B₁₂)
* Increased excretion of vitamin C
* Blocked synthesis of nicotinic acid (niacin)
* B₆ acts synergistically with vitamin E to control the metabolism of unsaturated fats, and with vitamin C in tyrosine metabolism
* Essential to lipid metabolism: its deficiency results in reduced absorption and storage of cobalamin and blocked synthesis of nicotinic acid

== Insufficiency and Deficiency ==

The specific enzymatic functions of vitamin B₆ that must be lacking to cause increased neuromuscular irritability and perpetuation of TrPs has not been established. Clear-cut symptoms of pyridoxine deficiency are unusual. Pyridoxine deficiency rarely occurs alone, but is usually seen with deficiency of the other vitamins of the B-complex. Milder, equivocal symptoms appear with inadequate amounts of the vitamin.

=== Clinical Presentations ===

'''Mild insufficiency / chronic partial deficiency:'''
Patients on poor diets were initially observed to have ill-defined central nervous system syndromes of:
* Weakness, irritability, nervousness
* Insomnia
* Difficulty in walking
* Loss of "sense of responsibility"
* Abnormal electroencephalograms
These changes do not respond to treatment with other members of the vitamin B-complex, but are relieved within 24 hours by ingesting pyridoxine.

'''Established deficiency:'''
* Dermatological lesions of pellagra (niacin deficiency) may result secondarily from vitamin B₆ deficiency, producing mixed symptoms of pyridoxine and niacin deficiencies
* A disproportionately high percentage of psychiatric patients are folic acid deficient; '''depression is their most probable psychiatric diagnosis'''
* In a group of 154 patients admitted to a psychiatric unit of a general hospital, the pyridoxine-deficient patients showed a disproportionately high incidence of depression compared to psychiatric patients without such a deficiency

'''Diabetic patients''' complaining of leg cramps, swelling of the hands, and impaired tactile sensation were relieved of their symptoms while taking 50 mg/day of pyridoxine orally.

'''Carpal tunnel syndrome (CTS):'''
The role of insufficient pyridoxine as a significant factor in CTS is controversial. One study found that pyridoxine supplementation for 12 weeks was effective in the treatment of CTS compared to placebo. A subsequent study failed to support their findings. In some cases, pyridoxine insufficiency may increase the vulnerability of peripheral nerves to entrapment enough to cause the symptoms of CTS.

== Pyridoxine Dependence ==

The need for very large amounts of pyridoxine occurs when one of the specific enzyme systems that require this vitamin is congenitally incomplete. Megadoses (10 times the RDA, or more) of pyridoxine at least partially compensate for the metabolic abnormality. Metabolic dependence on the vitamin is established clinically when both the symptoms and the characteristic abnormal metabolic intermediates recur promptly after resumption of an unsupplemented normal diet.

One should expect considerable variability among patients in their need for pyridoxine. Patients with chronic MPS are a select group who show a high prevalence of vitamin inadequacies. Many of these patients do well on large vitamin supplements — one likely explanation for this apparent partial dependence is the partial expression of one or more of the genetic enzyme deficiencies.

== Laboratory Tests ==

* '''LC-MS/MS for pyridoxal 5-phosphate (PLP) levels''' — the preferred current method; reliably reflects vitamin B₆ status in humans. Reference value (fasting): 5–50 mcg/l.
* '''Plasma pyridoxal phosphate (PLP) concentration''' — determined by a radioactive tyrosine and apodecarboxylase assay; reliably reflects vitamin B₆ levels in humans
* '''Measurement of circulating serum vitamin B₆''' — a decrease in this blood level is the earliest warning signal of an acute clinical deficiency; in mild-to-moderate chronic deficiency, the symptoms may depend as much on concomitant secondary deficiencies as on the blood level of pyridoxal phosphate
* Valid biological assay for vitamin B₆ requires time and/or special care. ''Saccharomyces carlsbergensis'' is the test organism commonly used because it is responsive to pyridoxal, pyridoxal, and pyridoxamine. Unlike most other test microorganisms, it is unable to use D-alanine to satisfy its vitamin B₆ requirement — it is therefore suitable for tests on human blood

== Requirements and Sources ==

Vitamin B₆ is highly conserved in the body. Excretion of vitamin B₆ and its metabolites is rapidly adjusted to changes in the intake of the vitamin. The vitamin B₆ requirement rises roughly in proportion to the increase in protein intake, and with age.

Recommended daily allowances (RDA) by age group:
* Infants 0–12 months: 0.1–0.3 mg/day
* Children 1–8 years: 0.5–0.6 mg/day
* Children 9–13 years: 1.0 mg/day
* Ages 14–18 years: 1.2–1.3 mg/day
* Adults ≥19 years: 1.3–1.7 mg/day
* Pregnant women: 1.9 mg/day
* Lactating women: 2.0 mg/day

Body stores normally contain about 0.60 mg (0.55–0.66 mg) of pyridoxal phosphate/0.45 kg (1 lb) of body weight — a total of about 108 mg in an 82-kg individual; 90% resides in a slow-turnover compartment with a half-life of nearly 33 days; 10% in a fast-turnover compartment with a half-life of about 16 hours.

=== Best Dietary Sources ===

Vitamin B₆ is widely distributed in nature, but not in large amounts:
* Liver, kidney
* White meat of chicken, halibut, tuna
* English walnuts, soybean flour, navy beans, bananas, avocados
* Yeast, lean beef, egg yolk, whole wheat, and milk

Fresh milk contains 0.6 mg of vitamin B₆/L (0.14 mg/8 oz serving) — very little — and much is lost when milk is exposed to sunlight for more than a few minutes. Animal sources are less susceptible to loss of the vitamin because of cooking or preserving than are plant sources.

The usual synthetic form of vitamin B₆ is pyridoxine hydrochloride, which is stable in acid solution, but rapidly destroyed by sunlight when in neutral or alkaline solution. This synthetic form is heat stable through most food processing.

=== Factors That Impair B₆ Availability ===

* '''Oral contraceptives''' — the majority of oral contraceptive users had abnormal tryptophan metabolism characteristic of pyridoxine deficiency; the oestrogenic component is responsible. There is no known contraindication to regularly supplementing the diet of oral contraceptive users with 5–10 mg of vitamin B₆ daily, except minimal cost
* '''Excessive alcohol consumption''' — pyridoxine deficiency is aggravated in alcoholics by: (1) reduced dietary intake; (2) impaired absorption of the natural dietary forms of B₆; (3) interference with the conversion of vitamin B₆ to the active phosphorylated form by both alcohol and liver disease. Acetaldehyde, an oxidation product of ethanol, interferes with the metabolism of vitamin B₆ by promoting the degradation of pyridoxal phosphate
* Pregnancy and lactation
* Antitubercular drugs (INH/isoniazid and cycloserine are potent pyridoxine antagonists; symptoms of pyridoxine deficiency due to INH can be prevented by 50 mg/day of oral pyridoxine)
* Corticosteroids
* Hyperthyroidism — the need for vitamin B₆ is increased
* Uraemia — pyridoxine deficiency often occurs in both dialysed and undialysed uraemic patients

== Therapy ==

Pyridoxine is available over-the-counter in 10-, 25-, and 50-mg tablets, and in larger amounts by prescription. Parenteral pyridoxine hydrochloride is supplied in vials in a concentration of 100 mg/ml.

* '''Oral: 50–100 mg/day to prevent neuropathy'''
* '''Intravenous: 100 mg/day in patients with seizures'''
* A single intramuscular injection of 100 mg of pyridoxine effectively raises the serum level of the vitamin
* '''Oral supplementation of at least 10 mg per day of vitamin B₆ is strongly recommended for those taking an oral contraceptive'''
* During pregnancy and lactation, the requirement is markedly increased; augmenting the basic RDA by 2.5 mg was not sufficient to raise blood PLP levels in pregnant women to those of non-pregnant women — monitoring is advisable
* B₆ therapy has provided effective prophylaxis against motion sickness in non-pregnant individuals, both adults and children
* A B-50 vitamin supplement contains 50 mg of pyridoxine and is an ample daily dose to protect nearly all individuals from pyridoxine insufficiency — it can be taken indefinitely as a form of health insurance
* Pharmacological doses of vitamin B₆, ranging from 10–100 mg or more daily, are indicated for the pyridoxine-dependent conditions described above and are non-toxic at these levels

=== Toxicity ===

Doses of 500 mg per day given chronically (6 months or longer) produce a peripheral sensory neuropathy and ataxia. Doses over 100 mg per day are unnecessary. '''Doses as low as 200 mg per day have produced a sensory neuropathy''', and constitute a warning against the use of such high pharmacological doses of the vitamin. These constitute a warning against using such high doses.

== The Biology of Starvation: Vitamin B₆ ==

Vitamin B₆ occupies a central position in the biology of protein catabolism during starvation — a process that accelerates when carbohydrate stores are exhausted. When glycogen is depleted (within approximately 24 hours of fasting), the body begins to derive glucose from amino acids through gluconeogenesis. This process depends critically on transamination reactions, all of which require pyridoxal phosphate.

The cascade proceeds:
# Muscle protein is mobilised, releasing amino acids into the circulation
# Transamination (pyridoxal phosphate-dependent) converts amino acids to their corresponding α-keto acids
# α-keto acids enter the Krebs cycle or are converted to glucose in the liver
# Without adequate pyridoxal phosphate, this transamination is impaired — the body cannot efficiently extract gluconeogenic precursors from protein

In states of marginal B₆ nutrition combined with starvation or high protein turnover, the consequences extend to neurotransmitter depletion: serotonin and GABA synthesis both require pyridoxal phosphate, so mood disturbance, anxiety, and sleep disruption often accompany the protein-wasting phase of starvation.

The specific relevance to myofascial pain is that patients with chronic pain who restrict food intake (due to fatigue, depression, or secondary gain), or who consume high-protein diets without adequate B₆, place their neurotransmitter synthesis and their muscle energy metabolism simultaneously at risk.

== Related Pages ==

* [[Concept:Perpetuating_Factors|Perpetuating Factors — Overview]]
* [[Concept:Vitamin_B1_Thiamine_and_TrPs|Vitamin B₁ (Thiamine) and Trigger Points]]
* [[Concept:Vitamin_B12_Cobalamin_and_TrPs|Vitamin B₁₂ (Cobalamin) and Trigger Points]]
* [[Concept:Folic_Acid_and_TrPs|Folic Acid and Trigger Points]]
* [[wikipedia:Pyridoxine|Pyridoxine — Wikipedia]]
* [[wikipedia:Pyridoxal_phosphate|Pyridoxal phosphate — Wikipedia]]
* [[wikipedia:Vitamin_B6|Vitamin B₆ — Wikipedia]]
* [[wikipedia:Transaminase|Transaminase — Wikipedia]]
* [[wikipedia:Gluconeogenesis|Gluconeogenesis — Wikipedia]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4, Section C.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]
[[Category:Nutrition]]

Concept:Perpetuating Factors

2026-04-19T19:29:38Z

Yatreyu: Created page with "'''Perpetuating factors''' are the systemic, structural, metabolic, and psychological conditions that keep myofascial trigger points (TrPs) active and prevent them from resolving spontaneously or with specific local treatment. Recognition and correction of perpetuating factors is, according to Travell and Simons, '''the most important single aspect''' of myofascial pain management, and the most neglected. The clinical importance of this concept is illustrated by the apo..."

'''Perpetuating factors''' are the systemic, structural, metabolic, and psychological conditions that keep myofascial trigger points (TrPs) active and prevent them from resolving spontaneously or with specific local treatment. Recognition and correction of perpetuating factors is, according to Travell and Simons, '''the most important single aspect''' of myofascial pain management, and the most neglected.

The clinical importance of this concept is illustrated by the apocryphal story of the man who stepped in a hole and broke his leg. The bones healed, but two months later he stepped in the same hole and broke the leg again. ''No one had patched the hole.'' If we treat myofascial pain syndromes without correcting the perpetuating factors that promptly reactivate TrPs, the patient is condemned to repeated cycles of treatment and relapse.

For patients with chronic myofascial pain who have suffered for many months or years, perpetuating factors often spell the difference between successful and failed therapy. '''When the patient fails to respond to specific myofascial therapy, or obtains only temporary relief, perpetuating factors must be ruled out as a major contributing cause.'''

== Categories of Perpetuating Factors ==

Perpetuating factors fall into several distinct but frequently overlapping categories. Several are often present simultaneously in any one patient.

=== Mechanical Stress ===

Structural and postural factors that produce chronic muscle overloading are among the most common perpetuators.

'''Structural inadequacies''' include:
* '''Lower limb-length inequality (LLLI)''' — a difference as small as 0.5 cm (3/16 in) can be clinically critical; causes a compensatory scoliosis maintained by sustained muscular effort. See the correction procedure described in Chapter 48, Section 14
* '''Small hemipelvis''' — tilts the sacral base; produces compensatory scoliosis when seated or standing; more commonly overlooked than LLLI; corrected with an ischial lift ("sit-pad")
* '''Short upper arms''' — leaves the shoulders unsupported in most seated positions; perpetuates upper trapezius and levator scapulae TrPs
* '''Morton's foot (short first, long second metatarsal)''' — produces a characteristic gait imbalance that can perpetuate TrPs throughout the lower limb, trunk, and up to the jaw

'''Postural stresses''' include misfitting furniture, poor posture habits, sustained muscle contraction, repetitive movement overload, and immobility. See [[wikipedia:Neutral_spine|Neutral spine]] and [[wikipedia:Ergonomics|Ergonomics]] for corrective principles. Postural correction is addressed in Chapter 41.

'''Constriction of muscles''' by tight clothing — brassiere straps, belts, tight collars, hosiery elastic — produces prolonged ischaemia and perpetuates TrPs in the compressed muscles.

=== Nutritional Inadequacies ===

Nutritional deficiencies are ''often crucial perpetuating factors'' and commonly occur alongside sources of mechanical stress. '''Low "normal" levels of vitamins B₁, B₆, B₁₂, and/or folic acid are suboptimal and frequently responsible for treatment failure.''' They are confirmed by serum measurement; symptoms usually respond to oral supplementation.

The five vitamins of special importance to myofascial pain syndromes are detailed in dedicated pages:

* [[Concept:Vitamin_B1_Thiamine_and_TrPs|Vitamin B₁ (Thiamine) and Trigger Points]]
* [[Concept:Vitamin_B6_Pyridoxine_and_TrPs|Vitamin B₆ (Pyridoxine) and Trigger Points]]
* [[Concept:Vitamin_B12_Cobalamin_and_TrPs|Vitamin B₁₂ (Cobalamin) and Trigger Points]]
* [[Concept:Folic_Acid_and_TrPs|Folic Acid and Trigger Points]]
* [[Concept:Vitamin_C_and_TrPs|Vitamin C (Ascorbic Acid) and Trigger Points]]

Dietary minerals of clinical importance include [[Concept:Iron_and_TrPs|iron]], [[Concept:Calcium_and_TrPs|calcium]], potassium, and magnesium — each addressed on its own page.

=== Metabolic and Endocrine Inadequacies ===

Any compromise of muscle energy metabolism aggravates and perpetuates myofascial TrPs. The three main metabolic perpetuators are:

* '''Hypometabolism (hypothyroidism)''' — even mild or subclinical hypothyroidism makes muscles more susceptible to TrP activation and produces only temporary relief from specific myofascial therapy. Correction of hypothyroidism can produce spontaneous resolution of TrPs and full recovery from MPS within 4–6 weeks. TSH should be screened in any patient with widespread or treatment-resistant TrPs.
* '''Hypoglycemia''' — both fasting and reactive (postprandial) hypoglycemia aggravate TrP activity through the mechanism of increased circulating epinephrine and impaired muscle energy supply
* '''Hyperuricemia and gout''' — TrPs respond poorly to spray and stretch when the patient is hyperuricemic; injection therapy is more effective than spray and stretch in these patients. Managed with standard uricosuric treatment.

=== Psychological Factors ===

Psychological factors can contribute to perpetuation of TrPs. The physician must be careful '''not to assume''' that psychological factors are primary — it is all too easy to blame the patient's psyche for the inability of the physician to recognise the musculoskeletal sources of the pain.

Factors include hopelessness (often from prior misdiagnosis as untreatable), depression (closely associated with chronic pain, bidirectionally), anxiety and tension (expressed as sustained muscle contraction), the '''[https://en.wikipedia.org/wiki/Pain_asymbolia "good sport" syndrome]''' (stoic over-activity that overloads muscles), and secondary gain behaviors.

=== Chronic Infection and Infestations ===

Chronic bacterial disease and some parasitic infestations can prevent recovery from myofascial pain syndromes. Of specific clinical relevance:
* '''Viral disease''' — including acute and chronic viral infections
* '''Bacterial infection''' — chronic bacterial disease as a background perpetuator
* '''Giardia lamblia''' — one of the most common intestinal parasites causing chronic malabsorption; confirmed by stool examination; causes malabsorption of carbohydrate, fat, and vitamin B₁₂
* '''Entamoeba histolytica''' — causes tissue invasion with ulceration; malabsorption perpetuates TrPs; diagnosis by stool examination or biopsy; treatment requires a combination of drugs

=== Other Factors ===

* '''Allergic rhinitis''' — hypersensitivity to allergens with histamine release acts as a perpetuating factor; allergy control significantly improves TrP treatment response
* '''Impaired sleep''' — disruption of restorative non-REM sleep perpetuates TrPs; addressed by correcting sleep posture and treating underlying sleep disorders
* '''Nerve impingement''' — radiculopathy and peripheral nerve entrapment maintain TrP irritability; TrPs and radiculopathy are diagnosed and treated independently

== Screening Laboratory Tests ==

The most useful routine tests to identify perpetuating factors are:

{| class="wikitable"
|-
! Test !! What it screens for
|-
| '''Serum vitamin levels''' — B₁, B₆, B₁₂, folic acid, vitamin C || Vitamin inadequacies; values in the '''lower quartile of normal''' are highly suspect as TrP perpetuators
|-
| '''Blood chemistry profile''' || Elevated cholesterol (hypothyroidism, folate deficiency); elevated uric acid (gout); low calcium (suspect ionised calcium); low potassium (aggravates TrPs); elevated fasting blood sugar (diabetes); elevated liver enzymes
|-
| '''Complete blood count (CBC) with indices''' || Low haemoglobin and haematocrit (anaemia); low MCV (iron deficiency); high MCV >92 fl (suspect folate or B₁₂ deficiency); elevated eosinophils (allergy or parasitic infestation); >50% mononuclear cells (viral infection or low thyroid function)
|-
| '''Erythrocyte sedimentation rate (ESR)''' || Elevated ESR: chronic bacterial infection, polymyositis, polymyalgia rheumatica, cancer; normal ESR helps exclude chronic bacterial infection
|-
| '''Thyroid tests''' — sTSH, FT₄ || Hypothyroidism; sTSH is the preferred initial test; if low, FT₄ and microsomal antibodies obtained; if borderline, CK and cholesterol help determine thyroid status
|}

'''Key principle:''' Values in the '''lower quartile of normal''' for water-soluble vitamins are less than optimal and are highly suspect as perpetuators of myofascial TrPs. Since a battery of B₁₂ and folic acid levels is readily available and not unreasonably expensive, it should be obtained routinely in patients with chronic myofascial pain. These patients are a select group who are more likely than most patients to have vitamin inadequacy.

== Related Pages ==

* [[Concept:Vitamin_B1_Thiamine_and_TrPs|Vitamin B₁ (Thiamine) and Trigger Points]]
* [[Concept:Vitamin_B6_Pyridoxine_and_TrPs|Vitamin B₆ (Pyridoxine) and Trigger Points]]
* [[Concept:Vitamin_B12_Cobalamin_and_TrPs|Vitamin B₁₂ (Cobalamin) and Trigger Points]]
* [[Concept:Folic_Acid_and_TrPs|Folic Acid and Trigger Points]]
* [[Concept:Vitamin_C_and_TrPs|Vitamin C (Ascorbic Acid) and Trigger Points]]
* [[Concept:Iron_and_TrPs|Iron and Trigger Points]]
* [[Concept:Calcium_and_TrPs|Calcium and Trigger Points]]

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1: The Upper Half of Body''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 4. With contributions by Robert D. Gerwin, MD.

[[Category:Concept]]
[[Category:Vol1 Ch4]]
[[Category:Perpetuating Factors]]

Muscle:Cervical Rotatores

2026-04-19T18:49:51Z

Yatreyu: Created page with "'''Cervical rotatores''' are the shortest and deepest paraspinal muscles of the posterior cervical spine. Their trigger points (TrPs) produce '''midline pain and tenderness at the segmental level of the TrP''' — a pattern analogous to that described for thoracolumbar rotatores. Unlike the longer posterior cervical muscles, their taut bands cannot be identified by palpation; they must be identified by characteristic deep tenderness to pressure in the groove lateral to s..."

'''Cervical rotatores''' are the shortest and deepest paraspinal muscles of the posterior cervical spine. Their trigger points (TrPs) produce '''midline pain and tenderness at the segmental level of the TrP''' — a pattern analogous to that described for thoracolumbar rotatores. Unlike the longer posterior cervical muscles, their taut bands cannot be identified by palpation; they must be identified by characteristic deep tenderness to pressure in the groove lateral to spinous processes, and by tenderness to pressure or tapping on the spinous process of the vertebra to which the muscle attaches.

TrPs in the cervical rotatores are closely and directly associated with articular dysfunction at the same segmental level. The articular dysfunctions commonly associated with them are often corrected by suboccipital decompression, or other manipulative medicine techniques.

== Contents ==
* [[#Anatomy|1 Anatomy]]
* [[#Referred Pain Patterns|2 Referred Pain Patterns]]
* [[#Activation and Perpetuating Factors|3 Activation and Perpetuating Factors]]
* [[#Clinical Examination|4 Clinical Examination]]
* [[#Differential Diagnosis|5 Differential Diagnosis]]
* [[#Treatment|6 Treatment]]
** [[#Trigger Point Release|6.1 Trigger Point Release]]
** [[#Trigger Point Injection|6.2 Trigger Point Injection]]
** [[#Corrective Actions|6.3 Corrective Actions]]
* [[#Satellite Trigger Points|7 Satellite Trigger Points]]
* [[#Related Pages|8 Related Pages]]
* [[#References|9 References]]

== Anatomy ==

The cervical rotatores, when present, begin at C₂ and continue downward segmentally. They are the shortest and deepest paraspinal muscles, connecting to adjacent or alternate vertebrae. They constitute the fourth and deepest layer of the posterior cervical muscles (with the cervical multifidi), lying directly over the laminae of the vertebrae. They are therefore the muscular layer immediately superficial to needle contact with the lamina during injection.

The degree of angulation of these muscles has important functional implications: the rotatores are the most angulated of all the posterior cervical muscles and therefore the most effective of these muscles for spinal rotation.

The cervical rotatores are '''often not as fully developed''' in the cervical region as they are in the thoracic region. Their taut bands cannot be identified by the direction of their fibres on palpation — they must be identified by deep pressure tenderness.

'''Primary actions:''' Rotation of the vertebrae to the opposite side (most effective paraspinal rotators due to maximum fibre angulation); extension of the vertebral column when acting bilaterally.

'''Innervation:''' Branches of the posterior primary divisions of the cervical spinal nerves.

'''Synergists''' (extension and rotation): Semispinalis cervicis; for each separate movement, additional synergists and antagonists are the same as those for the semispinalis cervicis.

== Referred Pain Patterns ==

When present, TrPs of the cervical rotatores produce '''midline pain and tenderness at the segmental level of the TrP''', analogous to that described for thoracolumbar rotatores under Deep Paraspinal Muscles in Chapter 48. Pain is elicited by application of pressure or tapping on the spinous process(es) of the vertebra(e) to which the muscle attaches.

This tenderness testing is used also to identify dysfunctional spinal articulations.

The pain arising from the cervical multifidi (with which the rotatores are functionally grouped) is analogous to the pattern of pain arising from the corresponding deep layer of muscles in the lumbar spine: both refer pain locally adjacent to the spinous process and may refer additional patterns several segments away from the TrP.

== Activation and Perpetuating Factors ==

* '''Articular dysfunction:''' The most direct activating factor for cervical rotatores TrPs is articular dysfunction at the same segmental level; the two conditions are closely associated and frequently coexist
* Motor vehicle accident (whiplash): the semispinalis cervicis, multifidi, and rotatores muscle groups can form articular dysfunctions at various levels of the cervical and upper thoracic spine depending on specific attachments
* Sustained forward head posture with the neck in flexion
* Neuropathy: increased nerve irritability from spinal radiculopathy or segmental dysfunction
* Extension dysfunctions of T₁–T₄: the bilateral posterior cervical muscles that attach to or span the upper thoracic vertebrae — particularly the semispinalis cervicis, multifidi, and rotatores with attachments in the upper thoracic region, as well as the semispinalis thoracis digitations that extend to and cross the upper thoracic vertebral segments — are particularly difficult to isolate; extension dysfunctions of T₁–T₄ are an important articular dysfunction associated with TrP involvement of these muscles

== Clinical Examination ==

The cervical rotatores '''lie too deep for the fibre direction of their taut bands to be identified by palpation'''. They must be identified by:

# '''Deep tenderness''' to pressure applied deep in the groove lateral to the spinous processes
# '''Tenderness to applied pressure or tapping on the spinous process''' of the vertebra to which the muscle attaches — this spinous process tenderness testing is used also to identify dysfunctional spinal articulations

'''Distinguishing rotatores from multifidi on examination:'''
* Multiple bilateral deep short rotatores can look like the longer but less angulated multifidi on palpation
* Rotatores involvement causes more restricted rotation than multifidi involvement
* Multifidi are less likely to cause a contiguous series of pressure-sensitive vertebrae with restricted joint mobility
* Multifidi involvement would not cause as much restricted rotation as the rotatores do

'''Articular assessment:''' The close relationship between rotatores TrPs and articular dysfunction means that a careful evaluation of cervical joint function at corresponding segmental levels is essential. Restriction in all directions usually indicates a capsular (arthritic) pattern rather than a dysfunctional (myofascial) one.

A '''flattened spot''' in the normally smooth curvature of the thoracic region, identified when tested by forward flexion (at least one spinous process fails to stand out prominently as expected), indicates the segmental level of TrP involvement in the deep paraspinal muscles.

== Differential Diagnosis ==

{| class="wikitable"
|-
! Condition !! Distinguishing features
|-
| Cervical zygapophysial joint pain || Tenderness to spinous process pressure is shared by both rotatores TrPs and articular dysfunction; the two conditions coexist so frequently that both must be assessed at each segmental level; myofascial TrP pain responds to TrP pressure release and injection; articular dysfunction responds to manipulation
|-
| Cervical multifidi TrPs || Multifidi are longer, less angulated, and less effective at rotation; rotatores TrPs produce more restricted rotation; multifidi TrPs are less likely to produce contiguous vertebral pressure sensitivity; palpation depth and fibre angulation differ
|-
| Cervical radiculopathy || Positive Spurling test; dermatomal limb signs; electrodiagnostic findings; TrPs and radiculopathy coexist — each diagnosed on its own criteria; posterior cervical TrPs alone do not produce limb symptoms
|-
| Counterstrain tender points (Jones) || Jones mapped tender tissue texture changes near bony attachments of tendons, ligaments, or muscle bellies in the upper posterior cervical region — at the C₁ transverse processes, along the mandibular rami — associated with impaired or altered function of the upper cervical segment; clinicians using both systems comment on significant overlap
|}

== Treatment ==

=== Trigger Point Release ===

Treatment of full-range stretching is '''contraindicated''' across joints that exhibit primary hypermobility. When TrPs cross hypermobile joints, use TrP pressure release, hold-relax (mild contraction only), counterstrain, indirect myofascial release, or TrP injection.

Released as part of the diagonal posterior cervical muscle group, using the same technique as for the semispinalis cervicis (flexion-with-rotation spray and stretch, Fig. 16.7). See [[Muscle:Semispinalis_Cervicis#Trigger_Point_Release|Semispinalis Cervicis — Trigger Point Release]] for the full diagonal stretch technique.

The articular dysfunctions commonly associated with TrPs in the deep diagonal semispinalis cervicis, multifidi, and rotatores muscles are often corrected by '''suboccipital decompression''', or other manipulative medicine techniques.

Restriction may respond well to appropriate bilateral stretch and spray of the deep paraspinal muscles that span the level of the flattening, or to manual techniques designed to affect both joint and muscle function. Treat extension dysfunctions from T₁ to T₄ using a manual stretch technique that incorporates contract-relax and forward flexion progressing down the spine segment by segment.

One must '''avoid''' injection at the point of neural entrapment (where the greater occipital nerve passes through the semispinalis capitis); however, injection of the TrP in the muscle that is contributing to the entrapment is appropriate therapy.

=== Trigger Point Injection ===

TrPs in the rotatores are reached by penetrating several layers of muscle — after passing through the trapezius, splenius capitis, semispinalis capitis, and semispinalis cervicis. The TrP is usually encountered at least 2 cm (¾ in) deep to the skin, and may lie beyond the reach of a 3.8-cm (1½-in) needle — a '''5-cm (2-in) needle''' is often needed (Fig. 16.8 of the source volume).

The rotatores lie directly over the laminae of the vertebrae, so they are the muscular layer immediately superficial to needle contact with the lamina. It helps to depress the skin on both sides of the needle while injecting.

Vertebral artery avoidance: avoid injections deep into the lateral posterior neck at, or above, the level of the C₂ spinous process (Fig. 16.5).

Following injection: passive rotation stretch during vapocooling, then active full rotations (two or three times each direction), then moist heat.

=== Corrective Actions ===

Same as for [[Muscle:Semispinalis_Capitis#Corrective_Actions|Semispinalis Capitis — Corrective Actions]].

Patients who exhibit primary hypermobility require '''stabilising exercises rather than stretching exercises'''. The patient can use TrP pressure release, self-massage, self-positioned counterstrain, and the hold-relax technique to inactivate or prevent reactivation of the TrP.

== Satellite Trigger Points ==

* [[Muscle:Cervical_Multifidi|Cervical multifidi]] — same deepest layer; co-active; segmental pain at the same levels
* [[Muscle:Semispinalis_Cervicis|Semispinalis cervicis]] — next superficial layer; co-active
* [[Muscle:Semispinalis_Capitis|Semispinalis capitis]] — more superficial layer; co-active in posterior cervical complex

== Related Pages ==

* [[Pain:Head_and_Neck|Pain:Head and Neck]] — Diagnostic algorithm
* [[Muscle:Cervical_Multifidi|Muscle:Cervical Multifidi]] — Same deepest layer, co-active
* [[Muscle:Semispinalis_Cervicis|Muscle:Semispinalis Cervicis]] — Next superficial layer

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1: The Upper Half of Body''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 16.

[[Category:Muscle]]
[[Category:Vol1 Ch16]]
[[Category:Head and Neck]]

Muscle:Cervical Multifidi

2026-04-19T18:49:44Z

Yatreyu: Created page with "'''Cervical multifidi''' are deep diagonal posterior cervical muscles whose trigger points (TrPs) refer pain strongly upward to the suboccipital region and downward over the neck and the upper part of the shoulder girdle. Unlike the longer semispinalis capitis, whose pain encircles the head to the temporal region, multifidi TrP pain is referred '''cephalad to the suboccipital region and caudad toward the scapula'''. Because TrPs in the cervical multifidi are closely ass..."

'''Cervical multifidi''' are deep diagonal posterior cervical muscles whose trigger points (TrPs) refer pain strongly upward to the suboccipital region and downward over the neck and the upper part of the shoulder girdle. Unlike the longer semispinalis capitis, whose pain encircles the head to the temporal region, multifidi TrP pain is referred '''cephalad to the suboccipital region and caudad toward the scapula'''.

Because TrPs in the cervical multifidi are closely associated with articular dysfunction at the same segmental levels, and because the articular dysfunction itself can activate and perpetuate the TrPs, satisfactory management of cervical musculoskeletal pain frequently requires evaluation and treatment of both the muscle TrPs and the associated cervical joint.

== Contents ==
* [[#Anatomy|1 Anatomy]]
* [[#Referred Pain Patterns|2 Referred Pain Patterns]]
* [[#Activation and Perpetuating Factors|3 Activation and Perpetuating Factors]]
* [[#Clinical Examination|4 Clinical Examination]]
* [[#Differential Diagnosis|5 Differential Diagnosis]]
* [[#Treatment|6 Treatment]]
** [[#Trigger Point Release|6.1 Trigger Point Release]]
** [[#Trigger Point Injection|6.2 Trigger Point Injection]]
** [[#Corrective Actions|6.3 Corrective Actions]]
* [[#Satellite Trigger Points|7 Satellite Trigger Points]]
* [[#Related Pages|8 Related Pages]]
* [[#References|9 References]]

== Anatomy ==

The cervical multifidi attach '''above''' to the spinous processes of vertebrae C₂ to C₅. They attach '''below''' to the articular processes of the last four cervical vertebrae (C₄ to C₇); multifidus fibres cross two to four vertebrae.

The cervical multifidi constitute the fourth and deepest layer of the posterior cervical muscles, together with the rotatores (Fig. 16.2). They are shorter and more angulated than the semispinalis cervicis and have digitations for every vertebral level from C₂ inferiorly. Since some digitations span more than one vertebra, TrPs in the multifidi could be found at any level between these processes, starting at about the interface between spinous processes C₃ and C₄, and continuing inferiorly as thoracic multifidi.

The anatomical designation of the multifidi into three names — semispinalis, multifidi, and rotatores — is quite arbitrary. In fact, there is a full and continuous transition of lengths at each spinal level. Each of these multiple digitations has its own endplate zone, so there are '''many''' endplate zones in the cervical paraspinal musculature on each side, and therefore many potential TrP locations.

'''Primary actions:''' Extension of the vertebral column when acting bilaterally; rotation of the vertebrae to the '''opposite''' side when acting unilaterally. The multifidi also contribute to lateral flexion of the spine. These deeper muscles seem to be designed for control and are said to control positional adjustments between vertebrae, rather than movements of the spine as a whole.

'''Innervation:''' Branches of the posterior primary divisions of the cervical spinal nerves.

'''Synergists''' (extension and rotation): Semispinalis cervicis; for each separate movement, additional synergists and antagonists are the same as those for the semispinalis cervicis.

== Referred Pain Patterns ==

A multifidus TrP in the cervical region refers pain and tenderness '''cephalad to the suboccipital region''' and '''caudad down the neck to the upper vertebral border of the scapula''' (Fig. 16.1D of the source volume).

The deeply placed cervical multifidi TrP location (Location 3 in Fig. 16.1A) and pain pattern are characteristic: the TrP is located approximately halfway between a spinous process and a lower transverse process.

The pain arising from the cervical multifidi is analogous to the pattern of pain arising from the corresponding deep layer of muscles found in the lumbar spine (see Chapter 48.2B of the source volume), in that both refer pain locally adjacent to the spinous process and may refer additional patterns several segments away from the TrP.

When cervical rotatores TrPs are present, they produce '''midline pain and tenderness at the segmental level of the TrP''', analogous to that described for thoracolumbar rotatores.

== Activation and Perpetuating Factors ==

* '''Articular dysfunction:''' The close association of TrPs with motor endplates, and the close association of TrPs with articular dysfunction, makes the complex and often enigmatic posterior cervical musculoskeletal pain symptoms easier to understand. Articular dysfunction itself can activate and perpetuate TrPs via increased nerve irritability from segmental dysfunction or entrapment
* Sustained forward head posture with the neck in flexion
* Motor vehicle accident (whiplash): the semispinalis cervicis, multifidi, and rotatores muscle groups can form articular dysfunctions at various levels of the cervical and upper thoracic spine depending on specific attachments
* Neuropathy: cervical radiculopathy from C₄–C₅ or C₅–C₆ can activate TrPs in the posterior cervical muscles; the radiculopathy and TrPs can occur separately or concurrently, and each must be diagnosed on its own criteria
* Facet joint articular dysfunction at the segmental levels spanned by the digitations

== Clinical Examination ==

Trigger points of the cervical multifidi can be located approximately halfway between a spinous process and a lower transverse process, exemplified at Location 3 in Figures 16.1A and D of the source volume.

Since there are digitations of the cervical multifidi for every segmental level from C₂ inferiorly, and since some digitations span more than one vertebra, TrPs in the multifidi could be found at any level between these processes.

The deepest muscles in the fourth layer — the rotatores — are often not as fully developed in the cervical region as they are in the thoracic region. These muscles lie too deep for the fibre direction of their taut bands to be identified by palpation. They must be identified by:
* Characteristic '''deep tenderness''' to pressure applied deep in the groove lateral to spinous processes
* '''Tenderness to applied pressure or tapping on the spinous process''' of the vertebra to which the muscle attaches — this tenderness testing is used also to identify dysfunctional spinal articulations

The segmental level of a TrP involvement can often be identified by a '''flattened spot''' in the normally smooth curvature of the thoracic region; when tested by forward flexion, at least one spinous process fails to stand out prominently as expected. Multiple bilateral deep short rotatores can look like the longer but less angulated multifidi; however, multifidi involvement would not cause as much restricted rotation as the rotatores do, and the multifidi are less likely to cause a contiguous series of pressure-sensitive vertebrae with restricted joint mobility.

'''Articular assessment:''' Altered segmental motion of the cervical spine to palpation is a common finding associated with posterior cervical muscular dysfunction. Restriction in '''all''' directions usually indicates a capsular (arthritic) pattern. TrPs in the neck muscles and cervical zygapophysial joints at corresponding levels can have remarkably similar pain patterns. The TrPs in the neck muscles and the cervical zygapophysial joints at corresponding levels are likely to be closely associated.

== Differential Diagnosis ==

{| class="wikitable"
|-
! Condition !! Distinguishing features
|-
| Cervical zygapophysial joint pain || Overlapping pain patterns of cervical zygapophysial joints and posterior cervical muscles are extensively documented; C₂–C₃ zygapophysial joints need particular consideration when dealing with semispinalis capitis and cervicis TrPs; C₃–C₄ and C₄–C₅ with multifidi TrPs; both must be treated — the myofascial and articular components are closely associated
|-
| Semispinalis cervicis TrPs || Semispinalis cervicis is superficial to the multifidi; both refer to the occipital and scapular regions; multifidi palpation is deeper and at a characteristic halfway-between-processes location; multifidi have more restricted rotation when involved; semispinalis cervicis TrPs are less likely to cause articular restriction
|-
| Cervical radiculopathy || Positive Spurling test; dermatomal limb signs or symptoms (radiculopathy from C₄–C₆ rarely fails to cause limb symptoms); electrodiagnostic findings; TrPs can coexist with radiculopathy — each diagnosed on its own criteria
|-
| Cervicogenic headache || Suboccipital articular dysfunction (OA, C₁, C₂) and TrPs commonly coexist; 91% of patients examined by Jaeger had at least 3 active TrPs; 10 of 11 patients had TrP palpation reproducing the headache; both conditions require treatment
|-
| Fibromyalgia || Widespread pain for at least 3 months; brief examination of designated fibromyalgia tender points allows clinical establishment or exclusion; fibromyalgia patients commonly also have myofascial TrPs contributing to their pain; TrP injections can produce dramatic results in fibromyalgia patients despite their intolerance of manual techniques
|}

== Treatment ==

=== Trigger Point Release ===

Treatment of full-range stretching is '''contraindicated''' across hypermobile joints. When TrPs cross hypermobile joints, use TrP pressure release, hold-relax (mild contraction), counterstrain, indirect myofascial release, or TrP injection.

Released as part of the diagonal posterior cervical muscle group, using the same technique as for the semispinalis cervicis (flexion-with-rotation spray and stretch, Fig. 16.7). See [[Muscle:Semispinalis_Cervicis#Trigger_Point_Release|Semispinalis Cervicis — Trigger Point Release]] for the full diagonal stretch technique.

Restriction may respond well to appropriate bilateral stretch and spray of the deep paraspinal muscles that span the level of the flattening, or to manual techniques designed to affect both joint and muscle function.

Injection of cervical multifidi TrPs bilaterally increased left lateral rotation 45° to reach full range of motion and increased right lateral rotation 25° to reach full range of motion in one patient with a chronically locked hypomobile cervical-occipital junction receiving osteopathic manipulation — demonstrating the power of deep paraspinal muscle shortening and the effectiveness of inactivating responsible TrPs.

=== Trigger Point Injection ===

TrPs in the multifidi are found at various levels about halfway between the spinous processes and the transverse processes of each vertebral segment spanned by digitations of the multifidi that harbour TrPs (Fig. 16.1A and D).

Reaching multifidi TrPs requires penetrating several layers of muscle — the semispinalis capitis and cervicis, after first passing through the trapezius and splenius capitis muscles. The TrP is usually encountered at least 2 cm (¾ in) deep to the skin, and may lie beyond the reach of a 3.8-cm (1½-in) needle — a '''5-cm (2-in) needle''' may be needed (Fig. 16.8). It helps to depress the skin on both sides of the needle while injecting.

The pain response to injection may seem out of proportion to the tenderness elicited by palpation, because of the depth of the TrPs.

Following injection, passive rotation stretch during vapocooling is performed; the patient then does active full rotations (two or three times in each direction), and moist heat is applied.

Vertebral artery avoidance: avoid injections deep into the lateral posterior neck at, or above, the level of the C₂ spinous process (Fig. 16.5).

=== Corrective Actions ===

Same as for [[Muscle:Semispinalis_Capitis#Corrective_Actions|Semispinalis Capitis — Corrective Actions]].

Additionally, where articular dysfunction is identified alongside TrP involvement, the extension dysfunctions of T₁ to T₄ should be treated using a manual stretch technique that incorporates contract-relax and forward flexion progressing down the spine segment by segment.

Patients who exhibit primary hypermobility require '''stabilising exercises rather than stretching exercises'''.

== Satellite Trigger Points ==

* [[Muscle:Semispinalis_Cervicis|Semispinalis cervicis]] — superficial to multifidi; co-active; similar pain distribution
* [[Muscle:Cervical_Rotatores|Cervical rotatores]] — deepest layer; immediately adjacent; co-active; produce midline spinous process pain
* [[Muscle:Semispinalis_Capitis|Semispinalis capitis]] — same posterior cervical complex
* [[Muscle:Splenius_Cervicis|Splenius cervicis]] — synergist for contralateral rotation
* [[Muscle:Trapezius/Upper|Upper trapezius]] — superficial layer; TrPs frequently co-active with posterior cervical complex

== Related Pages ==

* [[Pain:Occipital|Pain:Occipital]] — Suboccipital referral from cervical multifidi TrPs
* [[Pain:Head_and_Neck|Pain:Head and Neck]] — Diagnostic algorithm
* [[Muscle:Semispinalis_Cervicis|Muscle:Semispinalis Cervicis]] — Superficial companion muscle
* [[Muscle:Cervical_Rotatores|Muscle:Cervical Rotatores]] — Deepest layer, co-active

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1: The Upper Half of Body''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 16.

[[Category:Muscle]]
[[Category:Vol1 Ch16]]
[[Category:Head and Neck]]

Muscle:Semispinalis Cervicis

2026-04-19T18:49:33Z

Yatreyu: Created page with "'''Semispinalis cervicis''' is an intermediate-to-deep posterior cervical muscle whose trigger points (TrPs) refer pain into the occipital region in a pattern similar to that of the middle semispinalis capitis, and downward over the neck to the upper vertebral border of the scapula. It is primarily a cervical extensor and contralateral rotator, and its caudal attachments to the relatively immobile thoracic vertebrae serve primarily as anchors for movement of the cervical..."

'''Semispinalis cervicis''' is an intermediate-to-deep posterior cervical muscle whose trigger points (TrPs) refer pain into the occipital region in a pattern similar to that of the middle semispinalis capitis, and downward over the neck to the upper vertebral border of the scapula. It is primarily a cervical extensor and contralateral rotator, and its caudal attachments to the relatively immobile thoracic vertebrae serve primarily as anchors for movement of the cervical spine.

Because it lies deep to the semispinalis capitis and its digitations are diagonally oriented, it requires deeper palpation — approximately 1–2 cm lateral to the spinous processes — to access its TrPs. Its involvement is frequently part of a multi-muscle posterior cervical TrP complex.

== Contents ==
* [[#Anatomy|1 Anatomy]]
* [[#Referred Pain Patterns|2 Referred Pain Patterns]]
* [[#Activation and Perpetuating Factors|3 Activation and Perpetuating Factors]]
* [[#Clinical Examination|4 Clinical Examination]]
* [[#Differential Diagnosis|5 Differential Diagnosis]]
* [[#Treatment|6 Treatment]]
** [[#Trigger Point Release|6.1 Trigger Point Release]]
** [[#Trigger Point Injection|6.2 Trigger Point Injection]]
** [[#Corrective Actions|6.3 Corrective Actions]]
* [[#Satellite Trigger Points|7 Satellite Trigger Points]]
* [[#Related Pages|8 Related Pages]]
* [[#References|9 References]]

== Anatomy ==

The semispinalis cervicis lies deep to the semispinalis capitis. It attaches '''below''' to the transverse processes of the first to fifth or sixth thoracic vertebrae. '''Above''', it attaches to the spinous processes of the second to fifth cervical vertebrae. Toward its cephalic end, it becomes thicker and more muscular. The fibres of the semispinalis cervicis usually span 5 vertebrae. The diagonal orientation of its digitations can be seen in the cross-sectional view at Figure 48.4 of the source volume.

It is intermediate between the semispinalis capitis and multifidi in depth, fibre length, and angulation of fibres. It belongs to the third anatomical layer of the posterior cervical muscles (along with the semispinalis capitis), while the multifidi and rotatores constitute the fourth and deepest layer.

'''Primary actions:''' Extension of the cervical vertebral column; rotation of the cervical spine to the '''opposite''' side. The caudal attachments to the relatively immobile thoracic vertebrae serve primarily as anchors for movement of the cervical spine.

This muscle also provides a '''checkrein function during even slight flexion''' of the neck, analogous to the semispinalis capitis for the head.

'''Innervation:''' Third to sixth cervical spinal nerves.

'''Main synergists''' (extension): Splenius cervicis bilaterally, longissimus cervicis, semispinalis capitis, levator scapulae bilaterally, plus the multifidi acting bilaterally.

'''Synergists''' (neck rotation): Contralateral splenius cervicis and levator scapulae; ipsilateral multifidi and rotatores.

'''Antagonists:''' Anterior neck muscles, including the strap muscles and longus colli.

== Referred Pain Patterns ==

The TrP location and the pain pattern are not illustrated separately for this muscle in the source volume. It is likely to refer pain into the '''occipital region in a pattern similar to that shown for the middle semispinalis capitis''' (Location 3 pattern), and downward '''over the neck to the upper vertebral border of the scapula'''.

The C₂–C₃ zygapophysial joint refers pain in patterns that overlap part of the pain distribution of semispinalis cervicis TrPs and must be considered in the differential diagnosis.

== Activation and Perpetuating Factors ==

* Sustained forward head posture with the neck in flexion — checkrein overload is the dominant chronic mechanism, identical to semispinalis capitis
* Motor vehicle accident (whiplash): the semispinalis cervicis, multifidi, and rotatores muscle groups can form articular dysfunctions at various levels of the cervical and upper thoracic spine depending on specific attachments; whiplash activates TrPs throughout the posterior cervical complex
* Prolonged reading or writing at a flat surface, operating a computer terminal, or sewing
* Lying supine without a pillow or with a too-hard, poorly-fitted pillow (excessive cervical extension at night)
* Emotional depression
* Neuropathy: increased nerve irritability from spinal radiculopathy can be a significant factor in activation and perpetuation of posterior cervical TrPs
* Facet joint arthritis: C₃–C₄ and C₄–C₅ zygapophysial joints are particularly associated with semispinalis cervicis TrPs

== Clinical Examination ==

One palpates for TrP tenderness of this intermediate-to-deep posterior cervical muscle '''1–2 cm lateral to the spinous processes'''.

A common TrP location is at approximately the C₄–C₅ level. Deep pressure on the TrP may elicit referred pain over the occipital region, similar to the pattern shown for the middle semispinalis capitis (Fig. 16.1C of the source volume).

The digitations of this muscle are deep to the semispinalis capitis (see cross-sectional view at Fig. 16.8). The diagonal orientation of each digitation can be seen in Figure 48.4. Only rarely can one distinguish taut bands in this relatively deep muscle.

'''Slight flexion''' of the head and neck enhances taut band tension and makes TrPs more distinguishable by palpation if the posterior cervical musculature has been relaxed by providing adequate head and body support.

'''Articular screen:''' The semispinalis cervicis, multifidi, and rotatores groups can form articular dysfunctions at various levels. Extension dysfunctions of T₁–T₄ segments are an important articular dysfunction associated with TrP involvement of bilateral posterior cervical muscles that attach to or span the upper thoracic vertebrae — particularly the semispinalis cervicis, multifidi, and rotatores. Treat these extension dysfunctions from T₁ to T₄ using a manual stretch technique that incorporates contract-relax and forward flexion progressing down the spine segment by segment.

== Differential Diagnosis ==

{| class="wikitable"
|-
! Condition !! Distinguishing features
|-
| Semispinalis capitis TrPs || Semispinalis capitis lies superficial to semispinalis cervicis; semispinalis capitis refers in a band to the temporal region and over the eye; semispinalis cervicis refers to the occiput and toward the scapular border; both may coexist and palpation depth distinguishes them
|-
| C₂–C₃ zygapophysial joint pain || Overlapping pain patterns; both must be evaluated and treated; cervical joint pain provoked by passive motion assessment and joint palpation; myofascial TrP pain reproduced by muscle palpation; frequently coexist
|-
| Cervical multifidi TrPs || Multifidi lie deeper than semispinalis cervicis; multifidi TrP palpation is approximately halfway between a spinous process and a lower transverse process; articular dysfunctions at the same level commonly coexist with multifidi TrPs
|-
| Cervical radiculopathy C₄–C₈ || Radiculopathy from C₄–C₆ rarely fails to cause limb signs or symptoms; positive Spurling test; electrodiagnostic findings helpful; TrPs and radiculopathy can coexist — each must be diagnosed on its own criteria
|}

== Treatment ==

=== Trigger Point Release ===

Released as part of the diagonal posterior cervical muscle group using a flexion-and-rotation stretch:

'''Diagonal posterior cervical muscles — spray and stretch (Fig. 16.7):'''
# To stretch the right "∧" diagonal muscles (semispinalis cervicis, multifidi, rotatores), and the left "∨" diagonal muscles (splenius): patient gently flexes the neck and rotates the face to the '''left''' (opposite side from the right ∧ muscles being stretched), with manual monitoring by the clinician
# Vapocoolant is applied bilaterally in a diagonal upsweep pattern that follows the line of the stretched fibres on both sides of the neck, since stretch of the "∨" diagonal muscles on the right also stretches the "∧" diagonal muscles on the left
# Manual release of diagonal muscles (Fig. 16.7C): patient supine, examiner's hand cradles the head while the other hand stabilises at the level of the shoulder; direction of movement with traction is toward the left with neck flexion and left rotation; particularly effective for the right "∨" diagonal muscles (e.g., splenius)
# The corresponding procedure is done toward the opposite side with a change of hand position for the remaining diagonal muscles

Spray and stretch alone with unidirectional parallel sweeps usually releases that movement only partially. Adjacent tight restricting muscle fibres must also be released.

=== Trigger Point Injection ===

TrPs in the semispinalis cervicis are deep to the semispinalis capitis. TrPs are not likely to be found above the level of the C₄ spinous process. A common TrP location is at approximately the C₄–C₅ level.

The needle must penetrate several layers of muscle (the semispinalis capitis and cervicis, after first passing through the trapezius and splenius capitis muscles). The TrP is usually encountered at least 2 cm (¾ in) deep to the skin, and may lie beyond the reach of a 3.8-cm (1½-in) needle — a 5-cm (2-in) needle may be needed (Fig. 16.8).

Penetration into the spinal canal is avoided by always angling the needle slightly laterally when injecting the deeper paraspinal muscles. In some patients, the cervical spinal cord may not be covered by bone between vertebrae as far as 1 cm or more lateral to the edge of a cervical spinous process — depth of the lamina at 2 cm lateral to the lateral edge of a cervical spinous process should be established, and the needle should not be inserted to a greater depth whenever it is directed more medially.

Injection of posterior cervical muscles is frequently bilateral. Injection is followed immediately by spray and stretch and full active range of motion.

=== Corrective Actions ===

Same as for [[Muscle:Semispinalis_Capitis#Corrective_Actions|Semispinalis Capitis — Corrective Actions]]. The combined shower self-stretch exercise (Fig. 16.11) is a primary self-therapy tool.

== Satellite Trigger Points ==

* [[Muscle:Semispinalis_Capitis|Semispinalis capitis]] — superficial companion; TrPs frequently co-active
* [[Muscle:Cervical_Multifidi|Cervical multifidi]] — deeper layer; co-active in posterior cervical complex; articular dysfunctions at same levels
* [[Muscle:Cervical_Rotatores|Cervical rotatores]] — deepest layer; co-active; may form articular dysfunctions
* [[Muscle:Splenius_Cervicis|Splenius cervicis]] — synergist for contralateral rotation; frequently co-active
* [[Muscle:Levator_Scapulae|Levator scapulae]] — synergist for extension; frequently co-active

== Related Pages ==

* [[Pain:Occipital|Pain:Occipital]] — Semispinalis cervicis occipital referral pattern
* [[Pain:Head_and_Neck|Pain:Head and Neck]] — Diagnostic algorithm
* [[Muscle:Semispinalis_Capitis|Muscle:Semispinalis Capitis]] — Superficial companion muscle
* [[Muscle:Cervical_Multifidi|Muscle:Cervical Multifidi]] — Deeper layer, co-active
* [[Muscle:Splenius_Cervicis|Muscle:Splenius Cervicis]] — Synergist

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1: The Upper Half of Body''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 16.

[[Category:Muscle]]
[[Category:Vol1 Ch16]]
[[Category:Head and Neck]]

Muscle:Longissimus Capitis

2026-04-19T18:49:15Z

Yatreyu: Created page with "'''Longissimus capitis''' is a long, relatively narrow posterior cervical muscle whose trigger points (TrPs) refer pain concentrating in the region of the ear or just behind and below it, with possible extension a short distance down the neck and occasionally into a periorbital region behind the eye. It lies deep to the lateral part of the splenius capitis, and its nearly vertical fibre direction helps distinguish it from the more diagonal fibres of the splenius capitis..."

'''Longissimus capitis''' is a long, relatively narrow posterior cervical muscle whose trigger points (TrPs) refer pain concentrating in the region of the ear or just behind and below it, with possible extension a short distance down the neck and occasionally into a periorbital region behind the eye. It lies deep to the lateral part of the splenius capitis, and its nearly vertical fibre direction helps distinguish it from the more diagonal fibres of the splenius capitis during palpation.

Because it spans from the mastoid process to the transverse processes of the upper thoracic vertebrae, TrP tension in this muscle characteristically produces an '''apparent elevation of the first rib''' concurrent with a T₁ articular dysfunction — an indirect mechanical effect mediated through its pull on the costotransverse junction.

== Contents ==
* [[#Anatomy|1 Anatomy]]
* [[#Referred Pain Patterns|2 Referred Pain Patterns]]
* [[#Activation and Perpetuating Factors|3 Activation and Perpetuating Factors]]
* [[#Clinical Examination|4 Clinical Examination]]
* [[#Differential Diagnosis|5 Differential Diagnosis]]
* [[#Treatment|6 Treatment]]
** [[#Trigger Point Release|6.1 Trigger Point Release]]
** [[#Trigger Point Injection|6.2 Trigger Point Injection]]
** [[#Corrective Actions|6.3 Corrective Actions]]
* [[#Satellite Trigger Points|7 Satellite Trigger Points]]
* [[#Related Pages|8 Related Pages]]
* [[#References|9 References]]

== Anatomy ==

The longissimus capitis attaches '''below''' to the articular processes of the last 3 or 4 cervical vertebrae and to the transverse processes of the upper 4 or 5 thoracic vertebrae. It attaches '''above''' to the skull along the posterior margin of the mastoid process, deep to the splenius capitis and sternocleidomastoid muscles.

The longissimus capitis muscle is often partially or completely divided into two muscle bellies by a tendinous inscription, which would produce two endplate zones.

'''Primary actions:''' Extension of the head; lateral flexion of the head to the same side; rotation of the head toward the same side.

'''Innervation:''' Branches of the posterior primary divisions of the cervical spinal nerves.

'''Layer:''' The longissimus capitis forms part of the erector spinae of the cervical spine, together with the longissimus cervicis, iliocostalis cervicis, and the variable spinalis capitis and cervicis. In terms of functional anatomy, it belongs to the group of four muscles that attach to and control movement of the head (with upper trapezius, splenius capitis, and semispinalis capitis).

'''Articular effect of TrP tension:''' The muscle spans the region from the mastoid process to the transverse process of T₁, which allows it to '''indirectly affect the first rib''' through its pull on the costotransverse junction. Resultant rotation of the vertebra produces the '''apparent''' rib elevation commonly seen with longissimus capitis TrP involvement. One will frequently see an apparent elevation of the first rib concurrent with a T₁ articular dysfunction when TrP tension is present in this muscle.

== Referred Pain Patterns ==

The pain pattern of the longissimus capitis concentrates in the '''region of the ear or just behind and below it'''. The pain may extend a short distance down the neck and may also include a periorbital region behind the eye.

This pattern is distinct from:
* Semispinalis capitis — which refers in a band encircling the head to the temporal region and over the eye
* Splenius capitis — which refers to the vertex of the skull
* Splenius cervicis (upper TrP) — which refers diffusely through the inside of the head to the back of the eye

== Activation and Perpetuating Factors ==

* Sustained forward head posture with neck in flexion — checkrein overload, same as semispinalis capitis
* Motor vehicle accident (whiplash): automobile impact from any direction is likely to activate semispinalis capitis TrPs; longissimus capitis is frequently co-involved
* Prolonged reading or writing at a flat desk surface
* Emotional depression leading to sustained flexed posture
* Lying prone propped up on elbows for prolonged periods
* Eyeglasses with inadequate focal length requiring sustained neck flexion to read

== Clinical Examination ==

The longissimus capitis lies deep to the lateral part of the splenius capitis, near the level of the C₃ vertebra. It can be palpated by locating the splenius capitis (lateral to the trapezius and posterior to the sternocleidomastoid) and pressing anteriorly and medially through the lateral part of the splenius capitis.

'''If the splenius capitis has TrPs and taut bands, they must first be released''' — otherwise the deeper tenderness of the longissimus capitis may not be distinguishable.

If the longissimus capitis has severe TrPs, it should be prominent and firm; its nearly '''vertical fibres''' help distinguish it from the more diagonal fibres of the splenius.

Palpation range:
* Superior to the level of C₂: the longissimus capitis is too deep and covered by too many other muscles to be reliably identified, even indirectly
* Inferior to the level of C₄: similarly too deep to identify reliably

The primary accessible zone is between C₂ and C₄ spinous process levels.

'''Articular screen:''' Given the muscle's attachment to the costotransverse junction via T₁, assess for apparent first rib elevation and T₁ articular dysfunction whenever longissimus capitis TrPs are suspected. These articular dysfunctions are often corrected concurrently with TrP inactivation.

== Differential Diagnosis ==

{| class="wikitable"
|-
! Condition !! Distinguishing features
|-
| Semispinalis capitis TrPs || Semispinalis capitis refers in a band to the temporal region and over the eye; longissimus capitis refers to the ear region and just behind it; fibre directions differ (vertical in both, but longissimus capitis is more lateral)
|-
| Splenius capitis TrPs || Splenius capitis refers to the vertex; splenius capitis must be released before longissimus capitis can be reliably palpated; both occupy similar lateral posterior cervical territory
|-
| Deep masseter TrPs || Deep masseter refers to the region of the TMJ and deep into the ear; distinguish by palpation location (masseter is anterior to the tragus; longissimus capitis is posterior to the mastoid) and by associated jaw symptoms
|-
| T₁ rib dysfunction | Apparent first rib elevation concurrent with T₁ articular dysfunction is a direct mechanical consequence of longissimus capitis TrP tension; TrP inactivation should resolve the apparent rib elevation; persistent rib elevation after TrP treatment requires independent articular assessment
|}

== Treatment ==

=== Trigger Point Release ===

The longissimus capitis is released as part of the longitudinal posterior cervical muscle group, using the same spray and stretch technique as for the semispinalis capitis (Fig. 16.6A and B). See [[Muscle:Semispinalis_Capitis#Trigger_Point_Release|Semispinalis Capitis — Trigger Point Release]] for the full technique.

In addition, a specific treatment for the longissimus capitis employs the combination of a myofascial release technique with a contract-relax technique:
# Patient supine; clinician cradles the patient's head
# The clinician applies pressure along the distal attachments of the muscle with the other hand
# The clinician sidebends the patient's head '''away''' from the involved longissimus capitis and '''fine-tunes''' the muscle release by adding small amounts of head/neck rotation, taking up slack
# When the barrier is encountered and the area of the costotransverse junction seems to elevate against the monitoring thumb, that same hand applies '''gentle downward pressure''' for release, while the clinician's other hand stabilises the patient's head

This release technique can also release the scalene muscles (which directly elevate the first rib) if the neck is guided toward slight extension rather than flexion.

=== Trigger Point Injection ===

A TrP region in this long, relatively narrow muscle can be injected in the lateral part of the neck, deep to the splenius capitis and lateral to the semispinalis capitis, at approximately the level of C₃ — the most common location for TrPs in this muscle.

The needle should be directed laterally so as to pose no danger to the vertebral artery, and the muscle must not be injected superior to C₂.

Injection is followed immediately by spray and stretch and then by full active range of motion.

=== Corrective Actions ===

Same as for [[Muscle:Semispinalis_Capitis#Corrective_Actions|Semispinalis Capitis — Corrective Actions]]. The primary corrective measures are:
* Raising reading and work materials to eye level to eliminate sustained neck flexion
* Adequate focal length eyeglasses
* Ergonomic workstation setup — monitor elevated, lumbar support
* Combined self-stretch shower exercise (Fig. 16.11)
* Cervical pillow for sleeping

== Satellite Trigger Points ==

* [[Muscle:Semispinalis_Capitis|Semispinalis capitis]] — same functional layer; released together
* [[Muscle:Splenius_Capitis|Splenius capitis]] — superficial to longissimus capitis; must be released first before longissimus capitis can be palpated
* [[Muscle:Scalene|Scalene muscles]] — the longissimus capitis release technique also releases the scalenes when the neck is guided into slight extension; scalenes directly elevate the first rib
* [[Muscle:Suboccipital|Suboccipital muscles]] — treat suboccipital group first in the sequence of posterior cervical release

== Related Pages ==

* [[Pain:Ear_and_TMJ|Pain:Ear and TMJ]] — Longissimus capitis ear-region referral pattern
* [[Pain:Head_and_Neck|Pain:Head and Neck]] — Diagnostic algorithm
* [[Muscle:Semispinalis_Capitis|Muscle:Semispinalis Capitis]] — Companion longitudinal muscle; released together
* [[Muscle:Splenius_Capitis|Muscle:Splenius Capitis]] — Superficial layer; must be released first

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1: The Upper Half of Body''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 16.

[[Category:Muscle]]
[[Category:Vol1 Ch16]]
[[Category:Head and Neck]]

Muscle:Semispinalis Capitis

2026-04-19T18:49:07Z

Yatreyu: Created page with "'''Semispinalis capitis''' is a long, nearly vertical posterior cervical muscle whose trigger points (TrPs) produce a band-like headache that encircles the head halfway, reaching maximum intensity in the temporal region and continuing forward over the eye. It is one of the most common muscular sources of tension-type and cervicogenic headache, and its taut bands are responsible for the most clinically important entrapment of the greater occipital nerve. Because it provi..."

'''Semispinalis capitis''' is a long, nearly vertical posterior cervical muscle whose trigger points (TrPs) produce a band-like headache that encircles the head halfway, reaching maximum intensity in the temporal region and continuing forward over the eye. It is one of the most common muscular sources of tension-type and cervicogenic headache, and its taut bands are responsible for the most clinically important entrapment of the greater occipital nerve.

Because it provides a checkrein function during even slight neck flexion — the dominant posture of modern desk-based work — it is chronically strained by reading, writing, computing, and sewing with a forward head posture. Semispinalis capitis TrPs are frequently satellites of key TrPs in either the upper trapezius or the splenius capitis; elimination of those key TrPs often inactivates the semispinalis capitis without direct treatment.

== Contents ==
* [[#Anatomy|1 Anatomy]]
* [[#Referred Pain Patterns|2 Referred Pain Patterns]]
** [[#Upper TrP — Enthesopathy Zone|2.1 Upper TrP — Enthesopathy Zone (Location 1)]]
** [[#Upper-Third TrP|2.2 Upper-Third TrP (Location 2)]]
** [[#Middle-Third TrP|2.3 Middle-Third TrP (Location 3)]]
** [[#Greater Occipital Nerve Entrapment|2.4 Greater Occipital Nerve Entrapment]]
* [[#Activation and Perpetuating Factors|3 Activation and Perpetuating Factors]]
* [[#Clinical Examination|4 Clinical Examination]]
** [[#Range of Motion Assessment|4.1 Range of Motion Assessment]]
** [[#Trigger Point Examination|4.2 Trigger Point Examination]]
* [[#Differential Diagnosis|5 Differential Diagnosis]]
* [[#Treatment|6 Treatment]]
** [[#Trigger Point Release|6.1 Trigger Point Release]]
** [[#Trigger Point Injection|6.2 Trigger Point Injection]]
** [[#Corrective Actions|6.3 Corrective Actions]]
* [[#Satellite Trigger Points|7 Satellite Trigger Points]]
* [[#Related Pages|8 Related Pages]]
* [[#References|9 References]]

== Anatomy ==

The semispinalis capitis attaches '''below''' to the articular processes of cervical vertebrae C₄ to C₆ and to the transverse processes of thoracic vertebrae T₁ to T₆, and sometimes T₇. '''Above''', it attaches to the occiput between the superior and inferior nuchal lines.

The muscle is usually divided by a tendinous inscription at the level of C₆. Less frequently there is a tendinous inscription at C₂, most marked in the medial fibres from the thoracic vertebrae. These inscriptions can divide the muscle so there can be '''three endplate zones''', one in the middle of each third:
* Upper third endplate zone: nearly transverse line at the suboccipital level
* Middle third endplate zone: approximately C₃–C₄ level
* Lower third endplate zone: more widely distributed, from approximately C₇ to T₂

Since TrPs are specifically associated with the endplate zone, knowing these locations identifies where TrPs are likely to occur.

The semispinalis capitis overlies the semispinalis cervicis. It is covered above by the upper trapezius and, more laterally, by the splenius capitis.

'''Primary action:''' Extension of the head; antigravity control of the head. '''Importantly''', it provides a consistent checkrein function during even slight neck flexion — chronic loading of this checkrein function during sustained forward head posture is the primary mechanism of TrP activation.

'''Innervation:''' Branches of the posterior primary division of the first 4 or 5 cervical spinal nerves.

'''Main synergists''' (head extension): Deep suboccipital muscles, upper trapezius, splenius capitis, longissimus capitis.

'''Antagonists:''' Head flexors, especially the rectus capitis anterior and the anterior fibres of the sternocleidomastoid acting bilaterally.

== Referred Pain Patterns ==

=== Upper TrP — Enthesopathy Zone (Location 1) ===

A TrP at '''Location 1''' — the musculotendinous junction region at the base of the skull, approximately 1–2 cm from the midline — produces a pain pattern that '''travels forward like a band, encircles the head halfway, reaches maximum intensity in the temporal region, and continues on forward over the eye'''. This is the defining referral pattern of the semispinalis capitis upper TrP.

Tenderness at Location 1 is usually an area of enthesopathy induced by the sustained tension of the taut band fibres of a TrP in the upper third of the muscle (Location 2). The clinician should always check the midbelly portion of the involved muscle fibres for the TrP that is actually causing the patient's pain.

=== Upper-Third TrP (Location 2) ===

A TrP at '''Location 2''' — in the upper third of the semispinalis capitis, at or slightly above C₁ — has a pain distribution '''similar to Location 1''': the same band-like temporal and periorbital headache pattern.

'''INJECTION CAUTION: TrPs at Location 2 should NOT be injected''' because of proximity to the vertebral artery, which lies deep and below the lower margin of the occipital bone at this level.

=== Middle-Third TrP (Location 3) ===

A TrP at '''Location 3''' — in the middle third of the semispinalis capitis, lateral to the region of the C₃–C₄ spinous processes — produces a pain pattern referred '''over the posterior occiput'''. Sola identified two lower semispinalis capitis TrP locations that also refer pain to the suboccipital region and, in addition, to the vertex.

The semispinalis cervicis can also refer pain in a pattern similar to that of the middle semispinalis capitis.

=== Greater Occipital Nerve Entrapment ===

'''Entrapment of the greater occipital nerve''' is commonly caused by tension due to TrPs in the upper portion of the semispinalis capitis and/or the upper trapezius muscles. The greater occipital nerve (the medial branch of the dorsal primary division of the second cervical nerve) emerges below the posterior arch of the atlas, curves around the lower border of the obliquus capitis inferior, and crosses the semispinalis capitis and trapezius muscles near their attachments to the occipital bone.

In an autopsy study of 20 cases (40 nerves) without history of headache, the greater occipital nerve penetrated the semispinalis in 90% of cases. Eleven of 18 nerves that penetrated the trapezius showed evidence of compression — an unexpected finding in subjects without headache history.

'''Entrapment symptoms''' (additional to TrP pain): numbness, tingling, and burning pain in the scalp over the homolateral occipital region — so-called "occipital neuralgia." Patients with nerve entrapment:
* Usually prefer cold rather than heat
* Look for an ice-bag to relieve the burning neuropathic pain
* May have received anaesthetic blocks of the greater occipital nerve, with relief only for the duration of the local anaesthetic effect

Entrapment symptoms are often relieved by inactivation of TrPs in the semispinalis capitis and/or upper trapezius, which usually respond well to local procaine injection or dry needling.

== Activation and Perpetuating Factors ==

=== Acute Trauma ===
* Falling on the head, experiencing forceful head movement in a motor vehicle accident, or diving head-first — all produce forceful neck flexion and muscle strain even without fracture
* The semispinalis capitis was the '''third most frequently involved muscle''' in systematic whiplash studies: present in 73% of frontal impacts, 69% of passenger-side impacts, 63% of driver-side impacts, and 62% of rear impacts

=== Postural Stress ===

Chronic strain of the checkrein function is the dominant perpetuating factor:

* Reading, writing, or working at a computer with a forward head posture and the neck in sustained flexion
* The position may be assumed because:
** Eyeglass lenses have too short a focal length
** Eyeglass frames are adjusted improperly so the lower rim contacts the cheek (Fig. 16.4A)
** The chair has inadequate lumbar support
** Work equipment is ergonomically incorrectly positioned (e.g., keyboard)
** TrPs in the pectoralis major muscles produce round-shouldered posture and increase thoracic kyphosis
** The patient is emotionally depressed
* Excessive cervical extension at night: lying supine without a pillow, or with a too-hard or poorly-fitted pillow, places these muscles in a shortened position for a prolonged period. Young people lying prone propped up on elbows to watch television do the same.
* A patient with a long supple neck is more prone to develop active TrPs than one with a short stocky neck, because of the greater leverage and demand placed on the muscles for support

=== Key Trigger Points ===

Semispinalis capitis TrPs frequently develop as '''satellite TrPs''' in response to key TrPs in either the upper trapezius or splenius capitis muscles. Elimination of key TrPs in either of these two muscles usually inactivates the semispinalis capitis TrPs without direct treatment. Conversely, inactivating only the satellite TrP results in its reactivation and perpetuation by the key TrP.

=== Other Factors ===
* Neuropathy: increased nerve irritability from entrapment, as in spinal radiculopathy, can be a significant factor
* Facet joint arthritis: atlantoaxial (C₁–C₂) facet joint osteoarthritis produces a distinctive clinical syndrome with occipital TrPs as one of the major features
* A bathing cap that is too tight or a heavy overcoat with a tight collar that compresses the posterior cervical muscles and impairs blood flow may activate TrPs

== Clinical Examination ==

=== Range of Motion Assessment ===

Patients typically show '''marked restriction of head and neck flexion''', which can measure 5 cm short of the chin reaching the sternum. Altered segmental motion of the cervical spine to palpation is a common associated finding.

Marked restriction of head and neck rotation and sidebending usually indicates involvement of associated neck muscles. Restriction in '''all''' directions, however, usually indicates a capsular (arthritic) pattern.

Patients often:
* Hold the head and neck upright with the shoulders high
* Position the head with the face tilted up somewhat
* Tend to suppress the bobbing and nodding movements that ordinarily accompany talking

If TrP involvement is mainly unilateral and the head and neck are flexed, the muscles on the painful side may appear very prominent, like a rope from the skull to the level of the shoulder girdle.

=== Trigger Point Examination ===

All three posterior cervical locations are best examined by '''flat palpation''' with the posterior cervical musculature relaxed — achieved by providing adequate head and body support with the patient seated or sidelying. '''Slight flexion''' of the head and neck enhances taut band tension and tenderness, making TrPs more distinguishable.

'''Location 1''' (musculotendinous junction, suboccipital): usually feels indurated and often must be pressed very firmly to elicit referred pain. Found approximately 1–2 cm from the midline at the base of the skull. Tenderness here is usually enthesopathy — always check Location 2 or 3 for the causative mid-muscle TrP.

'''Location 2''' (upper third, at or above C₁): active TrP palpation elicits marked local tenderness and induces the characteristic referred pain pattern. A taut band in the semispinalis capitis may be palpated if the upper trapezius is relaxed, distinguished by its nearly vertical fibre direction.

'''Location 3''' (middle third, lateral to C₃–C₄ spinous processes): flat palpation elicits marked local tenderness and reproduces the occipital referred pain pattern. The muscle lies deep to both the upper trapezius and splenius capitis — relatively deep penetration of palpation is required.

'''Distinguishing taut bands:''' The semispinalis capitis fibres run nearly vertically, parallel to the vertebral column. The more diagonal fibres of the splenius capitis and the rotatores help distinguish them. A local twitch response is difficult to elicit by manual palpation of this muscle in many patients.

== Differential Diagnosis ==

{| class="wikitable"
|-
! Condition !! Distinguishing features
|-
| Tension-type headache || Semispinalis capitis TrPs are a primary unrecognised source of tension-type headache; the band-like temporal encirclement pattern is characteristic; confirm by reproducing the headache on TrP palpation at Locations 2 or 3
|-
| Cervicogenic headache || Bogduk and Simons report overlapping pain patterns of cervical zygapophysial joints and posterior cervical muscles; the C₂–C₃ zygapophysial joints particularly need consideration alongside semispinalis capitis TrPs; both conditions frequently coexist and both must be treated
|-
| Occipital neuralgia (greater occipital nerve entrapment) || Greater occipital nerve entrapment symptoms (burning, tingling, scalp numbness) often occur as a sequel to semispinalis capitis TrPs; Tinel's sign at the nerve emergence point; neuropathic quality (burning) superimposed on the dull TrP ache; ice preferred over heat; symptoms relieved by TrP inactivation
|-
| Fibromyalgia | Location 1 suboccipital tenderness is one of the designated fibromyalgia tender point sites; finding a positive occipital tender point should alert the examiner to the possibility of enthesopathy secondary to a semispinalis capitis TrP in the midbelly
|-
| Atlantoaxial (C₁–C₂) facet joint osteoarthritis || Distinctive clinical syndrome in elderly women: occipital and postauricular pain, palpable cervical crepitus, limited head rotation, tender points or TrPs confined to the occipital area, abnormal head position; crepitus and taut band recognition are the two most clearly distinguishing characteristics
|-
| Splenius capitis TrPs || Splenius capitis refers specifically to the vertex (same side); semispinalis capitis refers in a band pattern to the temple and over the eye; splenius capitis TrPs are a key TrP for semispinalis capitis satellites
|-
| Rheumatoid arthritis / spondyloarthropathy || Subaxial subluxation, enthesopathy with diastrophic calcification, and atlantoaxial involvement must be excluded by imaging before manual treatment; inflammatory markers and imaging distinguish
|}

== Treatment ==

=== Trigger Point Release ===

Treatment of full-range stretching is '''contraindicated''' across joints that exhibit primary hypermobility. When TrPs are in muscles that cross hypermobile joints, use TrP pressure release, hold-relax (mild contraction, not maximum), counterstrain, indirect myofascial release, TrP injection, deep stroking, or stripping massage rather than maximum stretch.

'''Longitudinal posterior cervical muscles (semispinalis capitis and longissimus capitis) — spray and stretch:'''
# Patient seated in an armchair, hips moved forward slightly to better recline the trunk against the backrest
# Patient lets the head and neck hang forward and relaxed, as the clinician's hand monitors and encourages this movement to take up the slack in the extensors
# Vapocoolant spray applied '''upward''' over the back of the neck and head (Fig. 16.6A)
# Patient asked to slump forward further as the operator continues to take up slack ('''does NOT use force''') and applies a downspray pattern bilaterally to cover the long paraspinal muscles from the occiput to the lower thorax (Fig. 16.6B)
# Facilitated by the patient trying to "hump the back" — adds reciprocal inhibition and voluntary stretch
# This can be continued down the lower thoracic and lumbar spine
# Can be combined with postisometric relaxation: patient looks up and gently breathes in (operator lightly resists the contraction of the posterior cervical musculature with one hand), then patient looks down, breathes out, and relaxes completely, letting the head fall forward (Fig. 16.6C)
# Hot pack applied immediately after spray and stretch

'''CAUTION:''' Do not apply forceful pressure to the head in the flexed position — this can stress the cervical spine enough to cause complications in medically compromised spines.

'''Manual release technique (Fig. 16.6C):'''
Patient supine. Clinician cradles the patient's head and, with the other hand, applies pressure along the distal attachments of the muscle, sidebending the patient's head away from the involved longissimus capitis and using small amounts of rotation to take up slack. When the endpoint of stretch is reached, the patient takes an easy shallow breath and then exhales slowly and fully during relaxation to augment the stretch.

=== Trigger Point Injection ===

Injection should be considered only after stretch and spray or other noninvasive treatment has been tried and the patient's TrP pain and restricted neck motion persist. Patients with fibromyalgia are relatively intolerant of manual release techniques — injection may be the preferred TrP therapy for them.

'''Location 1 (musculotendinous junction):''' The needle is angled upward, directed toward the occipital bone, '''not below the bony margin'''. This avoids the vertebral artery, which lies deep and below the lower margin of the occipital bone. Immediate restoration of full neck flexion may follow treatment here. Scalp pain and hyperesthesia from prior occipital nerve entrapment may last from a few days to several weeks after TrP inactivation.

'''Location 2 (upper third, near C₁):''' '''SHOULD NOT BE INJECTED''' because of proximity to the vertebral artery. Use intermittent cold and stretch, TrP pressure release, and deep massage to inactivate these TrPs.

'''Location 3 (middle third, near C₃–C₄):''' The most likely location of TrPs in this muscle. The middle portion lies deep to both the upper trapezius and splenius capitis muscles. Requires relatively deep penetration — injection of TrPs near the C₃–C₄ region usually does not pose a serious threat to the vertebral artery. The needle should not penetrate the area superior to C₂ where the artery is vulnerable. A 5-cm (2-in) needle may be needed.

Injection of the posterior cervical muscles is frequently bilateral. A common mistake is failure to inject deeply enough because of the possibility of penetrating the vertebral artery in the posterior cervical triangle or the dura mater of the spinal cord. In general, penetration into the spinal canal is avoided by always angling the needle slightly laterally when injecting the deeper paraspinal muscles.

Injection is followed immediately by spray and stretch (or another method of gentle muscle release and lengthening) of the injected muscle, then by full active range of motion. A hot pack can be applied to rewarm the skin.

=== Corrective Actions ===

'''Postural (primary):'''
# A reading stand or adjustable music stand to change the angle of, or to raise, the reading and work materials to approximate eye-level contact and avoid sustained head and neck flexion
# Elevation of the computer monitor when used continuously for prolonged periods or when it requires a downward gaze
# Eyeglasses with adequate focal length so the patient can see clearly with the head in a balanced upright position; otherwise, a new prescription for longer focal length lenses ("card playing or computer glasses") should be obtained
# Selection of bifocal insets that are large, fully half the height of the entire lens, when needed for close work such as reading or sewing
# Adjustment of eyeglass frames so the lower portion of the rim does not occlude the line of sight on looking down
# Exercising on a stationary bicycle sitting upright with the arms swinging freely or placed on the hips, and '''not''' hunched over holding low handlebars
# Placing a cloth roll or pillow behind the thoracolumbar junction while sitting, to maintain the normal lumbar lordotic curve and lift the sternum
# Inactivation of pectoralis major or minor TrPs that induce round-shouldered posture and functional thoracic kyphosis

'''Sleeping posture:'''
* Excessive cervical extension at night is corrected by obtaining a slightly softer (non-sagging) mattress, or by using a small soft neck pillow that comfortably supports the normal cervical curve (e.g. Cervipillo)
* A jiggly foam rubber pillow must be discarded and replaced with one filled with a non-springy material, such as feathers or shredded dacron

'''Environmental:'''
* Keep the neck covered at night (turtle-neck sweater worn in bed, or a loose scarf draped around the neck) to prevent chilling of fatigued muscles
* Protect the neck from cold drafts during the day; long hair offers natural protection

'''Exercise therapy (combined self-stretch in the shower — Fig. 16.11):'''
This is a primary form of self-therapy combining levator scapulae, upper trapezius, posterior cervical, and suboccipital muscles:
* A: Self-stretch of the right levator scapulae — looking down toward the opposite axilla, grasping the rotated head above the mastoid area, taking up slack, while reaching downward toward the floor with the free hand to lengthen the muscle
* B: Self-stretch of the right upper trapezius — sidebending the neck to the opposite side, rotating the face as far as comfortable to the same side as the involved muscle, slowly exhaling, allowing the weight of the arm to take up slack
* C: Self-stretch of the posterior cervical muscles — the occipital region grasped by the thumbs as the hands assist active head flexion, while the patient looks down and slowly exhales
* Active range of motion should follow each stretch
* '''NOTE:''' By slowly sidebending and turning the head, one can explore intermediate positions for any taut bands that need release. The warm shower water assists in relaxation and release. Head-rolling exercises or other movements which hold the head in extreme positions while changing the direction of stretch should be '''avoided'''

A lightweight sandbag may be placed on the head during periods of the day for posture training.

A soft collar worn loosely as a chin rest ('''NOT''' tightly for immobilisation) may temporarily relieve neck strain after an acute exacerbation, when riding in a car or working at a desk.

== Satellite Trigger Points ==

* [[Muscle:Trapezius/Upper|Upper trapezius]] — key TrP for semispinalis capitis; inactivation of upper trapezius often resolves semispinalis capitis satellites
* [[Muscle:Splenius_Capitis|Splenius capitis]] — key TrP for semispinalis capitis; inactivation resolves satellites
* [[Muscle:Semispinalis_Cervicis|Semispinalis cervicis]] — deep to semispinalis capitis; frequently co-active; similar pain pattern in the middle region
* [[Muscle:Longissimus_Capitis|Longissimus capitis]] — same functional layer; ear/postauricular referral when involved
* [[Muscle:Levator_Scapulae|Levator scapulae]] — released together in the combined shower self-stretch
* [[Muscle:Suboccipital|Suboccipital muscles]] — treat suboccipital group first before releasing the longer posterior cervical muscles

== Related Pages ==

* [[Pain:Temporal_Headache|Pain:Temporal Headache]] — Band-like semispinalis capitis referral pattern
* [[Pain:Occipital|Pain:Occipital]] — Middle and lower semispinalis capitis TrP referral
* [[Pain:Head_and_Neck|Pain:Head and Neck]] — Diagnostic algorithm
* [[Muscle:Semispinalis_Cervicis|Muscle:Semispinalis Cervicis]] — Deep companion muscle; similar mid-region pain pattern
* [[Muscle:Longissimus_Capitis|Muscle:Longissimus Capitis]] — Same functional layer
* [[Muscle:Splenius_Capitis|Muscle:Splenius Capitis]] — Key TrP; superficial to semispinalis capitis
* [[Muscle:Trapezius/Upper|Muscle:Trapezius/Upper]] — Key TrP; covers semispinalis capitis

== References ==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 1: The Upper Half of Body''. 2nd ed. Baltimore: Williams & Wilkins; 1999. Chapter 16.

[[Category:Muscle]]
[[Category:Vol1 Ch16]]
[[Category:Head and Neck]]

Vertex Headache

2026-04-19T18:35:30Z

Yatreyu: Redirected page to Pain:Vertex Headache

#REDIRECT [[Pain:Vertex_Headache]]

Head & Neck

2026-04-19T18:34:08Z

Yatreyu:

<imagemap>
File:Headregionv3.png|

poly 357 153 373 115 418 111 396 168 359 166 [[Frontal Headache|Frontal Headache Pain]]
poly 646 103 715 116 764 100 780 137 775 173 761 189 754 210 754 221 757 233 761 245 760 252 724 276 695 275 676 272 661 268 652 258 649 252 652 210 649 201 639 182 634 175 629 171 625 154 626 121 [[Back of Head|Back of Head Pain]]
poly 89 182 100 200 106 210 103 227 105 237 99 247 95 245 88 243 81 240 74 231 71 221 65 207 65 196 66 188 [[Ear & Temporomandibular Joint|Ear & Temporomandibular Joint Pain]]
poly 131 250 156 247 172 245 184 248 191 255 191 262 185 270 175 275 164 282 150 278 141 277 133 272 129 268 [[Toothache|Toothache Pain]]
poly 104 276 139 305 164 309 186 300 209 278 221 268 220 333 203 376 163 388 136 379 126 368 103 335 99 312 [[Throat & Neck|Throat & Neck Pain]]
poly 402 299 437 273 454 259 456 242 472 242 480 276 483 323 479 361 468 370 419 383 [[Throat & Neck|Throat & Neck Pain]]
poly 478 252 494 311 489 343 490 367 522 364 546 358 540 342 528 310 520 289 517 273 512 268 504 269 497 264 494 253 487 247 [[Posterior Neck|Posterior Neck Pain]]
poly 658 260 687 274 719 272 746 258 762 249 757 290 757 316 766 350 751 366 720 378 684 372 656 362 648 359 650 305 652 253 [[Posterior Neck|Posterior Neck Pain]]
poly 356 236 378 236 394 240 405 234 400 247 393 257 384 261 371 265 361 269 353 265 355 252 [[Toothache|Toothache Pain]]
poly 221 193 216 214 213 221 217 234 222 241 227 242 232 237 235 233 245 220 244 214 248 199 248 192 240 182 [[Ear & Temporomandibular Joint|Ear & Temporomandibular Joint Pain]]
poly 429 205 428 218 434 227 440 227 446 231 452 239 456 241 464 245 473 247 481 243 490 236 494 221 499 214 498 202 495 190 491 183 487 177 478 173 465 172 461 177 [[Ear & Temporomandibular Joint|Ear & Temporomandibular Joint Pain]]
poly 635 177 646 196 653 208 651 217 641 233 638 238 633 233 625 215 622 203 618 192 617 184 [[Ear & Temporomandibular Joint|Ear & Temporomandibular Joint Pain]]
poly 779 177 768 186 759 203 758 225 763 237 771 242 777 239 783 224 787 210 788 193 788 183 [[Ear & Temporomandibular Joint|Ear & Temporomandibular Joint Pain]]
poly 449 118 468 157 466 170 493 176 496 201 502 220 495 233 488 245 502 269 515 267 529 227 541 201 546 175 544 155 531 124 524 115 508 106 500 102 454 108 [[Back of Head|Back of Head Pain]]
poly 99 111 134 108 152 104 167 103 184 104 209 101 193 87 183 80 165 75 142 77 121 84 105 94 [[Vertex Headache|Vertex Pain]]
poly 378 116 418 114 446 107 459 106 475 104 495 100 507 102 502 94 476 83 446 81 421 83 400 90 391 91 [[Vertex Headache|Vertex Pain]]
poly 652 108 699 118 725 117 745 105 761 96 750 86 720 81 701 75 682 80 666 86 [[Vertex Headache|Vertex Pain]]
poly 100 207 98 198 95 194 96 188 100 179 108 172 119 169 130 166 143 168 155 170 167 170 177 170 191 169 203 170 210 173 221 185 220 189 221 203 215 211 208 209 198 206 186 205 174 207 168 203 164 203 154 201 148 203 141 207 134 208 [[Eye & Eyebrow|Eye & Eyebrow Pain]]
poly 356 189 364 198 374 202 384 206 394 203 401 202 408 192 408 185 404 176 398 170 385 167 379 164 364 164 357 164 [[Eye & Eyebrow|Eye & Eyebrow Pain]]
poly 90 189 83 182 77 170 75 157 75 145 73 129 79 116 82 113 90 111 96 112 104 124 109 137 114 148 115 160 112 171 103 179 99 189 98 194 102 200 [[Temporal Headache|Temporal Headache ]]
poly 210 169 218 160 219 151 216 141 213 135 207 131 208 124 211 118 216 112 221 113 228 118 233 133 239 151 239 160 236 173 233 181 231 189 223 191 211 175 [[Temporal Headache|Temporal Headache]]
poly 397 164 405 138 413 123 417 114 429 108 441 107 448 111 457 128 462 145 463 162 463 170 452 180 444 191 439 199 434 204 424 203 413 203 407 199 407 193 [[Temporal Headache|Temporal Headache]]
poly 115 168 116 154 113 140 109 129 103 118 99 112 109 112 129 113 180 108 193 111 202 114 206 120 208 128 209 139 213 151 213 157 204 169 199 169 [[Frontal Headache|Frontal Headache]]
poly 354 192 371 203 388 206 401 199 406 197 414 200 423 204 428 208 428 219 434 225 444 230 449 235 452 244 453 251 442 264 428 271 414 283 408 291 395 299 377 300 367 295 358 291 356 282 359 271 371 264 395 252 401 252 401 242 408 239 406 233 406 231 396 232 388 235 381 233 373 231 366 232 363 227 363 221 359 220 346 220 343 216 342 213 [[Cheek & Jaw|Cheek & Jaw Pain]]
poly 111 206 142 210 152 203 168 203 179 207 193 205 214 207 211 221 215 225 219 235 222 244 218 254 210 265 211 272 196 284 190 293 182 301 174 305 169 307 160 308 162 278 157 277 147 277 140 277 135 272 130 269 130 264 129 256 133 250 135 244 141 243 149 243 159 243 157 242 154 239 154 238 148 238 142 239 143 234 145 230 155 225 160 225 166 226 170 226 174 228 175 234 171 235 169 238 165 237 162 238 158 241 160 245 176 242 183 247 187 249 189 253 189 257 189 261 189 265 183 269 177 274 173 277 168 281 164 281 162 304 153 306 139 302 129 294 125 292 119 287 112 279 103 272 100 268 96 250 109 239 111 231 108 223 [[Cheek & Jaw|Cheek & Jaw Pain]]

desc bottom-left
</imagemap>

DiagnosticTree/Vertex

2026-04-19T18:32:21Z

Yatreyu: Created page with "{ "tree_id": "head-neck", "region": "Head and Neck Pain \u2014 Myofascial", "start": "rom-1", "redflags": { "emergency": [ { "id": "rf-e1", "label": "Subarachnoid Haemorrhage", "question": "Sudden-onset thunderclap headache \u2014 the worst headache of the patient\u2019s life, reaching maximal intensity within seconds to a minute; may be accompanied by neck stiffness, vomiting, photophobia, or brief loss of consciousness?",..."

{
"tree_id": "head-neck",
"region": "Head and Neck Pain \u2014 Myofascial",
"start": "rom-1",
"redflags": {
"emergency": [
{
"id": "rf-e1",
"label": "Subarachnoid Haemorrhage",
"question": "Sudden-onset thunderclap headache \u2014 the worst headache of the patient\u2019s life, reaching maximal intensity within seconds to a minute; may be accompanied by neck stiffness, vomiting, photophobia, or brief loss of consciousness?",
"rationale": "The classic \u2018thunderclap\u2019 headache is a neurosurgical emergency until proven otherwise. Myofascial headache is never of sudden thunderclap onset.",
"action": "Call emergency services immediately. Do not proceed with myofascial assessment."
},
{
"id": "rf-e2",
"label": "Vertebral or Carotid Artery Dissection",
"question": "New severe unilateral neck pain or occipital headache, especially following recent neck manipulation, trauma, or sudden neck movement; associated with ipsilateral face or neck pain, Horner syndrome, or new neurological symptoms (dysarthria, dysphagia, limb weakness, diplopia)?",
"rationale": "Arterial dissection can present identically to posterior cervical muscle pain. Any new focal neurological sign in this context requires immediate vascular imaging.",
"action": "Call emergency services immediately. Note: SCM TrPs produce autonomic phenomena resembling Horner syndrome \u2014 exclude true Horner before attributing to TrPs."
},
{
"id": "rf-e3",
"label": "Meningitis / Encephalitis",
"question": "Headache with fever, photophobia, phonophobia, and neck stiffness (Kernig\u2019s or Brudzinski\u2019s sign positive); non-blanching petechial or purpuric rash; altered consciousness or seizure?",
"rationale": "Neck stiffness from meningism is fundamentally different from myofascial restriction \u2014 meningism resists passive neck flexion in all planes whereas myofascial restriction has a directional pattern.",
"action": "Call emergency services immediately."
},
{
"id": "rf-e4",
"label": "Cervical Epidural Abscess / Cord Compression",
"question": "Severe progressive neck pain with fever and exquisite midline spinal tenderness; new upper or lower limb weakness, sensory level, or bladder / bowel dysfunction?",
"rationale": "Spinal cord or cauda equina compromise requires emergency decompression.",
"action": "Call emergency services immediately."
}
],
"urgent": [
{
"id": "rf-u1",
"label": "Temporal Arteritis (Giant Cell Arteritis)",
"question": "New temporal headache in a patient aged over 50; scalp tenderness, jaw claudication, visual disturbance, or loss of vision; elevated ESR or CRP; tender, thickened, or pulseless temporal artery?",
"rationale": "Visual loss from temporal arteritis is irreversible. A tender temporal artery in a patient over 50 is temporal arteritis until proven otherwise. Temporalis muscle TrPs do not cause scalp tenderness or jaw claudication.",
"action": "Same-day GP or emergency referral. High-dose corticosteroids must not be delayed. Do not proceed with myofascial assessment."
},
{
"id": "rf-u2",
"label": "Cervical Fracture or Instability",
"question": "Neck pain following significant trauma (fall, motor vehicle accident, axial load injury, diving); midline cervical tenderness; any neurological sign; known osteoporosis, rheumatoid arthritis with atlantoaxial involvement, or Down syndrome?",
"rationale": "Cervical spine must be cleared radiologically before any manual assessment or treatment. Whiplash TrPs are common but require fracture and instability to be excluded first.",
"action": "Urgent same-day referral for cervical imaging. Do not proceed with myofascial examination."
},
{
"id": "rf-u3",
"label": "Space-Occupying Lesion / Raised Intracranial Pressure",
"question": "Headache that is progressively worsening over weeks, worse on waking, worse on Valsalva, coughing, or bending forward; associated with personality change, focal neurological signs, papilloedema, or unexplained weight loss?",
"rationale": "Progressive morning headache with postural or Valsalva aggravation is a cardinal feature of raised ICP. Myofascial headache does not worsen consistently on waking or with Valsalva.",
"action": "Urgent same-day GP referral for CT or MRI. Do not proceed with myofascial assessment."
},
{
"id": "rf-u4",
"label": "New Headache in Immunocompromised Patient",
"question": "New or changing headache pattern in a patient who is HIV-positive, on immunosuppressants, or has had a recent systemic infection; any fever, night sweats, or neck stiffness?",
"rationale": "Cryptococcal meningitis, CNS lymphoma, and toxoplasmosis must be excluded in immunocompromised patients before attributing headache to myofascial causes.",
"action": "Urgent same-day GP or infectious diseases referral."
}
]
},
"nodes": {
"rom-1": {
"type": "rom",
"question": "Is the head or neck pain aggravated by active rotation of the head and neck to the same side as the pain \u2014 turning to look over the shoulder?",
"movement": "Active cervical rotation \u2014 ipsilateral",
"direction": "aggravating",
"muscles_implicated": [
"Splenius Capitis",
"Splenius Cervicis",
"Levator Scapulae"
],
"muscles_excluded": [
"SCM (sternal division) \u2014 rotation toward affected side relieves SCM stretch",
"SCM (clavicular division)"
],
"clinical_rationale": "Painful restriction of active rotation to the same side is the cardinal ROM finding for splenius capitis and splenius cervicis TrPs. The SCM is an antagonist to this movement and is not typically painful with ipsilateral rotation.",
"yes": "rom-2",
"no": "rom-3"
},
"rom-2": {
"type": "rom",
"question": "Is passive rotation and flexion of the head and neck toward the OPPOSITE side also restricted or uncomfortable \u2014 i.e., is there restriction in both directions, forming a bilateral pattern of limited mobility?",
"movement": "Passive cervical rotation and flexion \u2014 contralateral",
"direction": "aggravating",
"muscles_implicated": [
"Splenius Capitis",
"Splenius Cervicis"
],
"muscles_excluded": [
"Levator Scapulae \u2014 typically restricts rotation more toward the ipsilateral side only"
],
"clinical_rationale": "Splenius TrPs characteristically produce moderate restriction of passive rotation and flexion toward the opposite side alongside the painful active restriction to the same side. This bidirectional pattern distinguishes splenius involvement from pure levator scapulae restriction.",
"yes": "symptom-1",
"no": "rom-4"
},
"rom-3": {
"type": "rom",
"question": "Is the pain aggravated by sustained or repeated rotation of the head away from the painful side \u2014 such as when driving, working at a screen placed to one side, or looking over the contralateral shoulder for prolonged periods?",
"movement": "Sustained cervical rotation \u2014 contralateral (postural loading)",
"direction": "aggravating",
"muscles_implicated": [
"SCM (sternal division)",
"SCM (clavicular division)"
],
"muscles_excluded": [
"Splenius Capitis",
"Splenius Cervicis"
],
"clinical_rationale": "SCM TrPs are aggravated by sustained loading in the lengthened position \u2014 i.e., rotation away from the affected SCM. This is the opposite direction to splenius aggravation. Forward head posture is the dominant perpetuating factor.",
"yes": "symptom-3",
"no": "rom-5"
},
"rom-4": {
"type": "rom",
"question": "Is ipsilateral shoulder elevation painful or restricted \u2014 such that shrugging the shoulder on the same side as the neck pain reproduces or worsens the pain?",
"movement": "Shoulder elevation \u2014 ipsilateral",
"direction": "aggravating",
"muscles_implicated": [
"Levator Scapulae"
],
"muscles_excluded": [
"Splenius Capitis",
"Splenius Cervicis \u2014 neither contracts with shoulder elevation"
],
"clinical_rationale": "The levator scapulae contracts with shoulder elevation but not with neck extension. The splenius cervicis contracts with neck extension but not with shoulder elevation. This distinguishes the two muscles during the examination when ipsilateral active rotation is painful but the bidirectional restriction pattern is absent.",
"yes": "exam-levator-1",
"no": "symptom-3"
},
"rom-5": {
"type": "rom",
"question": "Is the pain located in the anterior neck, face, or head \u2014 rather than posterior neck or occiput \u2014 and associated with any of: dizziness, imbalance, ear symptoms, tearing, or autonomic phenomena on the same side as the pain?",
"movement": "Symptom distribution and autonomic screen",
"direction": "present",
"muscles_implicated": [
"SCM (sternal division)",
"SCM (clavicular division)"
],
"muscles_excluded": [
"Splenius Capitis",
"Splenius Cervicis",
"Levator Scapulae"
],
"clinical_rationale": "SCM TrPs are among the most clinically complex in the body. Dizziness and disequilibrium (clavicular division), profuse ipsilateral tearing, apparent ptosis, rhinitis, and ear symptoms (sternal division) are autonomic phenomena not produced by the posterior cervical muscles.",
"yes": "symptom-3",
"no": "exam-palpation-screen"
},
"symptom-1": {
"type": "symptom",
"question": "Is the head pain located specifically at the VERTEX \u2014 the very top of the skull \u2014 on the same side as the restricted rotation, described as a sharply localised ache that the patient can point to with a single finger?",
"symptom_name": "Vertex headache \u2014 ipsilateral, sharply localised",
"muscles_implicated": [
"Splenius Capitis"
],
"muscles_excluded": [
"Splenius Cervicis \u2014 upper TrP refers through the inside of the head to the back of the eye, not to the vertex",
"SCM sternal division \u2014 refers to the vertex only rarely and diffusely",
"Levator Scapulae \u2014 does not refer to the vertex"
],
"clinical_rationale": "Sharply localised vertex pain on the same side as the painful rotation restriction is the defining, must-have feature of splenius capitis TrP involvement. No other cervical muscle reliably produces this pattern. SCM sternal division can refer to the vertex but does so diffusely and as part of a wider pattern that includes cheek, temple, and supraorbital referral.",
"yes": "symptom-2",
"no": "symptom-4"
},
"symptom-2": {
"type": "symptom",
"question": "Is there also an \u2018ache inside the skull\u2019 \u2014 pain that seems to radiate through the inside of the head toward the back of the ipsilateral eye or orbit \u2014 in addition to or instead of the vertex pain?",
"symptom_name": "Intracranial ache with orbital projection \u2014 ipsilateral",
"muscles_implicated": [
"Splenius Capitis (craniad TrP near C\u2082)",
"Splenius Cervicis (upper TrP)"
],
"muscles_excluded": [
"Splenius Capitis (typical mid-muscle TrP) \u2014 refers to vertex without orbital component",
"Levator Scapulae"
],
"clinical_rationale": "An unusually craniad splenius capitis TrP (near the level of C\u2082, just caudad to the exposed vertebral artery) adds an intracranial quality with orbital projection to the vertex pattern. The upper splenius cervicis TrP produces the same orbital / intracranial quality but without the vertex localisation. If both vertex AND orbital referral are present simultaneously, both muscles are likely involved.",
"yes": "symptom-2b",
"no": "exam-splenius-cap-1"
},
"symptom-2b": {
"type": "symptom",
"question": "Is there also blurring of NEAR vision in the eye on the same side \u2014 not dizziness, not double vision, not conjunctivitis \u2014 that may improve immediately when the neck is repositioned or the muscle is released?",
"symptom_name": "Ipsilateral near-vision blurring \u2014 without dizziness or conjunctivitis",
"muscles_implicated": [
"Splenius Cervicis (upper TrP)"
],
"muscles_excluded": [
"Splenius Capitis \u2014 does not produce near-vision blurring",
"SCM \u2014 visual disturbance is a different quality (contrast sensitivity, venetian blind effect), not near-vision blur"
],
"clinical_rationale": "Blurring of near vision in the homolateral eye without dizziness or conjunctivitis is a clinically decisive marker of upper splenius cervicis TrP involvement. It sometimes resolves immediately and completely on TrP inactivation. This symptom is not produced by splenius capitis or SCM.",
"yes": "exam-splenius-cerv-1",
"no": "exam-splenius-cap-1"
},
"symptom-3": {
"type": "symptom",
"question": "Is there a dry, tingling cough \u2014 not explained by respiratory illness \u2014 OR a sensation of sore throat or pharyngeal pain on swallowing, without pharyngeal infection?",
"symptom_name": "Dry tingling cough / pharyngeal sore throat",
"muscles_implicated": [
"SCM (sternal division)"
],
"muscles_excluded": [
"SCM (clavicular division)",
"Splenius Capitis",
"Splenius Cervicis"
],
"clinical_rationale": "A dry tingling cough TrP and referred pharyngeal sore throat that resolves with SCM pincer compression are pathognomonic features of the SCM sternal division. They are not produced by any posterior cervical muscle.",
"yes": "exam-scm-sternal-1",
"no": "symptom-5"
},
"symptom-4": {
"type": "symptom",
"question": "Is the pain located at the ANGLE OF THE NECK on the same side \u2014 the posterior lateral triangle where the neck meets the shoulder \u2014 with pain referring upward toward the base of the skull and medially toward the upper cervical spine?",
"symptom_name": "Angle-of-neck pain with upward and medial referral",
"muscles_implicated": [
"Splenius Cervicis (lower / central TrP)"
],
"muscles_excluded": [
"Splenius Capitis \u2014 does not refer to the angle of the neck",
"Levator Scapulae \u2014 refers to the angle of the neck but also to the posterior shoulder; pattern lies more laterally"
],
"clinical_rationale": "The lower splenius cervicis TrP refers pain to the angle of the neck with spread upward to the base of the skull and some spread medially \u2014 lying in the upper part of the levator scapulae pain pattern but with medial spread. Splenius capitis does not produce this pattern.",
"yes": "exam-splenius-cerv-1",
"no": "exam-palpation-screen"
},
"symptom-5": {
"type": "symptom",
"question": "Is there postural dizziness or imbalance \u2014 a sense of unsteadiness or veering when walking or turning \u2014 that is worse on changing head position, lying without a pillow, or quick head rotation, but WITHOUT Romberg\u2019s sign or nystagmus?",
"symptom_name": "Postural dizziness / disequilibrium \u2014 without Romberg or nystagmus",
"muscles_implicated": [
"SCM (clavicular division)"
],
"muscles_excluded": [
"SCM (sternal division)",
"Splenius Capitis",
"Splenius Cervicis"
],
"clinical_rationale": "Postural dizziness and disequilibrium caused by clavicular SCM TrPs has a characteristic profile: Romberg negative, nystagmus absent, straight-line walking veers toward the active TrP side. True vestibular pathology produces a positive Romberg (worse with eyes closed) and nystagmus. This distinction is clinically critical.",
"yes": "exam-scm-clav-1",
"no": "exam-palpation-screen"
},
"exam-splenius-cap-1": {
"type": "examination",
"question": "Does flat palpation in the muscular triangle posterior and medial to the sternocleidomastoid \u2014 below the occiput, at approximately the level of the C\u2082 spinous process \u2014 reproduce the vertex pain or produce a localised taut band with exquisite tenderness?",
"exam_type": "palpation",
"landmark": "Muscular triangle bounded anteriorly by the SCM, posteriorly by the upper trapezius, caudad by the levator scapulae. Patient turns face TOWARD the side being examined and extends the head against light resistance to contract the diagonal splenius capitis fibres. Palpate across the fibre direction for taut bands. The TrP is typically mid-muscle near the level of C\u2082.",
"positive_finding": "Reproduces vertex pain on the same side; OR localised taut band with jump sign in the muscular triangle",
"clinical_rationale": "Splenius capitis is palpable in the muscular triangle. Contraction against resistance identifies fibre direction and location. Tenderness near the mastoid insertion indicates enthesopathy secondary to a mid-muscle TrP, not a primary insertion TrP.",
"muscles_implicated": [
"Splenius Capitis"
],
"yes": "result-splenius-cap",
"no": "exam-splenius-cerv-1"
},
"exam-splenius-cerv-1": {
"type": "examination",
"question": "Does pressure applied from the SIDE \u2014 sliding the palpating finger anterior to the free border of the upper trapezius at approximately the level of C\u2087, then directing pressure medially toward the spine \u2014 reproduce the patient\u2019s neck, occipital, or orbital pain?",
"exam_type": "palpation",
"landmark": "Patient sidelying or seated. Operator\u2019s finger slides anterior to the free border of upper trapezius at approximately C\u2087 spinous process level, past the levator scapulae if non-tender, directing pressure medially toward the spine. Alternatively: posterior approach, approximately 2 cm lateral to the spine at C\u2087, just above the angle of the neck. Splenius cervicis contracts with neck extension \u2014 distinguish from levator scapulae which contracts with shoulder elevation.",
"positive_finding": "Medially directed pressure reproduces orbital, occipital, or angle-of-neck pain; OR diagonal taut bands palpable running caudad from lateral to medial in patients with mobile connective tissue",
"clinical_rationale": "The splenius cervicis is not palpable from directly behind (entirely covered by trapezius). The only approach with reliable access is from the side, through or around the levator scapulae. Neck extension (not shoulder elevation) confirms the contracting muscle is splenius cervicis.",
"muscles_implicated": [
"Splenius Cervicis"
],
"yes": "result-splenius-cerv",
"no": "exam-levator-1"
},
"exam-scm-sternal-1": {
"type": "examination",
"question": "Does pincer palpation of the SCM sternal division reproduce familiar head, face, or chest pain \u2014 AND does sustained pincer compression of the sternal head relieve the sore throat or cough when present?",
"exam_type": "palpation",
"landmark": "Patient seated or supine, ear tilted toward the shoulder to slack the muscle. Grasp the entire sternal division between thumb and forefinger from mastoid to sternal attachment. Snapping a taut band may cause a reflexive head jerk. SCM Compression Test: pincer grip steadily compresses the muscle belly; ask the patient to swallow. Positive result: pharyngeal pain resolves with compression.",
"positive_finding": "Reproduces familiar head, face, ear, or upper sternal pain; OR pincer compression relieves sore throat / cough on swallowing",
"clinical_rationale": "The SCM Compression Test is pathognomonic \u2014 pharyngeal pain that resolves with muscle compression cannot arise from true pharyngeal pathology. Profuse ipsilateral tearing, apparent ptosis, conjunctival redness, and rhinitis are autonomic phenomena confirming sternal division TrP activation.",
"muscles_implicated": [
"SCM (sternal division)"
],
"yes": "result-scm-sternal",
"no": "exam-scm-clav-1"
},
"exam-scm-clav-1": {
"type": "examination",
"question": "Does flat palpation of the clavicular division of the SCM \u2014 along the medial clavicle upward toward the mastoid, posterior to the sternal head \u2014 reproduce frontal headache, dizziness, or ear symptoms? Perform the straight-line walking test: does the patient veer toward the side of the suspected TrP when walking toward a fixed point across the room?",
"exam_type": "palpation",
"landmark": "Clavicular division: flat palpation from medial clavicle upward, posterior and deep to the sternal head. Straight-line walking test: patient walks toward a fixed point while fixing their gaze on it \u2014 veering toward the TrP side indicates clavicular division involvement. Romberg test: negative (normal sway with eyes closed) confirms myofascial rather than vestibular origin.",
"positive_finding": "Reproduces frontal headache or dizziness on palpation; OR straight-line walking test veers toward the TrP side; OR Romberg negative with dizziness present",
"clinical_rationale": "The straight-line walking test and Romberg negative combination is the clinical hallmark of clavicular division SCM TrP dizziness, distinguishing it from vestibular pathology. Weight perception dysmetria (same object feels heavier on the unaffected side) further confirms clavicular division involvement.",
"muscles_implicated": [
"SCM (clavicular division)"
],
"yes": "result-scm-clav",
"no": "exam-levator-1"
},
"exam-levator-1": {
"type": "examination",
"question": "Does flat palpation of the levator scapulae \u2014 at the angle of the neck where the muscle emerges from beneath the trapezius, and along the posterior border of the SCM \u2014 reproduce ipsilateral neck pain or posterior shoulder pain? Is shoulder elevation on the same side painful or does it provoke neck pain?",
"exam_type": "palpation",
"landmark": "Levator scapulae: palpate at the angle of the neck (posterior to SCM, anterior to trapezius) and along the medial scapular border. Levator scapulae contracts with shoulder elevation \u2014 use this to confirm muscle identity. Distinguish from splenius cervicis (contracts with neck extension, not shoulder elevation).",
"positive_finding": "Reproduces posterior neck pain or posterior shoulder pain; shoulder elevation provokes or reproduces the pain; taut band palpable at the angle of the neck",
"clinical_rationale": "Levator scapulae and splenius cervicis share an attachment at the transverse processes of the upper cervical vertebrae and frequently co-activate. Levator scapulae TrPs often mask coexisting splenius cervicis TrPs \u2014 the latter only become apparent after the levator is inactivated. Shoulder elevation activates levator but not splenius cervicis.",
"muscles_implicated": [
"Levator Scapulae"
],
"yes": "result-levator",
"no": "exam-palpation-screen"
},
"exam-palpation-screen": {
"type": "examination",
"question": "Systematic palpation screen: does palpation of any of the following reproduce the patient\u2019s familiar pain? (a) Upper trapezius \u2014 flat palpation across the crest of the shoulder; (b) Semispinalis capitis \u2014 just lateral to midline from occiput to C\u2084; (c) Suboccipital muscles \u2014 between the occiput and C\u2082, in the suboccipital triangle; (d) Temporalis \u2014 flat palpation over the temporal fossa in three zones?",
"exam_type": "palpation",
"landmark": "(a) Upper trapezius: pinch the muscle crest between thumb and forefinger across the shoulder to neck. (b) Semispinalis capitis: flat palpation just lateral to midline, occiput to C\u2084. (c) Suboccipital: pressure in the suboccipital triangle between occiput and C\u2082 spinous process. (d) Temporalis: flat palpation in anterior, middle, and posterior zones of the temporal fossa.",
"positive_finding": "Any muscle reproduces the patient\u2019s familiar pain pattern on palpation",
"clinical_rationale": "Head and neck pain is almost always multi-muscle in origin. When the primary splenius and SCM screens are negative or equivocal, systematic palpation of the remaining major head and neck muscles is required before concluding the examination.",
"muscles_implicated": [
"Upper Trapezius",
"Semispinalis Capitis",
"Suboccipital Muscles",
"Temporalis"
],
"yes": "result-overlap",
"no": "result-no-trp"
},
"result-splenius-cap": {
"type": "result",
"diagnosis": "Splenius Capitis Trigger Point",
"confidence": "high",
"wiki_page": "Muscle:Splenius_Capitis",
"chapter_ref": "Travell & Simons Vol.1 \u2014 Ch.15 Splenius Capitis and Splenius Cervicis",
"notes": "The defining feature is sharply localised vertex pain on the same side \u2014 the patient points to the crown with a single finger. An unusually craniad TrP near C\u2082 adds an intracranial ache projecting to the back of the eye. Splenius capitis was the second most frequently injured muscle in systematic whiplash studies (present in 94% of frontal impacts). Active TrPs rarely appear in the splenii alone \u2014 levator scapulae and posterior cervical muscles are almost always co-involved.",
"confirmatory": [
"Vertex pain \u2014 ipsilateral, sharply localised, single-finger location \u2014 pathognomonic",
"Painful restriction of ACTIVE rotation to the same side",
"Moderate restriction of PASSIVE rotation and flexion to the opposite side",
"Taut band with jump sign in the muscular triangle posterior and medial to the SCM, approximately at C\u2082 level",
"Only the splenius capitis (not splenius cervicis) is further elongated by flexion of the HEAD on the cervical spine beyond neck flexion alone \u2014 use this to distinguish the two muscles"
],
"treatment_hint": "Release together with splenius cervicis and levator scapulae as one functional unit. Spray and stretch: up-stroke vapocoolant pattern, head rotated 20\u201330\u00b0 away and gently flexed toward the opposite side, upward traction. INJECTION CAUTION: needle aimed caudad, below C\u2081\u2013C\u2082 junction; craniad musculotendinous junction injection is not recommended. Hot pack after stretch. See Muscle:Splenius_Capitis for full protocol.",
"less_likely": [
{
"muscle": "Splenius Cervicis",
"reason": "Upper splenius cervicis refers through the inside of the head to the back of the eye, not to the vertex; lower TrP refers to the angle of the neck, not the vertex"
},
{
"muscle": "SCM sternal division",
"reason": "SCM vertex referral is rare and diffuse, part of a wider pattern including cheek, temple, and supraorbital pain; autonomic phenomena (tearing, rhinitis) distinguish SCM"
},
{
"muscle": "Semispinalis Capitis",
"reason": "Semispinalis capitis refers to the occiput and posterior head, not specifically to the vertex"
}
]
},
"result-splenius-cerv": {
"type": "result",
"diagnosis": "Splenius Cervicis Trigger Point",
"confidence": "high",
"wiki_page": "Muscle:Splenius_Cervicis",
"chapter_ref": "Travell & Simons Vol.1 \u2014 Ch.15 Splenius Capitis and Splenius Cervicis",
"notes": "The upper TrP produces a diffuse intracranial ache that focuses strongly behind the ipsilateral eye \u2014 an \u2018ache inside the skull.\u2019 The lower (central) TrP refers to the angle of the neck. Near-vision blurring in the homolateral eye without dizziness or conjunctivitis is a clinically decisive marker. Splenius cervicis involvement is frequently masked by levator scapulae TrPs and only becomes apparent after the levator is inactivated. Trifocal eyeglasses are a named perpetuating factor specific to this muscle.",
"confirmatory": [
"Intracranial ache projecting to the back of the ipsilateral eye \u2014 distinguishes upper TrP from splenius capitis vertex referral",
"Near-vision blurring in the homolateral eye without dizziness or conjunctivitis \u2014 sometimes resolves immediately on TrP inactivation",
"Pain at the angle of the neck (lower TrP) with spread upward and medially",
"Painful restriction of active rotation to the same side with moderate contralateral passive restriction",
"TrP only accessible from the side, through or around the levator scapulae \u2014 medially directed pressure at C\u2087 level reproduces pain",
"Neck extension (not shoulder elevation) contracts splenius cervicis \u2014 distinguishes from levator scapulae",
"Involvement often only apparent AFTER levator scapulae TrPs are inactivated"
],
"treatment_hint": "Release together with splenius capitis and levator scapulae. Spray and stretch: up-stroke pattern with spray also covering the angle of the shoulder and lateral head to the eye (protect eye from spray). Injection: needle directed lateral to medial, superficial to ribs posterior to transverse processes; CAUTION \u2014 some patients faint with autonomic response on needle contact. Do not wear trifocal eyeglasses. See Muscle:Splenius_Cervicis for full protocol.",
"less_likely": [
{
"muscle": "Splenius Capitis",
"reason": "Splenius capitis refers to the vertex, not through the inside of the head to the eye; capitis is further elongated by head-on-cervical-spine flexion, cervicis is not"
},
{
"muscle": "Levator Scapulae",
"reason": "Levator scapulae contracts with shoulder elevation, not neck extension; levator TrPs often co-exist and must be inactivated first to unmask splenius cervicis"
},
{
"muscle": "Suboccipital muscles",
"reason": "Suboccipitals refer to the occiput and posterior head; they do not produce near-vision blurring or orbital intracranial quality"
}
]
},
"result-scm-sternal": {
"type": "result",
"diagnosis": "SCM Trigger Point \u2014 Sternal Division",
"confidence": "high",
"wiki_page": "Muscle:Sternocleidomastoid",
"chapter_ref": "Travell & Simons Vol.1 \u2014 Ch.7 Sternocleidomastoid",
"notes": "The sternal division refers ipsilaterally to cheek, temple, supraorbital ridge, occiput, and vertex, and downward to the upper sternal region. The dry tingling cough TrP and pharyngeal sore throat that resolves with SCM compression are pathognomonic. Autonomic phenomena \u2014 profuse ipsilateral tearing, apparent ptosis, conjunctival redness, rhinitis \u2014 are frequently the patient\u2019s most alarming symptoms. SCM TrPs activate masseter, temporalis, and other head muscles as satellites \u2014 treat SCM first.",
"confirmatory": [
"Dry tingling cough TrP \u2014 not explained by respiratory illness \u2014 pathognomonic for SCM sternal division",
"SCM Compression Test positive \u2014 pincer grip compression relieves pharyngeal pain and/or cough on swallowing",
"Profuse ipsilateral tearing, conjunctival redness, or apparent ptosis (palpebral fissure narrowing, not true ptosis)",
"Head tilts toward the affected side with strongly activated TrPs \u2014 pain on holding the head upright",
"Cheek, temple, supraorbital, and occipital pain in the same referral pattern",
"Forward head posture \u2014 the single most important perpetuating factor"
],
"treatment_hint": "Spray and stretch in superior-to-inferior direction over the muscle belly and referred pain zone. Passive stretch into contralateral rotation and lateral flexion. Correct forward head posture with axial extension exercise. Address satellite TrPs (masseter, temporalis) only AFTER SCM is inactivated. See Muscle:Sternocleidomastoid for full protocol including neurological screen.",
"less_likely": [
{
"muscle": "Splenius Capitis",
"reason": "Splenius capitis refers to the vertex only, without the autonomic phenomena, cough, or sore throat of SCM sternal division"
},
{
"muscle": "Temporalis",
"reason": "Temporalis refers to the teeth and temporal region; it is frequently a satellite of SCM and should be treated after SCM"
},
{
"muscle": "Sinusitis / Rhinitis",
"reason": "SCM sternal division TrPs produce ipsilateral rhinitis and apparent sinus symptoms without true sinus infection; fever, purulent discharge, and radiographic changes absent"
}
]
},
"result-scm-clav": {
"type": "result",
"diagnosis": "SCM Trigger Point \u2014 Clavicular Division",
"confidence": "high",
"wiki_page": "Muscle:Sternocleidomastoid",
"chapter_ref": "Travell & Simons Vol.1 \u2014 Ch.7 Sternocleidomastoid",
"notes": "The clavicular division produces three dominant presentations \u2014 frontal headache, postural dizziness and disequilibrium, and dysmetria \u2014 any one of which may predominate. Dizziness is postural and worsens on changing head load, rolling over in bed, or quick head rotation. Hearing may rarely be impaired on the same side. Straight-line walking veers toward the active TrP side \u2014 pathognomonic when Romberg is negative.",
"confirmatory": [
"Frontal headache \u2014 ipsilateral, often mistaken for tension or sinus headache",
"Postural dizziness and disequilibrium: Romberg NEGATIVE, nystagmus ABSENT, straight-line walking veers toward the TrP side",
"Dysmetria: the same object feels heavier when held on the UNAFFECTED side (no bilateral TrP present)",
"Dizziness worsens on changing head load, lying without a pillow, rolling over in bed, or quick head rotation",
"Hearing restoration manoeuvre positive: rotating toward the affected side with chin down temporarily restores hearing",
"Forward head posture \u2014 the single most important perpetuating factor"
],
"treatment_hint": "Spray and stretch clavicular head separately from sternal. Ischemic compression on clavicular division taut bands. Postural correction essential \u2014 axial extension exercise. Advise patient to roll the head on the pillow rather than lifting it when turning in bed. See Muscle:Sternocleidomastoid for full neurological screen protocol (Romberg, nystagmus, postural BP, carotid auscultation) before attributing dizziness to myofascial cause.",
"less_likely": [
{
"muscle": "M\u00e9ni\u00e8re\u2019s Disease",
"reason": "M\u00e9ni\u00e8re\u2019s produces episodic rotational vertigo with fluctuating unilateral hearing loss and nystagmus \u2014 nystagmus is absent in SCM TrP dizziness"
},
{
"muscle": "Benign Paroxysmal Positional Vertigo (BPPV)",
"reason": "BPPV produces brief rotational vertigo (seconds) with a positive Dix-Hallpike; SCM TrP dizziness is a sustained postural unsteadiness without rotational vertigo"
},
{
"muscle": "Splenius Capitis / Cervicis",
"reason": "Posterior cervical muscles do not produce dizziness, disequilibrium, or dysmetria"
}
]
},
"result-levator": {
"type": "result",
"diagnosis": "Levator Scapulae Trigger Point",
"confidence": "high",
"wiki_page": "Muscle:Levator_Scapulae",
"chapter_ref": "Travell & Simons Vol.1 \u2014 Ch.19 Levator Scapulae",
"notes": "Levator scapulae TrPs refer pain to the angle of the neck and posterior shoulder. Ipsilateral shoulder elevation reproduces or provokes the pain. Active TrPs rarely appear in the splenii alone \u2014 levator scapulae is almost always co-active and frequently masks coexisting splenius cervicis TrPs. Inactivating levator TrPs first is essential before the splenius cervicis can be properly assessed.",
"confirmatory": [
"Pain at the angle of the neck and posterior shoulder \u2014 characteristic referral zone",
"Shoulder elevation on the same side reproduces or provokes the neck pain",
"Levator scapulae contracts with shoulder elevation (not neck extension) \u2014 distinguishes from splenius cervicis",
"Taut band palpable at the angle of the neck, posterior to the SCM and anterior to the trapezius",
"Often reveals splenius cervicis TrPs after inactivation"
],
"treatment_hint": "Inactivate levator scapulae TrPs BEFORE assessing splenius cervicis. Spray and stretch of levator scapulae. Re-assess splenius cervicis after levator treatment. See Muscle:Levator_Scapulae for full protocol.",
"less_likely": [
{
"muscle": "Splenius Cervicis",
"reason": "Splenius cervicis contracts with neck extension, not shoulder elevation; splenius cervicis TrPs are frequently unmasked AFTER levator scapulae is inactivated"
},
{
"muscle": "Upper Trapezius",
"reason": "Upper trapezius refers to the lateral neck and temple; it does not produce the specific angle-of-neck pattern with shoulder elevation provocation"
}
]
},
"result-overlap": {
"type": "overlap",
"text": "Findings suggest multi-muscle involvement \u2014 common in head and neck pain. Perform a systematic palpation screen of all primary head and neck pain muscles. Note: active TrPs rarely appear in the splenii alone; levator scapulae and other posterior cervical muscles are almost always co-involved.",
"screen_these": [
"Splenius Capitis \u2014 flat palpation in the muscular triangle posterior and medial to the SCM, with head rotation against resistance to identify fibre direction",
"Splenius Cervicis \u2014 approach from the side, anterior to the free border of upper trapezius at C\u2087; medially directed pressure toward the spine",
"SCM sternal division \u2014 pincer palpation full length; SCM Compression Test for pharyngeal symptoms",
"SCM clavicular division \u2014 flat palpation from medial clavicle upward; Romberg test and straight-line walking test if dizziness present",
"Levator scapulae \u2014 palpate at the angle of the neck; shoulder elevation provocation test",
"Upper trapezius \u2014 pincer palpation across the crest of the shoulder",
"Semispinalis capitis \u2014 flat palpation just lateral to midline from occiput to C\u2084",
"Suboccipital muscles \u2014 pressure in the suboccipital triangle",
"Temporalis \u2014 flat palpation in anterior, middle, and posterior zones of the temporal fossa"
],
"wiki_page": "Pain:Head_and_Neck"
},
"result-no-trp": {
"type": "overlap",
"text": "Systematic palpation screen negative for reproducible TrP tenderness. Myofascial trigger point involvement is not confirmed by this assessment. Consider: (1) red flag conditions not yet excluded; (2) primary headache disorders (migraine, tension-type, cluster); (3) cervicogenic headache from cervical articular dysfunction; (4) referred pain from visceral structures; (5) neuralgias (occipital, trigeminal). Re-examine if symptoms change or persist.",
"screen_these": [
"Confirm all red flag conditions excluded",
"Cervical articular dysfunction assessment \u2014 C\u2082 dysfunction most commonly associated with splenius capitis TrPs",
"Primary headache disorder classification \u2014 refer to GP or neurology if indicated",
"Occipital neuralgia \u2014 lancinating quality, positive Tinel\u2019s at the greater occipital nerve"
],
"wiki_page": "Pain:Head_and_Neck"
},
"refer-neuro": {
"type": "neuro_referral",
"urgency": "emergency",
"title": "Serious Pathology NOT Excluded \u2014 Do Not Proceed",
"body": "One or more red flag groups have not been screened or cleared. Myofascial head and neck pain can closely mimic subarachnoid haemorrhage, vertebral artery dissection, meningitis, temporal arteritis, and cervical cord compression. A positive myofascial TrP examination does NOT exclude coexisting serious pathology. SCM TrPs produce autonomic phenomena that superficially resemble Horner syndrome \u2014 true Horner must be excluded before attributing to TrPs.",
"action": "Return to the red flag screen. Act on any positive group per that group\u2019s action before proceeding. For any uncleared doubt about intracranial or vascular origin: refer to Emergency Department immediately."
}
},
"broad_differential": [
{
"id": "bd-1",
"condition": "Migraine \u2014 without aura",
"confidence": "common",
"mimics": "Unilateral throbbing headache overlapping with splenius capitis and SCM sternal division TrP patterns",
"distinguishing_feature": "Migraine: pulsating quality, moderate to severe intensity, nausea/vomiting, photophobia or phonophobia, lasts 4\u201372 hours untreated. Myofascial headache: dull ache, reproduced by TrP palpation, no consistent pulsating quality. Note: active SCM and posterior cervical TrPs are a common trigger for migraine episodes \u2014 both may coexist.",
"action": "Palpate for active TrPs in SCM, splenius capitis, and upper trapezius \u2014 TrP inactivation may reduce migraine frequency. Refer to GP or neurology for migraine classification and prophylaxis."
},
{
"id": "bd-2",
"condition": "Tension-Type Headache",
"confidence": "very common",
"mimics": "Bilateral pressing or tightening headache overlapping with bilateral splenius capitis, SCM, and upper trapezius TrP patterns",
"distinguishing_feature": "Tension headache: bilateral pressing quality, mild to moderate, not aggravated by routine activity. Myofascial headache: reproduced by TrP palpation with direction-specific ROM restriction. Many patients diagnosed with tension headache have unrecognised active TrPs in the cervical muscles as the primary source.",
"action": "Systematic TrP palpation of all head and neck muscles. Active TrP inactivation is first-line treatment before prophylactic medication."
},
{
"id": "bd-3",
"condition": "Cervicogenic Headache",
"confidence": "common",
"mimics": "Unilateral posterior to anterior headache from cervical articular dysfunction \u2014 overlaps extensively with splenius capitis and SCM referral patterns",
"distinguishing_feature": "Cervicogenic headache: pain provoked by cervical movements or sustained postures, ipsilateral neck/shoulder arm pain, reduced cervical ROM, joint tenderness on examination. Note: C\u2082 dysfunction is the most common articular dysfunction associated with splenius capitis TrPs \u2014 both muscle and joint sources frequently coexist and require treatment.",
"action": "Assess for cervical articular dysfunction (C\u2081\u2013C\u2082 occipitoatlantal, C\u2082\u2013C\u2083) alongside TrP examination. Inactivate TrPs and mobilise the joint \u2014 either intervention alone is often insufficient."
},
{
"id": "bd-4",
"condition": "Benign Paroxysmal Positional Vertigo (BPPV)",
"confidence": "common",
"mimics": "Postural dizziness overlapping with SCM clavicular division TrP dizziness",
"distinguishing_feature": "BPPV: brief (seconds) rotational vertigo with a positive Dix-Hallpike test; nystagmus present. SCM clavicular TrP dizziness: sustained postural unsteadiness, no rotational vertigo, Romberg negative, nystagmus absent, straight-line walking veers toward the TrP side.",
"action": "Dix-Hallpike test to screen for BPPV. Romberg and nystagmus screen to confirm myofascial origin before attributing dizziness to SCM TrPs."
},
{
"id": "bd-5",
"condition": "Occipital Neuralgia",
"confidence": "uncommon",
"mimics": "Posterior head and occipital pain overlapping with splenius capitis, semispinalis capitis, and suboccipital TrP patterns",
"distinguishing_feature": "Occipital neuralgia: lancinating, electric-shock quality in the greater or lesser occipital nerve distribution; positive Tinel\u2019s sign at the nerve emergence; may have hypersensitivity of the scalp. Myofascial pain: dull aching quality, reproduced by muscle palpation. Note: splenius capitis TrP pain has previously been misdiagnosed as occipital neuralgia.",
"action": "Palpate for TrPs in splenius capitis and semispinalis capitis before attributing pain to occipital neuralgia. Tinel\u2019s sign at the greater occipital nerve confirms neuralgic component."
},
{
"id": "bd-6",
"condition": "Spasmodic Torticollis (Cervical Dystonia)",
"confidence": "rare",
"mimics": "Involuntary head rotation and cervical muscle tautness overlapping with unilateral splenius capitis and SCM TrP-driven head posture",
"distinguishing_feature": "Spasmodic torticollis: paroxysmal or clonic contractions, muscle hypertrophy with fibrotic change, geste antagoniste (touch of the jaw reduces rotation), dystonic movement ceases completely during sleep. Myofascial tautness: steady resistance without paroxysmal contractions, no hypertrophy, no geste antagoniste.",
"action": "Geste antagoniste test and sleep cessation observation. If positive: refer to neurology \u2014 botulinum toxin is first-line. Myofascial TrPs may coexist and can be treated alongside neurological management."
},
{
"id": "bd-7",
"condition": "Whiplash-Associated Disorder",
"confidence": "common",
"mimics": "Multi-muscle head and neck pain with restricted ROM following acceleration-deceleration injury \u2014 splenius capitis is the second most commonly injured muscle in MVA studies",
"distinguishing_feature": "Whiplash: history of acceleration-deceleration mechanism; splenius capitis present in 94% of frontal impacts; multiple anterior and posterior muscles injured simultaneously. Recovery requires inactivation of TrPs in BOTH posterior muscles (splenius capitis, semispinalis capitis) AND anterior muscles (SCM, pectoralis minor). Focusing only on posterior muscles is a common treatment error.",
"action": "Examine all anterior and posterior neck muscles. Baker\u2019s study: splenius capitis and semispinalis capitis are the most commonly active TrPs following MVA; however, anterior muscle involvement (SCM, pectoralis minor) is the most commonly overlooked. Neurological screen required before manual treatment."
},
{
"id": "bd-8",
"condition": "TMJ Internal Derangement / Bruxism",
"confidence": "common",
"mimics": "Facial, temple, and preauricular pain overlapping with SCM sternal division and masseter TrP patterns",
"distinguishing_feature": "TMJ derangement: click or crepitus on jaw opening, mandibular deviation on opening. SCM and masseter TrPs activated by forward head posture and parafunctional habits may drive TMJ symptoms as satellite patterns. SCM is a key TrP that activates masseter, temporalis, and other masticatory muscles as satellites.",
"action": "Treat SCM TrPs first \u2014 satellite resolution in masseter and temporalis often follows. Full TMJ screening examination if joint symptoms persist after SCM inactivation. See Pain:TMJ_Screening_Examination."
}
]
}

<gallery>
Example.jpg|Caption1
Example.jpg|Caption2
</gallery>

Muscle:Abdominal Wall/Belch Button

2026-04-19T06:59:37Z

Yatreyu: Created page with "The '''belch button''' is an uncommon but clinically important trigger point (TrP) that has not been consistently localised to a specific named muscle. It is a dorsal TrP that may lie in the posterior fringe of the external oblique, or it may be a fascial TrP in the '''lumbodorsal fascia''', or it may represent an attachment TrP of the transversus abdominis where it attaches to the thoracolumbar fascia at the a..."

The '''belch button''' is an uncommon but clinically important trigger point (TrP) that has not been consistently localised to a specific named muscle. It is a dorsal TrP that may lie in the posterior fringe of the [[Muscle:External_Oblique|external oblique]], or it may be a fascial TrP in the '''lumbodorsal fascia''', or it may represent an attachment TrP of the [[Muscle:Transversus_Abdominis|transversus abdominis]] where it attaches to the thoracolumbar fascia at the angle of the twelfth rib. It is included as a separate page because its clinical presentation — spontaneous, involuntary belching and projectile vomiting — is highly distinctive and may not be recognised as myofascial in origin, and because it represents a '''serious postoperative complication risk'''.

==Location==

The belch button is found on the left or right side, usually '''at or just below the angle of the twelfth rib''', in the most posterior abdominal wall musculature or in the connective tissue of this region.

'''Key physical finding:''' When located by palpation, a rib is palpable beneath the examining finger. This is the defining anatomical landmark for identifying the correct location.

It has not been consistently localised to a single muscle and may represent:
* A TrP in the '''posterior fringe of the external oblique''' at the level of its most lateral and posterior fibres
* A '''fascial TrP in the lumbodorsal fascia'''
* An attachment TrP of the '''transversus abdominis''' at its posterior attachment to the thoracolumbar fascia near the twelfth rib angle

==Somatovisceral Effects==

Unlike most abdominal TrPs, the belch button does not primarily produce a referred pain pattern felt by the patient as pain. Instead, its principal effect is '''somatovisceral''':

* When sufficiently active, causes '''spontaneous, involuntary belching'''
* In severe cases, '''projectile vomiting'''
* The patient is likely to complain of a "stomach problem" with much belching of gas

'''Supporting clinical observations:'''
* Gutstein reported 7 patients who responded with belching following injection of "fibrositic spots" (interpreted as TrPs) in the abdominal musculature; a few patients belched in response to pressure applied to tender abdominal spots
* Alvarez reported that some patients belched every time the physician touched a trigger area in the back
* When the TrP is pressed and the patient belches as pressure is applied, this constitutes a positive provocation test and confirms the diagnosis

==Clinical Significance — Postoperative Risk==

Projectile vomiting from an active belch button TrP represents a '''serious postoperative complication'''. A patient harbouring an active belch button TrP who undergoes abdominal or other surgery may experience projectile vomiting in the recovery period — carrying risks of aspiration and wound dehiscence. This presentation is deeply embarrassing to clinical staff who are unaware of the myofascial cause.

'''Preoperative screening:''' Patients with a history of excessive belching, particularly if provocation of the TrP at the twelfth rib angle elicits belching, should have the TrP inactivated before surgery.

==Activation and Perpetuating Factors==

* Visceral disease affecting the upper gastrointestinal tract
* Acute trauma to the posterior lateral abdominal wall
* Chronic occupational strain in a sustained twisted posture
* The same perpetuating factors as for the [[Muscle:External_Oblique|external oblique]] and [[Muscle:Transversus_Abdominis|transversus abdominis]]
* Satellite TrP activation from key TrPs in the paraspinal muscles at the T12 level or in the quadratus lumborum

==Clinical Examination==

# Locate the angle of the twelfth rib on the affected side — the most posterior and inferior bony landmark of the rib cage on that side
# Apply flat palpation just at or below this angle, pressing into the posterior abdominal wall musculature or lumbodorsal fascia
# '''A rib must be palpable beneath the examining finger''' — this confirms correct location
# Apply steady, increasing pressure
# '''If the patient belches as pressure is applied, the diagnosis is confirmed'''

The TrP may be on either the left or right side and may be bilateral. Bilateral involvement may give rise to bilateral belching provocation.

==Differential Diagnosis==

{| class="wikitable"
! Condition !! Distinguishing features
|-
| Gastro-oesophageal reflux disease (GORD) || Acid reflux belching associated with heartburn, regurgitation, worse when supine or postprandially; pH monitoring and endoscopy differentiate; TrP pressure at the twelfth rib angle reproduces and may provoke belching in the myofascial case
|-
| Aerophagia / functional belching || Habitual air swallowing, often associated with anxiety; belch button TrP is a specific, localised, palpable point — distinguished by direct provocation during palpation
|-
| Small intestinal bacterial overgrowth (SIBO) || Excessive gas and belching with bloating; hydrogen breath test differentiates; may coexist with TrPs
|-
| Hiatal hernia || Upper GI series and endoscopy; hiatal hernia and belch button TrP may coexist — the TrP is a myofascial component of the symptom complex that can be independently treated
|-
| Postoperative nausea and vomiting || In the postoperative context, projectile vomiting from a belch button TrP may be misattributed to ileus or obstruction — distinguished by absence of abdominal distension and characteristic TrP location; responds to TrP pressure release
|}

==Treatment==

===Trigger Point Injection===

* Inject precisely at the TrP located at the angle of the twelfth rib, with a rib palpable beneath the finger
* Approach from the lateral or slightly posterior direction
* '''Do not direct the needle medially or deeply toward the intercostal space''' — the pleura lies medially and deeply in this region

===Pressure Release===

* Sustained firm pressure over the TrP at the twelfth rib angle
* Patient may self-administer while lying comfortably on the contralateral side
* '''Successful inactivation:''' belching should diminish or cease with sustained pressure and should not recur spontaneously

===Corrective Actions===

* Identify and treat any key TrPs in the paraspinal muscles at the T12 level and in the quadratus lumborum
* Abdominal (diaphragmatic) breathing
* Eliminate upper GI perpetuating factors (treat GORD if present; dietary modification as appropriate)
* Address any sustained twisted postural habits

==Satellite Trigger Points==

* [[Muscle:External_Oblique|External oblique]] — most likely muscle of origin; satellite relationship with paraspinal key TrPs
* [[Muscle:Transversus_Abdominis|Transversus abdominis]] — possible alternative muscle of origin via lumbodorsal fascia attachment
* Quadratus lumborum — likely key TrP at the T12–L1 level activating the belch button as satellite
* Paraspinal muscles T12 — key TrPs

==Related Pages==

* [[Muscle:External_Oblique|Muscle:External Oblique]] — Most likely muscle of origin
* [[Muscle:Transversus_Abdominis|Muscle:Transversus Abdominis]] — Alternative muscle of origin; lumbodorsal fascia attachment
* [[Pain:Belching|Pain:Belching]] — Diagnostic algorithm including the belch button TrP
* [[Pain:Epigastric|Pain:Epigastric]] — Belch button as myofascial source of upper GI symptoms

==References==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 2: The Lower Extremities''. Baltimore: Williams & Wilkins; 1992. Chapter 49.
* Alvarez WC. ''An Introduction to Gastro-enterology''. Ed. 3. Paul B. Hoeber, New York, 1940 (p. 144).
* Gutstein RR. The role of abdominal fibrositis in functional indigestion. ''Miss Val Med J'' 66:114–24, 1944.

[[Category:Muscle]]
[[Category:Vol2_Ch49]]
[[Category:Torso]]
[[Category:Fascial_TrP]]

Muscle:Pyramidalis

2026-04-19T06:58:38Z

Yatreyu: Created page with "'''Pyramidalis''' is a small, variable, triangular muscle located within the anterior rectus sheath, just above the symphysis pubis. Its TrP refers pain close to the midline between the symphysis pubis and the umbilicus. The pyramidalis is absent bilaterally in approximately 17–20% of individuals and is absent unilaterally more commonly than bilaterally — its presence should never be assumed. It lies entirely within the anterior rectus sheath, and its TrP is closely..."

'''Pyramidalis''' is a small, variable, triangular muscle located within the anterior rectus sheath, just above the symphysis pubis. Its TrP refers pain close to the midline between the symphysis pubis and the umbilicus. The pyramidalis is absent bilaterally in approximately 17–20% of individuals and is absent unilaterally more commonly than bilaterally — its presence should never be assumed. It lies entirely within the anterior rectus sheath, and its TrP is closely associated with lower rectus abdominis TrPs and with pelvic floor dysfunction.

==Anatomy==

The pyramidalis attaches '''below''' to the anterior surface of the ramus of the pubis and '''above''' to the linea alba approximately mid-way between the symphysis pubis and the umbilicus. It lies entirely within the anterior rectus sheath.

'''Primary action:''' Tensing the linea alba.

'''Innervation:''' Branch of the twelfth thoracic nerve.

'''Frequency of absence:'''
* Absent bilaterally in approximately 3.3% of Japanese subjects
* Absent bilaterally in approximately 25% of Scottish subjects
* Absent bilaterally in 15–20% of bodies in general population studies
* In a study of 430 sides, absent in 17.7%
* Unilateral absence is more common than bilateral absence

==Referred Pain Pattern==

The pyramidalis refers pain close to the '''midline between the symphysis pubis and the umbilicus''' — a central lower abdominal pain that may be confused with pain from the lower rectus abdominis or from pelvic visceral structures. The pain is strictly midline and suprapubic, which helps distinguish it from lower rectus abdominis TrP pain which tends to be slightly more lateral and located above the pubic attachment.

==Somatovisceral Effects==

A TrP just above the pubis may cause spasm of the detrusor and urinary sphincter muscles. Given the pyramidalis' intimate anatomical relationship with the lower rectus abdominis TrPs and pelvic floor, these somatovisceral effects are difficult to attribute to the pyramidalis in isolation — they are more reliably attributed to the closely associated lower rectus abdominis.

==Activation and Perpetuating Factors==

===Surgery===
Lower abdominal and pelvic surgery (caesarean section, hysterectomy, prostatectomy, appendicectomy) places the pyramidalis directly in the surgical field; TrP activation from retractor stretch and ischaemia is probable.

===Pelvic Visceral Disease===
The same viscerosomatic cycle as for other abdominal muscles — pelvic visceral disease activates TrPs which may persist after the primary disease has resolved.

===Related TrP Activity===
TrP activity in the lower rectus abdominis — the pyramidalis' primary functional neighbour — likely activates pyramidalis TrPs as satellites.

==Clinical Examination==

The pyramidalis lies within the anterior rectus sheath just above the symphysis pubis and is palpated by flat palpation in the suprapubic region:

* The examiner presses down '''against the upper edge of the pubic arch''' — not on the flat anterior surface of the pubis
* These TrPs feel like small buttons or short bands at the region of attachment
* The midline location distinguishes pyramidalis TrPs from the slightly more lateral lower rectus abdominis attachment TrPs

The [[Muscle:External_Oblique#Abdominal_Tension_Test|Abdominal Tension Test]] is performed as described for all abdominal muscles.

'''Note for injection:''' Distinguish the pyramidalis TrP from the lower rectus abdominis attachment TrP by the strictly midline location and by the direction of needle injection — for the pyramidalis the needle is directed cephalad (away from the bone, toward the umbilicus), whereas for the lower rectus abdominis pubic attachment the needle is directed toward the pubic bone.

==Differential Diagnosis==

{| class="wikitable"
! Condition !! Distinguishing features
|-
| Lower rectus abdominis TrP || Pyramidalis TrP is strictly midline and suprapubic; lower rectus TrPs are located above the pubic attachment and slightly more lateral; both may coexist and are treated separately
|-
| Symphysis pubis dysfunction || Symphysis pubis pain reproduced by compression or distraction; pyramidalis TrP pain reproduced by direct TrP palpation; imaging may show symphysis changes in true symphysis pubis dysfunction
|-
| Cystitis / urethritis || Midline suprapubic TrP pain mimics bladder pain; urinalysis and culture differentiate
|-
| Gynaecological pathology || Central lower abdominal TrP pain may mimic dysmenorrhoea, endometriosis, or ovarian pathology — gynaecological examination and pelvic ultrasound differentiate
|-
| Detrusor instability || TrP just above the pubis may cause detrusor and sphincter spasm; distinguishing from primary detrusor instability may require urodynamic studies; TrP inactivation resolves symptoms in the myofascial case
|}

==Treatment==

===Trigger Point Injection===

* The needle is directed '''cephalad, close to the midline, away from the pubis''' — rather than toward the bone
* This direction injects the pyramidalis muscle and distinguishes it from the lower rectus abdominis pubic attachment injection, where the needle is directed toward the pubic bone
* Injection proceeds as for other suprapubic attachment TrPs

===Corrective Actions===

* Direct pressure release on the suprapubic TrP, pressing toward the pubic arch; self-administration is valuable between menstrual periods
* Pelvic-tilt exercise (see [[Muscle:Rectus_Abdominis#Corrective_Actions_and_Exercises|Muscle:Rectus Abdominis — Corrective Actions]])
* Abdominal (diaphragmatic) breathing
* Sit-back/Abdominal-curl exercise sequence when pain-free (see [[Muscle:Rectus_Abdominis#Corrective_Actions_and_Exercises|Muscle:Rectus Abdominis — Corrective Actions]])

==Satellite Trigger Points==

* [[Muscle:Rectus_Abdominis|Rectus abdominis]] — primary functional partner; lower rectus TrPs commonly co-active
* Pelvic floor muscles — close anatomical relationship; commonly co-active in pelvic pain syndromes
* [[Muscle:Internal_Oblique|Internal oblique]] — conjoined tendon relationship at pubic arch

==Related Pages==

* [[Pain:Suprapubic|Pain:Suprapubic]] — Pyramidalis and lower rectus as myofascial sources
* [[Pain:Dysmenorrhoea|Pain:Dysmenorrhoea]] — Lower rectus and pyramidalis TrPs
* [[Muscle:Rectus_Abdominis|Muscle:Rectus Abdominis]] — Primary functional partner
* [[Muscle:Internal_Oblique|Muscle:Internal Oblique]] — Conjoined tendon partner at pubic arch

==References==

* Travell JG, Simons DG. ''Myofascial Pain and Dysfunction: The Trigger Point Manual, Volume 2: The Lower Extremities''. Baltimore: Williams & Wilkins; 1992. Chapter 49.
* Beaton LE, Anson BJ. The pyramidalis muscle: its occurrence and size in American white and negroes. ''Am J Phys Anthropol'' 25:261–269, 1939.
* Anson BJ, Beaton LE, McVay CB. The pyramidalis muscle. ''Anatomical Record'' 72:405–411, 1938.

[[Category:Muscle]]
[[Category:Vol2_Ch49]]
[[Category:Torso]]